Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,40411,0.157218692233552,0.0026684193474322,0.151988590312585,0.162448794154519,0
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,40332,0.157671585443154,0.00263557498250464,0.152505858477445,0.162837312408863,0
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PON3,Serum paraoxonase/lactonase 3,40422,0.0769848927415768,0.00247533403513492,0.0721332380327124,0.0818365474504413,3.1519298019743e-206
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRAP1,Proline-rich acidic protein 1,37998,-0.112665854543747,0.00381252419845024,-0.120138401972709,-0.105193307114784,4.71578591433752e-186
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOM,Apolipoprotein M,40372,0.0712565514113827,0.002426435438532,0.06650073795186,0.0760123648709054,1.18046847995776e-184
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFPI,Tissue factor pathway inhibitor,40309,0.0805735852065147,0.00282599595246553,0.0750346331396823,0.0861125372733471,2.05064568655237e-174
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRSS8,Prostasin,40293,-0.104176365245806,0.00366013966247298,-0.111350238984253,-0.0970024915073585,7.86243907300575e-174
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOF,Apolipoprotein F,37987,0.0599432208455675,0.00219147050096516,0.0556479386636758,0.0642385030274592,2.19403096643237e-160
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGSF9,Protein turtle homolog A,37990,-0.186325088199468,0.00722707077104639,-0.200490146910719,-0.172160029488217,3.94963662458548e-143
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40500,0.271764887821312,0.0106988142096396,0.250795211970418,0.292734563672206,1.37449621085502e-139
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GCG,Pro-glucagon,39980,-0.287707931677145,0.0113493951612864,-0.309952746193266,-0.265463117161024,5.91413049269895e-139
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MFGE8,Lactadherin,40332,-0.0967229483910652,0.00384275164026829,-0.104254741605991,-0.0891911551761394,4.07986941811236e-137
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADIPOQ,Adiponectin,38013,0.142736000433298,0.00606895039273141,0.130840857663545,0.154631143203052,6.44634921026784e-120
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA14,Carbonic anhydrase 14,40489,0.0739545703323354,0.00315725122695728,0.0677663579274992,0.0801427827371717,2.45042232383519e-119
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,40359,0.0570045954332235,0.00246165976497705,0.0521797422938685,0.0618294485725785,1.04502472127398e-116
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OXT,Oxytocin-neurophysin 1,40471,-0.275125265066692,0.0120967944341658,-0.298834982157657,-0.251415547975727,1.00467608445397e-112
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PYY,Peptide YY,37562,-0.195103172457408,0.00869089243004986,-0.212137321620306,-0.17806902329451,1.4947676599252e-109
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NTRK3,NT-3 growth factor receptor,40471,0.0447771788559293,0.00199849048687397,0.0408601375016563,0.0486942202102023,1.66462342591216e-109
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MET,Hepatocyte growth factor receptor,40375,0.0410344166499499,0.0018438186242859,0.0374205321463496,0.0446483011535503,4.44726022468626e-108
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,40228,-0.0586189632597504,0.00268943139132448,-0.0638902487867464,-0.0533476777327544,8.55527941285906e-104
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INHBC,Inhibin beta C chain,40332,-0.082367563228372,0.00390146223667876,-0.0900144292122624,-0.0747206972444816,1.34886340669306e-97
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37900,-0.105461255640706,0.00499369478288106,-0.115248897415153,-0.0956736138662595,2.02073826752567e-97
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOC1,Apolipoprotein C-I,37981,0.0699070163522389,0.00332497879439109,0.0633900579152324,0.0764239747892455,1.35442199273945e-96
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL17RB,Interleukin-17 receptor B,40126,0.102045480275752,0.00490458901007011,0.0924324858160144,0.111658474735489,7.26856387777077e-95
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MCAM,Cell surface glycoprotein MUC18,40403,0.0638457111879269,0.00312679173212771,0.0577171993929565,0.0699742229828972,1.67406036555687e-91
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS4,Galectin-4,40357,-0.0986430935071498,0.00485444747607192,-0.108157810560251,-0.0891283764540489,1.20418520365329e-90
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37942,0.0685375704021785,0.00337282927947496,0.0619268250144076,0.0751483157899494,1.90289257170229e-90
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHA1,Ephrin type-A receptor 1,40400,-0.0610166223400905,0.00313883682253605,-0.0671687425122612,-0.0548645021679199,3.29405700336625e-83
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,40372,0.0512934484100179,0.00273288832364646,0.0459369872956708,0.0566499095243649,9.35074204790696e-78
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37790,-0.0446229151207994,0.00238542333688746,-0.0492983448610989,-0.0399474853805,4.23670283876484e-77
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,37671,0.0522934092747833,0.00280383885407788,0.0467978851207907,0.057788933428776,1.19786677216611e-76
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RTN4R,Reticulon-4 receptor,40489,-0.0566241337274271,0.00311528726983568,-0.062730096776305,-0.0505181706785491,4.31050290697884e-73
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLUL1,Clusterin-like protein 1,40338,0.0756334858229047,0.00419340566139676,0.0674144107265671,0.0838525609192424,5.28097098351122e-72
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMPRSS15,Enteropeptidase,40305,-0.151342835615022,0.00848345041537306,-0.167970398429153,-0.13471527280089,1.6955614727636e-70
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LPL,Lipoprotein lipase,40359,0.0753781598761155,0.00422565250452392,0.0670958809672486,0.0836604387849824,1.73288556109092e-70
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40228,-0.0525110465258708,0.00295079945473028,-0.0582946134571421,-0.0467274795945994,3.70915045254762e-70
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD300LG,CMRF35-like molecule 9,40332,0.0609503168221696,0.00346797858733402,0.0541530787909949,0.0677475548533443,1.69801174800513e-68
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSB,Cathepsin B,40353,0.0874139892887283,0.00498005097903981,0.0776530893698103,0.0971748892076464,2.49347657482059e-68
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C9,Complement component C9,37987,0.077760652410871,0.00448820295718747,0.0689637746147836,0.0865575302069584,1.57267658654101e-66
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC39A5,Zinc transporter ZIP5,40341,-0.0853739523400829,0.00493384351260368,-0.0950442856247861,-0.0757036190553796,1.79194138488994e-66
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40341,0.0609753529039501,0.00357501236853762,0.0539683286616164,0.0679823771462839,1.18649851575501e-64
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOD,Apolipoprotein D,37345,0.0700123033097887,0.00410816498910196,0.0619602999311488,0.0780643066884285,2.02246952679576e-64
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLTP,Phospholipid transfer protein,40461,0.0533569288043588,0.00315275627033194,0.0471775265145082,0.0595363310942094,1.07310803565439e-63
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40516,0.0399727068232643,0.00239036289446062,0.0352875955501215,0.0446578180964071,3.02163608729738e-62
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHBG,Sex hormone-binding globulin,37987,0.0831392684016148,0.0049746522461872,0.0733889499990879,0.0928895868041417,4.4427414095634e-62
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCAM2,Neural cell adhesion molecule 2,40332,0.0412119746327753,0.00248943997769212,0.0363326722764987,0.0460912769890518,4.80580738606736e-61
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACAN,Aggrecan core protein,40224,0.0433374887384273,0.00262268740749128,0.0381970214197444,0.0484779560571102,7.98634552393759e-61
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASPN,Asporin,37990,0.041170398086363,0.00251678945008767,0.0362374907641911,0.0461033054085348,1.41370907947775e-59
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPP4,Dipeptidyl peptidase 4,40068,0.0450709115026408,0.00275918343865733,0.0396629119628725,0.0504789110424092,1.73519728032291e-59
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGAV,Integrin alpha-V,40489,0.0246229511709994,0.00151063647455033,0.0216621036808808,0.0275837986611181,2.96828185921187e-59
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,40044,-0.0837366756150497,0.00514530528535404,-0.0938214739743436,-0.0736518772557558,4.60058878948968e-59
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OMD,Osteomodulin,40422,0.0659224448538124,0.00409429577801635,0.0578976251289003,0.0739472645787244,7.15971963933115e-58
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPY,Pro-neuropeptide Y,40489,-0.0983292809968809,0.00614539078642617,-0.110374246938276,-0.0862843150554856,3.51172526728686e-57
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPR37,Prosaposin receptor GPR37,40042,-0.099250555260047,0.00620435075964049,-0.111411082748942,-0.0870900277711516,3.82411985743613e-57
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF21,Fibroblast growth factor 21,40453,-0.172578734467868,0.0107914222056369,-0.193729921990917,-0.15142754694482,4.01174191669156e-57
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPM,Carboxypeptidase M,40415,-0.0504419846650865,0.00315716759765998,-0.0566300331565001,-0.0442539361736729,5.11576030282984e-57
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UMOD,Uromodulin,40502,0.0796723361956965,0.00500072900742391,0.0698709073411456,0.0894737650502474,1.03158707078627e-56
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40536,0.0507244100909897,0.0031945273907875,0.0444631364050462,0.0569856837769332,2.39118998578334e-56
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REN,Renin,40359,-0.103683627413762,0.00659172561781739,-0.116603409624684,-0.0907638452028398,2.48521012617547e-55
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EGFR,Epidermal growth factor receptor,40536,0.0237153698122679,0.00151275341294076,0.020750373122904,0.0266803665016318,5.5491068770582e-55
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,40379,0.0452910055641551,0.00292998367619092,0.0395482375588209,0.0510337735694893,1.63627721884997e-53
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37969,0.0682502428955436,0.00446906776724494,0.0594908700717435,0.0770096157193437,3.21935618297217e-52
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,40313,-0.0774312654311064,0.00508499185557012,-0.0873978494680239,-0.067464681394189,5.42356755637709e-52
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,40305,-0.0766491737677755,0.00506237531415271,-0.0865714293835149,-0.0667269181520362,1.99009485636291e-51
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,40319,0.0340704968796713,0.00227151763513575,0.0296183223148052,0.0385226714445373,1.65376835460951e-50
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMOT,Angiomotin,37671,-0.0576675959808449,0.00385569328547243,-0.0652247548203709,-0.050110437141319,3.63263665271993e-50
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40411,-0.0479368636637769,0.00320985852094679,-0.0542281863648326,-0.0416455409627212,4.29854549188138e-50
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL16,C-C motif chemokine 16,40536,-0.0728401329243552,0.00488837619975778,-0.0824213502758805,-0.06325891557283,7.01864122643965e-50
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTN1,Contactin-1,40536,0.037965122417527,0.00255412114137847,0.0329590449804252,0.0429711998546288,1.200855761199e-49
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F9,Coagulation factor IX,40372,-0.024605300915875,0.00166158917138206,-0.0278620156917838,-0.0213485861399662,2.75517150194669e-49
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACY1,Aminoacylase-1,40359,-0.0811493017808964,0.00549639215025812,-0.0919222303954023,-0.0703763731663905,5.2675475814514e-49
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FURIN,Furin,40411,-0.045892139330587,0.0031086332237953,-0.0519850604492258,-0.0397992182119482,5.35580592598156e-49
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MVK,Mevalonate kinase,40044,-0.103855198602303,0.00708975788684803,-0.117751124060525,-0.0899592731440812,2.87670795364096e-48
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NHLRC3,NHL repeat-containing protein 3,37370,-0.0431810126294497,0.00295141917743686,-0.048965794217226,-0.0373962310416735,4.34354192127785e-48
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCAM1,Neural cell adhesion molecule 1,40403,0.0372347049386532,0.00255807356226786,0.0322208807566082,0.0422485291206982,1.08538979019841e-47
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40379,0.0461333935215389,0.00317505990941634,0.0399102760990829,0.0523565109439949,1.57691117150425e-47
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40497,0.0851168606385721,0.00587225206080201,0.0736072465994001,0.096626474677744,2.60271871171092e-47
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCAN,Brevican core protein,40228,0.0446830757012808,0.0031037410830672,0.0385997431784691,0.0507664082240925,1.07549925108512e-46
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTN5,Contactin-5,40367,0.0488858498627709,0.00342569284847062,0.0421714918797685,0.0556002078457733,6.42925857854275e-46
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CKB,Creatine kinase B-type,37998,0.0793550631845789,0.00558697302482232,0.0684045960559271,0.0903055303132306,1.84472235124708e-45
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMBP,Protein AMBP,40470,-0.0262271586802957,0.00184805272163977,-0.0298493420147097,-0.0226049753458818,1.94203735513239e-45
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB1,Integrin beta-1,40333,0.028556379114668,0.00202666285797353,0.0245841199130399,0.0325286383162962,8.10712635023472e-45
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40516,-0.0496590339785887,0.0035297814866196,-0.0565774056923631,-0.0427406622648143,1.09119176021085e-44
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGA11,Integrin alpha-11,40341,0.0441981637958382,0.00315307330097347,0.0380181401259302,0.0503781874657462,2.23957921067734e-44
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,40063,-0.0546293753406941,0.00391741651182739,-0.0623075117038758,-0.0469512389775124,6.16870223758408e-44
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37671,-0.0484116844524861,0.00347971529472539,-0.0552319264301478,-0.0415914424748243,1.08006307398643e-43
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGRP,Agouti-related protein,40516,-0.068375959925085,0.00494052262004329,-0.0780593842603698,-0.0586925355898001,2.59785441354199e-43
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,40355,0.0464519808362514,0.00336058688687694,0.0398652305379726,0.0530387311345302,3.31121480046492e-43
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCAN,Neurocan core protein,40471,0.0468680905316815,0.00344812200833683,0.0401097713953413,0.0536264096680217,7.5857105154336e-42
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DSG2,Desmoglein-2,40332,0.0338163414956209,0.00248832746862223,0.0289392196571213,0.0386934633341205,7.86829848424151e-42
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIP,Gastric inhibitory polypeptide,37628,-0.064988564812316,0.00478310023452617,-0.0743634412719873,-0.0556136883526447,9.1246919135482e-42
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GHR,Growth hormone receptor,37671,-0.0361507968244116,0.00266739108638186,-0.04137888335372,-0.0309227102951032,1.44371977083684e-41
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GDF15,Growth/differentiation factor 15,40536,-0.0532395530577149,0.003983932509397,-0.061048060776133,-0.0454310453392968,1.62363587575684e-40
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPOCK1,Testican-1,40228,0.0310655222952642,0.00233098311161193,0.0264967953965049,0.0356342491940236,2.65554800008596e-40
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEZ6L2,Seizure 6-like protein 2,40305,0.0293446483465201,0.00220203387565263,0.0250286619502409,0.0336606347427992,2.68669017801767e-40
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CES1,Liver carboxylesterase 1,40352,-0.093571202164453,0.00703508897751515,-0.107359976560383,-0.0797824277685233,3.76089490893471e-40
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40536,0.0386133949898429,0.00292570143038071,0.0328790201862967,0.0443477697933891,1.44679923948864e-39
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB6A,Ras-related protein Rab-6A,40341,0.0583056422496108,0.00442398998904811,0.0496346218710765,0.0669766626281451,1.85665937083036e-39
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD209,CD209 antigen,40382,0.0472140394239761,0.00359938904643118,0.040159236892971,0.0542688419549812,4.18317116622653e-39
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,POSTN,Periostin,37998,0.0459206181747812,0.00350030269644529,0.0390600248897484,0.052781211459814,4.43264297282059e-39
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSN,Gelsolin,37928,0.0231098109152096,0.00176514079708836,0.0196501349529164,0.0265694868775028,6.29305200906355e-39
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,40424,-0.055778779035942,0.00426758672925217,-0.0641432490252763,-0.0474143090466078,7.69819546504683e-39
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPY,Pancreatic prohormone,40337,-0.121882593358587,0.00933024756379679,-0.140169878583629,-0.103595308133545,8.47093288758165e-39
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40411,-0.0413000613812419,0.00319346712389594,-0.0475592569440779,-0.0350408658184058,4.57301106822456e-38
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSO,Cathepsin O,40516,-0.0358682894767051,0.00278509494471544,-0.0413270755683474,-0.0304095033850628,9.12770801393061e-38
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UPB1,Beta-ureidopropionase,37990,-0.108205442287587,0.00844459769030558,-0.124756853760586,-0.0916540308145884,2.26913736301526e-37
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPE,Carboxypeptidase E,40360,0.0452279171224065,0.00353669041007134,0.0382960039186666,0.0521598303261463,2.91181743970639e-37
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,40411,0.0502988476687075,0.00393384975899372,0.0425885021410798,0.0580091931963352,2.9844348620771e-37
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,40411,0.0285469163770866,0.0022545249302393,0.0241280475138175,0.0329657852403556,1.43863094761298e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,40357,0.044836156745532,0.00354139398168202,0.0378950245414352,0.0517772889496287,1.4673416448921e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSD,Cathepsin D,39243,-0.0466989942012614,0.0036979235453519,-0.0539469243501511,-0.0394510640523716,2.26730271878089e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLA,Alpha-galactosidase A,37642,-0.0420563642752303,0.00335045072632589,-0.048623247698829,-0.0354894808516315,6.18340571615148e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AFM,Afamin,38013,-0.0216369229222437,0.00172714092129734,-0.0250221191279865,-0.0182517267165009,8.32337975933691e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AREG,Amphiregulin,40305,-0.0574490270956332,0.00459326481645983,-0.0664518261358945,-0.0484462280553719,1.00495015590383e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HGF,Hepatocyte growth factor,40516,-0.0395640121549944,0.00317161476710144,-0.0457803770985133,-0.0333476472114756,1.50457235830583e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40305,0.0485002806805693,0.00388914557002076,0.0408775553633286,0.05612300599781,1.58387369477945e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GDF2,Growth/differentiation factor 2,40359,0.0411922292778748,0.00331041015439474,0.0347038253752611,0.0476806331804885,2.22379621862768e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPA2,Carboxypeptidase A2,40398,-0.0736128553280941,0.00593304180020624,-0.0852416172564983,-0.0619840933996898,3.46867454023308e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,40305,0.0299699315402537,0.00245092690885332,0.0251661147989012,0.0347737482816062,3.14202257340675e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40516,-0.0421285909232423,0.0034590200817918,-0.0489082702835542,-0.0353489115629304,5.65454884264201e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL32,Interleukin-32,40341,0.0477350076495291,0.00395833704303407,0.0399766670451824,0.0554933482538759,2.420888222705e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38484,0.0350144584124941,0.00290644309370478,0.0293178299488327,0.0407110868761555,2.92829571508781e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MUC13,Mucin-13,39961,-0.0560579285057349,0.00465510137363417,-0.0651819271980578,-0.0469339298134119,2.99775627928954e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACE2,Angiotensin-converting enzyme 2,40042,-0.0546007014824695,0.00453415530966195,-0.0634876458894069,-0.0457137570755321,2.99853248859507e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLAU,Urokinase-type plasminogen activator,40332,0.0327190030639683,0.00271895952984268,0.0273898423854766,0.03804816374246,3.29803982477139e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFHR4,Complement factor H-related protein 4,37973,0.0819118444478404,0.00681726191712378,0.0685500110902778,0.095273677805403,4.34942949232493e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRP1,Neuropilin-1,40424,0.0312228315780844,0.00261000591328734,0.0261072199880412,0.0363384431681276,7.69316010608122e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,40044,0.0422878733572401,0.00357888866586952,0.0352732515721358,0.0493024951423443,4.42626640604495e-32
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37998,-0.0335248168608793,0.00285942243560101,-0.0391292848346573,-0.0279203488871014,1.35930061718166e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NECTIN2,Nectin-2,40330,-0.031373218059319,0.00267999429586276,-0.03662600687921,-0.026120429239428,1.59176685366073e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHI3L1,Chitinase-3-like protein 1,40054,-0.0804045821160737,0.00689566974235963,-0.0939200948110985,-0.0668890694210488,2.74598083967362e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCG2,Secretogranin-2,40392,-0.0347469292900243,0.00298531704060654,-0.0405981506896132,-0.0288957078904355,3.47910883230045e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",40305,-0.0829250547974187,0.00713993723024633,-0.0969193317687015,-0.0689307778261359,4.65952692467882e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSTA1,Glutathione S-transferase A1,40333,-0.0886338707671325,0.00766283027568232,-0.10365301810747,-0.0736147234267952,8.07411509611509e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRP2,Neuropilin-2,40332,0.0311131447431796,0.0026904842943351,0.0258397955262828,0.0363864939600764,8.31901548625354e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37990,0.0352897935341887,0.00305988893199704,0.0292924112274745,0.0412871758409029,1.25009341346451e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HJV,Hemojuvelin,37959,-0.0491903682543413,0.00426776176449715,-0.0575551813127557,-0.0408255551959269,1.35587005221901e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BMP10,Bone morphogenetic protein 10,37671,0.0305176368396727,0.00266394217280119,0.0252963101809823,0.035738963498363,3.05384957315559e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTSS1,Protein MTSS 1,37901,-0.117204783297329,0.0102439900186159,-0.137283003733816,-0.0971265628608413,3.58378480329605e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40305,-0.0439933057265791,0.00384878945272921,-0.0515369330539283,-0.0364496783992298,3.86694137482083e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL15,C-C motif chemokine 15,40536,-0.0470687274112462,0.00412569595164427,-0.055155091476469,-0.0389823633460235,4.93735798239258e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ROBO2,Roundabout homolog 2,40471,0.024582758001447,0.00215732703971979,0.0203543970035963,0.0288111189992978,5.77571879749433e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM20A,Pseudokinase FAM20A,37990,-0.029840205537618,0.00261874910342287,-0.0349729537803268,-0.0247074572949092,6.07421732210811e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFF3,Trefoil factor 3,40309,-0.0563446086127578,0.00495579453516837,-0.0660579659016878,-0.0466312513238278,7.74629945906547e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40536,0.0255299716525735,0.00224591286080519,0.0211279824453953,0.0299319608597517,7.90713996884137e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGF,Placenta growth factor,40516,-0.0275212825721258,0.00243447799248305,-0.0322928594373926,-0.022749705706859,1.60612585612132e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C4BPB,C4b-binding protein beta chain,40411,0.0431060331670096,0.00382293936170756,0.0356130720180628,0.0505989943159564,2.23621532162836e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASET2,Ribonuclease T2,40465,-0.0275178776433296,0.00244845623778245,-0.0323168518693832,-0.022718903417276,3.37924483595368e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSZ,Cathepsin Z,40345,-0.0323778140498778,0.00288094741638386,-0.0380244709859902,-0.0267311571137655,3.39589011438187e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F11R,Junctional adhesion molecule A,40332,-0.0587486384889686,0.00522832691364179,-0.0689961592397065,-0.0485011177382307,3.47360985914232e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39839,-0.105541783427168,0.00940355379696647,-0.123972748869223,-0.0871108179851142,4.05190103901377e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BOC,Brother of CDO,40042,0.0246125542066032,0.00219347718098643,0.0203133389318698,0.0289117694813366,4.16771929869377e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39980,-0.0607362563106871,0.00542352481748233,-0.0713663649529525,-0.0501061476684217,5.34595422607359e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39961,-0.0568052300777758,0.00507551715009861,-0.0667532436919691,-0.0468572164635825,5.7614997797021e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37598,0.0333564107322417,0.00299068616109144,0.0274946658565025,0.039218155607981,9.2736711789483e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39980,-0.0635158533264382,0.00570443277895896,-0.0746965415731978,-0.0523351650796787,1.09472242881307e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40042,-0.0868942415231218,0.00780444431541477,-0.102190952381335,-0.0715975306649088,1.10010844222473e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,40309,-0.0402218406084293,0.00361323802893746,-0.0473037871451467,-0.0331398940717119,1.12199646838988e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GUSB,Beta-glucuronidase,40419,-0.0601629358150397,0.00541275040564234,-0.0707719266100987,-0.0495539450199807,1.34971630103198e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,40305,-0.0810644871214285,0.00733422141512673,-0.0954395610950769,-0.0666894131477801,2.69244354964205e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANPEP,Aminopeptidase N,40370,0.0286652072053268,0.00262611524070045,0.023518021333554,0.0338123930770997,1.21863936875423e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF23,Fibroblast growth factor 23,40469,-0.0622684150643264,0.0057161357830527,-0.0734720411991097,-0.0510647889295431,1.54712891700586e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40403,0.0378552397094822,0.00348315572400354,0.0310282544904353,0.0446822249285291,2.04108426717763e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSTA3,Glutathione S-transferase A3,39980,-0.0760346453286416,0.00700520017025895,-0.0897648376623492,-0.0623044529949341,2.3923518387737e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTBS,Di-N-acetylchitobiase,37819,-0.0272245353237565,0.00251215590542005,-0.0321483608983798,-0.0223007097491332,2.97999782772721e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD248,Endosialin,37998,0.0401438915573498,0.00371077976546636,0.0328707632170357,0.0474170198976639,3.64550554228648e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MEP1A,Meprin A subunit alpha,37901,-0.0680797224373147,0.00633911384336416,-0.0805043855703084,-0.0556550593043209,8.51570874378766e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NXPH3,Neurexophilin-3,37598,0.0301722009901608,0.0028133888586532,0.0246579588272005,0.035686443153121,1.00735492712269e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IDS,Iduronate 2-sulfatase,40516,0.00860022459716692,0.000802659763490391,0.00702701146072575,0.0101734377336081,1.06932254867918e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFASC,Neurofascin,40516,-0.0269355491041415,0.00252619483877411,-0.0318868909881388,-0.0219842072201442,1.86891404304962e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FETUB,Fetuin-B,40372,-0.0334283245370451,0.00313509070693064,-0.0395731023226291,-0.027283546751461,1.86964237464236e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APLP1,Amyloid-like protein 1,40359,0.051438239324041,0.00482679507286205,0.0419777209812314,0.0608987576668506,1.98990285945788e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LDLR,Low-density lipoprotein receptor,40356,-0.0517205033080309,0.00485392555906277,-0.0612341974037939,-0.0422068092122678,2.02022363010742e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,40408,0.0239441175898089,0.00224726485857976,0.0195394784669926,0.0283487567126253,2.03216614482886e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CGA,Glycoprotein hormones alpha chain,40332,0.0883571038236429,0.00830227793890079,0.0720846390633973,0.104629568583888,2.31850166628282e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBP5,Retinol-binding protein 5,40305,-0.0544411760004088,0.0051321883497032,-0.0645002651658271,-0.0443820868349906,3.35613484616797e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40332,-0.028316998255227,0.00267973721222305,-0.0335692831911842,-0.0230647133192698,5.16647159438308e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,40443,-0.0301915315807746,0.00285973644637811,-0.0357966150156757,-0.0245864481458735,5.71270449655224e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAST,Gastrin,37942,-0.127285950216113,0.0120685573565709,-0.150940322634992,-0.103631577797234,6.62148095222021e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INSL5,Insulin-like peptide INSL5,37901,-0.0913181598026443,0.00870741337216434,-0.108384690012086,-0.0742516295932022,1.23942757693931e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VEGFD,Vascular endothelial growth factor D,40483,0.0323688889259248,0.00309142931792203,0.0263096874627976,0.038428090389052,1.42672057980785e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK14,Kallikrein-14,40489,0.0445805752524589,0.00426076306953581,0.0362294796361687,0.0529316708687491,1.54298776973676e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37562,-0.0545873667508458,0.00522114632601703,-0.0648208135498392,-0.0443539199518525,1.74970487209733e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUSD2,Sushi domain-containing protein 2,40332,0.0276768844704159,0.00265399194731913,0.0224750602536704,0.0328787086871614,2.22178516919057e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,40391,-0.0223498483817923,0.00214706990998229,-0.0265581054053576,-0.018141591358227,2.70558889910056e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,40341,-0.0591000565280141,0.00568064500027457,-0.0702341207285523,-0.0479659923274759,2.87319121821279e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40403,0.0427961225611405,0.00411446655148346,0.0347317681202329,0.0508604770020481,2.94324922375929e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40471,-0.0334904979447553,0.00322123159876126,-0.0398041118783274,-0.0271768840111832,3.08470509839844e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NME3,Nucleoside diphosphate kinase 3,40379,0.023073309966378,0.00222427086521702,0.0187137390705526,0.0274328808622033,3.93854548124422e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,40341,-0.0509468988749918,0.00492601460222613,-0.060601887495355,-0.0412919102546286,5.43687818398622e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPB1,Carboxypeptidase B,40536,-0.0535754105734385,0.00522591376150279,-0.063818201545984,-0.0433326196008931,1.3815733002458e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40453,-0.0398039457460541,0.00388651981166971,-0.0474215245769267,-0.0321863669151815,1.53774009893606e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",40310,-0.0645796101759787,0.00631291297582164,-0.0769529196085891,-0.0522063007433683,1.73800656997348e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37920,-0.0787354345059511,0.00770934869999331,-0.093845757957938,-0.0636251110539642,2.12864272975906e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPO,Erythropoietin,40341,-0.0738683626301145,0.00726903773723828,-0.0881156765951015,-0.0596210486651275,3.47203244767326e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40160,-0.043256981360797,0.00426117110949353,-0.0516088767354043,-0.0349050859861897,3.87646745758484e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40044,-0.0411525504940938,0.00407423320274724,-0.0491380475714784,-0.0331670534167092,6.4984381703723e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WIF1,Wnt inhibitory factor 1,40489,0.0320541222732451,0.00317479280044171,0.0258315283843793,0.0382767161621108,6.7520326303291e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OSM,Oncostatin-M,40268,-0.0678124064480043,0.00672934289942589,-0.081001918530879,-0.0546228943651295,8.22903928792108e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SELE,E-selectin,40536,-0.0466663732363777,0.00463621243208997,-0.0557533496032741,-0.0375793968694814,9.21748494001524e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTH,Parathyroid hormone,37572,-0.0735698746908257,0.00731591391598727,-0.0879090659661608,-0.0592306834154907,1.05181083927532e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD200,OX-2 membrane glycoprotein,40341,0.0242675973123288,0.00241517616233614,0.01953385203415,0.0290013425905077,1.10375433752989e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,40332,0.0490459519623162,0.0048854005944776,0.0394705667971401,0.0586213371274923,1.20466101406384e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40042,-0.0507026848614546,0.00505708966272743,-0.0606145806004004,-0.0407907891225089,1.38039325724613e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNXB,Tenascin-X,40332,0.0236503437331846,0.00236203447005434,0.0190207561718781,0.0282799312944911,1.57410948359744e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,40332,0.0376945454218755,0.00376471865776393,0.0303156968526582,0.0450733939910928,1.5760220174145e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,L1CAM,Neural cell adhesion molecule L1,40411,0.0262689058013325,0.0026262545408592,0.0211214469012484,0.0314163647014165,1.7438955168729e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCLY,Selenocysteine lyase,40434,-0.0440663896156334,0.0044132755979265,-0.0527164097875693,-0.0354163694436975,2.07715609750133e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37628,0.0589421345807531,0.00590170246825374,0.0473747977429757,0.0705094714185304,2.09795609276317e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COMP,Cartilage oligomeric matrix protein,40198,0.0312688000837324,0.00314350204089819,0.025107536083572,0.0374300640838929,3.03983680969477e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPTX1,Neuronal pentraxin-1,40332,0.0362137356322358,0.00365773371727249,0.0290445775463817,0.0433828937180899,4.82564822543992e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPARCL1,SPARC-like protein 1,40346,0.025375211331563,0.00256434980089317,0.0203490857218124,0.0304013369413136,5.08162039496291e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40305,-0.0281185879845491,0.0028556154537716,-0.0337155942739414,-0.0225215816951567,8.22937315170892e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,40489,-0.0337391917403866,0.0034302462547442,-0.0404624743996852,-0.027015909081088,9.15639802922489e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,40141,-0.134906671633615,0.0137397486626194,-0.161836579012349,-0.107976764254881,1.08723997875995e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37942,-0.0783582667975694,0.00799843446826712,-0.0940351983553729,-0.0626813352397658,1.38352089218041e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD4,T-cell surface glycoprotein CD4,40309,-0.0276868801732169,0.00283042272457142,-0.0332345087133769,-0.0221392516330569,1.55962689494204e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,40359,-0.026999355326663,0.00277206592927159,-0.0324326045480354,-0.0215661061052907,2.35515569754553e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VCAN,Versican core protein,40471,0.0269978666948419,0.00278890587718552,0.0215316111755583,0.0324641222141255,4.19724548765406e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40228,-0.0493256976591075,0.00510076739701155,-0.0593232017572501,-0.0393281935609648,4.64460838968787e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERMAP,Erythroid membrane-associated protein,37598,-0.0401594644267559,0.00416403392904152,-0.0483209709276773,-0.0319979579258346,6.1386414512754e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,POF1B,Protein POF1B,37598,-0.0415154506239603,0.00431174881257695,-0.0499664782966111,-0.0330644229513095,7.16004777495043e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHAD,Chondroadherin,37671,0.0480670530393843,0.0049972239071805,0.0382724941813105,0.057861611897458,7.85583002222638e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MME,Neprilysin,40305,-0.0723756226638058,0.00755115241718165,-0.0871758814014819,-0.0575753639261298,1.06164638788178e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPIND1,Heparin cofactor 2,37981,-0.024330444664846,0.00254123561567356,-0.0293112664715662,-0.0193496228581258,1.20143894362835e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM3B,Protein FAM3B,40305,-0.0320602596848946,0.00335458794729368,-0.0386352520615902,-0.025485267308199,1.38405942801986e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,40359,0.0228528141025284,0.0023939708296405,0.018160631276433,0.0275449969286238,1.53972989354873e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,40332,-0.0382914095387862,0.00401964878097951,-0.0461699211495061,-0.0304128979280664,1.86418023966496e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37998,0.0291274353021044,0.00305890870171573,0.0231319742467416,0.0351228963574672,1.9791930667583e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSME2,Proteasome activator complex subunit 2,40152,-0.0327284817507732,0.00343989594435075,-0.0394706778017007,-0.0259862856998457,2.08768135564824e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37628,-0.0505010341395781,0.00530956045464216,-0.0609077726306767,-0.0400942956484795,2.20435097318719e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TF,Serotransferrin,38013,-0.0192549909507094,0.00202743326211414,-0.0232287601444531,-0.0152812217569657,2.51097454913859e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LEPR,Leptin receptor,40359,0.0269914726324136,0.00284714626441047,0.0214110659541691,0.0325718793106582,2.88862239186472e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40228,-0.0329607071240767,0.00348233469223751,-0.0397860831208622,-0.0261353311272912,3.33781557741609e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH1,Cadherin-1,39806,-0.035131142767274,0.00372652796590672,-0.0424351375804511,-0.0278271479540968,4.79613363007364e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGR3,Anterior gradient protein 3,39963,-0.0518279618518654,0.00551377950695927,-0.0626349696855055,-0.0410209540182252,6.21920996383955e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,40422,-0.0247870577564652,0.00264334322551642,-0.0299680104784774,-0.0196061050344531,7.66676570138602e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40359,-0.0294350562617776,0.00314406572416983,-0.0355974250811505,-0.0232726874424047,8.84012534677519e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TTR,Transthyretin,37871,-0.0221967405875035,0.00237095288538025,-0.0268438082428488,-0.0175496729321582,9.05599549831192e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37998,0.0183807433953762,0.00196453749185506,0.0145302499113402,0.0222312368794121,9.53974375396535e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37998,0.0223342143236744,0.00240183972331744,0.0176266084659722,0.0270418201813766,1.63485315941187e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A14,Protein S100-A14,37959,-0.0463823545772677,0.00499532243328413,-0.0561731865465046,-0.0365915226080308,1.85762006863623e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,40228,-0.0515012616493634,0.00555729618548614,-0.0623935621729163,-0.0406089611258106,2.15031328007467e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC3B,Tetranectin,37681,0.0181573308663169,0.00196041992117366,0.0143149078208165,0.0219997539118172,2.31264360149887e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTN4,Contactin-4,40332,0.0208562099892091,0.0022546597011476,0.0164370769749598,0.0252753430034584,2.51853825626943e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LBR,Delta(14)-sterol reductase LBR,40471,-0.0561980462129514,0.00607786532131672,-0.0681106622427322,-0.0442854301831706,2.60952394966866e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40379,-0.0254829725081681,0.0027609303980665,-0.0308943960883784,-0.0200715489279577,3.04395364260163e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37959,0.0227934134121515,0.00247694650654912,0.0179385982593152,0.0276482285649878,4.01410931409376e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYOC,Myocilin,40332,0.0390691643490809,0.00425274918010093,0.0307337759560831,0.0474045527420788,4.53732589180376e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,40341,-0.0556592564551214,0.00606917842914663,-0.0675548461762488,-0.0437636667339939,5.25941069426103e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOMO1,Nodal modulator 1,40332,-0.0200201223223041,0.00219318274792419,-0.0243187605082355,-0.0157214841363727,7.77631287781891e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FST,Follistatin,40396,0.0438109914532199,0.00482576731436491,0.0343524875170647,0.0532694953893752,1.22661982102426e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MENT,Protein MENT,37671,0.0182652235225121,0.00201429245701389,0.0143172103067649,0.0222132367382594,1.38348170309546e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",40042,-0.0767741316072604,0.00852734885536869,-0.093487735363783,-0.0600605278507378,2.43949162762309e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFA,Protransforming growth factor alpha,40341,-0.0399527100276014,0.00445036913655486,-0.0486754335352489,-0.0312299865199539,3.07761128013631e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP1,"Fatty acid-binding protein, liver",40357,-0.0774365205835493,0.00863186475229338,-0.0943549754980443,-0.0605180656690543,3.26008713300412e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VEGFA,Vascular endothelial growth factor A,40456,-0.0488549757032824,0.00545110612708657,-0.0595391437123721,-0.0381708076941927,3.52143010174597e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,40305,-0.0870242041350828,0.00973245234763458,-0.106099810736447,-0.067948597533719,4.24977836102153e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40332,0.0200048568400575,0.00223749770765015,0.0156193613330632,0.0243903523470518,4.28457460083262e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD2AP,CD2-associated protein,40359,-0.0530013691134862,0.00593386581408327,-0.0646317461090894,-0.041370992117883,4.6333311803203e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37990,-0.0601228134318778,0.00673573475510922,-0.0733248535518919,-0.0469207733118637,4.98082218017851e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37987,0.0214883321794337,0.00240871923573443,0.0167672424773942,0.0262094218814731,5.20436218899083e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL21,C-C motif chemokine 21,40422,-0.0349686963144958,0.00394848105757838,-0.0427077191873494,-0.0272296734416422,9.1318154890516e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AOC3,Membrane primary amine oxidase,40403,0.0250230072462226,0.00282635977296996,0.0194833420912014,0.0305626724012437,9.36388134980724e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40377,0.0185562808227699,0.00209637885263251,0.0144473782716101,0.0226651833739296,9.52142145802193e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FSHB,Follitropin subunit beta,37628,0.0574623721269787,0.00649526535577782,0.0447316520296542,0.0701930922243032,1.01408618431007e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OCLN,Occludin,37959,-0.0356775987686772,0.00404660039236511,-0.0436089355377128,-0.0277462619996416,1.32170673224622e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VASN,Vasorin,40116,0.0224902567807452,0.00255249614970938,0.0174873643273148,0.0274931492341755,1.36749366841266e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BPIFB1,BPI fold-containing family B member 1,40261,0.0503489518831104,0.00572159481428652,0.0391346260471088,0.061563277719112,1.50998600025275e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLSTN2,Calsyntenin-2,40516,0.0319170239454347,0.00362780916171699,0.0248065179884694,0.0390275299024,1.53372708118578e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHRDL1,Chordin-like protein 1,40396,0.02494237793873,0.00283526407406759,0.0193852603535575,0.0304994955239025,1.54411800494847e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39980,-0.0293550038605153,0.00333685058336291,-0.0358952310039066,-0.022814776717124,1.54779267205395e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMPRSS5,Transmembrane protease serine 5,40159,0.0309044721251075,0.00351492288125479,0.0240152232778482,0.0377937209723669,1.61406338451815e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,37598,-0.0991825663567143,0.0112827717875781,-0.121296799060367,-0.0770683336530612,1.67034948741202e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IDUA,Alpha-L-iduronidase,40489,-0.0368208337993217,0.00419223449134368,-0.0450376134023553,-0.0286040541962881,1.74846692450868e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40516,0.023730554978397,0.00270187370234506,0.0184348825218007,0.0290262274349933,1.74981753929233e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37901,0.0238358158778715,0.00271463439192004,0.0185151324697082,0.0291564992860348,1.82222121541214e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEZ6L,Seizure 6-like protein,40411,0.0223493370905913,0.00254929825053994,0.017352712519533,0.0273459616616496,2.01954612282417e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,40396,0.0370780539646633,0.00423873316551395,0.028770136960256,0.0453859709690707,2.39736889133421e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,40332,0.0348561434506197,0.00399697057774085,0.0270220811182476,0.0426902057829918,3.03634708814269e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,40341,0.0278485991011024,0.00319553144433065,0.0215853574702143,0.0341118407319905,3.19448769771177e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,40305,-0.0545133658383504,0.00626912453425923,-0.0668008499254985,-0.0422258817512023,3.78568734997413e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM3C,Protein FAM3C,40330,-0.0239470799212764,0.00275670939906586,-0.0293502303434454,-0.0185439294991073,4.0847982033657e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37628,0.0165144679007107,0.00190593790119455,0.0127788296143694,0.020250106187052,5.0482013589802e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,40305,0.0503696067086532,0.00585406768144795,0.0388956340530152,0.0618435793642911,8.39557225145821e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,40305,-0.0472449384737446,0.00551283750702496,-0.0580500999875135,-0.0364397769599757,1.12916781533428e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD27,CD27 antigen,40411,-0.0323735711665522,0.00377817963897223,-0.0397788032589378,-0.0249683390741667,1.14247684012649e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADM,Pro-adrenomedullin,40489,-0.0212277207724063,0.00249872153389394,-0.0261252149788384,-0.0163302265659742,2.14303022096848e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFAP,Glial fibrillary acidic protein,39959,0.0368574830442948,0.0043513884996887,0.0283287615849049,0.0453862045036846,2.66526443149644e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MBL2,Mannose-binding protein C,37810,0.0839240713897554,0.00992606375379005,0.0644689864323269,0.103379156347184,3.08020021467088e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFNA4,Ephrin-A4,40203,-0.0231381803510299,0.00273728212451658,-0.0285032533150824,-0.0177731073869774,3.08557189852319e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL18R1,Interleukin-18 receptor 1,40516,-0.0255439761979674,0.00302272704417763,-0.0314685212045555,-0.0196194311913792,3.14261034449875e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,40359,-0.0329169042340643,0.00390684827494835,-0.0405743268529631,-0.0252594816151656,3.89798452665255e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSME1,Proteasome activator complex subunit 1,40216,-0.0294516872913234,0.00350072851231594,-0.0363131151754627,-0.0225902594071842,4.33501713980621e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFI,Complement factor I,38013,-0.0157045019651232,0.00186721921205514,-0.0193642516207513,-0.0120447523094951,4.48214365072745e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F7,Coagulation factor VII,40376,-0.0232705797586623,0.0027794325782994,-0.0287182676121291,-0.0178228919051955,6.10925129340254e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASE6,Ribonuclease K6,37917,-0.0229677889164183,0.00274280711566104,-0.0283436908631139,-0.0175918869697226,6.12473901859821e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SBSN,Suprabasin,37977,0.0260272166436279,0.0031175511730153,0.0199168163445179,0.0321376169427379,7.57307071734017e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAP,Prolyl endopeptidase FAP,40536,0.0209657270409995,0.00251307917572385,0.0160400918565807,0.0258913622254182,7.84793923810108e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPA1,Carboxypeptidase A1,40536,-0.044304281171576,0.00531329597780843,-0.0547183412880805,-0.0338902210550715,8.13490298408117e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,A1BG,Alpha-1B-glycoprotein,38013,-0.0135626316438859,0.00162870211502454,-0.016754887789334,-0.0103703754984379,9.0603288215729e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,40359,0.0135141343788969,0.00162422385656171,0.010330655620036,0.0166976131377579,9.47371755396984e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPT2,Angiopoietin-2,40489,-0.0298054105500683,0.00359539693025673,-0.0368523885333715,-0.0227584325667651,1.22257142331936e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD58,Lymphocyte function-associated antigen 3,40335,0.0135854047857667,0.00164368485129601,0.0103637824772265,0.0168070270943069,1.50363320906968e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD5,T-cell surface glycoprotein CD5,40470,-0.025523886436067,0.00309904826195295,-0.0315980210294948,-0.0194497518426393,1.91620356508229e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HEPH,Hephaestin,37990,-0.0191507803008913,0.00232841796804806,-0.0237144795182655,-0.0145870810835171,2.13218687537508e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100P,Protein S100-P,40042,-0.0409145457448674,0.00498779999770027,-0.0506906337403599,-0.0311384577493748,2.52764025762731e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40489,-0.0250546165966147,0.00305833206526192,-0.0310489474445281,-0.0190602857487013,2.75557110476588e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRTAC1,Cartilage acidic protein 1,40536,0.022259627762649,0.00272188630564339,0.016924730603588,0.0275945249217101,3.0991144925116e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37815,-0.0235169960313482,0.00287540224180169,-0.0291527844252795,-0.0178812076374169,3.12712551832474e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,40359,-0.0266707015899788,0.00328025233707821,-0.0330999961706521,-0.0202414070093055,4.58073381316917e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40536,-0.0370353562050837,0.00455678379415862,-0.0459666524416346,-0.0281040599685328,4.69775233514908e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALCA,Calcitonin,40192,-0.0415197316940452,0.00510926914096257,-0.0515338992103318,-0.0315055641777585,4.75018404492694e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOA1,Apolipoprotein A-I,38013,0.0208424085160132,0.00256617354604457,0.0158127083657659,0.0258721086662606,4.98020779610307e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,40411,-0.0161087898217175,0.00198374688995523,-0.0199969337260298,-0.0122206459174053,4.98387170171761e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRP,Gastrin-releasing peptide,37628,-0.041064184410254,0.00505662804842847,-0.0509751753851738,-0.0311531934353342,5.03807112116968e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37942,-0.0566689298267199,0.00699171085705424,-0.0703726831065462,-0.0429651765468936,5.71855663989814e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL12B,Interleukin-12 subunit beta,40516,-0.0408352283359816,0.00504208091482042,-0.0507177069290296,-0.0309527497429335,5.94158708595656e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRSS2,Trypsin-2,40403,-0.037760830347571,0.00466310829170944,-0.0469005225993215,-0.0286211380958205,5.99837574862236e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,40411,0.0179835400677049,0.00222282647023271,0.0136268001860488,0.022340279949361,6.3718612787602e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTGR1,Prostaglandin reductase 1,37990,-0.0594112091786972,0.00737889326294956,-0.0738738399740783,-0.0449485783833161,8.85683462719403e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40042,-0.0365867561293549,0.0045460504850862,-0.0454970150801239,-0.027676497178586,9.01602222509961e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OPTC,Opticin,40305,0.03369603015165,0.00419377903384129,0.0254762232453211,0.0419158370579789,1.00311766972643e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,40332,-0.0203684440405725,0.00253593972562368,-0.0253388859027949,-0.0153980021783501,1.0265179672304e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP1,Interstitial collagenase,39757,-0.0695111856795494,0.00866498295057419,-0.0864945522626748,-0.052527819096424,1.11457079379403e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37671,-0.0360951436234104,0.0045117789231806,-0.0449382303128444,-0.0272520569339764,1.34509614161909e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KHK,Ketohexokinase,37628,-0.047894393910941,0.00598672018925312,-0.0596283654818771,-0.0361604223400048,1.34649497461884e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNGR2,Interferon gamma receptor 2,40228,-0.0383533053054501,0.00479777442585837,-0.0477569431801325,-0.0289496674307677,1.39642910793306e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,40341,-0.0205261218594501,0.00256850316887582,-0.0255603880704467,-0.0154918556484535,1.42432833903819e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNR,Tenascin-R,40228,0.0312810544582525,0.0039473864116036,0.0235441770915094,0.0390179318249955,2.44283458597447e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,40192,-0.0538125135172238,0.00680736240023309,-0.0671549438216806,-0.0404700832127669,2.854867450777e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40411,0.0329266025706765,0.00416539315340261,0.0247624319900074,0.0410907731513456,2.85797776249349e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCN1,Ficolin-1,37967,-0.04138767705184,0.00524630041891809,-0.0516704258729194,-0.0311049282307605,3.28112351244752e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ESM1,Endothelial cell-specific molecule 1,40357,0.0247501007857204,0.00314704319945853,0.0185818961147817,0.0309183054566591,3.94059527428223e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL12A_IL12B,Interleukin-12,40305,-0.0573028364769127,0.00728917623055375,-0.0715896218887981,-0.0430160510650274,4.04293099905981e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GZMA,Granzyme A,40516,-0.0256340275911366,0.00327014374222747,-0.0320435093259025,-0.0192245458563708,4.83215524780639e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REG1B,Lithostathine-1-beta,40536,-0.0405003460439454,0.00519566905158428,-0.0506838573850506,-0.0303168347028402,6.83197385939379e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37562,-0.0492686283152396,0.00632688695714211,-0.0616693267512382,-0.0368679298792411,7.36494428251719e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPPC,C-type natriuretic peptide,40341,-0.0311624236852264,0.00400373625087099,-0.0390097467369335,-0.0233151006335192,7.4966242904016e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SELL,L-selectin,38013,0.0167786832016971,0.00215699006812142,0.0125509826681792,0.0210063837352151,7.85177106130261e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,40312,-0.0146634302453819,0.00188921839762685,-0.0183662983047305,-0.0109605621860332,8.89294944179712e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40332,-0.026139944314947,0.00336919066714364,-0.0327435580225485,-0.0195363306073454,9.11257295360935e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL1A1,Collagen alpha-1(I) chain,40536,0.0187377807317103,0.00241520749911086,0.014003974033453,0.0234715874299676,9.12545014353621e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEMA3F,Semaphorin-3F,40359,-0.0185985710411853,0.00240208768123674,-0.0233066628964093,-0.0138904791859613,1.03185626199568e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMN,Protein amnionless,40044,-0.0342613152404849,0.00442991780536931,-0.0429439541390087,-0.0255786763419611,1.10501594974889e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37900,-0.0364798931733286,0.00473993757858845,-0.0457701708273619,-0.0271896155192952,1.49822376454972e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REG4,Regenerating islet-derived protein 4,40379,-0.0347375180997727,0.00452168894302757,-0.0436000284281067,-0.0258750077714386,1.65163644986026e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,40341,-0.0269292077822571,0.00350540547688562,-0.0337998025169529,-0.0200586130475613,1.65476779820568e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,40341,-0.044194298760121,0.00575880180371784,-0.055481550295408,-0.032907047224834,1.76065639308882e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASE1,Ribonuclease pancreatic,37987,-0.0172528332339864,0.00224885976036684,-0.0216605983643054,-0.0128450681036674,1.81142476760468e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,40341,0.0242559422168614,0.00316617503794913,0.0180502391424811,0.0304616452912417,1.95156232468037e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RETN,Resistin,40283,-0.0294298634952483,0.0038505317517071,-0.0369769057285942,-0.0218828212619024,2.24235234710945e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,40234,-0.0209642994335133,0.00274739834975319,-0.0263492001990295,-0.015579398667997,2.46972886141348e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCN1,CCN family member 1,40280,-0.0550555366203308,0.00724216105597966,-0.0692501722900509,-0.0408609009506107,3.07694361222986e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICAM4,Intercellular adhesion molecule 4,40341,0.0372501202171387,0.00490673729243391,0.0276329151239683,0.0468673253103092,3.33418535016319e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39980,-0.0565594490412368,0.00745522783831643,-0.071171695604337,-0.0419472024781366,3.47127887070414e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40359,0.022211240628024,0.0029308789394828,0.0164667179066377,0.0279557633494103,3.69197898203727e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CX3CL1,Fractalkine,40228,0.0240593198789541,0.00317929987174074,0.0178278921303422,0.0302907476275659,4.01472996821524e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEL1L,Protein sel-1 homolog 1,37628,-0.0228425008631252,0.00302049432534741,-0.0287626697408062,-0.0169223319854443,4.21527341650765e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37628,0.0182416448521461,0.00241266334946925,0.0135128246871864,0.0229704650171058,4.27090680063566e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLAT,Tissue-type plasminogen activator,40490,-0.0343076220234084,0.00454971407317832,-0.0432250616068379,-0.0253901824399789,4.9276142438438e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40502,-0.0265277101661927,0.00351967065535619,-0.0334262646506908,-0.0196291556816946,5.06576105786938e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39865,-0.026491480217557,0.00351722923323886,-0.0333852495147052,-0.0195977109204089,5.27693186222296e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DKK3,Dickkopf-related protein 3,40536,0.0205956031030802,0.00273772441705961,0.0152296632456434,0.025961542960517,5.64044356889008e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40305,-0.030602276817404,0.00407547514990115,-0.0385902081112103,-0.0226143455235978,6.28017032682115e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL23,C-C motif chemokine 23,40422,-0.0285181643669697,0.00380562234376958,-0.0359771841607581,-0.0210591445731813,7.04654273740735e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,40422,-0.0188527070578705,0.00251603911160468,-0.0237841437166157,-0.0139212703991253,7.08316013087514e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CES3,Carboxylesterase 3,40305,-0.0476991333437873,0.00637803097970644,-0.0602000740640119,-0.0351981926235627,7.90091696979205e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40536,-0.0468271100748711,0.00627133773481319,-0.059118932035105,-0.0345352881146372,8.63447509044722e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LSP1,Lymphocyte-specific protein 1,40341,-0.0277061970709207,0.00371139002746728,-0.0349805215247566,-0.0204318726170849,8.74931497847309e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHISA5,Protein shisa-5,37998,-0.0171951117176391,0.00230907347906846,-0.0217208957366133,-0.012669327698665,1.01437720274655e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40357,-0.026570510939976,0.00356876557941078,-0.0335652914756211,-0.0195757304043309,1.01678817748511e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSTB,Cystatin-B,40097,-0.0287957315893808,0.00388592752469807,-0.036412149537789,-0.0211793136409726,1.3248999495273e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,40536,-0.0235929522194789,0.00318885243408191,-0.0298431029902794,-0.0173428014486783,1.44448262599549e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPTXR,Neuronal pentraxin receptor,40359,0.0233253717799179,0.00315735768183696,0.0171369507235175,0.0295137928363183,1.56888998160724e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40471,-0.0357379211660427,0.00484010675370453,-0.0452245304033036,-0.0262513119287818,1.61508504866015e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFBR2,TGF-beta receptor type-2,40411,-0.0216311595016188,0.00293212348670877,-0.027378121535568,-0.0158841974676696,1.69469550715665e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40471,0.0309547025896119,0.00420008164685047,0.022722542561785,0.0391868626174389,1.78917664137035e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37663,-0.0310542746206142,0.00422788071223366,-0.0393409208165922,-0.0227676284246362,2.17628732485471e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37628,-0.0206800877087768,0.00281881605533098,-0.0262049671772255,-0.015155208240328,2.32170993097564e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COMMD9,COMM domain-containing protein 9,37900,-0.026750981239925,0.00364858853835536,-0.0339022147751015,-0.0195997477047485,2.39927168694355e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EGLN1,Egl nine homolog 1,40341,-0.0361099389774771,0.00492956035311022,-0.0457718772695732,-0.0264480006853811,2.50018857528961e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP9,Matrix metalloproteinase-9,40312,-0.0415296347316268,0.00567415714383161,-0.0526509827335367,-0.0304082867297168,2.61632052557678e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,40405,-0.0345168320253509,0.00474266692572476,-0.0438124591997714,-0.0252212048509304,3.54747132898261e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39961,-0.0373978983060042,0.0051426964678227,-0.0474775833829367,-0.0273182132290717,3.7101245344657e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40332,-0.0178460041955045,0.00245702027532725,-0.0226617639351459,-0.013030244455863,3.95374183708743e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PXN,Paxillin,39961,-0.0349462201365686,0.00481158987483152,-0.0443769362912384,-0.0255155039818988,3.96811030477687e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXLNA,Alpha-taxilin,40228,-0.0601180641513899,0.00828017986496915,-0.0763472166867295,-0.0438889116160504,4.03717628718913e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTN2,Contactin-2,40489,0.0302169380094951,0.00416525688164499,0.0220530345214709,0.0383808414975193,4.21519633233015e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTN3,Contactin-3,40332,-0.0235076750084338,0.00324233320939262,-0.0298626480988433,-0.0171527019180243,4.35220726834148e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL3,C-C motif chemokine 3,40341,-0.0414011796846022,0.00571803155660779,-0.0526085215355535,-0.030193837833651,4.67644408932868e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS9,Galectin-9,40350,-0.0215457484161065,0.0029862275483043,-0.0273987544107829,-0.0156927424214301,5.63518844741117e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PVR,Poliovirus receptor,40471,-0.0246049215906634,0.00341186079494227,-0.0312921687487503,-0.0179176744325766,5.77765765209703e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,B2M,Beta-2-microglobulin,38013,-0.0212663355306555,0.00295383108668517,-0.0270558444605584,-0.0154768266007525,6.35785926330606e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL15,Interleukin-15,40341,-0.0219373755718495,0.00304917730874835,-0.0279137630969962,-0.0159609880467027,6.54778961653647e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPEP2,Dipeptidase 2,40305,0.0192071576618008,0.00267018456178661,0.013973595920699,0.0244407194029025,6.61226473005745e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37628,0.0242659022980961,0.00338020762049941,0.0176406953619173,0.030891109234275,7.40833717061801e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,40489,0.0385408313105777,0.00538190466557632,0.0279922981660481,0.0490893644551073,8.34527314787203e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,40305,-0.0584106993121936,0.00815815017715184,-0.0744006736594112,-0.042420724964976,8.43426370625457e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37900,-0.0381748888021476,0.00533173427127513,-0.0486250879738468,-0.0277246896304483,8.49041131384705e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FSTL3,Follistatin-related protein 3,40293,-0.0208004937770873,0.00290795342011192,-0.0265000824805067,-0.015100905073668,8.86379963862148e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HAO1,Hydroxyacid oxidase 1,40489,-0.0864994384748504,0.0120983873171685,-0.110212277616501,-0.0627865993332001,9.07405841811032e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLB1,Beta-galactosidase,40228,-0.0269123840634079,0.00379249488301179,-0.034345674034111,-0.0194790940927048,1.33670510878609e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BACH1,Transcription regulator protein BACH1,40341,-0.0477852259693931,0.00674388632755328,-0.0610032431713975,-0.0345672087673887,1.44142844854263e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASE4,Ribonuclease 4,37575,-0.017909737051941,0.00254272755993908,-0.0228934830694216,-0.0129259910344604,1.96794367936958e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F10,Coagulation factor X,37987,-0.0169853637692397,0.00241323575615769,-0.0217153058513087,-0.0122554216871706,2.03796316599737e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,40489,0.0400486396015271,0.00569265887460496,0.0288910282073014,0.0512062509957528,2.07112572820183e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GH1,Somatotropin,40330,0.114292481988685,0.0162702046508031,0.0824028808731106,0.146182083104259,2.23317602091366e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPCAM,Epithelial cell adhesion molecule,40358,-0.0651877884358209,0.00928103005009879,-0.0833786073340145,-0.0469969695376272,2.24713725388681e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TOP2B,DNA topoisomerase 2-beta,37598,-0.0514955118128423,0.00733841814126953,-0.0658788113697306,-0.037112212255954,2.37368856978859e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39961,-0.0174454042887364,0.00248698781364872,-0.0223199004034879,-0.0125709081739849,2.40019042946616e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,40280,-0.0166923866831031,0.00237989910615362,-0.0213569889311642,-0.012027784435042,2.41138567927782e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CST3,Cystatin-C,40372,-0.0182846004961747,0.00261065862681038,-0.023401491404723,-0.0131677095876263,2.59030238385189e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TREH,Trehalase,37998,-0.0483009528746801,0.0069083361722357,-0.0618412917722621,-0.0347606139770981,2.84315148838669e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37598,-0.0280592698873227,0.00401743352677856,-0.0359334395998087,-0.0201851001748368,2.99885221641011e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,40167,-0.0182414530889046,0.00261318555187334,-0.0233632967705764,-0.0131196094072329,3.05806532676862e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,40228,-0.0373031850611178,0.00534911599595568,-0.047787452413191,-0.0268189177090447,3.20943297018278e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,40451,-0.0276483693198434,0.00397557747305536,-0.0354405011670319,-0.0198562374726549,3.67367840992698e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37900,-0.0371974942493559,0.00534791076394745,-0.0476793993466929,-0.0267155891520189,3.67503394443843e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37990,-0.0420605815537414,0.00606033713141775,-0.0539388423313202,-0.0301823207761626,4.09062905215743e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37998,-0.0148606555264116,0.00214724402350706,-0.0190692538124855,-0.0106520572403378,4.69282990401272e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,40422,0.0132549166436091,0.00191574980251336,0.00950004703068293,0.0170097862565353,4.72394250182177e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLA2G15,Phospholipase A2 group XV,40411,-0.0165271637960887,0.00238980932299267,-0.0212111900691543,-0.0118431375230231,4.83282567172296e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANG,Angiogenin,40309,-0.0221352786519929,0.00320413833942091,-0.0284153897972578,-0.0158551675067279,5.09005357909175e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,40422,0.0181452244239662,0.00262734057894863,0.0129956368892269,0.0232948119587055,5.16188136120128e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37835,-0.0210629987939981,0.00306116371121647,-0.0270628796679824,-0.0150631179200139,6.22015095252956e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FEN1,Flap endonuclease 1,39980,-0.0394335544385136,0.00575559563478788,-0.0507145218826978,-0.0281525869943293,7.59103509278083e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40516,-0.0281261669362727,0.00410653140087968,-0.0361749684819969,-0.0200773653905486,7.69952313344755e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40305,-0.061835896092237,0.00903445789393254,-0.0795434335643448,-0.0441283586201292,7.95844640727909e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,40357,-0.0177980279537585,0.00260727580334404,-0.0229082885283129,-0.0126877673792042,9.02871704258244e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH17,Cadherin-17,40359,-0.0429239482786372,0.00629891837273685,-0.0552698282892014,-0.030578068268073,9.79912733989741e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNAP23,Synaptosomal-associated protein 23,40359,-0.0549922098890275,0.00807609790122491,-0.0708213617754283,-0.0391630580026266,1.016165553276e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GASK1A,Golgi-associated kinase 1A,37562,-0.0274737834159767,0.00403536703478333,-0.035383102804152,-0.0195644640278014,1.03095749835302e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39886,-0.0347451687544691,0.00510491871765114,-0.0447508094410653,-0.0247395280678728,1.03891882227562e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARSA,Arylsulfatase A,40332,-0.028126499417721,0.00413517707286765,-0.0362314464805416,-0.0200215523549004,1.07034459947442e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37959,-0.0361695784120732,0.0053257082779217,-0.0466079666367997,-0.0257311901873467,1.15610744784665e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40536,0.00977994394988867,0.00144346789481201,0.00695074687605713,0.0126091410237202,1.28445488773266e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCGN,Secretagogin,40044,-0.0276324112284886,0.00408979750297548,-0.0356484143343206,-0.0196164081226567,1.46445866460666e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37987,-0.0139579096624527,0.00206703844520774,-0.0180093050150599,-0.00990651430984555,1.51129827838539e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLIN3,Perilipin-3,40359,-0.0265886594330782,0.0039459152529986,-0.0343226533289554,-0.0188546655372009,1.65780545050727e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFF1,Trefoil factor 1,40261,-0.0485295019605566,0.00721644198955936,-0.0626737282600929,-0.0343852756610203,1.81794984951021e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,40284,0.0217708274643937,0.00323884616748309,0.0154226889761268,0.0281189659526605,1.8564329482125e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPEP1,Dipeptidase 1,40192,0.0317528237234527,0.00472562209438336,0.0224906044184613,0.0410150430284441,1.88877770796327e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,40009,-0.0322841607050855,0.00480982802904145,-0.0417114236420068,-0.0228568977681643,1.98443170686881e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,40332,-0.0214029295547101,0.00319602200337078,-0.0276671326813169,-0.0151387264281034,2.20269967710546e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPY30,Protein dpy-30 homolog,40414,-0.0367811053736427,0.00551403641656134,-0.0475886167501029,-0.0259735939971825,2.63399148291083e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37628,-0.0434499425114,0.0065152595941307,-0.0562198513158961,-0.0306800337069038,2.6791677177978e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40042,-0.0355077207252731,0.00534078407868072,-0.0459756575194874,-0.0250397839310589,3.06116848976124e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS3BP,Galectin-3-binding protein,38013,-0.0183208283539382,0.0027569166619608,-0.0237243850113814,-0.012917271696495,3.13934020022657e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSHB,Thyrotropin subunit beta,40359,0.0517927317189773,0.00779936393866477,0.0365059783991943,0.0670794850387602,3.22450616742039e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39957,0.0174206979344003,0.00262439735580914,0.0122768791170144,0.0225645167517862,3.28565084316381e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,XCL1,Lymphotactin,40489,-0.0347301857454096,0.0052349640715792,-0.0449907153257048,-0.0244696561651144,3.36539764441124e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BECN1,Beclin-1,37628,-0.0373429116471365,0.00566927486919127,-0.0484546903907514,-0.0262311329035216,4.66176396241238e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNC,Tenascin,40403,0.0289524482287156,0.00439874639200239,0.0203309053003909,0.0375739911570403,4.78708498424549e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37901,-0.0352890634113582,0.00536328131271904,-0.0458010947842875,-0.0247770320384289,4.88680221446548e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEMA4C,Semaphorin-4C,40305,0.0173359955480814,0.00263759332203757,0.0121663126368878,0.0225056784592751,5.0967430155865e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUCB2,Nucleobindin-2,40447,-0.0226378711884981,0.00344702582542194,-0.0293940418063251,-0.0158817005706711,5.27924554459195e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C8B,Complement component C8 beta chain,38013,0.0186208601166754,0.00284508920438658,0.0130444852760777,0.0241972349572731,6.16702136803751e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCTN1,Dynactin subunit 1,40489,-0.0398636807184269,0.00610104209897285,-0.0518217232324137,-0.0279056382044401,6.6003086637244e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,37563,-0.0299868652874943,0.00459365476621217,-0.0389904286292702,-0.0209833019457185,6.91593285114677e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,40471,-0.0582933892710137,0.00893622675182138,-0.0758083937045836,-0.0407783848374438,7.08536688398833e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,40303,-0.0293062665134392,0.00449299061838757,-0.0381125281254788,-0.0205000049013995,7.11606367091433e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPP1,Tripeptidyl-peptidase 1,40255,-0.0271147303381722,0.00415878492432261,-0.0352659487898446,-0.0189635118864999,7.25023701284101e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTRC,Chymotrypsin-C,40360,0.0380552950423237,0.00583829663525305,0.0266122336372277,0.0494983564474197,7.32874229347147e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,40357,0.0240981538585097,0.00369867967335585,0.0168487416987322,0.0313475660182872,7.4703754666169e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39980,-0.0367681685774206,0.00564989685442431,-0.0478419664120922,-0.0256943707427489,7.86166871471519e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MATN2,Matrilin-2,40379,0.0179317393759946,0.00275956343282425,0.0125229950476591,0.0233404837043301,8.37910870931293e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,40305,0.0198184638196148,0.00305454884084838,0.013831548091552,0.0258053795476776,8.94543506237774e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CST7,Cystatin-F,40376,-0.0554798737988108,0.00855342339632116,-0.0722445836556003,-0.0387151639420213,9.05763644335095e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PKD1,Polycystin-1,37990,0.0156072599185187,0.00240663003008501,0.0108902650595521,0.0203242547774853,9.17457257856682e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FMNL1,Formin-like protein 1,39961,-0.0361003866534181,0.00557535866305948,-0.0470280896330147,-0.0251726836738215,9.76692814231189e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37990,-0.0357948915499093,0.00554220249153163,-0.0466576084333113,-0.0249321746665073,1.09282934480795e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40489,0.0194601824952495,0.00301480947307434,0.0135511559280238,0.0253692090624752,1.11425888348841e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRIP2,Cysteine-rich protein 2,40228,-0.0216623782936883,0.00335839783590955,-0.028244838052071,-0.0150799185353056,1.14944218514754e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40042,0.0125387579968864,0.00194699254310174,0.00872265261240704,0.0163548633813659,1.22918083867764e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,37671,0.0160197163805979,0.00248780066825592,0.0111436270708163,0.0208958056903795,1.24169512618309e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37942,-0.0278617559408203,0.00432936192393736,-0.0363473053117375,-0.019376206569903,1.2719861514766e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCTN2,Dynactin subunit 2,40305,-0.0562169909055868,0.0087503189237522,-0.0733676159961411,-0.0390663658150325,1.36017046505547e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCARF2,Scavenger receptor class F member 2,40471,0.0177054749536571,0.00276182137793801,0.0122923050528986,0.0231186448544156,1.4880988555348e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNAP29,Synaptosomal-associated protein 29,40411,-0.0538611225464828,0.00846353498837809,-0.0704496511237039,-0.0372725939692618,2.02053029134922e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THBS2,Thrombospondin-2,40332,-0.0211561229268542,0.0033252237583883,-0.0276735614932952,-0.0146386843604131,2.04175946218332e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCN,Decorin,40042,0.013512307584561,0.0021243987805562,0.00934848597467084,0.0176761291944511,2.06657772511964e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40333,-0.0361639569819389,0.00568684901507708,-0.0473101810514899,-0.0250177329123878,2.08314067234859e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40414,-0.0343282799100032,0.00540531500303629,-0.0449226973159543,-0.023733862504052,2.19936439937307e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FUS,RNA-binding protein FUS,39960,-0.023231567802207,0.00366305681890365,-0.0304111591672581,-0.0160519764371558,2.32891837586492e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39980,-0.0370433858913357,0.0058455742835794,-0.0485007114871513,-0.0255860602955201,2.40745984185072e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH5,Cadherin-5,40536,0.0178931150469953,0.00282515665995954,0.0123558079934747,0.023430422100516,2.46032018101677e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ELOA,Elongin-A,40305,-0.0300447118368237,0.00474463415125337,-0.0393441947732803,-0.0207452289003671,2.479454965231e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,40350,-0.0290543427290777,0.00458907165291058,-0.0380489231687825,-0.020059762289373,2.49782546108793e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSF,Cathepsin F,40411,-0.0235397294915887,0.00371842671151556,-0.0308278458461592,-0.0162516131370182,2.5079462398673e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,40422,-0.0246572983103066,0.00389964021031771,-0.0323005931225294,-0.0170140034980839,2.63403258251387e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IMMT,MICOS complex subunit MIC60,37900,-0.0260904915020077,0.00412722754833534,-0.034179857496745,-0.0180011255072705,2.67124996300912e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40305,0.022657767021512,0.0035885806031078,0.0156241490394207,0.0296913850036033,2.79416704836876e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB6,Integrin beta-6,40044,0.0177470595093105,0.0028112548791597,0.0122369999461575,0.0232571190724635,2.81332618435563e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFH,Complement factor H,37301,-0.0136267601554228,0.00215882650766606,-0.0178580601104483,-0.00939546020039734,2.8429963555521e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLO1,Lactoylglutathione lyase,40042,-0.034693813270839,0.0055140800658292,-0.0455014101998642,-0.0238862163418137,3.22060064437754e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37942,0.0181165148124815,0.002886476015499,0.0124590218221034,0.0237740078028595,3.57236058504453e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37942,-0.0225518347663484,0.00359515085655301,-0.0295983304451923,-0.0155053390875045,3.65328092135923e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAT,Linker for activation of T-cells family member 1,40516,-0.0440176735274281,0.00702013723963505,-0.0577771425171128,-0.0302582045377434,3.69793226219711e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FYB1,FYN-binding protein 1,40311,-0.0529618511795948,0.00847391967983689,-0.0695707337520751,-0.0363529686071145,4.20987314833607e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40536,0.0168201921107013,0.0026944744084252,0.0115390222701879,0.0221013619512147,4.41495817110962e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,40305,-0.0494507472937085,0.00793231503744696,-0.0649980847671046,-0.0339034098203125,4.65918121774672e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPA33,Cell surface A33 antigen,40305,-0.079090043040342,0.0126870689995142,-0.10395669827939,-0.0542233878012942,4.6644658090861e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LPA,Apolipoprotein(a),37735,0.102069762889728,0.0164094848723897,0.0699071725398445,0.134232353239612,5.11519279882778e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL18,Interleukin-18,40292,-0.0273299192605709,0.00439970200725236,-0.0359533351947856,-0.0187065033263563,5.37006953461998e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ULBP2,UL16-binding protein 2,40228,-0.0215145986737389,0.00346898426990157,-0.028313807842746,-0.0147153895047318,5.71436166880922e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39980,0.0216494125063858,0.00349231231891265,0.014804480361317,0.0284943446514546,5.81989950313834e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37594,-0.0222827541947386,0.0035941760658495,-0.0293273392838036,-0.0152381691056736,5.82702775270487e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRSS53,Serine protease 53,37942,0.0211542750577759,0.00341665200129237,0.0144576371352429,0.027850912980309,6.13140625576534e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMG3,Proteasome assembly chaperone 3,40341,-0.0294523667224327,0.00476535415594952,-0.0387924608680938,-0.0201122725767716,6.54498833823591e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFHR5,Complement factor H-related protein 5,37785,0.0240488186323066,0.0038908469967149,0.0164227585187454,0.0316748787458678,6.56073967185027e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",40422,-0.0157113935551974,0.00254898569347871,-0.0207074055144156,-0.0107153815959791,7.27334653426231e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP5,Fatty acid-binding protein 5,40432,-0.0395297563227374,0.0064170177714462,-0.0521071111547719,-0.0269524014907028,7.4419125139823e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",37541,-0.0353486223756498,0.00574079461770572,-0.046600579826353,-0.0240966649249466,7.60909266375396e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL6,C-X-C motif chemokine 6,40516,-0.0444100155899363,0.00722162094275825,-0.0585643926377425,-0.0302556385421301,7.95210196212716e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD70,CD70 antigen,40341,0.0237793449684393,0.00386890844790175,0.0161962844105519,0.0313624055263268,8.12214240538801e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37942,-0.0435710651519662,0.00709088288336167,-0.0574691956033551,-0.0296729347005773,8.23899937117526e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37990,0.0186752272062041,0.00304120058582045,0.012714474057996,0.0246359803544122,8.44343785768802e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HEXIM1,Protein HEXIM1,40341,-0.0465799157555531,0.00759092402302203,-0.0614581268406763,-0.0317017046704299,8.6488576739653e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37959,-0.0351131745337006,0.00573362769524103,-0.0463510848163731,-0.0238752642510282,9.37408066766466e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDA,Cytidine deaminase,37970,-0.0259805077714335,0.00426215921715627,-0.0343343398370598,-0.0176266757058072,1.11979250419465e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37598,-0.0244248275060806,0.0040080105080058,-0.032280528101772,-0.0165691269103893,1.1320033267405e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37608,-0.0455961499832142,0.00748467209913237,-0.0602661072975136,-0.0309261926689147,1.14664751050078e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARF6,ADP-ribosylation factor 6,37901,-0.0593875263642865,0.00975588339865591,-0.0785090578256521,-0.0402659949029209,1.17913752138557e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37959,-0.0294300982606828,0.00483568897479559,-0.0389080486512821,-0.0199521478700834,1.18884524041525e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,40291,-0.0164129971293643,0.002698014949067,-0.0217011064295356,-0.011124887829193,1.20395977859706e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40332,-0.0237769136390435,0.00390992007830298,-0.0314403569925173,-0.0161134702855697,1.22036607388907e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,40044,-0.0394194669119451,0.00648353866066432,-0.0521272026868471,-0.026711731137043,1.23037436896086e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40379,-0.0187065788910208,0.00307868771671022,-0.0247408068157728,-0.0126723509662688,1.25901689205843e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BGN,Biglycan,39956,0.0685818705031624,0.0112881991761306,0.0464570001179465,0.0907067408883783,1.26462757916128e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGA,Fibrinogen alpha chain,37698,0.0173867596193601,0.00287216315593067,0.011757319833736,0.0230161994049842,1.45524342406392e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LEP,Leptin,40359,-0.0359336591196,0.00593675227722931,-0.0475696935829694,-0.0242976246562305,1.45592911092997e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PIGR,Polymeric immunoglobulin receptor,40154,-0.0197409052223741,0.00326474854162179,-0.0261398123639529,-0.0133419980807954,1.51206167013797e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNST,Consortin,40359,-0.0605326980271905,0.0100206477585228,-0.0801731676338952,-0.0408922284204857,1.56770633434326e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37562,-0.0416059401453614,0.006901570376268,-0.0551330180828467,-0.0280788622078762,1.69960858554559e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAXX,Protein PAXX,37671,-0.025396553002703,0.00421528332052427,-0.0336585083109305,-0.0171345976944754,1.73738685372505e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40384,0.0171393438638276,0.00284604077568547,0.0115611039434841,0.0227175837841711,1.75873832859079e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC51B,Organic solute transporter subunit beta,37562,-0.0447442836166901,0.00743068465208991,-0.0593084255347863,-0.0301801416985939,1.7736781381965e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37901,-0.0168623012201616,0.00280281730901723,-0.0223558231458354,-0.0113687792944879,1.83199221096179e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGAM,Integrin alpha-M,40332,0.0176707611327111,0.00294268347210989,0.0119031015273757,0.0234384207380464,1.95523790066046e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPON1,Spondin-1,40379,0.0183795300702313,0.00306106531876807,0.0123798420454459,0.0243792180950167,1.9634257101251e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCF2,Neutrophil cytosol factor 2,40324,-0.0464222046433675,0.00773151948427475,-0.0615759828325461,-0.031268426454189,1.96372178269218e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB7,Integrin beta-7,40489,0.0253992632379592,0.00423077445303363,0.0171069453100133,0.0336915811659051,1.97326813903583e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAEP,Glycodelin,40228,-0.0734804157782321,0.0122411957512636,-0.0974731594507089,-0.0494876721057554,1.9829550261991e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,40403,0.0153511168075903,0.00256160464226838,0.0103303717087443,0.0203718619064363,2.10732176360357e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SORD,Sorbitol dehydrogenase,40417,-0.0371442209253602,0.00620170924317793,-0.049299571041989,-0.0249888708087315,2.1519900386176e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IKBKG,NF-kappa-B essential modulator,40341,-0.0511684439404297,0.008544109448657,-0.0679148984597975,-0.034421989421062,2.16031488180115e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THBS4,Thrombospondin-4,40355,0.0251207413316396,0.00420030392347313,0.0168881456416322,0.0333533370216469,2.26945084023962e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SFRP4,Secreted frizzled-related protein 4,37671,-0.023275395064199,0.00389377242173859,-0.0309071890108066,-0.0156436011175914,2.32289926678127e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DSC2,Desmocollin-2,40177,-0.018720800996717,0.00313340788787519,-0.0248622804569524,-0.0125793215364817,2.35658874013998e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGT,Angiotensinogen,37987,-0.0134762144177288,0.00225680306444261,-0.0178995484240363,-0.00905288041142124,2.41158092779487e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40330,-0.0571844934985133,0.0095816929559957,-0.0759646116922649,-0.0384043753047618,2.45140454026565e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39961,-0.0470925730968085,0.00791262764318583,-0.0626013232774527,-0.0315838229161642,2.71302497334187e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIAE,Sialate O-acetylesterase,40374,-0.0258836360962023,0.00434922753454922,-0.0344081220639188,-0.0173591501284859,2.71572990167596e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MLN,Promotilin,40341,-0.0490642418117651,0.00824678047644456,-0.0652279315455964,-0.0329005520779337,2.74607170402428e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37628,-0.0466773309857355,0.0078498993564731,-0.0620631337244228,-0.0312915282470482,2.81330226693551e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,40341,-0.0302868640031766,0.00509473232614164,-0.0402725393624142,-0.020301188643939,2.82691325907531e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YES1,Tyrosine-protein kinase Yes,40305,-0.062710043509366,0.0105523444569859,-0.0833926386450584,-0.0420274483736736,2.86137010582622e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40277,-0.0575189825612118,0.00969529535828524,-0.0765217614634508,-0.0385162036589727,3.04263952416065e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PODXL,Podocalyxin,40305,0.00839336491657306,0.00141556649656379,0.00561885458330802,0.0111678752498381,3.10485724492738e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOBR,Apolipoprotein B receptor,37628,0.0233894507002466,0.00394798414886941,0.0156514017684626,0.0311274996320307,3.21254497477185e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37671,-0.0158427564561157,0.00267709493310794,-0.0210898625250072,-0.0105956503872241,3.34171089664089e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB2,Integrin beta-2,40221,0.0157728086510716,0.00266756632526894,0.0105443786535445,0.0210012386485987,3.43269805351583e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOD3,Extracellular superoxide dismutase,37987,0.0325709122627463,0.00551143078419551,0.0217685079257231,0.0433733165997695,3.50969745096461e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCARB2,Lysosome membrane protein 2,40011,-0.0169507954326982,0.00286874812220724,-0.0225735417522244,-0.011328049113172,3.51851300867975e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCAM,Basal cell adhesion molecule,40332,0.013001510459561,0.00220066929749617,0.00868819863646848,0.0173148222826535,3.5340776975755e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL5A1,Collagen alpha-1(V) chain,37671,-0.0218302162505974,0.0037030653549322,-0.0290882243462645,-0.0145722081549303,3.8341529279919e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,40424,0.0115137505888866,0.00195497292811018,0.00768200364979063,0.0153454975279825,3.95218618757864e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EREG,Proepiregulin,40192,-0.043917762070845,0.007458324829358,-0.0585360787363867,-0.0292994454053034,3.978392258241e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39980,-0.0270971640026698,0.00460402351465959,-0.0361210500914026,-0.018073277913937,4.04929910334218e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39980,-0.0367601673191154,0.00625320374184159,-0.0490164466531249,-0.0245038879851059,4.22200591637702e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,40335,-0.0245132242725302,0.00417799139625216,-0.0327020874091844,-0.0163243611358759,4.5195800110549e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37978,-0.0132842092181864,0.00226399184883273,-0.0177216332418986,-0.00884678519447427,4.52480495716523e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,40434,-0.0392855660232738,0.00671546329785744,-0.0524478740870744,-0.0261232579594733,5.011307572579e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37901,-0.0431295851611135,0.00737516425999393,-0.0575849071107016,-0.0286742632115254,5.09228592704642e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPL,N-acetylneuraminate lyase,37990,-0.0234045521366466,0.00400745383033565,-0.0312591616441045,-0.0155499426291887,5.33171947495761e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLXNB2,Plexin-B2,40472,-0.0126539158417797,0.00216739234080892,-0.0169020048297652,-0.00840582685379419,5.37517335429371e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA6,Carbonic anhydrase 6,40295,0.0345492590452944,0.00592262804591683,0.0229409080752974,0.0461576100152914,5.53566243160586e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40280,-0.0409862432530865,0.00703919563284975,-0.054783066693472,-0.027189419812701,5.90703206062983e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTDH,Protein LYRIC,37598,-0.0494658264324643,0.00849946612026368,-0.0661247800281811,-0.0328068728367475,6.02651080109802e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,40305,-0.0367402812387298,0.00631809887253009,-0.0491237550288888,-0.0243568074485708,6.17692647023693e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HEG1,Protein HEG homolog 1,37671,-0.0142450377171023,0.00245755687791063,-0.0190618491978072,-0.0094282262363975,6.92906882116633e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39980,-0.0252179533142793,0.00435305635256927,-0.0337499437653151,-0.0166859628632435,7.04113289204355e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGRN,Agrin,40422,-0.0178626225595721,0.00308436229620429,-0.0239079726601325,-0.0118172724590117,7.11351596401877e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37901,-0.0273573370283826,0.00473146677332322,-0.0366310119040961,-0.0180836621526691,7.54576462990541e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HYAL1,Hyaluronidase-1,40214,-0.01234907886386,0.00213797992452857,-0.016539519515936,-0.00815863821178403,7.79161749215026e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEZ6,Seizure protein 6 homolog,37572,0.0168018289634419,0.00291759309661098,0.0110833464940843,0.0225203114327994,8.66140735993754e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCL2L15,Bcl-2-like protein 15,37598,-0.0302450830559294,0.00525533480509109,-0.0405455392739079,-0.0199446268379508,8.85123031898502e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SARG,Specifically androgen-regulated gene protein,37931,-0.0580321543564844,0.0100896086086457,-0.07780778722943,-0.0382565214835387,9.0281506197691e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLA2G1B,Phospholipase A2,40514,0.0223792475084067,0.00390155105798241,0.0147322074347612,0.0300262875820523,9.86906018969765e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM5,Tripartite motif-containing protein 5,40341,-0.0453910404524301,0.00791350425283046,-0.0609015087879779,-0.0298805721168824,9.87626324739714e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFRA2,GDNF family receptor alpha-2,40305,0.0113396502952134,0.00197783787969412,0.00746308805101289,0.0152162125394138,1.0025449510838e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENO3,Beta-enolase,37628,-0.0302255165022743,0.0052808195925263,-0.0405759229036259,-0.0198751101009228,1.06536766587472e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYH9,Myosin-9,37998,-0.0595480191922139,0.0104206741094297,-0.0799725404466961,-0.0391234979377317,1.12402267060105e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGBL1,Integrin beta-like protein 1,37998,-0.0185167539083178,0.00324457558984851,-0.0248761220644208,-0.0121573857522147,1.17401826721399e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40536,-0.016610163309677,0.00291101244237788,-0.0223157476967376,-0.0109045789226163,1.177158566063e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL13,C-X-C motif chemokine 13,40471,-0.0335588248321906,0.00588560449204932,-0.0450946096366073,-0.022023040027774,1.20604373330594e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM3D,Protein FAM3D,37901,-0.043577259724357,0.00765273516197013,-0.0585766206418185,-0.0285778988068956,1.26442332843506e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39980,-0.0279182418191083,0.00490595537770595,-0.0375339143594119,-0.0183025692788046,1.28815443043019e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,JAM3,Junctional adhesion molecule C,37671,-0.0268142007697073,0.00471178333384274,-0.0360492961040391,-0.0175791054353755,1.29068908349684e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,40325,0.0118094534841387,0.00208007919493133,0.00773249826207334,0.0158864087062041,1.39145295391877e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOA4,Apolipoprotein A-IV,38013,-0.0194469556777294,0.00343004845607655,-0.0261698506516394,-0.0127240607038193,1.46061762066606e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSAP,Prosaposin,37901,-0.0149405995848638,0.00263934809136944,-0.0201137218439479,-0.00976747732577968,1.53823688362932e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HGFAC,Hepatocyte growth factor activator,37849,0.0152531137242543,0.00269966273131643,0.00996177477087406,0.0205444526776345,1.63708706378147e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40502,-0.0199324950653098,0.00353094124731325,-0.0268531399100438,-0.0130118502205758,1.67884062601692e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40471,-0.025352516333312,0.0044916638662704,-0.034156177511202,-0.016548855155422,1.68617015821756e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40044,-0.0303531384021667,0.00540117283670385,-0.0409394371621062,-0.0197668396422271,1.94528167728392e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40341,-0.0497293213730245,0.0088512260145366,-0.0670777243615162,-0.0323809183845328,1.96019298996371e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40403,-0.0215924007862724,0.00384834913002109,-0.0291351650811138,-0.0140496364914311,2.04715447009123e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KYNU,Kynureninase,40516,-0.0232293428884646,0.00414486245596252,-0.0313532733021511,-0.015105412474778,2.12448041312021e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39961,-0.0313428831993465,0.00559788999457829,-0.0423147475887199,-0.020371018809973,2.19181107092214e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39708,0.019480331089237,0.00348290514963151,0.0126538369959592,0.0263068251825148,2.26845547385692e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,40305,-0.0184868849782038,0.00331199194863415,-0.0249783891975268,-0.0119953807588809,2.41940106887833e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40471,0.014148785538716,0.00254076550483307,0.00916888514924316,0.0191286859281888,2.60756982124026e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUMB,Protein numb homolog,37598,-0.0431443417727126,0.00774825444129028,-0.0583309204776415,-0.0279577630677837,2.62331198306498e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOB,Apolipoprotein B-100,37987,0.0115794979659172,0.00208143168482497,0.00749989186366026,0.0156591040681741,2.6983945498964e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MARCO,Macrophage receptor MARCO,40359,0.0137305021696275,0.00247138156221194,0.00888659430769214,0.0185744100315629,2.80775032372895e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNCG,Gamma-synuclein,40228,-0.0345253654536733,0.00622506261214158,-0.0467264881734708,-0.0223242427338758,2.9665551528592e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PEPD,Xaa-Pro dipeptidase,37987,0.0133439929041385,0.00240596426210177,0.00862830295041904,0.018059682857858,2.97393280415713e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,40341,0.0242854878836409,0.00438911977946692,0.0156828131158857,0.032888162651396,3.19571239368998e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AZU1,Azurocidin,39809,-0.0399663989691853,0.00723534902590929,-0.0541476830599675,-0.0257851148784031,3.37193439905201e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REG1A,Lithostathine-1-alpha,40274,-0.0250410689247811,0.00454097241084056,-0.0339413748500286,-0.0161407629995336,3.55305874459305e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37981,0.00955129823973344,0.00173408698513205,0.00615248774887463,0.0129501087305922,3.69621687088872e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37901,-0.0527583500764287,0.00958271129692536,-0.0715404642184024,-0.033976235934455,3.74706984391313e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL17C,Interleukin-17C,40044,-0.0359937029789801,0.00654379724194882,-0.0488195455731998,-0.0231678603847604,3.84826836481811e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37562,-0.0189707856111232,0.0034497628631918,-0.0257323208229791,-0.0122092503992673,3.88757160054416e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,40203,-0.0453435471485907,0.00826386675306741,-0.0615407259846029,-0.0291463683125786,4.15206923217611e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40489,-0.0275206154803131,0.00501764115134983,-0.0373551921369588,-0.0176860388236675,4.20267094108525e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDCD6,Programmed cell death protein 6,40359,0.03562524678901,0.00649543995767928,0.0228941844719586,0.0483563091060614,4.2059546079776e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40422,0.0211732914690156,0.00386092639088775,0.0136058757428756,0.0287407071951556,4.22146096946771e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,40359,-0.0293035578923011,0.00534736009698433,-0.0397843836823904,-0.0188227321022118,4.31779866166184e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37671,-0.0186190772512021,0.00339848959781176,-0.0252801168629132,-0.0119580376394911,4.3646698559965e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40411,-0.0134534809685041,0.0024649025179012,-0.0182846899035905,-0.0086222720334178,4.88661562355799e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,40305,0.0208978452981691,0.00383112292903225,0.0133888443572659,0.0284068462390723,4.97744415115037e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39961,-0.0248028449482463,0.00454841686816012,-0.0337177420098401,-0.0158879478866524,5.0264263052538e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,40332,-0.0267053334405219,0.00490215604224816,-0.0363135592833283,-0.0170971075977155,5.17929626216769e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LY75,Lymphocyte antigen 75,40341,0.0197084348551393,0.00362085868496833,0.0126115518326014,0.0268053178776773,5.31588015764475e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHB4,Ephrin type-B receptor 4,40536,-0.0124462003836553,0.00229181315033258,-0.0169381541583071,-0.00795424660900342,5.69409535410686e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40228,-0.0353257095116495,0.00650755901813481,-0.0480805251871938,-0.0225708938361053,5.76976704256969e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37901,-0.0419708080093232,0.00773352677292565,-0.0571285204842575,-0.0268130955343889,5.8261867736863e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPON2,Spondin-2,40267,-0.0174286332588255,0.00321245218140634,-0.0237250395343819,-0.011132226983269,5.86960368989318e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPP1,Osteopontin,40497,0.0239754235703083,0.00443118428830278,0.0152903023652349,0.0326605447753818,6.37099189907185e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,40228,0.0587567519790433,0.0108743045054899,0.037443115148283,0.0800703888098035,6.63878807957103e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39980,-0.0350705521246175,0.00649700550131661,-0.0478046829071981,-0.0223364213420369,6.83939969242387e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLU,Clusterin,38013,0.0166063366587898,0.00308420149535701,0.01056130172789,0.0226513715896895,7.39295649266958e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39961,-0.0251711632324976,0.0046760194326878,-0.0343361613205657,-0.0160061651444295,7.4306635347356e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,40341,-0.0530075939786704,0.00985123857000189,-0.0723160215758741,-0.0336991663814667,7.52043112621277e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL12,Stromal cell-derived factor 1,40044,0.0203634235308511,0.00378693989750665,0.0129410213317381,0.0277858257299642,7.6710302376831e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UNC5D,Netrin receptor UNC5D,37598,0.0133793111110074,0.00249149941721173,0.00849597225327242,0.0182626499687424,8.00835832065279e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40305,-0.0226987142949797,0.00422865327384983,-0.0309868747117254,-0.014410553878234,8.08085086280414e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAT2,Linker for activation of T-cells family member 2,40305,-0.060964461612228,0.0113703363349324,-0.0832503208286956,-0.0386786023957604,8.35919650820704e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40536,0.0164769553009754,0.00307492849770443,0.0104500954454747,0.022503815156476,8.50790442445973e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,37562,-0.0316964450272431,0.00591948290907378,-0.0432986315290277,-0.0200942585254585,8.71940477518094e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTRB1,Chymotrypsinogen B,40332,-0.0264510890596797,0.00494246652334645,-0.0361383234454387,-0.0167638546739206,8.82929712166106e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39535,-0.0189732187742532,0.00354520317571114,-0.025921816998647,-0.0120246205498593,8.8356861488454e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37900,-0.033713095160588,0.00630225703786401,-0.0460655189548014,-0.0213606713663745,8.97075966417986e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCHE,Cholinesterase,37748,-0.014066390120074,0.00263194116169248,-0.0192249947969913,-0.00890778544315676,9.21678177459671e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINB8,Serpin B8,40516,-0.0271043522037574,0.00507308238135036,-0.0370475936712041,-0.0171611107363107,9.27808449198132e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUSD5,Sushi domain-containing protein 5,37604,0.0170262882627985,0.00318863402033547,0.0107765655829409,0.023276010942656,9.46592349908004e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,40152,-0.0577391943780965,0.0108158416208433,-0.0789382439549494,-0.0365401448012436,9.507905354217e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GHRL,Appetite-regulating hormone,40359,0.0390930145059488,0.00733344733579115,0.0247194577277982,0.0534665712840995,9.91250919149694e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL25,C-C motif chemokine 25,40516,-0.024229988414188,0.00454591577068395,-0.0331399833247285,-0.0153199935036474,9.95083700675061e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PENK,Proenkephalin-A,37671,-0.0152693966982541,0.00287115040971567,-0.0208968515012969,-0.00964194189521142,1.06497188350844e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37714,-0.0218029294250853,0.00410734639299486,-0.0298533283553552,-0.0137525304948153,1.12450907879792e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKAP12,A-kinase anchor protein 12,37671,0.0107831591203162,0.00203206080932951,0.00680031993403032,0.014765998306602,1.1354657136458e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCRLB,Fc receptor-like B,39980,-0.030102401543894,0.00567513192427282,-0.0412256601154687,-0.0189791429723193,1.14679657325917e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA4,Kallistatin,37781,-0.0118344552884751,0.00223153353124638,-0.016208261009718,-0.00746064956723219,1.15555634794297e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CES2,Cocaine esterase,40305,-0.0263984267481384,0.00497999529606957,-0.0361592175284348,-0.0166376359678421,1.16781113324298e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37901,-0.0132647734013899,0.00250425702705626,-0.0181731171744202,-0.00835642962835963,1.19648536721054e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40042,0.015821918508855,0.00299025185247833,0.00996102487799751,0.0216828121397125,1.23183419017678e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MATN3,Matrilin-3,40203,0.0153715101568568,0.00291145244102724,0.00966506337244341,0.0210779569412702,1.31134566200135e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP8,Neutrophil collagenase,40442,-0.0358869707789763,0.00680533187285266,-0.0492254212497675,-0.022548520308185,1.3569142495058e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37671,-0.0407335992593038,0.00772778059697005,-0.0558800492293651,-0.0255871492892424,1.37772208806508e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA6,Corticosteroid-binding globulin,38013,0.008770959524593,0.00166551557396223,0.00550654899962703,0.012035370049559,1.41395133160611e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40305,-0.0372371681723316,0.00708090824166248,-0.0511157483259901,-0.0233585880186732,1.46872071214482e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL24,C-C motif chemokine 24,40396,0.0405386516134115,0.00771089062288165,0.0254253059925635,0.0556519972342595,1.48052237869544e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40305,-0.0266368472353079,0.0050720157364289,-0.0365779980787086,-0.0166956963919073,1.52625885302434e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AXIN1,Axin-1,40341,-0.0458203337044139,0.00873443905820303,-0.0629398342584918,-0.028700833150336,1.57484461424879e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40228,-0.0360729873801971,0.00687832810757692,-0.0495545104710479,-0.0225914642893464,1.58781237983469e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VNN1,Pantetheinase,37987,-0.0353413175216219,0.00673978891023684,-0.0485513037856861,-0.0221313312575577,1.59772641460555e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFRA3,GDNF family receptor alpha-3,40194,0.013921990432704,0.00265738563946633,0.00871351457935,0.019130466286058,1.63547926400655e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40359,-0.0311583704443448,0.00595453056609924,-0.0428292503538993,-0.0194874905347903,1.69157741181358e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37900,-0.0351110307426685,0.00671368646503789,-0.0482698562141427,-0.0219522052711942,1.72267685170757e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHA2,Ephrin type-A receptor 2,39759,-0.0149861961901962,0.00287436849813459,-0.02061995844654,-0.00935243393385244,1.87483918644197e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APP,Amyloid-beta precursor protein,40309,-0.0323773917808837,0.00621829927189438,-0.0445652583537966,-0.0201895252079707,1.94533611189655e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,40359,0.0135770820073026,0.0026281704367247,0.00842586795132215,0.018728296063283,2.42068547442276e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CR1,Complement receptor type 1,37959,0.017404713342559,0.003375648121433,0.0107884430245503,0.0240209836605677,2.55897832129202e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MFAP5,Microfibrillar-associated protein 5,40536,-0.0196493760768733,0.00381424726255221,-0.0271253007114757,-0.012173451442271,2.61362032293486e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37922,-0.0400982810541471,0.00778857024300296,-0.0553638787304329,-0.0248326833778613,2.66491044239029e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINI1,Neuroserpin,37642,0.0152676414625888,0.00297205600858686,0.00944241168575857,0.0210928712394191,2.83045729352784e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,40341,-0.0173137354594182,0.00337829073106101,-0.0239351852922978,-0.0106922856265386,3.01028464526892e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TAX1BP1,Tax1-binding protein 1,37942,-0.0305400917643789,0.00596024597539911,-0.0422221738761611,-0.0188580096525966,3.03308390993984e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCG3,Secretogranin-3,40379,0.0159091157151627,0.00310520578261941,0.00982291238122869,0.0219953190490968,3.03629968936787e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37958,0.00703294276583588,0.00137327923881784,0.00434131545775293,0.00972457007391884,3.07651874480046e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GOLGA3,Golgin subfamily A member 3,37959,-0.0372969685982963,0.00728350321482688,-0.051572634899357,-0.0230213022972356,3.08517088041894e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADD1,Alpha-adducin,37671,-0.0334292096230163,0.00653297228542069,-0.0462338353024409,-0.0206245839435917,3.14788701221205e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RASSF2,Ras association domain-containing protein 2,39980,-0.0261319542753672,0.00510846168996539,-0.0361445391876993,-0.016119369363035,3.16763630614271e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37900,-0.0226399413613108,0.00442983232842956,-0.0313224127250328,-0.0139574699975889,3.25215341553907e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39980,-0.0261460458731599,0.00512699534609464,-0.0361949567515053,-0.0160971349948144,3.44229124808395e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,40396,-0.0245374831890671,0.00481454805831519,-0.0339739973833648,-0.0151009689947693,3.4989336424987e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37860,-0.0513174118267762,0.0100697401720408,-0.0710541025639761,-0.0315807210895762,3.51253471092727e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RFC4,Replication factor C subunit 4,37900,-0.00972038682323562,0.00190794095725122,-0.013459951099448,-0.00598082254702323,3.54026559052189e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40489,-0.0147195674773554,0.00289898709727786,-0.02040158218802,-0.00903755276669081,3.86745926363237e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40306,-0.0326596670331941,0.0064453277474106,-0.0452925094181189,-0.0200268246482694,4.08282168051901e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40471,-0.0310083899123948,0.00612553257956816,-0.0430144337683484,-0.0190023460564412,4.19141200864726e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TJAP1,Tight junction-associated protein 1,40411,-0.0387591529341491,0.00766434807138204,-0.0537812751540579,-0.0237370307142403,4.30463635561734e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37628,-0.0364042672704094,0.00721532113578089,-0.05054629669654,-0.0222622378442789,4.58572419475483e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37900,-0.0180870191468561,0.0035853141128948,-0.0251142348081299,-0.0110598034855823,4.60032861185302e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39980,-0.0300425724508331,0.00595780709647962,-0.0417198743599332,-0.0183652705417331,4.64531208653989e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTD,Biotinidase,38013,-0.00966345429743315,0.00192333815742693,-0.0134331970859899,-0.00589371150887638,5.11667301000479e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDCD5,Programmed cell death protein 5,40471,-0.0271515548236464,0.00541605273045972,-0.0377670181753474,-0.0165360914719453,5.4114111265186e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH3,Cadherin-3,40471,-0.0164889960343911,0.0032949466442626,-0.0229470914571458,-0.0100309006116364,5.66513967180132e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH6,Cadherin-6,40359,0.0176401510413744,0.00352936649906687,0.0107225927032033,0.0245577093795455,5.8511114584053e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39961,-0.0283759964302328,0.00569280590612888,-0.0395338960062454,-0.0172180968542202,6.27805875324098e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSV,Cathepsin L2,40444,0.0196350230381242,0.00394434895403762,0.0119040990882104,0.0273659469880379,6.49086048714247e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39980,-0.0238381209413088,0.00479511684556303,-0.0332365499586124,-0.0144396919240053,6.7203257273952e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37990,-0.035536338546876,0.0071622156542653,-0.049574281229236,-0.021498395864516,7.07492964545659e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39980,-0.0283566670464493,0.00572347139251665,-0.039574670975782,-0.0171386631171167,7.32975346654552e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NBN,Nibrin,40044,-0.0235000956120751,0.00474361510614621,-0.0327975812201217,-0.0142026100040286,7.34468599602379e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39980,-0.0161491560053405,0.00326024464688086,-0.022539235513227,-0.009759076497454,7.3710877727097e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A4,Protein S100-A4,40411,-0.0265598424975263,0.00536295647273746,-0.0370712371840918,-0.0160484478109609,7.40291309390529e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40471,-0.0377140833852816,0.00762593485747613,-0.0526609157059348,-0.0227672510646284,7.67167339294213e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HEPACAM2,HEPACAM family member 2,37942,0.0187364307258985,0.00378842758673378,0.0113111126559003,0.0261617487958967,7.67836021716803e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSS,Cathepsin S,37057,-0.0113521929552364,0.0022962431531648,-0.0158528295354394,-0.00685155637503334,7.75956947294134e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIMAP7,GTPase IMAP family member 7,37671,0.0149358546676345,0.00302222238010117,0.00901229880263621,0.0208594105326328,7.82682840863315e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BMPER,BMP-binding endothelial regulator protein,37671,-0.0103346902975458,0.00209234691118645,-0.0144356902434713,-0.00623369035162039,7.93694910278728e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGA4,Pepsin A-4,37987,-0.0313098450094275,0.00634010917641417,-0.0437364589951993,-0.0188832310236558,7.97154410453331e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,40341,-0.0248578672895103,0.00503407816649206,-0.0347246604958348,-0.0149910740831859,7.97623913839972e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,40042,-0.0443303639284437,0.0089808115909046,-0.0619327546466167,-0.0267279732102707,8.0515445434004e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP20,Centrosomal protein 20,39980,-0.0337312893781436,0.0068354784216919,-0.0471288270846597,-0.0203337516716275,8.10904171455727e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD160,CD160 antigen,40516,-0.0209540773598065,0.0042526927925185,-0.0292893552331427,-0.0126187994864702,8.42256531917114e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AFP,Alpha-fetoprotein,40182,0.0318603921207976,0.00646937655724643,0.0191804140685946,0.0445403701730006,8.53032962497343e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD93,Complement component C1q receptor,39725,0.0144502357358297,0.00293706983547062,0.00869357885830728,0.0202068926133521,8.74679925512352e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSE,Cathepsin E,37671,-0.0235749384522842,0.00480063463778763,-0.032984182342348,-0.0141656945622205,9.17915944229705e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK10,Kallikrein-10,40354,0.0179241112336541,0.00365075417803917,0.0107686330446973,0.0250795894226108,9.21202701872067e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB27B,Ras-related protein Rab-27B,37990,-0.0374147663524659,0.00762511263241837,-0.0523599871120059,-0.0224695455929259,9.36598664064003e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39980,-0.0374945146124891,0.00764716203239464,-0.0524829521959826,-0.0225060770289956,9.53075172269537e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,40264,-0.0121531115616628,0.00248274960148096,-0.0170193007805655,-0.00728692234276011,9.92646014640579e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37671,-0.0266871785012236,0.00545194566856378,-0.0373729920116086,-0.0160013649908386,9.94751222609828e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37628,-0.0340402216491824,0.00696312121044261,-0.0476879392216499,-0.0203925040767149,1.02729388448048e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39980,-0.0493127162573149,0.010091657236635,-0.0690923644411194,-0.0295330680735104,1.03676967885354e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LY96,Lymphocyte antigen 96,40228,-0.0157831825586585,0.00323184078715881,-0.0221175905014898,-0.00944877461582727,1.05159489171539e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS8,Galectin-8,40471,-0.0273975303826147,0.005610310464493,-0.038393738893021,-0.0164013218722084,1.05264423752648e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37598,-0.0164438208494262,0.00336962055412798,-0.023048277135517,-0.00983936456333534,1.07318658242984e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39961,-0.0358167092765939,0.00734072087127022,-0.0502045221842835,-0.0214288963689043,1.07584858617586e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PODXL2,Podocalyxin-like protein 2,40411,0.0123701397460078,0.00253857702854871,0.00739452877005235,0.0173457507219633,1.11048170113803e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,40332,-0.0235959875471708,0.00484379975863426,-0.033089835074094,-0.0141021400202477,1.11889717875158e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37998,0.0161764485341606,0.00332257259527546,0.00966420624742067,0.0226886908209005,1.13629856304287e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD63,CD63 antigen,40203,-0.0235740838548167,0.00484930551057551,-0.0330787226555447,-0.0140694450540887,1.17722499738967e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37598,-0.0380791083574331,0.00783439081732097,-0.0534345143593822,-0.022723702355484,1.18438184319354e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,40341,0.0181475105527984,0.00373710245611046,0.0108227897388219,0.0254722313667749,1.20897435093061e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37598,-0.0316096223550992,0.00652125385925395,-0.0443912799192369,-0.0188279647909614,1.26666764136788e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A16,Protein S100-A16,39934,-0.0280898627745873,0.00579925204094395,-0.0394563967748374,-0.0167233287743371,1.28672953856458e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RALY,RNA-binding protein Raly,37900,-0.0217188563144631,0.00448840736695127,-0.0305161347536876,-0.0129215778752386,1.32023096737528e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDT,D-dopachrome decarboxylase,37998,-0.0183828999169886,0.00380058045950952,-0.0258320376176272,-0.0109337622163499,1.33352815196638e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,40042,-0.0170115817976658,0.00352238504906667,-0.0239154564938365,-0.0101077071014952,1.38132119681661e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YTHDF3,YTH domain-containing family protein 3,40044,-0.0380835677664652,0.00788681166348498,-0.0535417186268957,-0.0226254169060346,1.386853190902e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCR,Breakpoint cluster region protein,40341,-0.0408417218351086,0.00846208440769661,-0.057427407274194,-0.0242560363960232,1.4028870255505e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,40203,0.015070796600345,0.00312829203701468,0.00893934420779627,0.0212022489928938,1.4666262171828e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,40333,-0.0434530361233702,0.00902471845381184,-0.0611414842928414,-0.025764587953899,1.48637027189408e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40490,-0.00938163076068716,0.00194881785423926,-0.0132013137549961,-0.00556194776637822,1.49279049894949e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFRAL,GDNF family receptor alpha-like,37477,0.0278195940289372,0.00578227115310837,0.0164863425688448,0.0391528454890296,1.51717348010845e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL27,C-C motif chemokine 27,40359,-0.0265835189405267,0.00552987561525249,-0.0374220751464216,-0.0157449627346318,1.54415961907439e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA7,Thyroxine-binding globulin,38013,-0.00836547582143869,0.00174305415980858,-0.0117818619746635,-0.00494908966821387,1.60902001396222e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPT1,Angiopoietin-1,40263,-0.0377924415744423,0.00790074387982104,-0.0532778995788915,-0.022306983569993,1.73907075941454e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OLFM4,Olfactomedin-4,37177,-0.0549267270706637,0.0114884780156886,-0.0774441439814135,-0.032409310159914,1.76354625754315e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37900,-0.0506733488519196,0.0106069970588149,-0.0714630630871967,-0.0298836346166425,1.79495532613071e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDHR5,Cadherin-related family member 5,40359,-0.0172931422468712,0.00362024112107986,-0.0243888148441877,-0.0101974696495547,1.79701697024774e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37628,0.0205340552202606,0.00429840681491618,0.0121091778630249,0.0289589325774963,1.79730041181267e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40228,-0.0420315416236539,0.00880399529677733,-0.0592873724053375,-0.0247757108419703,1.82092876480731e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBKS,Ribokinase,39991,-0.022070078374619,0.00462606742761805,-0.0311371705327504,-0.0130029862164877,1.85156052742614e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TADA3,Transcriptional adapter 3,37900,-0.0172502979148463,0.0036157294107051,-0.0243371275598283,-0.0101634682698643,1.85327958482382e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37942,-0.0305146486845223,0.00640904546169418,-0.0430763777894429,-0.0179529195796017,1.94459955461865e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD22,B-cell receptor CD22,40516,0.0181208809032723,0.0038120365531763,0.0106492892590468,0.0255924725474979,2.01562451389732e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL18BP,Interleukin-18-binding protein,40403,-0.0134924134706007,0.00283937634122161,-0.019057591099395,-0.00792723584180631,2.03277423015748e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,40359,0.0125438657817952,0.00265043072733483,0.00734902155621895,0.0177387100073715,2.23388080026127e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NADK,NAD kinase,40359,-0.0235545675417982,0.00498100746102831,-0.0333173421654137,-0.0137917929181827,2.27702951019913e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,40341,-0.0455310197810624,0.00963589251923253,-0.0644173691187582,-0.0266446704433666,2.31916711438276e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP43,Centrosomal protein 43,39934,-0.0303396864899221,0.00642285062981642,-0.0429284737243623,-0.0177508992554819,2.33613070756697e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,40305,-0.015178419476007,0.00321399838589032,-0.021477856312352,-0.00887898263966193,2.34846171310027e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA2,Annexin A2,37441,-0.0314526417852081,0.00666304432009482,-0.044512208652594,-0.0183930749178223,2.37767848581823e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNMBP,Dynamin-binding protein,40228,-0.0270270112766508,0.0057306636804617,-0.0382591120903557,-0.0157949104629458,2.42336117483886e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTSS2,Protein MTSS 2,37900,-0.0430144973778987,0.00913050523115879,-0.0609102876309699,-0.0251187071248274,2.48879253632135e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40305,-0.014145938337057,0.00300820576516757,-0.0200420216367854,-0.00824985503732854,2.59223371850935e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40536,0.0120037321114595,0.00255466075688301,0.00699659702796879,0.0170108671949502,2.63915507325709e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37959,0.0151595268037404,0.00323195465265575,0.0088248956845351,0.0214941579229456,2.75190260487768e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37391,-0.0152672117933207,0.00325976965672435,-0.0216563603205004,-0.00887806326614096,2.84851321091893e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD99,CD99 antigen,40332,0.00845090870323554,0.00180498745495441,0.0049131332915249,0.0119886841149462,2.86471936973691e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP10,Caspase-10,39961,-0.0312584312564504,0.00668079709169591,-0.0443527935561744,-0.0181640689567264,2.90928689109417e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD69,Early activation antigen CD69,40288,-0.0381822908035494,0.00816936843338825,-0.0541942529329904,-0.0221703286741084,2.98060322529353e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37942,0.0264052971654179,0.00564927877701906,0.0153327107624606,0.0374778835683753,2.98102029695608e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,40159,0.0257392473935375,0.00551180956125728,0.0149361006534732,0.0365423941336017,3.03935569166035e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALB2,Calretinin,39961,-0.0136873547043763,0.00293348606076335,-0.0194369873834724,-0.0079377220252801,3.09835992927515e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C19orf12,Protein C19orf12,39961,-0.026956449124421,0.00578558858789546,-0.0382962027566961,-0.0156166954921459,3.20015984215616e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37628,0.0148049597385521,0.00318428618172979,0.00856375882236176,0.0210461606547425,3.36165181824867e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37942,-0.0170867648003995,0.00367538877506909,-0.0242905267995349,-0.00988300280126408,3.36762197535212e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37901,0.0218785681068166,0.00470890966531686,0.0126491051627956,0.0311080310508377,3.4130138467576e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100G,Protein S100-G,37959,0.0192126777823286,0.00414293184937894,0.0110925313575459,0.0273328242071113,3.5602557468572e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37901,-0.0279961994623971,0.00604097261461035,-0.0398365057870333,-0.0161558931377608,3.61361260178794e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD302,CD302 antigen,40305,-0.0129678302136664,0.00280193798732984,-0.0184596286688329,-0.00747603175849994,3.71844016886772e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HLA_E,,40341,-0.0124075475674071,0.00268199427916813,-0.0176642563545766,-0.00715083878023751,3.75304043199476e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLXNA4,Plexin-A4,40341,-0.0354913494211442,0.00767368038500355,-0.0505317629757512,-0.0204509358665372,3.77415225219956e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37628,-0.0311281330837923,0.00673077035934532,-0.0443204429881092,-0.0179358231794755,3.78617421331168e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40536,0.0149842842192174,0.00324134401056271,0.0086312499585145,0.0213373184799203,3.8142538606465e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37990,-0.0204321676481688,0.00442396529942689,-0.0291031396350455,-0.0117611956612921,3.90047999863392e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37901,0.0296848775604746,0.00643216461293833,0.0170778349191155,0.0422919202018337,3.96599058469273e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL17D,Interleukin-17D,40044,0.0147178636401322,0.00319407389902886,0.00845747879803567,0.0209782484822288,4.10046009362454e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40192,-0.0478041668268586,0.0103793185102797,-0.0681476311070068,-0.0274607025467104,4.14273902832665e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL14,C-C motif chemokine 14,40309,-0.0167161705237049,0.00362958861082562,-0.0238301642009231,-0.00960217684648671,4.14619735919314e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFF2,Trefoil factor 2,40396,-0.0243193810622863,0.0053061743671513,-0.0347194828219029,-0.0139192793026698,4.61337435313054e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40332,0.0153365857843921,0.00334672748799499,0.00877699990792189,0.0218961716608623,4.62811315210186e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",40305,-0.0255125857552501,0.00558401715646468,-0.0364572593819209,-0.0145679121285793,4.940848361692e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PI3,Elafin,40074,-0.0227505752691874,0.00498159304997318,-0.0325144976471348,-0.01298665289124,4.98705809284801e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHMP6,Charged multivesicular body protein 6,37990,-0.0236553691197374,0.00518085343775123,-0.0338098418577298,-0.013500896381745,5.01687800824038e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL22,Interleukin-22,37900,-0.0277098908433759,0.00607215365191099,-0.0396113120011215,-0.0158084696856304,5.07684224270999e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFP,Properdin,38013,0.00928534016715482,0.00203559638885093,0.005295571245007,0.0132751090893026,5.12385570025681e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NIT1,Deaminated glutathione amidase,37628,-0.0210248507023265,0.00461727809487153,-0.0300747157682747,-0.0119749856363783,5.32293654480091e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39939,-0.0244821058652625,0.00537832596279847,-0.0350236247523475,-0.0139405869781775,5.35443408653728e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40228,-0.0190693870050721,0.00418934182533974,-0.0272804969827379,-0.0108582770274062,5.3565470914894e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40516,-0.0422791460488905,0.00929595647555567,-0.0604992207409796,-0.0240590713568014,5.45224929133802e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37942,-0.0123271127475527,0.0027126172663109,-0.017643842589522,-0.0070103829055833,5.55806271765882e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COMMD1,COMM domain-containing protein 1,37628,-0.0259786545839065,0.00572941608243153,-0.0372083101054723,-0.0147489990623407,5.83157954286454e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,40305,0.00871070983329511,0.00192281517195906,0.00494199209625534,0.0124794275703349,5.93619596832194e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPBP,Platelet basic protein,37934,-0.0353801820245675,0.00781542566221862,-0.050698416322516,-0.020061947726619,6.03483420285936e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSPB6,Heat shock protein beta-6,40489,-0.0153418363057823,0.00338987943244096,-0.0219859999933666,-0.008697672618198,6.06066741389857e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37628,0.0155075253495657,0.00343746652152728,0.00877009096737228,0.0222449597317592,6.49812500374899e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,40044,-0.0289280598074275,0.00642298413481642,-0.0415171087116677,-0.0163390109031873,6.72223578364624e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERBIN,Erbin,40305,-0.042919806364875,0.00953001506045779,-0.0615986358833723,-0.0242409768463778,6.7274333785314e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EEF1D,Elongation factor 1-delta,37990,-0.0383125531222784,0.00851532199154286,-0.0550025842257024,-0.0216225220188544,6.87619139502167e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37987,-0.025294618843424,0.00562223319050293,-0.0363141958968097,-0.0142750417900382,6.88314427830875e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37628,-0.0210967001527599,0.00469074993937263,-0.0302905700339303,-0.0119028302715896,6.93410660139325e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD207,C-type lectin domain family 4 member K,40029,-0.0160880997200024,0.00357790126063281,-0.0231007861908427,-0.00907541324916206,6.95737292642538e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QL2,Complement C1q-like protein 2,37598,0.0179683908216687,0.00400125629024699,0.0101259284927846,0.0258108531505528,7.15982193777327e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37942,-0.0150037927989884,0.00334155711095217,-0.0215532447364546,-0.00845434086152212,7.17934891794351e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HPSE,Heparanase,37848,-0.0386261029614529,0.00862631037923684,-0.0555336713047572,-0.0217185346181487,7.60719881344107e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WASHC3,WASH complex subunit 3,37942,-0.0311915749042624,0.00697007180298092,-0.044852915638105,-0.0175302341704198,7.70108411958415e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALCAM,CD166 antigen,40536,0.00806889311608399,0.00180508553946927,0.00453092545872423,0.0116068607734437,7.87213531187124e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DGKA,Diacylglycerol kinase alpha,37598,-0.0225427600107827,0.0050494690666729,-0.0324397193814615,-0.0126458006401038,8.09686052625804e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37598,-0.018588624923704,0.00417312104689456,-0.0267679421756174,-0.0104093076717907,8.48343829278511e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SULT2A1,Bile salt sulfotransferase,40341,-0.0220611780987946,0.004953772883227,-0.0317705729499195,-0.0123517832476697,8.50937961803721e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37671,-0.0326034575020183,0.00734671565726624,-0.0470030201902602,-0.0182038948137765,9.16066582099803e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37572,-0.0297299833076655,0.00670041705637266,-0.0428628007381559,-0.0165971658771751,9.19496671212764e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL19,Interleukin-19,39924,-0.0280674107965622,0.0063286087955719,-0.0404714840358831,-0.0156633375572413,9.27048945041163e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,40536,-0.0296196995741176,0.00668413231992406,-0.0427205989211688,-0.0165188002270665,9.42658746664974e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40422,-0.0426307999181023,0.00963091402909572,-0.0615073914151299,-0.0237542084210747,9.64297097356456e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37942,-0.0364497646760514,0.00823774935550031,-0.052595753412832,-0.0203037759392708,9.73228080214568e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37959,0.0194652750686438,0.00440229771683576,0.0108367715436457,0.0280937785936419,9.87298697054001e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40341,-0.0618081449295301,0.0140063076144715,-0.0892605078538942,-0.034355782005166,1.02676545731574e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,37541,0.0117564469483332,0.00266427570602843,0.00653446656451753,0.016978427332149,1.02941838349348e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37990,-0.0303755025144779,0.0068861162228495,-0.0438722903112629,-0.0168787147176929,1.03629966481019e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCN4,CCN family member 4,40489,-0.0167741987155503,0.00380350892116717,-0.024229076201038,-0.00931932123006266,1.03951953231939e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1R9B,Neurabin-2,40516,-0.038428921886803,0.00872664346554947,-0.05553314307928,-0.0213247006943261,1.07141482837209e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRTG,Protogenin,40489,0.0102787657034712,0.00234071170209593,0.00569097076736315,0.0148665606395792,1.13396705996417e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39980,-0.0164667771002006,0.00375124159633284,-0.023819210629013,-0.00911434357138823,1.1426344085021e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOE,Apolipoprotein E,38013,0.0306542476252112,0.00698861534253647,0.0169565615538397,0.0443519336965826,1.16158196721041e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37900,0.0167535663683859,0.00382078307675863,0.00926483153793897,0.0242423011988328,1.16946537483157e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,40403,0.0135722498620339,0.00309570332017539,0.00750467135449013,0.0196398283695777,1.17145825460046e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL7,C-C motif chemokine 7,40341,-0.0247690168364614,0.00565728017022108,-0.0358572859700948,-0.0136807477028281,1.20397517279983e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37544,0.0165040836600632,0.00377018863606017,0.00911451393338532,0.0238936533867412,1.20966906648705e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39980,-0.0266665707823616,0.00609488488325145,-0.0386125451535344,-0.0147205964111888,1.22091136055455e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40396,-0.035502112937036,0.00811603166896194,-0.0514095350082014,-0.0195946908658706,1.22584961695795e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MDK,Midkine,40352,-0.0205930125210703,0.00470965728870453,-0.0298239408069311,-0.0113620842352094,1.23607794659876e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL5,C-C motif chemokine 5,40403,-0.0407177186863363,0.00931861729997022,-0.0589822085942779,-0.0224532287783946,1.25316583228667e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,37598,-0.0197483158399528,0.00452241233493018,-0.028612244016416,-0.0108843876634897,1.27064278109629e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39980,-0.01844457900408,0.0042241146857433,-0.0267238437881368,-0.0101653142200231,1.27072728206951e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPPK1,Epiplakin,37628,-0.02988131449672,0.00685023828648452,-0.0433077815382297,-0.0164548474552104,1.29808521579803e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CETN2,Centrin-2,39961,-0.0272468132416385,0.00625480006312619,-0.0395062213653659,-0.0149874051179112,1.33223269335958e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FUOM,Fucose mutarotase,37671,-0.0252763604399608,0.00580701577206097,-0.0366581113532003,-0.0138946095267213,1.35464078108338e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ECE1,Endothelin-converting enzyme 1,39961,0.0142839035455652,0.00328661741385405,0.00784213341441125,0.0207256736767191,1.3947376693317e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40489,-0.0140051023795463,0.00322299653975297,-0.0203221755974621,-0.00768802916163045,1.39898200266783e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAX,Apoptosis regulator BAX,39934,-0.0361121090873341,0.00832171864188652,-0.0524226776254317,-0.0198015405492366,1.43711539466351e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37687,-0.0259851213215483,0.00598812694382471,-0.0377218501314448,-0.0142483925116519,1.43905322251503e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,40044,-0.0153872381261968,0.00354628268640348,-0.0223379521915477,-0.00843652406084603,1.44048129472363e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD7,T-cell antigen CD7,37567,-0.0173267959722808,0.00399543174261662,-0.0251578421878094,-0.00949574975675222,1.45749753202056e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40305,-0.0111757365918558,0.00257776411306196,-0.0162281542534572,-0.00612331893025438,1.46367318334913e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL6,Interleukin-6,40305,-0.0294648243481064,0.00679832778325201,-0.0427895468032803,-0.0161401018929324,1.47240349929731e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40276,0.0242274462040166,0.00560712619186806,0.0132374788679552,0.035217413540078,1.56390625393851e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",40293,0.0232599382656587,0.00538555947692679,0.0127042416908822,0.0338156348404352,1.577300748671e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OGFR,Opioid growth factor receptor,40305,-0.0132645776834193,0.00307475662721117,-0.0192911006727532,-0.00723805469408544,1.6127878520665e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFNA1,Ephrin-A1,40303,-0.0109301381821866,0.00253689341016488,-0.0159024492661097,-0.00595782709826339,1.65375184587465e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAA80,N-alpha-acetyltransferase 80,37572,-0.0475404226406498,0.0110641077035683,-0.0692260737396437,-0.0258547715416558,1.74518162737259e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40379,0.0106536299384537,0.00248039582709213,0.00579205411735309,0.0155152057595542,1.75622807617816e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F11,Coagulation factor XI,37810,0.0121241818086652,0.00282379386409695,0.00658954583503522,0.0176588177822953,1.77056304169308e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOLR1,Folate receptor alpha,40299,-0.0113260171384036,0.00263982840767925,-0.016500080817455,-0.00615195345935232,1.79379163908731e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40332,-0.0182217556129801,0.00424994378885333,-0.0265516454391326,-0.00989186578682752,1.81738117284322e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SYT1,Synaptotagmin-1,37942,0.0156221052656357,0.00364367739079429,0.00848049757967886,0.0227637129515925,1.81987146113619e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINE2,Glia-derived nexin,37990,-0.0255936708878808,0.00597185784465143,-0.0372985122633976,-0.013888829512364,1.83412996774494e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40228,-0.0216148312678865,0.00504865518660279,-0.031510195433628,-0.0117194671021451,1.86898261704582e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOXO1,Forkhead box protein O1,40341,-0.0336436754623813,0.00786565655838343,-0.0490603623168128,-0.0182269886079498,1.90289882702113e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37635,0.0193614206029304,0.00452822398181058,0.0104861015985817,0.0282367396072791,1.91860679105225e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PI16,Peptidase inhibitor 16,37987,0.00982116079424266,0.00229739400783609,0.00531826853888393,0.0143240530496014,1.92520952918894e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40396,-0.030444270732778,0.00712616511200214,-0.0444115543523022,-0.0164769871132538,1.94692094243371e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37628,-0.0177178330142653,0.00415274212815402,-0.0258572075854472,-0.00957845844308346,1.99915814948775e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37942,0.0106145701006146,0.00248807447006753,0.00573794413928219,0.0154911960619469,2.00205316328325e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ING1,Inhibitor of growth protein 1,39925,-0.0177091657759586,0.00415449682400316,-0.0258519795510048,-0.00956635200091238,2.03213449822829e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,40516,-0.0268865586548616,0.00631523737824601,-0.0392644239162238,-0.0145086933934995,2.0798261870755e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,40042,-0.0161601639804392,0.00379807668490271,-0.0236043942828485,-0.00871593367802986,2.10430852731054e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40432,0.0110579287582577,0.00259928897881898,0.00596332235977248,0.0161525351567429,2.10979679062544e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,37419,-0.0212302293554223,0.00499183864663258,-0.0310142331028221,-0.0114462256080224,2.12415671200148e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SRPK2,SRSF protein kinase 2,40341,-0.0326766390036175,0.00768801608342346,-0.0477451505271275,-0.0176081274801076,2.14669288420262e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TALDO1,Transaldolase,37966,-0.0176037840207339,0.00414279433690438,-0.0257236609210665,-0.00948390712040129,2.15921644381921e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37628,-0.0225287514298319,0.00530740097133586,-0.0329312573336502,-0.0121262455260136,2.20306016461055e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40228,-0.0307825473787053,0.00725519364937641,-0.045002726931483,-0.0165623678259275,2.21979069217568e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,40272,0.00914651116308171,0.00215744835974581,0.00491791237797993,0.0133751099481835,2.25285171559283e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDHR2,Cadherin-related family member 2,40305,-0.0302784080476233,0.00715045804625396,-0.044293305818281,-0.0162635102769655,2.3038152203561e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPTN,Neuroplastin,39980,0.0332974202735468,0.0078644457714566,0.0178831065614918,0.0487117339856017,2.30975449716702e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENG,Endoglin,40536,0.00671127415264894,0.0015869529083001,0.00360084645238075,0.00982170185291713,2.35996773639546e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RPL14,60S ribosomal protein L14,37628,-0.0162699104603973,0.0038516990471206,-0.0238192405927537,-0.00872058032804093,2.41524300655047e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39961,-0.0182766831998429,0.0043280966365554,-0.0267597526074915,-0.0097936137921943,2.42662437664449e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37714,-0.0438074567238848,0.0103867211709109,-0.0641654302188702,-0.0234494832288993,2.48510869420009e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,40422,-0.01013653825116,0.00240508616487352,-0.0148505071343121,-0.00542256936800787,2.51567673937644e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCARF1,Scavenger receptor class F member 1,40536,-0.0165813065766271,0.00393897413080339,-0.0243016958730017,-0.00886091728025245,2.57270283811396e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NSFL1C,NSFL1 cofactor p47,40471,-0.0260535023675851,0.00619333289811233,-0.0381924348478852,-0.0139145698872849,2.60534730001794e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD55,Complement decay-accelerating factor,39802,0.0102975818299494,0.00244891898410709,0.00549770062109953,0.0150974630387993,2.6262016355431e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRAP,BRCA1-associated protein,37778,-0.0427359196298415,0.0101672862670567,-0.0626638007132725,-0.0228080385464104,2.64794102548686e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPC5,Glypican-5,40228,0.0218533878926904,0.00521184776881416,0.0116381662658146,0.0320686095195662,2.76765527511659e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40341,-0.0145841259519668,0.00348423971384066,-0.0214132357910945,-0.00775501611283915,2.85766469517836e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMSB10,Thymosin beta-10,40332,-0.0294897666715892,0.0070479758747152,-0.043303799386031,-0.0156757339571474,2.87777838228617e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHRDL2,Chordin-like protein 2,40359,-0.0221722752617143,0.00530043353124565,-0.0325611249829558,-0.0117834255404728,2.89095126408575e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICAM3,Intercellular adhesion molecule 3,40536,0.00981905589376055,0.00234981240182861,0.00521342358617647,0.0144246882013446,2.94786546440015e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLSTN3,Calsyntenin-3,37942,0.0118737855372557,0.00284466134433976,0.00629824930234978,0.0174493217721616,3.01096652695625e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SFRP1,Secreted frizzled-related protein 1,40178,0.0169288885945274,0.00405631113109598,0.00897851877757932,0.0248792584114756,3.016094711619e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CYTL1,Cytokine-like protein 1,37998,0.00891836476989762,0.00213793709944897,0.00472800805497764,0.0131087214848176,3.04511883841716e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHGA,Chromogranin-A,37998,-0.0350171391669536,0.00839658347370428,-0.051474442775414,-0.0185598355584932,3.05954253045909e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPT,Dermatopontin,40536,0.0102722257203491,0.00246446749479282,0.00544186943055516,0.015102582010143,3.08712614866623e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40355,0.0193557575901063,0.00464495516874059,0.0102516454593747,0.0284598697208379,3.10198577926133e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD109,CD109 antigen,40332,0.0129320543064589,0.00310632481289219,0.00684365767319024,0.0190204509397276,3.15561138407527e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNAP25,Synaptosomal-associated protein 25,37541,0.0181396611248667,0.00435965803848798,0.00959473136943029,0.0266845908803032,3.19161803761629e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OGA,Protein O-GlcNAcase,37901,-0.027098058083831,0.00652458391507464,-0.0398862425573773,-0.0143098736102847,3.29847429702323e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPXM1,Probable carboxypeptidase X1,40411,-0.0265182390116663,0.00639004119013097,-0.039042719744323,-0.0139937582790096,3.34297846233512e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THOP1,Thimet oligopeptidase,40288,-0.0115396926608411,0.00278426016965494,-0.0169968425933648,-0.00608254272831746,3.42151737870769e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARSB,Arylsulfatase B,40305,-0.0211705344263936,0.00511178270736921,-0.0311896285328373,-0.01115144031995,3.46803475190797e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37959,-0.0144075615507806,0.00348898188853807,-0.0212459660523153,-0.00756915704924603,3.65825628795007e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRELP,Prolargin,40357,0.00891934330359813,0.00216010197104426,0.00468554344035138,0.0131531431668449,3.65995988258408e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPR,Nucleoprotein TPR,37562,-0.0180724644260309,0.00437814694924756,-0.0266536324465561,-0.00949129640550564,3.68388760548651e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH15,Cadherin-15,40435,-0.0169907913911877,0.00411653347791815,-0.0250591970079073,-0.00892238577446815,3.68666262559444e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37993,-0.00745266992205298,0.00180633497689367,-0.0109930864767646,-0.00391225336734138,3.71573928116027e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDGFC,Platelet-derived growth factor C,39980,-0.0113818084911589,0.00275911697746264,-0.0167896777669857,-0.00597393921533215,3.72401394733225e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40192,-0.0364994242134909,0.00886223298939985,-0.0538694008727147,-0.0191294475542672,3.83234686408664e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL9,C-X-C motif chemokine 9,40422,-0.0259520959663712,0.00630304647576221,-0.0383060670588652,-0.0135981248738773,3.85115372044215e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40228,0.0108570972733359,0.00263822800641137,0.00568617038076963,0.0160280241659022,3.88642257257857e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAYN,Layilin,40192,-0.0131535718355846,0.00319842760689636,-0.0194224899451015,-0.00688465372606775,3.93365014139381e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FBLN2,Fibulin-2,37998,0.0117870746994435,0.002868850859523,0.00616412701477846,0.0174100223841086,4.00337503967874e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,QDPR,Dihydropteridine reductase,40290,-0.0167126013042932,0.00407048534379479,-0.024690752578131,-0.00873445003045546,4.04938066359062e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MB,Myoglobin,40536,-0.0187565202924954,0.00457383547299747,-0.0277212378195704,-0.00979180276542034,4.13695584716346e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATG4A,Cysteine protease ATG4A,39980,-0.0226600954831718,0.00553199896258367,-0.0335028134498358,-0.0118173775165078,4.2214292886791e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37959,-0.0292905769161676,0.00715073709926153,-0.0433060216307202,-0.015275132201615,4.22505793112158e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37562,0.00772157687682069,0.00188705457964427,0.00402294990071792,0.0114202038529235,4.30474460451001e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39961,-0.0253157383723512,0.00619263006233231,-0.0374532932945225,-0.0131781834501799,4.3721962949122e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40411,-0.0362019893947119,0.00885588513255016,-0.0535595242545102,-0.0188444545349136,4.37423508734384e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37942,-0.0236844572907611,0.00579563920593981,-0.0350439101344031,-0.0123250044471191,4.40274802016669e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40489,0.00961388867832451,0.00235358999738772,0.00500085228344458,0.0142269250732044,4.43336409208858e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WDR46,WD repeat-containing protein 46,37900,-0.0134974227969553,0.00330766108976108,-0.0199804385328871,-0.00701440706102362,4.51683019120975e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADA,Adenosine deaminase,40516,-0.0129119699385899,0.00316472309632239,-0.0191148272073818,-0.00670911266979807,4.52593229663876e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD36,Platelet glycoprotein 4,37598,-0.0168305116589236,0.00412515297736281,-0.0249158114945547,-0.00874521182329247,4.53068386596481e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATXN10,Ataxin-10,39961,-0.0275141899276299,0.00675102113446366,-0.0407461913511786,-0.0142821885040811,4.61324441285458e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37714,-0.0252139273289077,0.0061885639818788,-0.0373435127333902,-0.0130843419244253,4.64260331853782e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,40042,-0.0210449087826189,0.00516990682459753,-0.0311779261588301,-0.0109118914064078,4.7112309485314e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFB,Complement factor B,37770,-0.0124504011265271,0.00305915058798328,-0.0184463362789743,-0.00645446597407983,4.73071572256266e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,40306,-0.0136285017494393,0.00335255647602746,-0.0201995124424531,-0.00705749105642549,4.8242029568869e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37572,-0.0306800292539916,0.00755042631590702,-0.0454788648331694,-0.0158811936748139,4.86549748956878e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SELENOP,Selenoprotein P,38013,0.00856079821437539,0.00210730924596366,0.00443047209228661,0.0126911243364642,4.88376718129117e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40536,0.0110938542990298,0.00273305080730671,0.00573707471670866,0.016450633881351,4.94852990722671e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",40359,0.0291037626324458,0.0071952570508208,0.0150010588128371,0.0432064664520546,5.26028431127141e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCS1,Neuronal calcium sensor 1,40489,-0.0107073865586296,0.00265397789317199,-0.0159091832292467,-0.00550558988801252,5.4980003356712e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,40305,-0.0209071013023634,0.00518809784083005,-0.0310757730703903,-0.0107384295343365,5.60801250363949e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL4,C-C motif chemokine 4,40376,-0.0253284017306059,0.00628920632885691,-0.0376552461351655,-0.0130015573260464,5.66871711107943e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OPLAH,5-oxoprolinase,37628,-0.0255095036066996,0.00634068777153552,-0.0379372516389093,-0.01308175557449,5.77468575606023e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40182,0.0153058651008371,0.00381290024502463,0.00783258062058881,0.0227791495810854,5.99162381244413e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,37628,0.0146311908173943,0.00364532678046645,0.00748635032768,0.0217760313071085,6.01090916937479e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSPAN8,Tetraspanin-8,37901,-0.0388062963861928,0.00967053511811205,-0.0577605452176924,-0.0198520475546932,6.03179169588465e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPHS1,Nephrin,37598,0.012960724930524,0.00322999870427267,0.00662992747014956,0.0192915223908984,6.03838261909674e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DTYMK,Thymidylate kinase,37990,-0.0258309663882101,0.00643795681938275,-0.0384493617542003,-0.0132125710222199,6.045532385922e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLA2,Src-like-adapter 2,37959,-0.0384505306596911,0.00958692404727616,-0.0572409017923523,-0.0196601595270298,6.0858025122784e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40522,0.0205363621127062,0.0051415677963306,0.0104588892318982,0.0306138349935142,6.52067951195339e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37671,-0.0250113056578931,0.0062617817474468,-0.0372843978828888,-0.0127382134328973,6.52427184132783e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37942,0.0243431505289333,0.00611057489817152,0.0123664237285172,0.0363198773293495,6.81856745078092e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F12,Coagulation factor XII,38013,-0.0154990231150513,0.00389171152245923,-0.0231267776990714,-0.00787126853103126,6.85291973226889e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THY1,Thy-1 membrane glycoprotein,40471,-0.0103691272596626,0.0026047777300191,-0.0154744916105001,-0.0052637629088252,6.89835151225227e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DKK1,Dickkopf-related protein 1,40471,-0.0219693297022034,0.00553971756320647,-0.0328271761260881,-0.0111114832783187,7.34727842991287e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37562,-0.0228812788884832,0.00577806279201907,-0.0342062819608405,-0.0115562758161258,7.53376676339717e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37942,0.0131467645815856,0.00332049709368576,0.0066385902779615,0.0196549388852097,7.5563126097836e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL16,Pro-interleukin-16,40516,-0.0148316695636888,0.00375390090257324,-0.0221893153327323,-0.00747402379464521,7.81573751998995e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40228,0.0256382710096388,0.00648936413510748,0.0129191173048281,0.0383574247144494,7.82247748192938e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,40307,-0.0240014679103872,0.00608099118288686,-0.0359202106288455,-0.012082725191929,7.94891207084914e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DSG4,Desmoglein-4,40250,0.0187170085324147,0.00474285251099318,0.00942101761086806,0.0280129994539613,7.96912913141046e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL11,C-X-C motif chemokine 11,40471,-0.0291248183238921,0.0073862161624817,-0.0436018020023563,-0.014647834645428,8.07668305635437e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BID,BH3-interacting domain death agonist,40341,-0.0244883726868171,0.00622791188394983,-0.0366950799793587,-0.0122816653942754,8.45869503110061e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRNN,Cornulin,39857,0.0242985518511287,0.00618293650751344,0.0121799962964024,0.036417107405855,8.53392425781421e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37562,0.00941523864360901,0.00239764852913952,0.00471584752649556,0.0141146297607225,8.65013365531936e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37562,-0.0248610961954785,0.00633198316313558,-0.0372717831952242,-0.0124504091957327,8.6713540171524e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK1,Kallikrein-1,40209,0.0465580583032812,0.0118632158833354,0.0233061551719439,0.0698099614346185,8.72527997261266e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,40228,0.0131766503278529,0.00335963982439686,0.0065917562720351,0.0197615443836708,8.81731613292603e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCND2,G1/S-specific cyclin-D2,37714,0.0134139214544242,0.00342506139397215,0.00670080112223878,0.0201270417866096,9.03301437477553e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCRL5,Fc receptor-like protein 5,40332,-0.0203745311789581,0.00520263247776607,-0.0305716908353796,-0.0101773715225366,9.03331062622946e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37959,-0.0172444152005758,0.00440439596180381,-0.0258770312857113,-0.00861179911544032,9.07454274158706e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CBLN4,Cerebellin-4,40489,0.0114574425992198,0.00292802651501549,0.00571851062978941,0.0171963745686501,9.15231420282446e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LEFTY2,Left-right determination factor 2,40453,0.0188549728215763,0.00482276125070357,0.00940236077019727,0.0283075848729553,9.28378368607279e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37562,-0.0244397699571713,0.00625130333190927,-0.0366923244877135,-0.0121872154266291,9.29345334913144e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCDH17,Protocadherin-17,40359,-0.0126739446922954,0.00324478240580955,-0.0190337182076821,-0.00631417117690871,9.42454458502603e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SELP,P-selectin,40403,-0.0209191054356641,0.00536334163782127,-0.0314312550457938,-0.0104069558255344,9.64329833476397e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,40536,-0.00785080890462601,0.00201353234515966,-0.0117973323011389,-0.00390428550811307,9.69737800294757e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OGN,Mimecan,40332,-0.0147065777078447,0.00378552214608763,-0.0221262011141765,-0.00728695430151295,0.000102764682047241
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,40305,-0.0497729803037379,0.0128139096667666,-0.0748882432506005,-0.0246577173568753,0.000103044863800162
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COCH,Cochlin,37990,-0.0168419222718524,0.00433720286186023,-0.0253428398810985,-0.00834100466260637,0.000103610404332094
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40228,-0.0147832213674405,0.00380851408590518,-0.0222479089758146,-0.00731853375906634,0.000104183395205694
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA11,Serpin A11,40536,0.0145156119850339,0.00373976073338713,0.00718568094759514,0.0218455430224727,0.000104259421391336
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPARC,SPARC,40411,-0.0255302099050912,0.00657940189191372,-0.0384258376132421,-0.0126345821969403,0.000104736704951083
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37901,-0.0186790491845459,0.0048193357714867,-0.0281249472966598,-0.009233151072432,0.000106755324557426
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL19,C-C motif chemokine 19,40471,-0.0471666444424839,0.0121769025357203,-0.0710333734124957,-0.023299915472472,0.000107731398230754
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STK11,Serine/threonine-protein kinase STK11,40042,-0.0262808281761734,0.0067914669427169,-0.0395921033838985,-0.0129695529684482,0.000109420390290767
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ESYT2,Extended synaptotagmin-2,37942,-0.0292686489035843,0.00758428913342965,-0.0441338556051064,-0.0144034422020622,0.000114328143415179
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KITLG,Kit ligand,40359,-0.0130718211263659,0.00338747757963034,-0.0197112771824413,-0.0064323650702904,0.000114364264895555
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37598,-0.0127680224696036,0.003309010821918,-0.0192536836805629,-0.00628236125864434,0.00011460116605903
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLPS,Colipase,40311,0.0245711707925964,0.00637143340372414,0.0120831613212971,0.0370591802638957,0.000115495967384081
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39853,-0.0318384754775907,0.0082674135847199,-0.0480426061036417,-0.0156343448515398,0.00011807375819833
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IMPACT,Protein IMPACT,37942,-0.0203605935843991,0.00529022825899711,-0.0307294409720335,-0.0099917461967648,0.000119285355522896
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39980,0.0110798982829439,0.00287997000353001,0.0054351570760251,0.0167246394898627,0.000119940003418115
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37950,-0.00710724232711948,0.00184784727230558,-0.0107290229808384,-0.00348546167340055,0.000120501421752677
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39934,0.0192009122603533,0.00499825091573729,0.00940434046550818,0.0289974840551983,0.00012275930766238
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37901,-0.0272314289115691,0.00709602422406655,-0.0411396363907395,-0.0133232214323986,0.000124830573222052
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,38013,0.00913608678790733,0.00238379531921937,0.00446384796223736,0.0138083256135773,0.000127378676068655
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37901,-0.0274257498230323,0.00715843844331133,-0.0414562891719225,-0.0133952104741421,0.000128074737780252
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37959,-0.034117011900359,0.00890563950536646,-0.0515720653308772,-0.0166619584698407,0.00012822987014513
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,40044,-0.0214287820532111,0.00560314616777878,-0.0324109485420575,-0.0104466155643647,0.000131590944787174
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RLN2,Prorelaxin H2,37643,-0.0502299340864944,0.0131499363653191,-0.0760038093625199,-0.0244560588104689,0.000134180002044734
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40273,0.00960068466246836,0.00251480496576066,0.00467166692957747,0.0145297023953593,0.000135233872303647
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRH,Corticoliberin,39947,-0.0308491996935209,0.0080844595195115,-0.0466947403517635,-0.0150036590352784,0.000136234416800047
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYN,Tyrosine-protein kinase Lyn,40305,-0.0297331230696677,0.00781001607712521,-0.0450407545808331,-0.0144254915585023,0.000141163661847059
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39980,0.0175963119932128,0.00462355761080665,0.00853413907603178,0.0266584849103939,0.000141892090649976
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F3,Tissue factor,40393,0.0099373116460639,0.0026112650349313,0.00481923217759856,0.0150553911145292,0.000142015722955345
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCN2,CCN family member 2,40358,-0.0203797289333599,0.00535639937601996,-0.0308782717103591,-0.0098811861563608,0.00014248226432978
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37990,-0.0258671613955985,0.0068097743867535,-0.0392143191936354,-0.0125200035975617,0.000146190712637209
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA2,Carbonic anhydrase 2,40291,-0.0249255951237188,0.00656259320004202,-0.0377882777958012,-0.0120629124516365,0.000146335193469969
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,40278,0.00903667904617858,0.00237987613169158,0.00437212182806307,0.0137012362642941,0.000146932621980016
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,40042,-0.0325244815838928,0.00857910867432057,-0.0493395345855612,-0.0157094285822245,0.000150530977010584
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLSCR3,Phospholipid scramblase 3,37919,-0.0210509824736566,0.00556792923310579,-0.031964123770544,-0.0101378411767693,0.000157027967643661
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37901,-0.0360438839775736,0.00953557677309136,-0.0547336144528327,-0.0173541535023145,0.000157545508686886
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PZP,Pregnancy zone protein,38013,-0.0229635334986527,0.00607733127478064,-0.0348751027972227,-0.0110519642000826,0.000158415666361736
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AZI2,5-azacytidine-induced protein 2,37959,-0.0193374253896,0.00512294054406973,-0.0293783888559766,-0.0092964619232233,0.00016090333177094
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NID2,Nidogen-2,40332,-0.0258404541525498,0.00685450669670831,-0.039275287278098,-0.0124056210270015,0.000163938038564101
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C3,Complement C3,37360,-0.0165648725357412,0.00439759947557521,-0.0251841675078687,-0.00794557756361381,0.000166088849412346
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37900,-0.02787114916565,0.007402467728734,-0.0423799859139687,-0.0133623124173314,0.000167180566165785
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37959,-0.0217447597518493,0.00578010708163952,-0.0330737696318627,-0.0104157498718358,0.000169272674995483
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DOK2,Docking protein 2,40359,-0.0422108518307714,0.0112215903297144,-0.0642051688770117,-0.0202165347845312,0.000169452325932574
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37987,-0.00947657292774403,0.00252079946216001,-0.0144173398735777,-0.00453580598191041,0.000171070352929781
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH2,Cadherin-2,40359,-0.0123258181678192,0.00327896189000036,-0.0187525834722199,-0.00589905286341855,0.000171162189673045
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39961,-0.0223747248947312,0.00596000032131604,-0.0340563255245107,-0.0106931242649518,0.000174566847662597
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINH1,Serpin H1,37714,-0.0449085901322617,0.0119841270227594,-0.0683974790968702,-0.0214197011676532,0.000179478206262273
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SH2B3,SH2B adapter protein 3,39980,-0.033916673327993,0.00907237236210058,-0.0516985231577101,-0.0161348234982758,0.000185817737689092
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STC1,Stanniocalcin-1,40471,-0.0143397449716691,0.00384610825417289,-0.021878117149848,-0.00680137279349029,0.000193379927107393
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COLEC12,Collectin-12,40357,-0.00886103254580979,0.00237823960145154,-0.0135223821646548,-0.00419968292696477,0.00019530930097323
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40536,0.00991205833099153,0.0026607879473069,0.00469691395427,0.0151272027077131,0.000195801111930543
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,40422,-0.0361387890563729,0.00970875332836712,-0.0551679455799724,-0.0171096325327733,0.000198102400681739
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37716,-0.0146037473182529,0.00392761789702902,-0.0223018783964298,-0.00690561624007603,0.000201457651268992
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DLL1,Delta-like protein 1,40411,-0.0101280076501063,0.00272420958931116,-0.0154674584451562,-0.00478855685505641,0.000201669771395738
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALPP,"Alkaline phosphatase, placental type",40305,-0.035693696240044,0.00960171695162767,-0.0545130614652342,-0.0168743310148538,0.000201953584214353
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRTN3,Myeloblastin,39897,-0.0162536631738969,0.00437696671910869,-0.02483251794335,-0.0076748084044439,0.000205169246232937
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFC1,Cryptic protein,39980,-0.0159414141759565,0.00429320849854002,-0.0243561028330949,-0.00752672551881803,0.000205395172588683
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DAG1,Dystroglycan,40422,-0.0162718183775726,0.00440139298807671,-0.024898548634203,-0.00764508812094227,0.000218918114952656
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37671,-0.0357375148331727,0.00966792698443878,-0.0546866517226727,-0.0167883779436727,0.000219473694284135
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,40330,-0.0251232555919931,0.00679681837430504,-0.038445019605631,-0.0118014915783552,0.000219477892587049
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37959,-0.0272268859942343,0.00736828322361845,-0.0416687211125264,-0.0127850508759421,0.000220628060894136
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37942,-0.010357842295042,0.00280516995595918,-0.015855975408722,-0.00485970918136201,0.000223013582429244
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,40208,-0.0138362696539129,0.00374801177707968,-0.021182372736989,-0.00649016657083669,0.000223573829031936
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40359,-0.00955944583692721,0.00259295872195169,-0.0146416449319525,-0.00447724674190191,0.000227941388427373
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAS6,Growth arrest-specific protein 6,40429,0.00880927471375229,0.00238990558918137,0.00412505975895681,0.0134934896685478,0.000228528808804388
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37959,0.014474161619167,0.00394079195786945,0.0067502093817429,0.0221981138565911,0.000240732918292382
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOXO3,Forkhead box protein O3,39980,-0.0330625830734474,0.00901164685474907,-0.0507254109087556,-0.0153997552381393,0.000244437316916937
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TLR4,Toll-like receptor 4,37598,0.00970371458685343,0.00265024324611627,0.00450923782446554,0.0148981913492413,0.000251782082313238
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNGR1,Interferon gamma receptor 1,40422,0.00697927002101187,0.00190689111203899,0.00324176344141545,0.0107167766006083,0.000253002831562496
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KAZN,Kazrin,37901,-0.035216276065053,0.00964638388916338,-0.0541231884878133,-0.0163093636422928,0.000262494383746236
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,40396,0.0287320250102239,0.00789119915995502,0.0132652746567121,0.0441987753637358,0.000272418087412867
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRG3,Proteoglycan 3,37998,0.0169671414462375,0.00466019913234123,0.00783315114684869,0.0261011317456263,0.000272739203475771
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37628,-0.0189998565574725,0.00522051298573868,-0.0292320620095203,-0.00876765110542466,0.00027425363328911
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BLVRB,Flavin reductase,40332,-0.0224297007228388,0.00616670368069037,-0.034516439936992,-0.0103429615086857,0.000276461493461308
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,40228,-0.0200344074583969,0.00551072426093088,-0.0308354270098215,-0.00923338790697242,0.000278291302918804
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37628,-0.0123837230172858,0.0034071737291773,-0.0190617835264733,-0.00570566250809827,0.00027946881099683
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STAB2,Stabilin-2,37998,-0.00943303279707524,0.00259598249933664,-0.014521158495775,-0.00434490709837543,0.000280414217203228
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40471,0.00778215846945577,0.0021421317877662,0.00358358016543401,0.0119807367734775,0.00028112516203921
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40516,0.0123406426772347,0.00339820782909163,0.00568015533221511,0.0190011300222543,0.000282638802248502
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNM3,Dynamin-3,37959,-0.0184911612079135,0.00510102492356725,-0.0284891700581053,-0.00849315235772172,0.000290035465086093
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LARP1,La-related protein 1,37900,-0.0213766098979185,0.00589986244889937,-0.0329403402977613,-0.00981287949807571,0.000292009228140329
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD274,Programmed cell death 1 ligand 1,40228,-0.0117156647019916,0.00323493301451594,-0.0180561334104429,-0.00537519599354039,0.000293693606986835
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39980,-0.0149593040497725,0.00413447490994021,-0.0230628748732553,-0.0068557332262897,0.000297615545477629
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPME1,Protein phosphatase methylesterase 1,40305,-0.0206437572621238,0.00570973258026281,-0.0318348331194389,-0.00945268140480871,0.000300653392268597
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,40373,-0.00903495205230359,0.0025020825566066,-0.0139390338632525,-0.00413087024135466,0.000305988005348256
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCN4B,Sodium channel subunit beta-4,37628,-0.0141075698397621,0.00390780158412335,-0.0217668609446439,-0.00644827873488034,0.000307209988572532
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37942,-0.035984788181659,0.00997594090743177,-0.0555376323602253,-0.0164319440030928,0.000310688407144191
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PROC,Vitamin K-dependent protein C,40372,0.0084629374321411,0.00234887455307472,0.00385914330811464,0.0130667315561676,0.000315553946698352
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,37541,0.0207754350963229,0.00576733343314347,0.00947146156736171,0.0320794086252841,0.00031663118591937
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFX1,Transcriptional repressor NF-X1,37562,-0.0227805050357284,0.00632500760099897,-0.0351775199336864,-0.0103834901377705,0.000317364727717221
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RILP,Rab-interacting lysosomal protein,40434,-0.020145307517785,0.00559371782030333,-0.0311089944455795,-0.0091816205899905,0.000317447309234788
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40305,0.00802582236080211,0.00222976265780939,0.00365548755149571,0.0123961571701085,0.000319916684047858
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MERTK,Tyrosine-protein kinase Mer,40516,0.00875628318923675,0.0024359715113106,0.00398177902706798,0.0135307873514055,0.000325893858269707
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSNAX,Translin-associated protein X,37562,-0.0132191735783875,0.00367981698123861,-0.0204316148616151,-0.00600673229515979,0.00032891477980209
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLB,Beta-klotho,39961,0.0246043874866817,0.00685522804016018,0.0111681405279677,0.0380406344453956,0.000332791030426278
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZNRD2,Protein ZNRD2,37901,-0.0226872675771112,0.00632714579158226,-0.0350884733286124,-0.0102860618256099,0.000337362289943484
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,40422,-0.0285532816430913,0.00796867721695615,-0.0441718889883253,-0.0129346742978572,0.000340434111840508
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37572,-0.0227653492622539,0.0063531916374751,-0.0352176048717051,-0.0103130936528027,0.000340518658857792
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLRX,Glutaredoxin-1,40260,-0.0188670723779864,0.00526788103253573,-0.0291921192017564,-0.00854202555421637,0.000342613497177598
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGXT,Serine--pyruvate aminotransferase,40359,-0.0255851786906174,0.00714971968188489,-0.0395986292671118,-0.011571728114123,0.000346616573052838
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,40465,0.0134839095096403,0.00377091302296176,0.00609291998463524,0.0208748990346454,0.000350229852464339
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ABO,Histo-blood group ABO system transferase,37987,0.0480775073763584,0.013457948658432,0.0216999280058317,0.074455086746885,0.000354919517945817
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCK2,Cytoplasmic protein NCK2,40422,-0.0346532245087535,0.00971422158816256,-0.0536930988215521,-0.0156133501959549,0.000361779293740298
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TUBB3,Tubulin beta-3 chain,37541,0.0092474366415587,0.00259744639979918,0.00415644169795232,0.0143384315851651,0.000371881901504461
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ISM1,Isthmin-1,40341,-0.0129107935832206,0.00362837544565314,-0.0200224094567008,-0.00579917770974048,0.000374372074678123
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37959,-0.0193377804559116,0.00543852199664428,-0.0299972835693344,-0.00867827734248882,0.000378255665692175
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB33A,Ras-related protein Rab-33A,37562,-0.0220969064973562,0.00621590848217673,-0.0342800871224226,-0.00991372587228985,0.000379460004336032
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD14,Monocyte differentiation antigen CD14,40048,0.0137321069399836,0.00386962003871051,0.00614765166411104,0.0213165622158562,0.000388280915869073
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,40332,-0.00755552508382449,0.002129554101816,-0.0117294511233839,-0.00338159904426513,0.000389379983604568
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",37562,-0.0207444345887685,0.00587337064494009,-0.0322562410528511,-0.00923262812468591,0.000413929087884589
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,40332,-0.00981237666996509,0.00278093337967325,-0.0152630060941247,-0.00436174724580552,0.000419186303604869
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40516,-0.0182996189062748,0.00520246163222195,-0.0284964437054298,-0.00810279410711981,0.000436847625997739
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39980,-0.0168315086037079,0.00478717668063948,-0.0262143748977613,-0.0074486423096545,0.000439420936490319
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STAMBP,STAM-binding protein,40192,-0.0211252253450802,0.00601344864300939,-0.0329115846853786,-0.00933886600478176,0.000444325428623809
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,40411,0.0287059003706959,0.00817601639306158,0.0126809082402952,0.0447308925010965,0.000447675612508943
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37901,-0.0152891659550565,0.00435537962632554,-0.0238257100226546,-0.00675262188745845,0.000448881646248077
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PADI2,Protein-arginine deiminase type-2,40044,-0.0183648116214664,0.00523255889205107,-0.0286206270498865,-0.00810899619304631,0.000449845824936066
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37901,-0.0166423087796814,0.00474789519724397,-0.0259481833662796,-0.00733643419308324,0.000457754504222885
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37901,-0.0274781473286442,0.00786575059614216,-0.0428950184970829,-0.0120612761602056,0.00047845957080439
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37944,0.0072083017825876,0.00206389731930219,0.0031630630367553,0.0112535405284199,0.000479931273971336
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37942,-0.0130119838034535,0.0037371378822958,-0.0203367740527532,-0.00568719355415369,0.0004996234277772
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39980,-0.0186874549127894,0.00537605606072937,-0.029224524791819,-0.00815038503375988,0.000510242469345779
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39980,-0.0215524840368724,0.00622039849674882,-0.0337444650905,-0.00936050298324468,0.000532043413553064
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37598,-0.0170995915964704,0.00494035283979232,-0.0267826831624633,-0.00741650003047744,0.000539464465299226
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F2,Prothrombin,38013,0.0047411000159528,0.00137133171693494,0.00205328985076032,0.00742891018114527,0.000547297938786524
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK7,Kallikrein-7,37352,0.0124508771770257,0.00360989244330566,0.00537548798814656,0.0195262663659047,0.000564257429370103
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,40341,-0.0151025846647271,0.00438089908901116,-0.0236891468791889,-0.00651602245026517,0.000567536218248708
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CENPF,Centromere protein F,37714,-0.0175460391051209,0.00509112668364994,-0.0275246474050748,-0.00756743080516706,0.000569877739104054
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,METAP2,Methionine aminopeptidase 2,40453,-0.0188307236888763,0.00546570339100807,-0.0295435023352521,-0.00811794504250045,0.000571991427564674
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLGN,Calmegin,37572,-0.0142598846567688,0.00414572148411967,-0.0223854987656434,-0.00613427054789423,0.000584250449441511
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,40400,-0.0227935019747631,0.00663040633610076,-0.0357890983935205,-0.00979790555600556,0.000588124466267679
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP6AP2,Renin receptor,39980,-0.0133202185763688,0.00387606939514639,-0.0209173145908557,-0.00572312256188188,0.00059076568494628
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40536,0.00720548779141538,0.00210221960376939,0.00308513736802738,0.0113258382148034,0.000610552128871029
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QA,Complement C1q subcomponent subunit A,40442,-0.00724587088676831,0.00211423642554755,-0.0113897742808415,-0.00310196749269511,0.000611417575813574
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A12,Protein S100-A12,40139,-0.0244129884297578,0.00713452277800203,-0.0383966530746418,-0.0104293237848739,0.000623642177528387
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BIN2,Bridging integrator 2,40332,-0.0287834739062898,0.00842551175663958,-0.0452974769493034,-0.0122694708632762,0.00063653955943794
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDSN,Corneodesmosin,40456,0.0137245338075145,0.00402053338603903,0.00584428837087798,0.021604779244151,0.000642670878015335
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATXN3,Ataxin-3,37942,-0.0197848674616454,0.00579709946473368,-0.0311471824125234,-0.00842255251076735,0.00064466538107579
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NINJ1,Ninjurin-1,39980,0.0178574939389464,0.00524302866808039,0.0075811577495088,0.0281338301283839,0.000661012322417003
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NGRN,Neugrin,37942,-0.00698072348729312,0.00204969764275296,-0.0109981308670889,-0.00296331610749731,0.000661789688994547
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BLMH,Bleomycin hydrolase,40536,0.0102350665628753,0.00300581335642998,0.00434367238427249,0.016126460741478,0.00066303704286493
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MIF,Macrophage migration inhibitory factor,40307,-0.0217742330652156,0.0064014429954564,-0.0343210613363102,-0.00922740479412108,0.00067193123880771
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37653,-0.0172477937883402,0.00507138067898205,-0.027187699919145,-0.00730788765753539,0.000673374413084083
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD226,CD226 antigen,37598,-0.0132447755235861,0.00389722338534193,-0.0208833333588563,-0.00560621768831588,0.000679536186290605
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DKK4,Dickkopf-related protein 4,40203,-0.0144116728246977,0.00424340532991064,-0.0227287472713226,-0.00609459837807287,0.000684842721130792
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,40332,-0.0184212958616986,0.00543190585008589,-0.029067831327867,-0.00777476039553027,0.000697280093534729
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EHBP1,EH domain-binding protein 1,37990,-0.0235306964249307,0.00693998124883744,-0.0371330596726521,-0.00992833317720931,0.000699392040997456
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDHD2,Phospholipase DDHD2,37959,-0.0208541591380221,0.00615467744448298,-0.0329173269292087,-0.00879099134683545,0.000705170950200916
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37835,-0.0184754967892216,0.00545899622118671,-0.0291751293827475,-0.00777586419569562,0.000715354306097972
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40471,-0.0148258498721154,0.00438494467324756,-0.0234203414316806,-0.00623135831255019,0.000723739492095787
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BGLAP,Osteocalcin,37998,0.0286092940265884,0.0084814927994982,0.0119855681395719,0.0452330199136049,0.000745233215290699
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MSTN,Growth/differentiation factor 8,40042,0.0160746299298908,0.00476710615526252,0.00673110186557623,0.0254181579942053,0.000748087867151831
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39980,-0.0290264144381905,0.00861834693152234,-0.0459183744239743,-0.0121344544524067,0.000759052296700083
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,40359,-0.00971500745458985,0.00288498557162898,-0.0153695791749827,-0.00406043573419705,0.00076050150946527
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,40359,0.0123985281612275,0.00368643349879527,0.0051731185035888,0.0196239378188663,0.000772023900092167
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40442,-0.0087140909795454,0.0025913030881067,-0.0137930450322345,-0.00363513692685626,0.000773310774001729
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMIGO2,Amphoterin-induced protein 2,40305,0.00705345436525067,0.00210110943215782,0.00293527987822134,0.01117162885228,0.000789742733508422
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37562,0.0102887354188884,0.00306582533524459,0.00427971776180896,0.0162977530759678,0.000793194584211246
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40379,-0.0104339912778441,0.00311019072902779,-0.0165299651067385,-0.00433801744894959,0.000796148595177032
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39978,-0.015281251608602,0.00456605280052426,-0.0242307150976295,-0.00633178811957445,0.000819709824601764
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICAM5,Intercellular adhesion molecule 5,40359,0.013747063363846,0.00410815261265185,0.00569508424304837,0.0217990424846436,0.000820907941958801
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37959,-0.0136072399770307,0.0040714158900471,-0.021587215121523,-0.00562726483253841,0.000833609317848997
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RLN1,Prorelaxin H1,37959,-0.0256995843626609,0.0076915603487397,-0.0407750426461907,-0.010624126079131,0.000836220652965367
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMPD3,AMP deaminase 3,37942,-0.0225168269702974,0.00675208004260157,-0.0357509038537965,-0.00928275008679836,0.000855913250598535
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EGF,Pro-epidermal growth factor,40324,-0.031877434284774,0.00956420188736718,-0.0506232699840137,-0.0131315985855343,0.000861130160835033
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MITD1,MIT domain-containing protein 1,40228,-0.0299320881770577,0.00899065867124232,-0.0475537791726926,-0.0123103971814227,0.000872818478959779
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOXJ3,Forkhead box protein J3,37598,-0.013505080346428,0.00406267772668358,-0.0214679286907278,-0.00554223200212814,0.000889207299614775
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40228,-0.00910551842314519,0.00274254089227413,-0.0144808985720025,-0.00373013827428789,0.000901882606492751
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD300C,CMRF35-like molecule 6,40471,-0.0105265040016534,0.00317074741762521,-0.0167411689401988,-0.00431183906310798,0.00090256890079114
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAMR1,Inactive serine protease PAMR1,40332,0.00860824276266276,0.00259357088028601,0.00352484383730218,0.0136916416880233,0.000905210725682276
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37959,-0.0286466469554535,0.00863393785842743,-0.0455691651579713,-0.0117241287529358,0.000909326513172235
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAMDC2,MAM domain-containing protein 2,37990,0.0104885921567195,0.00316428909952239,0.00428658552165557,0.0166905987917834,0.000919904988435407
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39980,-0.0263307652981176,0.00795663955403239,-0.0419257788240211,-0.0107357517722141,0.000937484136758891
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37901,-0.0197595520494543,0.00597518595101408,-0.0314709165134419,-0.00804818758546667,0.000945699921680655
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1R1,Interleukin-1 receptor type 1,40303,-0.00685935872160539,0.00207549230067841,-0.0109273236309351,-0.0027913938122757,0.000952105894576591
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL11,Eotaxin,40516,-0.0115570597441029,0.00350174025521221,-0.0184204706443188,-0.00469364884388692,0.000967656635933458
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40341,-0.0138496946518047,0.00420421870139675,-0.0220899633065424,-0.0056094259970671,0.000989049353688543
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37900,-0.0107373878467483,0.00326529880712586,-0.017137373508715,-0.00433740218478162,0.00101041506986524
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA4,Carbonic anhydrase 4,40536,0.00715045109000446,0.00217460619136029,0.00288822295493828,0.0114126792250706,0.00101061234280497
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL8,Interleukin-8,40209,-0.0207058224384822,0.0063047096878995,-0.0330630534267652,-0.00834859145019919,0.00102501394791455
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STAT2,Signal transducer and activator of transcription 2,37598,-0.0234354424930383,0.00714319036229391,-0.0374360956031343,-0.00943478938294222,0.00103779400817488
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37598,-0.0273724326375539,0.0083539057649151,-0.0437460879367875,-0.0109987773383203,0.00105336286532035
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCXR,L-xylulose reductase,40411,-0.015904631945367,0.00485745073146256,-0.0254252353790336,-0.00638402851170039,0.001061588097193
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WNT9A,Protein Wnt-9a,40044,0.00873478794634423,0.00267547064519974,0.00349086548175274,0.0139787104109357,0.00109790385926286
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37998,0.00786512329036525,0.00241028755272626,0.00314095968702178,0.0125892868937087,0.00110455180673664
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37900,-0.0100464965709099,0.00309105948933667,-0.0161049731700098,-0.00398801997181007,0.00115615974284361
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HBQ1,Hemoglobin subunit theta-1,40489,0.017855503764128,0.00549609429634611,0.00708315894328964,0.0286278485849664,0.00116146874192648
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VWC2,Brorin,40167,-0.0117351679992137,0.00361829086695144,-0.0188270180984385,-0.00464331789998884,0.00118404361070754
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40305,-0.0104717791914094,0.00322904456068321,-0.0168007065303485,-0.00414285185247032,0.00118524462351894
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYL4,Myosin light chain 4,37628,-0.0159083699846478,0.00490657806380626,-0.0255252629897081,-0.00629147697958757,0.00118883411520876
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,40228,0.0152382755436541,0.0047020709548618,0.00602221647212502,0.0244543346151833,0.00119459378011661
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,40422,-0.0376371231915532,0.0116217414160008,-0.0604157363669148,-0.0148585100161916,0.00120401370579197
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STEAP4,Metalloreductase STEAP4,37541,0.0227888217663594,0.00703812457964242,0.00899409759026022,0.0365835459424585,0.00120708280319074
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,40044,-0.0131801463833982,0.00407223567336203,-0.0211617283031878,-0.00519856446360863,0.00121220773664494
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLRD1,Natural killer cells antigen CD94,40516,-0.0137058235689606,0.00424468209410391,-0.0220254004734043,-0.00538624666451695,0.00124499586014822
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,37541,0.0100105662470271,0.00310432677913115,0.00392608575993,0.0160950467341241,0.00126407974714814
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ECM1,Extracellular matrix protein 1,37655,0.0111424337766371,0.00345602408578122,0.00436862656850587,0.0179162409847683,0.00126693537597346
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39961,-0.0202506719799725,0.00629101008639734,-0.0325810517493113,-0.00792029221063369,0.00128909517838942
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIL1,Nucleotide exchange factor SIL1,37628,-0.00960446315981762,0.00298428865163182,-0.015453668917016,-0.00375525740261925,0.00129245748133144
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DBI,Acyl-CoA-binding protein,40270,-0.0235603826110631,0.00732799319807735,-0.0379232492792947,-0.00919751594283145,0.00130651518969317
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,40341,-0.0164972470369342,0.00513434403377824,-0.0265605613431396,-0.00643393273072891,0.00131564769910658
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LPP,Lipoma-preferred partner,37562,-0.0200224888094563,0.0062563563009052,-0.0322849471592305,-0.00776003045968211,0.00137590930524385
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMBS,Porphobilinogen deaminase,40489,-0.0135141244332165,0.00422776958879911,-0.0218005528272628,-0.00522769603917028,0.00139368775387289
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40434,-0.0218324790937123,0.00683507886576885,-0.0352292336706192,-0.00843572451680535,0.0014050022690411
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40341,-0.0213689852957894,0.0067048806502336,-0.0345105513702472,-0.00822741922133153,0.00143995615987459
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37990,-0.0139282078297016,0.00437233283891449,-0.0224979801939739,-0.00535843546542916,0.00144815611080538
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40332,-0.0112149911862337,0.00352086362887442,-0.0181158838988276,-0.00431409847363985,0.00144885726533832
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37959,-0.0194238768825166,0.00610627552541557,-0.0313921769123311,-0.0074555768527021,0.00147114914346835
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39887,-0.00544644466406775,0.00171829149274339,-0.00881429598984481,-0.0020785933382907,0.00152901696655495
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD72,B-cell differentiation antigen CD72,37671,-0.0125081655939102,0.00394621592286117,-0.0202427488027181,-0.00477358238510235,0.00152965036197777
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40490,-0.0094260757909375,0.00297974575314685,-0.0152663774671053,-0.00358577411476967,0.00156238180779986
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1R2,Interleukin-1 receptor type 2,40330,-0.00573796789164259,0.00181589847552581,-0.00929712890367318,-0.00217880687961199,0.0015814628585129
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX4,Syntaxin-4,40305,-0.0175727606346975,0.00556166873895208,-0.0284736313630436,-0.00667188990635145,0.00158271799607824
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LMOD1,Leiomodin-1,37959,0.0106640821379151,0.00337617265474707,0.00404678373461082,0.0172813805412193,0.00158861514613902
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39980,-0.0229895572742639,0.00727999180311844,-0.0372583412083761,-0.00872077334015178,0.00159208976692186
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40400,0.0188107359788135,0.00595692583973858,0.00713516133292586,0.0304863106247011,0.0015926495291905
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40341,-0.0281988879310004,0.00896361319254036,-0.0457675697883795,-0.0106302060736213,0.00165865845881454
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPTX2,Neuronal pentraxin-2,37998,0.00952324683804702,0.00303830807219429,0.00356816301654622,0.0154783306595478,0.00172578699736961
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PF4,Platelet factor 4,37934,-0.0283689225250655,0.00906108704723371,-0.0461286531376435,-0.0106091919124874,0.0017467239650702
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HNMT,Histamine N-methyltransferase,40147,-0.0135094615892429,0.00431755450968988,-0.021971868428235,-0.00504705475025073,0.00175746559949851
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37901,-0.0115210838238087,0.00368260912163277,-0.018738997702209,-0.0043031699454085,0.00176069613638091
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37900,-0.0191173252629775,0.00611144628302112,-0.0310957599776989,-0.00713889054825615,0.00176305167294166
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF2,Fibroblast growth factor 2,40341,-0.0192735969848385,0.00616180372492651,-0.0313507322856945,-0.00719646168398253,0.00176369265272454
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX8,Syntaxin-8,40341,-0.0142102869727014,0.00454530701310334,-0.0231190887183839,-0.00530148522701884,0.00177301127892966
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40502,-0.0147345434613588,0.0047353304775445,-0.024015791197346,-0.00545329572537155,0.00186391017727667
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRSS22,Brain-specific serine protease 4,37598,-0.010239616433343,0.00329195303766277,-0.016691844387162,-0.00378738847952398,0.00187171150199864
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLIN1,Perilipin-1,39961,-0.0102658941393251,0.00330139836455437,-0.0167366349338517,-0.0037951533447985,0.00187706014102978
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSC22D1,TSC22 domain family protein 1,37959,-0.0194508470715667,0.00626072484520719,-0.0317218677681728,-0.00717982637496065,0.00189513608043953
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37562,0.0116972051550573,0.00376500612074535,0.00431779315839637,0.0190766171517181,0.00189513947626814
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF19,Fibroblast growth factor 19,40422,0.0221296589660612,0.00712856787217563,0.00815766593659695,0.0361016519955254,0.00191022885711294
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,40136,0.00852658596280887,0.00275456553812603,0.00312763750808185,0.0139255344175359,0.00196868817281423
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTNNA1,Catenin alpha-1,37541,0.0104911510485592,0.00338948961142775,0.00384775141016078,0.0171345506869576,0.00197094712014479
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOH,Beta-2-glycoprotein 1,40332,-0.0102055248967703,0.00329864068462898,-0.0166708606386431,-0.00374018915489746,0.00197915281995847
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,37671,-0.0212809843202121,0.00687988934903458,-0.0347655674443199,-0.00779640119610437,0.00198412651797145
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL17A,Interleukin-17A,40028,-0.0123179992464959,0.00398248120470864,-0.0201236624077249,-0.00451233608526699,0.00198463520882941
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37942,-0.0261653013144031,0.0084637128965038,-0.0427541785915505,-0.00957642403725564,0.00199575138594292
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37572,-0.0174535243175783,0.00564704359976817,-0.0285217297731239,-0.00638531886203266,0.00200078774877682
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL2A1,Collagen alpha-1(II) chain,37628,-0.0236888371483214,0.00766650149521377,-0.0387151800789403,-0.00866249421770236,0.00200630933695754
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NT5E,5'-nucleotidase,40411,0.0166187078314148,0.00537920477964199,0.00607546646331651,0.0271619491995131,0.00200881711534866
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASAH2,Neutral ceramidase,40228,-0.0150683848798411,0.00488970129444407,-0.0246521994169515,-0.00548457034273073,0.00206206129759297
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB44,Ras-related protein Rab-44,37900,-0.0114242133417292,0.00370877123324842,-0.0186934049588961,-0.00415502172456234,0.00207193459711886
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNG,Interferon gamma,40044,-0.032631758433555,0.0105994495353808,-0.0534066795229013,-0.0118568373442086,0.00208317584289358
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRKL,Crk-like protein,40374,-0.0304534559149793,0.00990624769305696,-0.049869701393371,-0.0110372104365877,0.00211448613940455
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STK24,Serine/threonine-protein kinase 24,39961,-0.0176507069093536,0.00575211598400792,-0.0289248542380091,-0.00637655958069806,0.00215464977535037
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,40359,-0.018967682785561,0.00618396401981079,-0.0310882522643902,-0.00684711330673186,0.002164103634437
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRGN,Neurogranin,37987,-0.0258749991130735,0.0084399835119377,-0.0424173667964714,-0.00933263142967564,0.00217542276471121
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39980,-0.0162797144819404,0.00532003928008146,-0.0267069914709001,-0.00585243749298079,0.0022165966793887
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37628,-0.0292858382152731,0.0095714818408017,-0.0480459426232445,-0.0105257338073018,0.0022200592946
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSPAN15,Tetraspanin-15,37562,0.0145725194649065,0.00477213465184233,0.00521913554729555,0.0239259033825175,0.00226514641708215
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37959,-0.0215222067696888,0.00704854649437132,-0.0353373578986565,-0.00770705564072096,0.00226685567246148
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40471,-0.0190097525890763,0.0062277905866211,-0.0312162221388537,-0.00680328303929896,0.0022738585374368
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,40341,-0.0296254045693201,0.00972688520341664,-0.0486900995680167,-0.0105607095706235,0.00232501379894311
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUB1,NEDD8 ultimate buster 1,40341,-0.0236541745459984,0.00776711439584742,-0.0388777187618594,-0.00843063033013746,0.00232731275065219
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,XG,Glycoprotein Xg,40458,0.00848308576485895,0.00278717512483952,0.00302022252017349,0.0139459490095444,0.00234133948029413
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH22,Cadherin-22,37714,0.00836736336299477,0.00275320902288961,0.00297107367813113,0.0137636530478584,0.00237723641938663
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEPTIN8,Septin-8,37921,-0.00900775616463352,0.0029661214483305,-0.0148213542033613,-0.00319415812590575,0.00239497442075684
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRSF1,G-rich sequence factor 1,37402,-0.0223537409471605,0.00736222364092785,-0.0367836992833791,-0.00792378261094189,0.00239996342233026
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AAMDC,Mth938 domain-containing protein,37628,-0.0151476679211675,0.00499660072374814,-0.0249410053397139,-0.00535433050262115,0.00243738248783291
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37562,-0.0100943723220487,0.00333197458302636,-0.0166250425047803,-0.003563702139317,0.00245398128807739
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPI,Glucose-6-phosphate isomerase,37987,-0.0132089038914108,0.0043629248104598,-0.021760236519912,-0.00465757126290955,0.00247021844884296
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37562,-0.0113913644775425,0.00376775471355942,-0.018776163716119,-0.00400656523896609,0.00250449138239033
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37901,-0.0131341711675682,0.00434705510638083,-0.0216543991760747,-0.0046139431590618,0.00252085790059433
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37900,-0.0122268039150342,0.00404687895886162,-0.0201586866744029,-0.00429492115566537,0.00252171473605459
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37642,-0.0240347379289227,0.00796033771313696,-0.0396369998466712,-0.0084324760111743,0.002538344444173
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37714,-0.0148189578462565,0.00490866483029781,-0.0244399409136402,-0.00519797477887277,0.00254144075164309
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AP2B1,AP-2 complex subunit beta,37572,-0.0137555142069932,0.00455974989791172,-0.0226926240069002,-0.00481840440708623,0.00256010647284247
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37998,0.0139666671063258,0.00463079132679925,0.00489031610579931,0.0230430181068524,0.0025657160358045
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,37598,0.0124413510633297,0.00413002218249251,0.00434650758564439,0.020536194541015,0.00259668958598818
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37928,-0.0114229834514652,0.00379228138733432,-0.0188558549706404,-0.00399011193228992,0.00259871417877328
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37959,-0.0176766923597047,0.00587725744455559,-0.0291961169510337,-0.00615726776837577,0.00263766881553305
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MPO,Myeloperoxidase,40332,-0.0130498829680777,0.00434622461543929,-0.0215684832143387,-0.0045312827218167,0.00268119010532149
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40536,0.0082407752655509,0.00274686315047672,0.00285692349061653,0.0136246270404853,0.0027033307951537
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37901,-0.00762404206514409,0.00254140261428933,-0.0126051911891512,-0.002642892941137,0.00270532032896514
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RGMA,Repulsive guidance molecule A,40471,0.00863027443455341,0.00287760424366788,0.00299017011696436,0.0142703787521425,0.00271178416279085
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,38013,0.00754289770106533,0.00251526536218441,0.00261297759118389,0.0124728178109468,0.00271494371119029
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PADI4,Protein-arginine deiminase type-4,39934,-0.019414231682058,0.00647882468459212,-0.0321127280638586,-0.00671573530025749,0.00273470932329437
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DENR,Density-regulated protein,37598,-0.0160549417269199,0.00535912256589333,-0.0265588219560708,-0.00555106149776898,0.00274222435412072
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39980,-0.0274899298241307,0.00918315305925685,-0.0454889098202741,-0.00949094982798723,0.00276215708309927
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LEG1,Protein LEG1 homolog,37231,0.0194544768676554,0.00649917418062399,0.00671609547363233,0.0321928582616784,0.00276436558680302
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMCN2,Hemicentin-2,37648,-0.0159338689320922,0.00533260137410776,-0.0263857676253434,-0.00548197023884098,0.00281316515659594
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX7,Syntaxin-7,37598,-0.0139629660553794,0.00468423873642545,-0.0231440739787732,-0.00478185813198549,0.00287985211570032
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40310,-0.0174848682876219,0.00587152283308063,-0.02899305304046,-0.0059766835347839,0.00290659738584082
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EZR,Ezrin,40471,-0.0065360921590006,0.00219870729801169,-0.0108455584631035,-0.00222662585489769,0.00295634064281667
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40341,0.0167960819857232,0.00565555134996369,0.00571120133979436,0.027880962631652,0.00298400213359274
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYDGF,Myeloid-derived growth factor,37990,-0.0277256298425803,0.00933844125139774,-0.0460289746953199,-0.00942228498984077,0.00299315130753881
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PALM2,Paralemmin-2,37942,-0.0101860389862269,0.00343813714554054,-0.0169247877914863,-0.00344729018096741,0.00305523160079923
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,40332,0.00894595933286188,0.00302132452201563,0.00302416326971124,0.0148677553960125,0.00307155664583244
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37564,-0.00786165124549923,0.00265816206471595,-0.0130716488923425,-0.00265165359865597,0.00310646035972547
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DLK1,Protein delta homolog 1,40536,-0.0145768080710848,0.00493161879703844,-0.0242427809132801,-0.00491083522888942,0.00312326222912937
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL2,C-C motif chemokine 2,40203,-0.0145575590961418,0.00492567815204924,-0.0242118882741583,-0.00490322991812525,0.0031268313608499
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DTNB,Dystrobrevin beta,37878,-0.0114622465839083,0.00387920726037636,-0.019065492814246,-0.00385900035357068,0.00313424131203595
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEMIP2,Cell surface hyaluronidase,37598,-0.00927837092957814,0.00314355391611691,-0.0154397366051673,-0.003117005253989,0.00316737031227919
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37998,0.0081002150482207,0.00274875821028828,0.00271264895605567,0.0134877811403857,0.00321561921802716
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GMPR2,GMP reductase 2,37671,-0.0186061284006331,0.00631494469944084,-0.0309834200115371,-0.00622883678972904,0.00322094409193758
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,37598,-0.0267596097458635,0.00908942301042543,-0.0445748788462973,-0.00894434064542961,0.00324526688712288
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,40311,-0.023965344432452,0.00814791309472114,-0.0399352540981054,-0.00799543476679851,0.0032732477383641
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCRL1,Fc receptor-like protein 1,40359,0.0122966653231376,0.004191802114296,0.00408073317911747,0.0205125974671578,0.00335638402136875
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLIC5,Chloride intracellular channel protein 5,37572,0.00882500921219528,0.00301443451641417,0.00291671756002351,0.014733300864367,0.00342193936529458
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40450,-0.00824575724891369,0.00282388752088141,-0.0137805767898413,-0.00271093770798613,0.00350517545140362
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,40359,-0.0215046512838498,0.00737475376793993,-0.0359591686690121,-0.00705013389868757,0.00355065746521793
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA10,Annexin A10,39961,-0.0224323258438914,0.00770110267949143,-0.0375264870956946,-0.00733816459208819,0.00358632355849817
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37628,-0.0198758046314632,0.00683756246956382,-0.0332774270718083,-0.00647418219111815,0.00365690565091615
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RRAS,Ras-related protein R-Ras,37572,-0.0352880825635091,0.0121539547575995,-0.0591098338884041,-0.0114663312386142,0.0036972188739565
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL26,C-C motif chemokine 26,40341,0.023995053404104,0.00826991175225861,0.00778602636967715,0.0402040804385309,0.00371904344751887
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37714,-0.00940010388832204,0.00323976339689753,-0.0157500401462412,-0.00305016763040288,0.00372017169619505
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CMIP,C-Maf-inducing protein,37900,-0.0221181050982857,0.00762944749652988,-0.0370718221914842,-0.00716438800508713,0.00374907507904018
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40357,0.00799892205206616,0.00276010106926585,0.0025891239563051,0.0134087201478272,0.00375998645603549
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,37482,0.0155927165581676,0.0053813252059855,0.00504531915443599,0.0261401139618991,0.00376703468692837
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37942,-0.0143088143312076,0.00494285375266059,-0.0239968076864224,-0.00462082097599287,0.00379949534658045
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCRL6,Fc receptor-like protein 6,40341,-0.0181782660713873,0.00628946731593932,-0.0305056220106284,-0.00585091013214624,0.00385430687949286
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37959,-0.0132928961581234,0.00460481818727122,-0.0223183398051749,-0.00426745251107177,0.00389877385492817
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF5,Fibroblast growth factor 5,40044,0.00868676723748912,0.00300964859570948,0.00278785598989854,0.0145856784850797,0.00390327830825807
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INSL4,Early placenta insulin-like peptide,37900,-0.0145173348888563,0.00504173568111163,-0.0243991368238351,-0.0046355329538775,0.0039902084184502
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,40328,-0.0097275200685719,0.00338004660230494,-0.0163524114090896,-0.00310262872805421,0.00400834469948624
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37337,-0.0132321343198608,0.00460083480053096,-0.0222497705289015,-0.0042144981108201,0.00403373061121295
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37572,0.0176764405966402,0.00615798669748398,0.00560678666957158,0.0297460945237088,0.00410491267387918
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,40437,-0.0216872834106312,0.00755677513553073,-0.0364985626762714,-0.00687600414499097,0.00411123881749808
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD300E,CMRF35-like molecule 2,40436,-0.0106571341370228,0.00371449589473832,-0.0179375460907099,-0.00337672218333571,0.00412225172944324
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37901,-0.0371932123062818,0.0129683775534808,-0.0626112323111041,-0.0117751923014595,0.00413727442945877
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,40287,-0.0236850794508663,0.00826016980294952,-0.0398750122646473,-0.00749514663708521,0.00414426579998216
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LIFR,Leukemia inhibitory factor receptor,40341,0.00653723314366918,0.00228061421774036,0.00206722927689807,0.0110072370104403,0.0041566829843498
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNPO1,Transportin-1,37714,0.00948896555985509,0.00331374319074367,0.00299402890599749,0.0159839022137127,0.00419621095590931
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40341,-0.0267599749130011,0.00934906529931938,-0.045084142899667,-0.00843580692633508,0.00421107567050878
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VEGFC,Vascular endothelial growth factor C,40411,-0.0148191724996769,0.0051901398322153,-0.0249918465708189,-0.00464649842853494,0.00430577429472316
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37901,-0.00794102142599911,0.00278253938265101,-0.0133947986159951,-0.00248724423600314,0.00432554055528903
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD59,CD59 glycoprotein,39665,-0.00599677333833562,0.00210304265361473,-0.0101187369394205,-0.00187480973725075,0.00435755071900212
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HS1BP3,HCLS1-binding protein 3,37628,-0.0237035700095994,0.00832674247512396,-0.0400239852608423,-0.00738315475835643,0.00442460228222795
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK4,Kallikrein-4,40489,0.0160574426560725,0.00565860751920944,0.00496657191842197,0.027148313393723,0.00454965861217659
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40489,-0.00935614868407075,0.00329934419290234,-0.0158228633021593,-0.00288943406598216,0.00457739967543537
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNX5,Sorting nexin-5,37628,-0.00791496217865014,0.00279378533863106,-0.013390781442367,-0.00243914291493327,0.00461747034459863
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,40305,-0.0118575042735714,0.00418610898124388,-0.0200622778768094,-0.00365273067033339,0.00462317025821409
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OBP2B,Odorant-binding protein 2b,40184,0.0174451091107764,0.00617141016337713,0.00534914519055722,0.0295410730309956,0.00470805445053708
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLAMF8,SLAM family member 8,39980,-0.0140747412203431,0.00498007758092379,-0.0238356932789537,-0.00431378916173243,0.00471626433381771
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATXN2L,Ataxin-2-like protein,37959,-0.0126851400713098,0.00449018960932617,-0.0214859117055891,-0.00388436843703051,0.00473382753039019
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39976,-0.0204484663616859,0.00725297612882297,-0.034664299574179,-0.0062326331491929,0.00481863356166352
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PARK7,Parkinson disease protein 7,40332,-0.0140151041353589,0.00497170818242004,-0.0237596521729022,-0.00427055609781561,0.00482373925298746
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FRZB,Secreted frizzled-related protein 3,40176,0.00699647896627812,0.00248202341570213,0.00213171307150195,0.0118612448610543,0.00482546005548993
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37990,-0.0105034703289369,0.0037282741119492,-0.0178108875883573,-0.00319605306951647,0.00485073560943962
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EVPL,Envoplakin,37714,0.00906807871441183,0.0032228659056482,0.00275126153934137,0.0153848958894823,0.00490516725594627
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICA1,Islet cell autoantigen 1,40044,-0.0207749540475247,0.00738405838998346,-0.0352477084918923,-0.00630219960315711,0.00490686560670944
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RWDD1,RWD domain-containing protein 1,40471,-0.0168313918637031,0.0059853916976506,-0.0285627595910982,-0.00510002413630791,0.00492823178907804
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEC31A,Protein transport protein Sec31A,37628,-0.0200318136763709,0.00712405544787094,-0.033994962354198,-0.00606866499854387,0.00493294335124584
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBC1D17,TBC1 domain family member 17,39961,-0.0120538871649126,0.00428895190375489,-0.0204602328962722,-0.00364754143355302,0.00495341887179309
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37598,-0.0150340304676933,0.00535135988229588,-0.0255226958369932,-0.00454536509839336,0.00497095259647968
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39961,-0.0168513964746222,0.0060098805438775,-0.0286307623406221,-0.00507203060862235,0.00505436760076189
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37990,-0.016534022132495,0.00589899583135225,-0.0280960539619454,-0.00497199030304456,0.00507246570442652
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL5,C-X-C motif chemokine 5,40309,-0.0298638980737427,0.0106718679848055,-0.0507807593239616,-0.00894703682352387,0.00514222809458753
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F2R,Proteinase-activated receptor 1,40396,-0.0149582660951627,0.00534657741832864,-0.0254375578350868,-0.00447897435523853,0.00515252395154823
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,37541,0.00894352713841252,0.00319870128025075,0.00267407262912105,0.015212981647704,0.00518168981095995
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37628,-0.0242811885506009,0.00868448172609971,-0.0413027727337563,-0.00725960436744543,0.00518257975154139
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,40359,-0.0176466173387977,0.0063184447762749,-0.0300307691002965,-0.00526246557729885,0.00523045071666475
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PXDNL,Peroxidasin-like protein,37900,0.0152406128615813,0.00545711152231086,0.00454467427785198,0.0259365514453106,0.0052328053816395
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40305,0.00517219487548833,0.00185376545774713,0.00153881457830396,0.00880557517267271,0.00527543485144972
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",40228,-0.0152218281452879,0.00545778702876316,-0.0259190907216637,-0.00452456556891213,0.00529326221233799
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CIT,Citron Rho-interacting kinase,37572,-0.011723128835635,0.00420393283494446,-0.0199628371921261,-0.00348342047914384,0.00530110197282054
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39961,-0.0125997996276413,0.00453562423609784,-0.0214896231303931,-0.00370997612488955,0.00547664550634612
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YWHAQ,14-3-3 protein theta,37671,-0.0190860123767034,0.00687093058672051,-0.0325530363266756,-0.00561898842673118,0.00548068755741987
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOS1,"Nitric oxide synthase, brain",39961,-0.012910596049206,0.00465286027000835,-0.0220302021784224,-0.00379098991998963,0.00553076337818469
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGL1,Fibrinogen-like protein 1,37987,-0.016227640447157,0.00585341062382888,-0.0277003252698616,-0.00475495562445242,0.00557310652671407
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37562,0.0134663669525994,0.00486712653813199,0.00392679893786073,0.0230059349673381,0.00566887461963793
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NXPH1,Neurexophilin-1,39961,0.00970661648757068,0.00351649679742372,0.0028142827646202,0.0165989502105212,0.00578145939688904
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBP2,Retinol-binding protein 2,40305,0.0195684292225518,0.00709365405020997,0.00566486728414028,0.0334719911609634,0.00581192129960322
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAPG,Macrophage-capping protein,40185,-0.0148627719481861,0.00540159707040578,-0.0254499022061814,-0.00427564169019075,0.00593815955830689
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LMNB2,Lamin-B2,37942,-0.00700395891086745,0.00254609734032686,-0.0119943096979081,-0.00201360812382681,0.00595181973535341
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTGES2,Prostaglandin E synthase 2,37484,-0.0139756128109584,0.00509058159180303,-0.0239531527308924,-0.0039980728910245,0.00605225545473271
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,40042,-0.0190978205645464,0.00696133182410128,-0.0327420309397849,-0.00545361018930787,0.0060873313088164
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,40044,-0.0152069202774389,0.00555269135938829,-0.02609019534184,-0.00432364521303788,0.00617606380028931
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37901,-0.027687148656847,0.0101188982079599,-0.0475201891444484,-0.00785410816924557,0.00622381721393164
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL10,C-X-C motif chemokine 10,40422,-0.0171809888003473,0.00627967621265889,-0.0294891541771588,-0.0048728234235359,0.00622659147117831
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPP7,Dipeptidyl peptidase 2,40251,-0.0147782335593435,0.00540205620590685,-0.0253662637229209,-0.0041902033957661,0.006232324436628
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37598,-0.0234928262643059,0.00859377078312751,-0.0403366169992359,-0.00664903552937602,0.00627101000124765
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39961,-0.0213231351004077,0.00780650924513594,-0.0366238932208741,-0.00602237697994124,0.0063126498738097
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37628,-0.0164942978702424,0.00604065317380701,-0.0283339780909041,-0.00465461764958067,0.00633130482883083
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF20,Fibroblast growth factor 20,37598,0.0113876882763692,0.00417061272253763,0.00321328734019542,0.0195620892125429,0.00633304118651259
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD276,CD276 antigen,40357,0.0091468718656274,0.00335050799628751,0.00257987619290387,0.0157138675383509,0.00634048864869181
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUSD1,Sushi domain-containing protein 1,40042,-0.0125110952708937,0.0045878149464199,-0.0215032125658767,-0.00351897797591069,0.0063979282421439
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HCG22,Protein PBMUCL2,37562,0.0136071589282828,0.0049932864579598,0.00382031747068161,0.023394000385884,0.00643690896705774
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRCAM,Neuronal cell adhesion molecule,40359,0.00708885633561216,0.002605461348639,0.00198215209227972,0.0121955605789446,0.00652012212207016
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37790,-0.0141626620698925,0.00522227375684452,-0.0243983186333078,-0.00392700550647726,0.00669698864609139
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP2,Caspase-2,40341,-0.0170316577933611,0.00628886079695766,-0.0293578249553982,-0.00470549063132413,0.00677163024055963
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UROD,Uroporphyrinogen decarboxylase,37671,-0.0177458787871885,0.00655312338339209,-0.030590000618637,-0.00490175695574,0.00677764497042425
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39980,0.0136352915202056,0.00503998240534174,0.00375692600573578,0.0235136570346754,0.00682916109435481
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NIT2,Omega-amidase NIT2,37936,-0.01899754006199,0.00703060174457542,-0.0327775194813578,-0.0052175606426222,0.00689847907590027
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37598,0.0074041590540234,0.00274251346744116,0.00202883265783872,0.0127794854502081,0.00694759387752663
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL5,Interleukin-5,40044,0.0367514293564258,0.0136164053779966,0.0100632748155524,0.0634395838972992,0.00696115825825784
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39961,-0.00970762544602157,0.00359769139886319,-0.0167591005877934,-0.00265615030424972,0.00697715046159556
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNX18,Sorting nexin-18,37901,-0.0114201446418055,0.00423383250073703,-0.0197184563432501,-0.00312183294036096,0.00699800722168207
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,40516,-0.0147076862049277,0.00545625551171285,-0.0254019470078849,-0.00401342540197049,0.0070342726053897
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37863,0.0108472045389702,0.0040345317337836,0.00293952234075433,0.018754886737186,0.00718429982223709
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS3,Galectin-3,40374,-0.00739433153904878,0.0027509852514396,-0.0127862626318704,-0.00200240044622716,0.00719809544809613
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP1,Caspase-1,39961,-0.0168318041061607,0.00627152019803098,-0.0291239836943014,-0.00453962451801996,0.00728575554158307
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37959,-0.0225004657164835,0.00839971209804262,-0.038963901428647,-0.00603703000431997,0.00739939375704376
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37990,-0.00625793278302212,0.00234080829900793,-0.0108459170490777,-0.00166994851696657,0.00751752013344359
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SDC1,Syndecan-1,40359,0.00996081429465918,0.00372633128658597,0.00265720497295069,0.0172644236163677,0.00752330459136814
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40305,-0.00925016045592566,0.00346667436699342,-0.0160448422152328,-0.00245547869661856,0.00763115275593958
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,37541,0.014385488983916,0.00539454221162769,0.00381218624912573,0.0249587917187063,0.00766999746860527
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NTF3,Neurotrophin-3,40341,0.00867546280150268,0.00325499338164273,0.00229567577348294,0.0150552498295224,0.00770024236117093
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIMAP8,GTPase IMAP family member 8,37482,-0.0128443690677521,0.00482981951109337,-0.0223108153094951,-0.00337792282600907,0.00783782510204203
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFRA1,GDNF family receptor alpha-1,40453,-0.00684907942959423,0.00258646954540483,-0.0119185597385877,-0.00177959912060077,0.00810389204767491
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DMD,Dystrophin,37628,-0.0128149922616108,0.00484600907049561,-0.0223131700397822,-0.00331681448343941,0.00819226020199601
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBCC,Tubulin-specific chaperone C,40228,-0.0199706603398155,0.00756104705315865,-0.0347903125640064,-0.0051510081156245,0.00826807148726354
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37959,-0.00975883643683355,0.00369539917675656,-0.0170018188232764,-0.00251585405039068,0.00828039579921085
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39961,-0.0179870403676337,0.00682327055557071,-0.0313606506565523,-0.0046134300787151,0.00839406563573421
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFHR2,Complement factor H-related protein 2,37911,-0.0140466013930972,0.00533163262925799,-0.0244966013464428,-0.00359660143975152,0.00843384339887756
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX16,Syntaxin-16,39980,-0.014474936435271,0.0054947781959875,-0.0252447016994065,-0.00370517117113554,0.00843926884413642
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COMT,Catechol O-methyltransferase,39877,-0.0208777563733413,0.00793019187745723,-0.0364209324531575,-0.00533458029352512,0.00847954274801745
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,40411,-0.0204805352522204,0.00778064983845112,-0.0357306089355845,-0.00523046156885617,0.00849056467237705
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REST,RE1-silencing transcription factor,37482,0.0088238180917275,0.00335245122183461,0.00225301369693166,0.0153946224865233,0.00849714932455195
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPSG1,Tryptase gamma,37598,0.00669558112951846,0.00254620623362333,0.00170501691161673,0.0116861453474202,0.00855772958826466
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB10,Ras-related protein Rab-10,37990,-0.0131258107062851,0.004994185812064,-0.0229144148979306,-0.00333720651463967,0.00859302737133188
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UNC79,Protein unc-79 homolog,37482,-0.0138566793128457,0.00527461859036418,-0.0241949317499595,-0.00351842687573188,0.00862298671140256
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37671,-0.00766647714643367,0.00292409381351013,-0.0133977010209135,-0.00193525327195382,0.00875592332162113
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ROBO1,Roundabout homolog 1,40379,0.00586400175416139,0.00224181882471371,0.00147003685772252,0.0102579666506003,0.00891198554315011
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEO1,Neogenin,37959,0.0051945058858948,0.00198768481871664,0.00129864364121019,0.00909036813057942,0.00897601704139231
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40044,-0.0132975667848701,0.00509349911473603,-0.0232808250497527,-0.00331430851998746,0.00904451983193887
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37900,-0.011629673060759,0.0044560610879688,-0.0203635527931779,-0.00289579332834019,0.00906809918565082
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37959,-0.0165830972070565,0.00635420403492811,-0.0290373371155156,-0.00412885729859741,0.00906994676669238
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL17,C-X-C motif chemokine 17,40516,-0.0100474789468526,0.00385155428624541,-0.0175965253478936,-0.00249843254581156,0.00909759344114241
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37901,0.0133437633038604,0.00511857689883173,0.00331135258215018,0.0233761740255706,0.00914592910215201
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CREG1,Protein CREG1,40145,-0.00872230331369174,0.00334715539465717,-0.0152827278872198,-0.00216187874016369,0.00917236613728158
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TG,Thyroglobulin,37900,0.0284585317534945,0.0109369204230146,0.00702216772438579,0.0498948957826032,0.00927670175498936
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A13,Protein S100-A13,37598,0.00843927394577134,0.00324507627511231,0.00207892444655122,0.0147996234449915,0.00931542993718593
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37671,-0.0131932675968862,0.00507695896910683,-0.0231441071763356,-0.00324242801743686,0.00936935292413006
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BOLA1,BolA-like protein 1,37541,-0.0132476756013498,0.00511024659029466,-0.0232637589183274,-0.0032315922843723,0.00954217549698374
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAGED1,Melanoma-associated antigen D1,39980,-0.0117076603168695,0.00452079124646142,-0.0205684111599339,-0.00284690947380507,0.00961389497167014
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40228,-0.0251816908577923,0.00973588102142037,-0.0442640176597762,-0.00609936405580836,0.00970496459581285
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGMN,Legumain,40422,-0.00853720046686706,0.00330366416992777,-0.0150123822399255,-0.00206201869380863,0.00977041126077586
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40403,0.0102511737807632,0.00396723697162579,0.00247538931637667,0.0180269582451498,0.00977617437637909
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENPEP,Glutamyl aminopeptidase,37562,0.0112003606351523,0.00433573230874887,0.00270232531000455,0.0196983959603001,0.00979763887282634
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39980,-0.008152714769406,0.00316027216266912,-0.0143468482082375,-0.00195858133057453,0.00989626638235712
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CBS,Cystathionine beta-synthase,37628,-0.0122052055357408,0.00473174964025668,-0.0214794348306439,-0.00293097624083769,0.00990715544562036
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37942,0.00958687948412447,0.00371713747969793,0.00230129002391653,0.0168724689443324,0.00991622194503356
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37598,-0.0117186383656415,0.00454562108859817,-0.0206280556992939,-0.00280922103198905,0.00994801028304426
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37598,-0.00843832117413638,0.00327635819781848,-0.0148599832418606,-0.00201665910641216,0.0100198149112859
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37990,-0.0154418060015556,0.00600492344838869,-0.0272114559603974,-0.00367215604271374,0.0101357670213009
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FIS1,Mitochondrial fission 1 protein,40354,-0.0184485176540511,0.00717760555277869,-0.0325166245374973,-0.00438041077060484,0.0101704006244051
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNLZ,DNL-type zinc finger protein,37541,0.022820663449895,0.00888959470028253,0.00539705783734128,0.0402442690624488,0.0102656968874572
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD300A,CMRF35-like molecule 8,37671,-0.0070764447981582,0.0027573273305607,-0.0124808063660572,-0.00167208323025924,0.0102865079525325
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERI1,3'-5' exoribonuclease 1,37714,-0.00800933947385682,0.00313350871162247,-0.0141510165486369,-0.00186766239907678,0.0105984727922579
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGA2,Integrin alpha-2,37671,0.00801567436349129,0.00315436573194817,0.00183311752887287,0.0141982311981097,0.0110606013642582
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40536,0.00981878253177154,0.00386751400007932,0.00223845509161607,0.017399109971927,0.0111331914396163
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SULT1A1,Sulfotransferase 1A1,40471,-0.0302068711605897,0.0119610227074938,-0.0536504756672776,-0.00676326665390176,0.0115648439238048
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOL1,Apolipoprotein L1,37987,0.0153199538098515,0.0060663826107996,0.00342984389268431,0.0272100637270187,0.0115684689938567
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PKD2,Polycystin-2,37562,-0.0140074861331317,0.00555432733716239,-0.0248939677139699,-0.00312100455229338,0.0116838676873203
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37541,0.014443142629875,0.0057381534158883,0.00319636193473393,0.0256899233250161,0.0118464987395298
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYL3,Myosin light chain 3,37628,-0.0160119064308115,0.00637530213237111,-0.0285074986102589,-0.00351631425136414,0.0120320006312568
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC1,Sialoadhesin,40422,-0.0101211048992231,0.00403268640191633,-0.0180251702469791,-0.0022170395514671,0.0120908822466544
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRDX6,Peroxiredoxin-6,40489,-0.0139285807073043,0.00556049300424828,-0.024827146995631,-0.00303001441897769,0.0122578061049705
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FMR1,Synaptic functional regulator FMR1,39980,-0.00818195515919642,0.00326968071807248,-0.0145905293666185,-0.00177338095177435,0.0123466445892798
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37541,0.0135362751107205,0.00541165988197271,0.00292942174205397,0.024143128479387,0.0123853642434378
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40536,-0.0090997140035634,0.00363895476845141,-0.0162320653497282,-0.00196736265739863,0.0124067990302563
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37900,-0.00938195416181286,0.00375570784112165,-0.0167431415304113,-0.00202076679321443,0.0124996278505917
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,37628,-0.0123652759009631,0.00495027544367813,-0.0220678157705722,-0.00266273603135394,0.0125053590339135
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GTPBP2,GTP-binding protein 2,37572,-0.0185705400873035,0.00744394432865155,-0.0331606709714605,-0.00398040920314647,0.0126179354433775
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37671,-0.0165353018583373,0.00663300662612164,-0.0295359948455357,-0.00353460887113889,0.0126832398860652
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37572,0.0182465186896559,0.00732991665521955,0.0038798820454256,0.0326131553338862,0.0128110115825245
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMS,Spermine synthase,37541,-0.0148055987295305,0.00595953697261512,-0.0264862911958561,-0.00312490626320485,0.0129910835450057
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39980,0.0110348282015505,0.00445234015822455,0.00230824149143038,0.0197614149116706,0.0132066214865543
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMOX1,Heme oxygenase 1,40184,0.0108158646703818,0.00436463256118172,0.00226118485046564,0.019370544490298,0.0132199381264129
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAL,Galanin peptides,40422,0.0144061206838208,0.0058137537672649,0.00301116329998156,0.02580107806766,0.013224674237969
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",40332,-0.0178217677640572,0.00719327783531375,-0.0319205923212722,-0.00372294320684225,0.0132387891291675
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD83,CD83 antigen,40341,-0.00775200869424393,0.00313027220916548,-0.0138873422242083,-0.0016166751642796,0.0132794062991009
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40400,-0.0120046719633996,0.00485093320772537,-0.0215125010505413,-0.00249684287625784,0.0133446127364811
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TJP3,Tight junction protein ZO-3,37541,0.0101594541203384,0.00410651508989504,0.00211068454414412,0.0182082236965327,0.0133741405998534
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DBNL,Drebrin-like protein,40422,-0.0212313979869305,0.00858520710749631,-0.0380584039176233,-0.00440439205623773,0.013407953648967
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ELOB,Elongin-B,37562,-0.00922979961066598,0.00374530866878563,-0.0165706046014858,-0.00188899461984614,0.0137384399325933
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39980,-0.0145104205562378,0.00589042134255777,-0.026055646387651,-0.00296519472482455,0.0137736744552863
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SDHB,Succinate dehydrogenase,37901,0.0162905517125903,0.00661867078817292,0.00331795696777136,0.0292631464574092,0.0138558179658961
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINB6,Serpin B6,40433,-0.0136117058516839,0.00554934983906895,-0.024488431536259,-0.00273498016710874,0.0141836713473583
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DBH,Dopamine beta-hydroxylase,37967,0.0241488625881543,0.00984678290112203,0.00484916810195509,0.0434485570743534,0.0142007809628191
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,40411,-0.00758235566138783,0.00309217697870175,-0.0136430225396433,-0.0015216887831324,0.0142127888970504
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OPHN1,Oligophrenin-1,37942,-0.0243734876386556,0.00993962583450989,-0.043855154274295,-0.00489182100301622,0.014212989410804
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPB2,Carboxypeptidase B2,37981,0.00510681842568323,0.00208291741529239,0.00102430029171015,0.00918933655965631,0.0142284030181232
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40341,-0.00764928300759191,0.00312825406707782,-0.0137806609790644,-0.00151790503611937,0.0144869860020187
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNL1,Interferon lambda-1,39961,-0.0103361661296215,0.00422929135903401,-0.0186255771933282,-0.00204675506591483,0.0145386024010465
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DOK1,Docking protein 1,37942,-0.0309827058297246,0.0126781962196063,-0.055831970420153,-0.00613344123929615,0.0145470606397571
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37714,0.00662669976417153,0.00271247196328348,0.00131025471613591,0.0119431448122071,0.0145767448166609
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,37482,0.00689430491264133,0.00282280681278136,0.00136160355958987,0.0124270062656928,0.0146048629577647
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMG4,Proteasome assembly chaperone 4,37598,-0.0128301852467617,0.00525772748948151,-0.0231353311261455,-0.00252503936737792,0.0146900952050881
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL10,Interleukin-10,40044,-0.0195863275996182,0.00802840386743247,-0.0353219991797859,-0.0038506560194506,0.0147134161505907
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VIT,Vitrin,37990,0.00837338274761104,0.00343358973709904,0.00164354686289692,0.0151032186323252,0.0147542994535379
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37628,-0.0140869803439945,0.00577829649070545,-0.0254124414657772,-0.00276151922221182,0.0147854824550817
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSL,Cathepsin L1,40359,-0.00549810151919991,0.00225612758345309,-0.00992011158276796,-0.00107609145563187,0.014822043632876
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLAMF6,SLAM family member 6,39980,-0.00860338056761818,0.00353439575197107,-0.0155307962414815,-0.00167596489375489,0.0149364709668971
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37677,-0.014970004824999,0.00615153769149094,-0.0270270187003212,-0.00291299094967673,0.0149651924353704
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC12A2,Solute carrier family 12 member 2,37562,0.00649207325055107,0.00267284274173238,0.00125330147675561,0.0117308450243465,0.0151579733342212
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL20,C-C motif chemokine 20,40516,-0.0200532170201833,0.00825693527428648,-0.0362368101577848,-0.00386962388258181,0.015165996981646
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40305,0.0129114272829995,0.00532197485855443,0.0024803565602328,0.0233424980057662,0.0152748521319519
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBCB,Tubulin-folding cofactor B,40228,-0.0227803519309736,0.00941140745953455,-0.0412267105516613,-0.00433399331028591,0.0155102139862824
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPQ,Carboxypeptidase Q,37986,-0.00821631529590154,0.00339619237686073,-0.0148728523545486,-0.00155977823725452,0.0155646752424453
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP112,Centrosomal protein of 112 kDa,37562,-0.0106593544564712,0.00441224003549393,-0.0193073449260392,-0.00201136398690305,0.0157116730656486
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDCP1,CUB domain-containing protein 1,40228,-0.0109082048349247,0.00452044595572779,-0.0197682789081512,-0.0020481307616982,0.0158296039997084
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40517,-0.00610855524276131,0.00253202360119847,-0.0110713215011103,-0.00114578898441231,0.0158538377357082
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,40044,0.00910364482003415,0.00377412240102167,0.00170636491403167,0.0165009247260366,0.0158714333032773
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP10,Stromelysin-2,40341,-0.013441749833997,0.0055785874808943,-0.0243757812965498,-0.00250771837144418,0.015984567766744
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYO9B,Unconventional myosin-IXb,40044,-0.0148843530539927,0.00617872858400739,-0.0269946610786471,-0.00277404502933818,0.0160092655631495
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LIF,Leukemia inhibitory factor,39961,-0.011825831179026,0.00491006619906596,-0.0214495609291953,-0.00220210142885677,0.0160303801518007
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37598,-0.0204241689314906,0.00848214384553817,-0.0370491708687454,-0.00379916699423581,0.0160581807259903
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37959,-0.0240760969728477,0.0100204137482882,-0.0437161079194927,-0.00443608602620284,0.0162877207672246
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VWF,von Willebrand factor,40536,-0.0159951432941413,0.00665794269613192,-0.0290447109785599,-0.00294557560972277,0.0162984679240179
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CACYBP,Calcyclin-binding protein,37642,-0.0228612136111347,0.00954473301371047,-0.0415688903180072,-0.00415353690426216,0.0166267321101021
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERVV_1,,37562,0.0108243477673826,0.00451931050548534,0.00196649917663134,0.0196821963581339,0.0166283019732054
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,40359,0.00707315364063555,0.0029540638243479,0.00128318854491367,0.0128631187363574,0.0166599584119902
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL21R,Interleukin-21 receptor,37598,0.0124831326948747,0.00522522406958494,0.00224169351848823,0.0227245718712612,0.0169076797405374
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH23,Cadherin-23,37942,0.00588417946467113,0.00246304132323245,0.00105661847113552,0.0107117404582067,0.0169084500278675
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37562,0.012072642204159,0.00505540642265568,0.00216404561575389,0.0219812387925642,0.0169513876395448
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40228,-0.0210860661477757,0.00883354123907735,-0.0383998069763673,-0.00377232531918404,0.0169960891279586
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37572,0.0116428749779788,0.00487842615310046,0.00208115971790185,0.0212045902380557,0.0170188475410934
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,40296,0.0106243815789796,0.00445482194299578,0.00189293057070785,0.0193558325872513,0.0170946523428599
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CBLN1,Cerebellin-1,37541,0.0218721491189178,0.00917160937428192,0.00389579474532521,0.0398485034925103,0.017104103649456
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",40192,-0.0164278352969246,0.00689678623227442,-0.0299455363121824,-0.00291013428166672,0.0172328044978653
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37562,0.0110120422482091,0.0046311285487724,0.00193503029261518,0.020089054203803,0.017429043658918
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40305,-0.00978874290072031,0.0041173075329659,-0.0178586656653335,-0.00171882013610714,0.0174440211115187
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,37482,-0.00916703943298491,0.00385746742820695,-0.0167276755922705,-0.0016064032736993,0.0174949728022018
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40397,-0.0243161763989338,0.010235844319831,-0.0443784312658027,-0.00425392153206497,0.0175326358881411
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37990,-0.00714875787855192,0.00301319413313031,-0.0130546183794873,-0.00124289737761651,0.0176827724615512
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40536,-0.0134616274249632,0.00567610904089007,-0.0245868011451078,-0.0023364537048187,0.0177215461960904
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37714,-0.00815417340740647,0.00344526310670744,-0.0149068890965531,-0.00140145771825988,0.0179579666401006
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMA1,Laminin subunit alpha-1,37562,0.0124142423969215,0.00524792366678477,0.00212831201002333,0.0227001727838196,0.0180176268863281
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLF4,Krueppel-like factor 4,37541,-0.00861527378063275,0.00364525908741433,-0.0157599815919648,-0.00147056596930066,0.0181217246434297
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPRY2,Protein sprouty homolog 2,40044,-0.0202698908467057,0.00857722210299484,-0.0370812461685756,-0.00345853552483583,0.0181289510060051
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RGMB,RGM domain family member B,40471,0.00570514105415518,0.00241422935916103,0.000973251510199558,0.0104370305981108,0.0181331219866278
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM171B,Protein FAM171B,37900,0.00608815651193459,0.00257890487118677,0.00103350296440852,0.0111428100594607,0.0182520780093612
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,JAM2,Junctional adhesion molecule B,40471,-0.00571862501111466,0.00242819349882042,-0.0104778842688027,-0.000959365753426638,0.0185299910250637
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASC3,Protein CASC3,37572,-0.00899333791421603,0.00382012247980358,-0.016480777974631,-0.00150589785380102,0.018577206152542
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CIAPIN1,Anamorsin,40411,-0.0139259232416284,0.00593268812107453,-0.0255539919589345,-0.0022978545243223,0.0189211086058134
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,40422,-0.0083578758300328,0.00356488008966608,-0.0153450408057783,-0.00137071085428728,0.0190645867448861
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37572,-0.00942340807535523,0.00402177005422036,-0.0173060773816271,-0.00154073876908332,0.0191391288406264
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,40044,-0.00695091789602339,0.00297323953968376,-0.0127784673938035,-0.00112336839824322,0.019408833918224
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37541,0.00690104068624393,0.00295691745464145,0.00110548247514669,0.0126965988973412,0.0196179434768625
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37900,-0.023398264656227,0.0100347630073147,-0.0430664001505638,-0.0037301291618902,0.0197300787482804
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LMNB1,Lamin-B1,37874,0.0123556099961326,0.00530519449860727,0.00195742877886233,0.0227537912134028,0.0198757090525064
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",37628,-0.0188048372353715,0.00807579486966173,-0.0346333951799085,-0.0029762792908345,0.0198983272828864
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRD2,Bromodomain-containing protein 2,37541,0.007499862434469,0.00322786506008059,0.00117324691671104,0.013826477952227,0.0201689107211566
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCN3B,Sodium channel subunit beta-3,37541,0.00996264465859616,0.00428981042994797,0.00155461621589815,0.0183706731012942,0.0202268048643805
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TYMP,Thymidine phosphorylase,40257,-0.0144061086427931,0.0062064755574707,-0.0265708007354356,-0.00224141655015049,0.0202918571655739
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATOX1,Copper transport protein ATOX1,40411,-0.015477754651741,0.00666821823834352,-0.0285474623988943,-0.00240804690458772,0.020292739750379
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMEM106A,Transmembrane protein 106A,37900,-0.0151060016224057,0.00651323675454231,-0.0278719456613086,-0.00234005758350281,0.0203949149826099
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37575,-0.00768617471576167,0.00332175725156982,-0.0141968189288385,-0.00117553050268482,0.0206892285316885
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCGB1A1,Uteroglobin,40384,0.0122152350998648,0.00528248440994712,0.00186156565636843,0.0225689045433611,0.0207681425427011
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCNA,Proliferating cell nuclear antigen,37482,0.0135201929906464,0.00584717127271738,0.00205973729612031,0.0249806486851724,0.0207787480899179
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HLA_A,,37959,0.00703819420567662,0.00304780823667584,0.00106449006179198,0.0130118983495613,0.0209439417958744
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37628,-0.0209769071785152,0.00908968761317147,-0.0387926949003313,-0.00316111945669914,0.0210273556691256
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA3,Annexin A3,40442,-0.0149915125287123,0.00650360281575778,-0.0277385740475975,-0.00224445100982706,0.0211732183328674
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LIPF,Gastric triacylglycerol lipase,37628,-0.0128315393953327,0.00556855604649912,-0.023745909246471,-0.00191716954419446,0.0212221356474704
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40305,-0.0191810049188278,0.00833072972012012,-0.0355092351702632,-0.00285277466739236,0.0213232648772804
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37562,-0.0144850307060258,0.00630164655700718,-0.0268362579577599,-0.00213380345429174,0.0215427248337191
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPAG1,Sperm-associated antigen 1,37959,-0.0123146890603932,0.00536036152014369,-0.0228209976398748,-0.00180838048091156,0.0216133639764407
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37910,-0.00877657442179912,0.0038217775999216,-0.0162672585176455,-0.00128589032595278,0.0216646571150994
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37598,0.00901262755823405,0.00392481403073646,0.00131999205799058,0.0167052630584775,0.021673265218918
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZBP1,Z-DNA-binding protein 1,37598,-0.0085994483382129,0.00374962110586266,-0.0159487057057037,-0.00125019097072208,0.0218396591180113
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDK1,Cyclin-dependent kinase 1,37482,-0.00783776603709409,0.00342068808961414,-0.0145423146927378,-0.00113321738145038,0.0219629072670204
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,40305,0.00468974363486805,0.00204694737480521,0.000677726780249845,0.00870176048948626,0.0219711817699638
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RTBDN,Retbindin,40305,0.00623895365756162,0.00272578768473855,0.000896409795474064,0.0115814975196492,0.0221004227548317
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,40457,-0.00556195487695521,0.00243338292567137,-0.0103313854112711,-0.000792524342639329,0.0222855115419741
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37880,0.0185975251995228,0.00814216203894928,0.00263888760318225,0.0345561627958634,0.022381097443417
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP350,Centrosome-associated protein 350,37482,0.00799488384443285,0.00350494173372258,0.0011251980463366,0.0148645696425291,0.0225626253066637
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37562,-0.00759032995491527,0.00333586521414409,-0.0141286257746377,-0.00105203413519285,0.0228997687243611
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,40312,0.018808688013456,0.00826681090072123,0.00260573864804234,0.0350116373788696,0.022906929113393
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,40044,-0.00755906313440627,0.0033238287610496,-0.0140737675060635,-0.00104435876274905,0.0229672780062803
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSC,Dipeptidyl peptidase 1,40349,-0.00900987471915029,0.00396341832979625,-0.0167781746455509,-0.00124157479274964,0.0230238827886052
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,40385,-0.0252704504891578,0.011125208282511,-0.0470758587228793,-0.00346504225543619,0.0231325047802992
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37628,-0.0103521377048855,0.00455800175799006,-0.0192858211505461,-0.00141845425922503,0.0231508785760234
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37901,-0.0245864377920074,0.0108282266726779,-0.0458097620704561,-0.00336311351355871,0.023187695827301
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,40182,0.00607024217323327,0.00267497920975131,0.000827282922120715,0.0113132014243458,0.0232655715639387
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCARA5,Scavenger receptor class A member 5,40471,0.00617318890981859,0.00272491222173707,0.000832360955213936,0.0115140168644233,0.0234975495431516
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MEP1B,Meprin A subunit beta,40359,0.02486618078505,0.0110215768875749,0.00326389008540321,0.0464684714846967,0.024075611183494
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37959,-0.0128344699379933,0.00569727853421498,-0.0240011358650546,-0.00166780401093189,0.0242917205925721
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP170,Centrosomal protein of 170 kDa,37628,-0.0162125876747743,0.00719951244297643,-0.0303236320630081,-0.00210154328654047,0.0243449407304473
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLG,Plasminogen,37705,-0.00470368782837041,0.00209084976659725,-0.00880175337090102,-0.00060562228583979,0.024487280886888
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FKBPL,FK506-binding protein-like,37901,-0.0123165621034789,0.00548143154604486,-0.0230601679337269,-0.00157295627323102,0.0246586784704946
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,40225,-0.0121874008505364,0.00542851340953651,-0.0228272871332279,-0.00154751456784481,0.0247773389074899
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39961,-0.011000220938541,0.00491096867141371,-0.0206257195345119,-0.00137472234257014,0.0251096436655034
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39980,0.0091108875172555,0.00407268105765299,0.00112843264425564,0.0170933423902554,0.0252956594559045
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,USO1,General vesicular transport factor p115,40305,-0.0188456166588166,0.0084363587443983,-0.0353808797978373,-0.00231035351979594,0.0255063921728124
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37990,-0.00602561570730306,0.00270068797982349,-0.0113189641477571,-0.000732267266849027,0.0256881012867623
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRAF2,TNF receptor-associated factor 2,40341,-0.0147738906188612,0.00662398492902473,-0.0277569010797497,-0.00179088015797272,0.025737265482914
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37959,0.00557913931346104,0.00250517694609825,0.000668992499108478,0.0104892861278136,0.0259607506631778
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMTN,Smoothelin,37905,-0.019951962260216,0.00895992121117073,-0.0375134078341107,-0.00239051668632141,0.0259770590950472
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAT,Catalase,37786,-0.0113152890801766,0.0050814583350488,-0.0212749474168723,-0.00135563074348099,0.0259786257062817
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD40LG,CD40 ligand,40516,-0.0158592627750237,0.00712368006669428,-0.0298216757057445,-0.00189684984430295,0.0260096582597162
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37987,0.00983158997877634,0.00441918341129029,0.00116999049264737,0.0184931894649053,0.0261142708609807
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPPB,Natriuretic peptides B,40042,-0.0265806406316198,0.0119729850823926,-0.0500476913931092,-0.00311358987013029,0.0264296147856168
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCLRE1C,Protein artemis,37482,0.0065827725049801,0.00296961859136726,0.000762320065900267,0.0124032249440599,0.0266603620275677
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TOP1,DNA topoisomerase 1,37901,-0.0220335121694131,0.00994570065627047,-0.0415270854557032,-0.00253993888312293,0.0267506392354816
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DSG3,Desmoglein-3,40419,0.0068968718454364,0.00311637387579733,0.000788779048873629,0.0130049646419992,0.0269042904767776
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNM1,Dynamin-1,37901,0.0233372805610139,0.0105535802098688,0.00265226334967112,0.0440222977723567,0.0270308500616973
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSPAN7,Tetraspanin-7,37541,0.0189269883865741,0.00856101331606986,0.00214740228707714,0.035706574486071,0.0270644855978103
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUDC,Nuclear migration protein nudC,40516,-0.0130059263894973,0.0058844137909171,-0.0245393774196948,-0.00147247535929974,0.0271030288064328
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCN1,Transcobalamin-1,37766,0.00681421195860955,0.00308332012008125,0.000770904523250299,0.0128575193939688,0.0271204328734028
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCTN6,Dynactin subunit 6,39961,-0.0145713119517596,0.00659375733080752,-0.0274950763201424,-0.00164754758337688,0.0271291005976553
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BDNF,Brain-derived neurotrophic factor,37998,-0.0169736031324597,0.00768640304249427,-0.0320389530957484,-0.00190825316917089,0.0272425980318281
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37598,-0.00625945028684085,0.00283790409907855,-0.0118217423210348,-0.00069715825264689,0.0274250851089961
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RCOR1,REST corepressor 1,40042,-0.0091974658451802,0.00417765827670327,-0.0173856760675186,-0.00100925562284178,0.0277092989803416
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRAP2,GRB2-related adapter protein 2,40359,-0.0259802734295937,0.0118009782904798,-0.0491101908789341,-0.00285035598025327,0.0277124371234926
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA1,Annexin A1,37608,-0.00850030613105622,0.00386602957340669,-0.0160777240949333,-0.000922888167179115,0.0279153750501472
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,40341,-0.0163688581109096,0.00745428531730669,-0.0309792573328307,-0.00175845888898852,0.0281135709329893
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UPK3A,Uroplakin-3a,37541,0.010235498740046,0.00467866163486775,0.00106532193570517,0.0194056755443867,0.0287092312032589
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,40419,0.00647628074544602,0.0029614036148416,0.00067192966035648,0.0122806318305356,0.0287645994123457
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STC2,Stanniocalcin-2,40309,-0.005522269517508,0.00252517469341797,-0.0104716119166072,-0.000572927118408778,0.028765396392084
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,40042,0.00671414881977307,0.00307131050029796,0.000694380239189068,0.0127339174003571,0.0288241353392862
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLI2,Zinc finger protein GLI2,37598,0.0068596299592618,0.00314026621345548,0.000704708180889056,0.0130145517376345,0.028949713433731
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AIF1,Allograft inflammatory factor 1,39980,-0.010710622716178,0.00490487140739019,-0.0203241706746628,-0.00109707475769323,0.0290013870021219
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37959,-0.0145703522785405,0.00667661483296409,-0.0276565173511502,-0.00148418720593094,0.0291048353882353
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTF,Ciliary neurotrophic factor,37541,0.0068980775620134,0.00316504060449668,0.000694597977199904,0.0131015571468269,0.0293153211600649
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GUK1,Guanylate kinase,37562,0.00817705444630756,0.00375425023575005,0.000818723984237459,0.0155353849083777,0.0294178991346175
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,40340,-0.0114767473804606,0.00526962052023264,-0.0218052036001166,-0.00114829116080466,0.0294275623327775
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TP53,Cellular tumor antigen p53,39980,-0.00871340884948814,0.00400457760608565,-0.016562380957416,-0.000864436741560266,0.0295805959032194
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMY2A,Pancreatic alpha-amylase,39695,0.00955195770412914,0.00439579938194879,0.000936190915509512,0.0181677244927488,0.0297976248364209
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37562,-0.00835961340839289,0.00384945006979534,-0.0159045355451918,-0.000814691271594032,0.0299008216302645
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37572,0.00761173329257598,0.00351625223542097,0.000719878911150883,0.0145035876740011,0.0304264158553647
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,37541,0.0163642990418097,0.00756083685903278,0.00154505879810551,0.031183539285514,0.0304555022883676
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD82,CD82 antigen,37714,0.00846263029674362,0.00391153821235916,0.00079601540051966,0.0161292451929676,0.0305202038241597
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,40411,0.00486575049559683,0.00225429967134101,0.000447323139768444,0.00928417785142522,0.0309091939572786
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37482,0.00696761947774538,0.00322853332249482,0.000639694165655532,0.0132955447898352,0.0309353369446991
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,40042,-0.0222131546085766,0.0102991288839433,-0.0423994472211055,-0.00202686199604766,0.0310365390137875
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MUC2,Mucin-2,37998,0.0181900835044763,0.00843880725831643,0.00165002127817606,0.0347301457307765,0.0311381152698544
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37572,0.00987008783599572,0.0045811791136513,0.000890976773239169,0.0188491988987523,0.0312201978792013
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK6,Kallikrein-6,40387,0.00609745654635849,0.0028322508358231,0.000546244908145226,0.0116486681845718,0.0313441734496043
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACRV1,Acrosomal protein SP-10,37598,0.00706871743722248,0.00328652059587094,0.000627137069315443,0.0135102978051295,0.0315085043360519
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM13A,Protein FAM13A,37901,-0.0134546642521996,0.00626218575796414,-0.0257285483378093,-0.00118078016658985,0.0316873172746924
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCRIB,Protein scribble homolog,37628,-0.018624758684486,0.00867061090653306,-0.0356191560612908,-0.00163036130768124,0.031729307722669
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMED8,Protein TMED8,37901,-0.0204899835146934,0.00954637075503066,-0.0392008701945535,-0.00177909683483333,0.0318618092108715
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40044,0.00837876460376002,0.00390463251458905,0.000725684875165476,0.0160318443323546,0.0319001563937856
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37901,-0.0294026750003468,0.0137065671820358,-0.0562675466771369,-0.00253780332355675,0.0319585215416781
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GP6,Platelet glycoprotein VI,40311,-0.0174936597033117,0.0081691146057103,-0.0335051243305039,-0.00148219507611949,0.0322538542360611
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VGF,Neurosecretory protein VGF,37959,0.00607792613483236,0.00283937720782955,0.000512746807486445,0.0116431054621783,0.0323254319744655
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37671,-0.0167215797759582,0.00782445399447267,-0.0320575096051246,-0.00138564994679173,0.0326087901115161
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37572,0.00640443652107874,0.00300170033632819,0.000521103861875492,0.012287769180282,0.0328937956583704
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TWF2,Twinfilin-2,37998,-0.0164236441656991,0.00769936069747972,-0.0315143911327594,-0.00133289719863888,0.0329329760754314
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37942,-0.0123734652969206,0.00580194915793537,-0.023745285646474,-0.00100164494736731,0.0329723225600143
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,40422,-0.026124652450147,0.012272362847077,-0.0501784836304179,-0.00207082126987606,0.0332911538015863
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP3,Caspase-3,40536,-0.0174091245525807,0.0081909574078583,-0.033463401071983,-0.00135484803317842,0.0335677988665907
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,40341,-0.0220584949393289,0.010394535485822,-0.0424317844915399,-0.00168520538711783,0.0338427404603272
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PALLD,Palladin,37598,0.00821830793614563,0.00387333942429473,0.000626562664527965,0.0158100532077633,0.0338763056475954
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37598,-0.011166641729875,0.0052730624743889,-0.0215018441796773,-0.000831439280072805,0.0342211743637191
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CBX2,Chromobox protein homolog 2,37562,0.00813313853982489,0.00384486369881904,0.000597205690139567,0.0156690713895102,0.0344210174697358
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,40228,-0.0156027620656873,0.00739477152140254,-0.0300965142476362,-0.00110900988373828,0.0348764572584592
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNX15,Sorting nexin-15,37671,-0.0106500860630857,0.00504814794390952,-0.0205444560331484,-0.000755716093023094,0.0349028077902745
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39980,0.0115033594944003,0.00546069547093532,0.000800396371367041,0.0222063226174335,0.0351705172732625
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PROK1,Prokineticin-1,40341,-0.0135018948538433,0.00641566252156645,-0.0260765933961136,-0.000927196311573054,0.0353487121896077
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37572,-0.00972141185001887,0.00461950173290172,-0.0187756352465063,-0.000667188453531498,0.035360044246809
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37901,-0.0089085943644155,0.00423624448484067,-0.0172116335547032,-0.000605555174127782,0.0354890022040103
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,40182,0.00582996348779624,0.00277650828492119,0.000388007249350714,0.0112719197262418,0.0357670365730797
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GBP4,Guanylate-binding protein 4,39961,-0.00964227291220985,0.00459786505231909,-0.0186540884147553,-0.00063045740966444,0.0359991394500382
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD84,SLAM family member 5,40341,-0.00601189291681886,0.00286702603725657,-0.0116312639498417,-0.000392521883795993,0.0360173915077681
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37901,-0.0170929277351205,0.00815335595484451,-0.0330735054066158,-0.00111235006362531,0.0360628317077573
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRN1,Neuritin,37959,-0.00715377335750114,0.00341502647577082,-0.013847225250012,-0.000460321464990331,0.0362079829946971
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,40341,-0.0083649261434328,0.00399376512579218,-0.0161927057899855,-0.000537146496880126,0.0362315938708669
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37598,-0.0155222973591824,0.00741406837481504,-0.0300538713738198,-0.000990723344544905,0.0363122858818485
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37598,-0.0170472717362032,0.0081508130121442,-0.0330228652400058,-0.00107167823240058,0.0365040982659427
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INSR,Insulin receptor,37598,0.00328832533658675,0.00157304985552255,0.000205147619762553,0.00637150305341095,0.03659979276933
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBC1D23,TBC1 domain family member 23,40305,-0.0173832294375906,0.00834512253231508,-0.0337396696009282,-0.00102678927425309,0.0372635045480133
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF3,Granulocyte colony-stimulating factor,40044,-0.00946113949933245,0.00455561892159773,-0.018390152585664,-0.000532126413000895,0.0378357482253888
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37539,-0.00795070384234819,0.00383457769719598,-0.0154664761288523,-0.000434931555844073,0.0381523928767021
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCOF1,Treacle protein,37990,-0.00583309906743748,0.00281484405856843,-0.0113501934222316,-0.000316004712643355,0.0382597435280726
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39980,-0.00986143213846972,0.00475953055686248,-0.0191901120299202,-0.000532752247019264,0.0382880858831319
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC4A1,Band 3 anion transport protein,37998,-0.00889478144907885,0.00429922758832237,-0.0173212675221907,-0.000468295375967003,0.0385720054873548
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,37541,0.00821869917756275,0.0039757396404628,0.000426249482255663,0.0160111488728698,0.0387337349465942
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40341,-0.0117646839451761,0.00569264936885393,-0.0229222767081298,-0.00060709118222241,0.0387838035702332
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPART,Spartin,37671,-0.0148519008954286,0.0071873694487547,-0.0289391450149878,-0.000764656775869399,0.0388111990611407
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37959,-0.00596359456671785,0.00288680046194183,-0.0116217234721238,-0.000305465661311868,0.038865014262477
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NXPE4,NXPE family member 4,37562,0.00702161177302051,0.00340031945484842,0.000356985641517605,0.0136862379045234,0.0389439484533709
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40365,-0.00950089613739465,0.00460184016271218,-0.0185205028563105,-0.000481289418478767,0.0389783260813212
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,40203,0.00762387976110577,0.0036944883232835,0.0003826826474701,0.0148650768747414,0.0390737060375814
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,40109,0.00398029135444494,0.00192947279834368,0.00019852466969132,0.00776205803919855,0.0391394722235854
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37628,0.00869593281775983,0.00421579390619034,0.000432976761626762,0.0169588888738929,0.0391603601913716
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40341,-0.0163677531376933,0.00793670782117066,-0.0319237004671878,-0.000811805808198767,0.0391968335886143
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TK1,"Thymidine kinase, cytosolic",37714,-0.00859605863385793,0.00417401630647804,-0.0167771305945549,-0.000414986673160981,0.0394733605463717
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39823,0.0165821356699728,0.00807677083900062,0.000751664825531566,0.032412606514414,0.0400831596529276
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40333,-0.0141909564052781,0.00691648230801585,-0.0277472617289891,-0.000634651081567012,0.040209429253194
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FZD8,Frizzled-8,37541,0.00860576459186989,0.00419525936225254,0.000383056241854913,0.0168284729418849,0.0402569253396202
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PREB,Prolactin regulatory element-binding protein,40044,-0.00566992932166874,0.00276597432694292,-0.0110912390024769,-0.000248619640860626,0.0403923422470519
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASAH1,Acid ceramidase,37882,-0.00879605556021714,0.00429109421566122,-0.0172066002229131,-0.000385510897521141,0.0403994465191665
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENOPH1,Enolase-phosphatase E1,37900,0.0109206012337991,0.00534027208967216,0.000453667938041625,0.0213875345295565,0.0408789932884219
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDHR1,Cadherin-related family member 1,39961,-0.00838055348141016,0.00410165043802436,-0.0164197883399379,-0.000341318622882418,0.0410480296648547
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CADPS,Calcium-dependent secretion activator 1,37572,0.00859605672623161,0.00420994427167155,0.000344565953755373,0.0168475474987078,0.0411867934316911
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MGLL,Monoglyceride lipase,40396,-0.0163841479922926,0.00802784923185196,-0.0321187324867224,-0.000649563497862715,0.0412758330190315
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HPCAL1,Hippocalcin-like protein 1,40516,-0.0138679216648705,0.00682563945015433,-0.027246174987173,-0.000489668342568035,0.0421964531515192
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH4,Cadherin-4,37541,0.00939365524571077,0.00462829597312892,0.000322195138378086,0.0184651153530435,0.0424159590870923
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37562,0.0060345449546599,0.00297358674367082,0.000206314937065085,0.0118627749722547,0.04243950450248
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39961,0.00759161966291994,0.00374492398779142,0.000251568646848762,0.0149316706789911,0.0426614962486521
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39980,-0.0109141954157355,0.00538422132579119,-0.0214672692142862,-0.000361121617184762,0.0426722684618974
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37562,0.00716336464455927,0.00353749229722108,0.000229879742005954,0.0140968495471126,0.0428892522440436
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMEM132A,Transmembrane protein 132A,37628,0.0118594362045544,0.00586455861168051,0.000364901325660555,0.0233539710834482,0.0431736450686983
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CETN3,Centrin-3,37901,-0.0144201308085436,0.00713789348513392,-0.0284104020394061,-0.000429859577681132,0.0433801306700697
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37714,0.0130991276908126,0.00648744728646126,0.000383731009348546,0.0258145243722767,0.0434917351108412
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37990,-0.0183833994407251,0.00911177745565345,-0.0362424832538058,-0.000524315627644302,0.0436586104847258
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37541,0.00638515228633648,0.00316606723333456,0.000179660509000751,0.0125906440636722,0.0437424452548853
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,37541,0.00777756608227946,0.00385710343346464,0.000217643352688767,0.0153374888118702,0.0437757685497393
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37990,0.00496767128369731,0.00246729657893507,0.000131769988984567,0.00980357257841004,0.044091621333691
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39980,-0.0111051998252565,0.00551876873252164,-0.0219219865409989,-0.00028841310951413,0.0442097286557375
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37562,-0.00525294815181828,0.00261146960444714,-0.0103714285765347,-0.000134467727101879,0.0442940232830118
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACYP1,Acylphosphatase-1,37622,-0.0123761092518572,0.00615945570320421,-0.0244486424301374,-0.000303576073576927,0.0445271565092283
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GOLM2,Protein GOLM2,40471,-0.0041897545516353,0.00208547869268866,-0.00827729278930508,-0.000102216313965529,0.0445524627903315
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STXBP1,Syntaxin-binding protein 1,37959,0.0144588552708892,0.00719716961551258,0.000352402824484529,0.0285653077172938,0.0445608035264063
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37959,-0.0130074351426463,0.00647957326004488,-0.0257073987323343,-0.000307471552958349,0.0447213922348174
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,37541,0.01331980601701,0.00663625509341548,0.000312746033915706,0.0263268660001044,0.0447566760916274
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37990,-0.0115032560777395,0.00574955347396353,-0.022772380886708,-0.000234131268770995,0.0454423267625135
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HBZ,Hemoglobin subunit zeta,37990,0.019564000084933,0.00978463507731277,0.000386115333399956,0.038741884836466,0.0455784037575315
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37987,-0.0047765171321432,0.00239172092367617,-0.0094642901425485,-8.87441217378993e-05,0.0458337948984028
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39925,-0.00814528052703842,0.00408035318421584,-0.0161427727681015,-0.000147788285975378,0.0459275309793825
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37714,0.0137527240772456,0.00688949742709596,0.000249309120137483,0.0272561390343536,0.0459340001038398
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",40042,-0.0173053846983759,0.0086696292421916,-0.0342978580130715,-0.000312911383680416,0.0459411838677519
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTB,Lymphotoxin-beta,37900,0.00658220790237341,0.00329934192512158,0.000115497729135111,0.0130489180756117,0.0460623381393553
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40305,-0.0128820925550706,0.00648572423268543,-0.0255941120511341,-0.000170073059007157,0.0470257955010054
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRYM,Ketimine reductase mu-crystallin,37541,-0.0142621587660429,0.00718630618438564,-0.0283473188874387,-0.000176998644647016,0.0472064979306491
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL13,C-C motif chemokine 13,40483,-0.0128539811401786,0.00648645315442725,-0.025567429322856,-0.000140532957501159,0.0475337320039807
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39980,-0.00748012718346634,0.00378019530398599,-0.0148893099792789,-7.09443876537943e-05,0.0478598418639166
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39980,-0.00969474332273399,0.00490282075797186,-0.0193042720083588,-8.52146371091451e-05,0.0480162659544839
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,40341,0.00840548388790633,0.0042526101957395,7.03679042569211e-05,0.0167405998715557,0.0481101237020538
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEXN,Nexilin,37987,-0.0125718508358382,0.00636560066576773,-0.0250484281407429,-9.52735309334238e-05,0.0482921891071203
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,37184,0.00898794824044339,0.00455759214172835,5.50676426558233e-05,0.017920828838231,0.0486217853522721
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENAH,Protein enabled homolog,40044,0.00868628321213478,0.00441072945504519,4.12534802462228e-05,0.0173313129440233,0.0489302479918961
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37562,-0.0124196504686441,0.00630661718795483,-0.0247806201570356,-5.86807802526214e-05,0.0489391437004949
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39980,-0.0140298096235191,0.00714725624639301,-0.0280384318664494,-2.11873805888302e-05,0.0496681336919157
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNX9,Sorting nexin-9,40359,-0.0125276890072752,0.00639188164792549,-0.0250557770372092,3.99022658734149e-07,0.0500205202520411
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DAB2,Disabled homolog 2,40489,-0.0200681114521353,0.0102400423109775,-0.0401385943816512,2.37147738060828e-06,0.0500401584936213
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB37,Ras-related protein Rab-37,40044,-0.0151898822637605,0.00777497521008591,-0.0304288336755289,4.90691480079086e-05,0.0507558833677613
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37990,0.00606801732360452,0.00311029344651479,-2.81578315644588e-05,0.0121641924787735,0.0510839646181951
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37714,-0.0107492384962082,0.00552208913434068,-0.0215725331995159,7.40562070995054e-05,0.0516051034040499
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GZMH,Granzyme H,40042,-0.0135436628165273,0.00695879576562354,-0.0271829025171494,9.55768840948685e-05,0.0516408192646197
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37990,-0.00541126866524562,0.00278142840072375,-0.0108628683306642,4.03310001729322e-05,0.05173551271126
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDZD2,PDZ domain-containing protein 2,37562,-0.0111430360405056,0.00572937634724692,-0.0223726136811095,8.6541600098404e-05,0.0518089570648289
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37608,-0.0102528866744634,0.00527232144955722,-0.0205866367155955,8.08633666687601e-05,0.0518368736974374
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP7,Caspase-7,37942,-0.0151441894186266,0.00778894605129973,-0.0304105236791741,0.000122144841920824,0.0518778527445307
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40305,-0.00994735291724854,0.0051192912095967,-0.0199811636880581,8.6457853561003e-05,0.052020382417221
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37959,-0.0123540915865263,0.00636031691217319,-0.0248203127343858,0.000112129561333132,0.0521130285659236
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37900,-0.0148632821449311,0.00766345892838409,-0.0298836616445639,0.000157097354701697,0.052461313737677
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCDHB15,Protocadherin beta-15,37900,-0.00726816790326816,0.00375218364502496,-0.0146224478475171,8.61120409807589e-05,0.0527601297325967
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37562,0.00890616116585416,0.00460001942345858,-0.000109876904124655,0.017922199235833,0.052875230750394
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37942,-0.00676799168987227,0.00349661006027199,-0.0136213474080054,8.53640282608304e-05,0.0529392189762275
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADA2,Adenosine deaminase 2,40258,0.00755497044448689,0.00390394473307373,-9.67612323376143e-05,0.0152067021213114,0.0529817954003177
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",40359,-0.0130364519902101,0.00674147525508505,-0.0262497434901768,0.000176839509756567,0.053159324771336
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,JUN,Transcription factor AP-1,40044,-0.00934042000934768,0.0048381023213396,-0.0188231005591733,0.00014226054047794,0.0535511685254885
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNLR1,Interferon lambda receptor 1,40341,-0.00672182253063249,0.00348228933144083,-0.0135471096202565,0.000103464558991542,0.0535888948886478
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF9,Fibroblast growth factor 9,37457,0.00732224277247739,0.00379779430582092,-0.000121434066931608,0.0147659196118864,0.0538737497610124
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40489,-0.00605808792380326,0.00314468260057529,-0.0122216658209308,0.000105489973324311,0.0540653001162495
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37959,-0.00677923853115304,0.00352517455171881,-0.0136885806525219,0.000130103590215831,0.0544893693160789
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYZL2,Lysozyme-like protein 2,37482,-0.00643228511301537,0.00334846812818543,-0.0129952826442588,0.000130712418228083,0.0547581017998397
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCN3,CCN family member 3,40522,-0.00603863555353397,0.00314364597541301,-0.0122001816653435,0.000122910558275529,0.0547617474732234
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX6,Syntaxin-6,39980,-0.0122932483612119,0.00640518180154968,-0.0248474046922492,0.000260907969825509,0.0549689712057849
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37942,-0.00566862842110964,0.00296294297527125,-0.0114759966526413,0.000138739810422005,0.0557467991629772
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37919,-0.00680175720809476,0.00355556823140942,-0.0137706709416572,0.000167156525467701,0.0557708506137576
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YJU2,Splicing factor YJU2,37900,-0.00568545757533395,0.00297597724236241,-0.0115183729703643,0.000147457819696382,0.0560964631381883
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TEK,Angiopoietin-1 receptor,40411,0.00380909111894823,0.00200288080384242,-0.000116555256582919,0.00773473749447937,0.0572144850206222
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RSPO1,R-spondin-1,40228,0.00627151947646515,0.00330008757460666,-0.000196652169763905,0.0127396911226942,0.057397545167491
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40536,0.0124140240305268,0.00653481079757898,-0.000394205132728037,0.0252222531937816,0.0574935057647062
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK11,Kallikrein-11,40260,-0.00524834649828705,0.00276451736801491,-0.0106668005395963,0.000170107543022169,0.0576527132949737
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD46,Membrane cofactor protein,40250,-0.00505488618726673,0.00266840777584959,-0.0102849654279319,0.000175193053398463,0.058197415428925
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLSTN1,Calsyntenin-1,39961,0.00927158006427469,0.00490525031256514,-0.000342710548352981,0.0188858706769024,0.0587586783917263
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,37562,0.0126482714677394,0.00669772778550602,-0.000479274991852428,0.0257758179273312,0.058988674383032
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMOX2,Heme oxygenase 2,39961,0.0080105515281154,0.0042489340569726,-0.000317359223550891,0.0163384622797817,0.0594068743859285
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSPN,Persephin,40341,-0.0174156289648762,0.00925845621944758,-0.0355622031549935,0.000730945225241027,0.0599832425317047
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37562,-0.00674883467549879,0.00358839574390309,-0.0137820903335488,0.000284420982551259,0.0600296219768201
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37598,0.00748764053094416,0.00398134533172104,-0.000315796319229085,0.0152910773811174,0.0600374121950987
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRLF1,Cytokine receptor-like factor 1,40422,-0.00460012345526417,0.00244764889146577,-0.00939751528253708,0.000197268372008745,0.0602074133811106
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37990,-0.00534210966028807,0.00284358390074408,-0.0109155341057465,0.000231314785170339,0.0603132517063383
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,40044,0.00512511677286407,0.00272816648894856,-0.00022208954547511,0.0104723230912032,0.0603186143182763
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UROS,Uroporphyrinogen-III synthase,37572,-0.0122826357921554,0.006552845810053,-0.0251262135798593,0.00056094199554845,0.0608979024101596
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MICALL2,MICAL-like protein 2,37572,-0.0119602678253216,0.00638105162804894,-0.0244671290162975,0.000546593365654288,0.060905618283385
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37900,-0.00505425098067258,0.00269784484029964,-0.0103420268676599,0.000233524906314717,0.0610292943586822
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37562,0.0104908009306069,0.0056014511311135,-0.000488043286375615,0.0214696451475893,0.0611083002964551
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD300LF,CMRF35-like molecule 1,40489,0.0105761981145008,0.00564852531672151,-0.000494911506273361,0.021647307735275,0.0611719318303893
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,40042,-0.0059753014942923,0.00320271069343498,-0.0122526144534249,0.000302011464840264,0.0621019347554474
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNW1,Interferon omega-1,37562,0.00640346355029882,0.00344095348067625,-0.000340805271826632,0.0131477323724243,0.0627727380117577
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB5,Integrin beta-5,40411,0.00641416767143517,0.00344805492045891,-0.000344019972664289,0.0131723553155346,0.0628716835123269
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39925,-0.0114121668209019,0.0061554235440824,-0.0234767969673034,0.000652463325499621,0.0637579078380882
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,40305,-0.00969022463199003,0.00522714258629449,-0.0199354241011272,0.000554974837147169,0.0637822968902609
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAX,Protein max,39961,-0.0180010752220247,0.00972882116504249,-0.037069564705508,0.00106741426145855,0.0642917361679478
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,40305,0.00669742145224874,0.00361999020110771,-0.000397759341922378,0.0137926022464199,0.0643146449185705
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEMA6C,Semaphorin-6C,37598,0.00459200384919147,0.00248275968903819,-0.000274205141323381,0.00945821283970631,0.0643999551234874
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GMPR,GMP reductase 1,40516,-0.008776271195951,0.00474960765147321,-0.0180855021928385,0.000532959800936499,0.0646512920322449
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37942,-0.0122546393786275,0.00663863425996618,-0.0252663625281612,0.000757083770906187,0.0649202133977921
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRL,Prolactin,40471,0.0131588859785167,0.0071355087810399,-0.000826711232321536,0.0271444831893549,0.0651810139362796
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37901,0.00841293104146802,0.00456420939909483,-0.000532919380757852,0.0173587814636939,0.0653160401506422
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBM25,RNA-binding protein 25,37482,0.00798480745365009,0.0043331019275006,-0.000508072324251081,0.0164776872315513,0.0653887657188116
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37714,0.0110867907201623,0.0060233225658271,-0.000718921508858815,0.0228925029491834,0.0656961162032323
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37628,-0.00709796583874358,0.00386888814797773,-0.0146809866087799,0.00048505493129277,0.0665835403065784
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD164,Sialomucin core protein 24,40332,-0.00451159222840543,0.00246616972591114,-0.00934528489119127,0.000322100434380411,0.0673595810648527
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RRP15,RRP15-like protein,37541,0.0155452594889783,0.00851934525511475,-0.00115265721104664,0.0322431761890032,0.0680689155060054
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCN2,Ficolin-2,40291,-0.00696661947702079,0.00382085067416462,-0.0144554867983834,0.000522247844341865,0.0682743311586649
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37562,0.0119993105432008,0.00659841173050911,-0.000933576448597009,0.0249321975349987,0.0690082669933447
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LACTB2,Endoribonuclease LACTB2,40359,-0.011171615788182,0.00614339176583172,-0.0232126636492121,0.000869432072848222,0.0690100768217539
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37628,-0.00716756538032371,0.00394521243972016,-0.0149001817621752,0.0005650510015278,0.0692742021170391
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40470,0.0103232318142627,0.00568230775579223,-0.000814091387090069,0.0214605550156155,0.0692767999825827
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CILP,Cartilage intermediate layer protein 1,37998,0.00909522031962067,0.00500737866947124,-0.000719241872542964,0.0189096825117843,0.0693367088020415
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PVALB,Parvalbumin alpha,40417,0.0190395508705947,0.0104979716893237,-0.00153647364047976,0.0396155753816691,0.0697517954246177
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37951,-0.011449604157835,0.00632210935080796,-0.0238409384854186,0.000941730169748613,0.0701566039921035
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37959,0.00593627005385605,0.00327931488438527,-0.000491187119539076,0.0123637272272512,0.0702844266171466
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLINT1,Clathrin interactor 1,37482,0.00774486175422216,0.00429521287016471,-0.000673755471300682,0.016163478979745,0.0713896297774377
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICOSLG,ICOS ligand,40305,0.00320609085217044,0.0017822215888401,-0.000287063461956149,0.00669924516629703,0.072048858178505
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37901,-0.014922742189114,0.00831149130185367,-0.0312132651407472,0.00136778076251918,0.0726068654631413
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37959,-0.0190255891032702,0.0106048975655618,-0.0398111883317714,0.00176001012523097,0.0728294626929119
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37557,-0.0141063197122467,0.00786662820807386,-0.0295249110000714,0.00131227157557809,0.0729663981331563
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37901,0.00439821800112005,0.00245872959668785,-0.000420892008388147,0.00921732801062824,0.0736667447204243
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37572,0.0091031175566517,0.00508927841231092,-0.00087186813147771,0.0190781032447811,0.0736885731008688
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37900,-0.0100826740092974,0.00564235448300516,-0.0211416887959875,0.000976340777392708,0.0739661188919718
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37562,0.00867674693394938,0.00486598365267736,-0.000860581025298244,0.018214074893197,0.0745860823126482
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37572,-0.0102419023137967,0.00575985102447679,-0.0215312103217713,0.00104740569417778,0.0754017141988182
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL36A,Interleukin-36 alpha,37598,0.00980130866147665,0.00551611696314484,-0.00101028058628723,0.0206128979092405,0.0756161537928533
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40228,-0.00422606283337286,0.002379522204005,-0.00888992635322265,0.000437800686476941,0.0757500126010588
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37901,-0.00971041529066544,0.00547453529899798,-0.0204405044767015,0.00101967389537059,0.0761283952100031
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37671,-0.00683431058095611,0.00385600278033259,-0.014392076030408,0.000723454868495763,0.0763541668250903
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEFL,Neurofilament light polypeptide,39903,0.0070481483809196,0.00398218537000595,-0.000756934944292059,0.0148532317061313,0.0767602347365256
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPM1A,Protein phosphatase 1A,39980,0.00510919284593028,0.00288897159479657,-0.000553191479871006,0.0107715771717316,0.0769942889956522
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37598,0.00831948960144491,0.00471002867271273,-0.000912166597072044,0.0175511457999619,0.0773628277716158
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37562,-0.0103358007618468,0.00585581985168101,-0.0218132076711416,0.00114160614744799,0.0775790446342576
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEPTIN9,Septin-9,40305,0.00462666757723327,0.00262297149055527,-0.000514356544255056,0.0097676916987216,0.0777675505166771
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37572,0.0130785803516313,0.00741688125604002,-0.00145850691020718,0.0276156676134697,0.0778642330347474
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPRR3,Small proline-rich protein 3,37942,-0.0116733594834391,0.0066282626938007,-0.0246647543632885,0.00131803539641022,0.0782358071708317
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39980,-0.00985304486090007,0.00559518363707431,-0.0208196047895657,0.00111351506776558,0.0782603073306041
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37959,-0.0120900882838505,0.00687245557160113,-0.0255601012041888,0.00137992463648766,0.0785645904428006
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAD1,Glutamate decarboxylase 1,37482,0.00424589145992956,0.00241775052705876,-0.0004928995731056,0.00898468249296472,0.0790891942083445
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSDE1,Cold shock domain-containing protein E1,37562,-0.0191554767569216,0.0109214830647584,-0.0405615835638481,0.00225063005000499,0.0794664947225236
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39961,-0.00669785671171815,0.00382083107943438,-0.0141866856274095,0.000790972203973226,0.0796244663649529
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DLG4,Disks large homolog 4,37942,-0.0114305918006407,0.00652125205623413,-0.0242122458308596,0.00135106222957819,0.079655339514161
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37998,0.00631015677868323,0.00360505880706134,-0.000755758483156997,0.0133760720405235,0.0800785624482999
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MELTF,Melanotransferrin,37990,0.0047598706786338,0.00272093421057109,-0.000573160374085533,0.0100929017313531,0.0802529162091693
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,37482,-0.00824863674037592,0.0047159758058483,-0.0174919493198386,0.00099467583908675,0.0803000843058741
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD177,CD177 antigen,40316,-0.0207862870027711,0.0118864523448911,-0.0440837335987576,0.0025111595932154,0.0803557150979126
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBC1D5,TBC1 domain family member 5,40341,-0.012743327587634,0.0072924488685443,-0.0270365273699808,0.00154987219471284,0.0805753527563723
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,37541,0.00818797931048818,0.00468684177185535,-0.000998230562348313,0.0173741891833247,0.0806583213462835
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GZMB,Granzyme B,40341,-0.010233892325493,0.00586169614076324,-0.021722816761389,0.00125503211040293,0.0808489307154577
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PKLR,Pyruvate kinase PKLR,40374,-0.0107752458406914,0.00619648310035889,-0.0229203527173948,0.00136986103601207,0.0820665325854123
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMY2B,Alpha-amylase 2B,39311,0.00780345468237198,0.00449127059941323,-0.000999435692477945,0.0166063450572219,0.0823246991790867
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40042,-0.0142206518946878,0.00818639087179495,-0.0302659780034059,0.0018246742140303,0.0823877126536647
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCGB2A2,Mammaglobin-A,37562,0.00520043866109748,0.00299605668431689,-0.000671832440163629,0.0110727097623586,0.0826295796410128
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,40359,0.00567002411562346,0.00327166015609487,-0.000742429790322486,0.0120824780215694,0.0831021700452596
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAP3,Cytosol aminopeptidase,40044,-0.007916134855167,0.00457826474308899,-0.0168895337516214,0.00105726404128741,0.0838165710315037
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37562,0.00843524153391755,0.00488061686451479,-0.00113076752053143,0.0180012505883665,0.0839553775503629
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37942,-0.00739658497676479,0.00429389104544467,-0.0158126114258363,0.00101944147230676,0.0849868277673193
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PROCR,Endothelial protein C receptor,37562,0.00594243147327956,0.00345288889432076,-0.000825230759589127,0.0127100937061482,0.0852739087061445
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37959,-0.0189415747876908,0.0110107274568315,-0.0405226006030805,0.00263945102769899,0.0854037927220188
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OTOA,Otoancorin,37541,0.00880521599497865,0.00512186334687068,-0.00123363616488788,0.0188440681548452,0.0856119633843792
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TEX33,Testis-expressed protein 33,37714,0.00633553138468902,0.00368852522585508,-0.000893978057986931,0.013565040827365,0.0858869842905878
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37901,0.00672715321709659,0.00391888630898405,-0.000953863948512134,0.0144081703827053,0.0860756363259399
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37562,-0.00730098586118132,0.004262428706879,-0.0156553461266642,0.00105337440430151,0.0867601203823122
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TREML2,Trem-like transcript 2 protein,40332,-0.00532541618027125,0.00311541971207052,-0.0114316388159295,0.000780806455386963,0.0874013073019935
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37900,0.0056707845146569,0.00331837676784464,-0.000833233950318595,0.0121748029796324,0.087491964492977
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37598,-0.00499134352619319,0.00292380901573021,-0.0107220091970244,0.000739322144638025,0.0878201436908559
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOLR3,Folate receptor gamma,40355,0.0292559150090726,0.017165115310298,-0.00438771099911153,0.0628995410172567,0.0883292624343182
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRK1,Protein BRICK1,39961,0.00699851339530874,0.00411910977526833,-0.00107494176421719,0.0150719685548347,0.089332566266146
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GMFG,Glia maturation factor gamma,37990,-0.0113368108197477,0.00667414352264375,-0.0244181321241294,0.00174451048463406,0.0894144289799639
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,37541,0.00472833160013923,0.0028022684534899,-0.00076411456870097,0.0102207777689794,0.0915651160635009
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,37562,-0.00711914508255005,0.00424463611260217,-0.0154386318632503,0.0012003416981502,0.0935253118638476
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",40411,-0.00957299764608673,0.00570837431317328,-0.0207614112999064,0.00161541600773289,0.0935602188720329
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37541,0.00902041836799084,0.00538403535900684,-0.00153229093566257,0.0195731276716442,0.0938794613626452
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37900,-0.01349534656144,0.00805752484506064,-0.0292880952577589,0.00229740213487887,0.0939820193049196
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39961,-0.0126559627713325,0.00756342003877712,-0.0274802660473356,0.00216834050467069,0.0942860257696402
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40330,-0.00489685818129341,0.00293577355515429,-0.0106509743493958,0.000857257986808991,0.095336264048588
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALB1,Calbindin,40305,-0.00658293101485807,0.00395377451729227,-0.0143323290687509,0.00116646703903478,0.0959377419631897
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37978,-0.00748799036528777,0.00449925643108955,-0.0163065329702233,0.00133055223964775,0.0960810767059618
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37942,-0.0149540309017656,0.00899141718666194,-0.032577208587623,0.00266914678409182,0.0963066354546262
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37457,-0.0138639492036081,0.00833637311167468,-0.0302032405024905,0.00247534209527428,0.0963230685301674
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTC,Probetacellulin,39980,-0.0116533036648488,0.00700744129903758,-0.0253878886109625,0.00208128128126481,0.0963346511877907
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOX9,Transcription factor SOX-9,37572,0.00421683311212899,0.00253663938964049,-0.000754980091566374,0.00918864631582435,0.0964625069141383
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,37598,-0.0136983956158448,0.00824880019400979,-0.029866043996104,0.00246925276441439,0.0968069857090181
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37714,-0.00666494639040772,0.00401414859492605,-0.0145326776364628,0.00120278485564733,0.0968649598075271
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40341,0.0141848640303599,0.00855088017844301,-0.00257486111938837,0.0309445891801082,0.0971601858638423
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DHPS,Deoxyhypusine synthase,37900,-0.0063488376342821,0.00383141070257123,-0.0138584026113217,0.00116072734275752,0.0975327711092218
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C7,Complement component C7,37678,0.00487195389393227,0.00294216541458857,-0.000894690318661329,0.0106385981065259,0.0977642673632651
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RGCC,Regulator of cell cycle RGCC,37959,-0.0115334699963577,0.00696638843759313,-0.0251875913340403,0.00212065134132482,0.0978284865226621
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37628,-0.0081369455903433,0.00491684285920793,-0.0177739575943908,0.00150006641370424,0.0979660287647481
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37865,-0.00481888788562255,0.00291711057872254,-0.0105364246199187,0.000898648848673635,0.0985704532165576
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37562,0.00602730494264406,0.0036509695120495,-0.00112859530097296,0.0131832051862611,0.0987874582951927
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBCA,Tubulin-specific chaperone A,37671,-0.0133788692020109,0.0081168210104013,-0.0292878383823974,0.0025300999783757,0.0993170844304285
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNL2,Interferon lambda-2,37541,-0.00996738429633021,0.00605186156926811,-0.0218290329720957,0.00189426437943528,0.0995831281254065
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAPS,Calcyphosin,37942,0.0145583234562288,0.00884292986356757,-0.00277381907636368,0.0318904659888212,0.0997204629400216
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA1,Carbonic anhydrase 1,40003,-0.0095904002844411,0.00582938524182518,-0.0210159953584185,0.00183519478953626,0.0999524730998909
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,40357,-0.0448278939351922,0.0272548834608132,-0.0982474655183862,0.00859167764800173,0.100037926742625
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37671,0.00589441786330158,0.00358419440372398,-0.00113060316799742,0.0129194388946006,0.100084640720099
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39980,-0.00869908330526018,0.00529977676327692,-0.0190866457612829,0.00168847915076258,0.10073349793118
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37562,0.0067681634961878,0.00412641344175396,-0.00131960684964996,0.0148559338420256,0.100986564227736
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TEF,Thyrotroph embryonic factor,37562,0.00660072577171652,0.0040257851259701,-0.00128981307518487,0.0144912646186179,0.101109850501801
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GNLY,Granulysin,40332,0.00773896889563803,0.00472078832764045,-0.00151377622653725,0.0169917140178133,0.101162641739366
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHGB,Secretogranin-1,40406,0.00614646794547029,0.0037494172860127,-0.0012023899351146,0.0134953258260552,0.101167837408297
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39980,-0.00800638466736444,0.00489242644136551,-0.0175955404924408,0.00158277115771196,0.101758294700975
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BMP4,Bone morphogenetic protein 4,40203,0.00692663206755044,0.00423286345075143,-0.00136978029592237,0.0152230444310232,0.101777147064025
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37671,0.00615814608436018,0.00376621094040635,-0.00122362735883628,0.0135399195275566,0.102051084717636
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37714,0.00772099815004827,0.00472326580437974,-0.00153660282653603,0.0169785991266326,0.102141213091834
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNU13,NHP2-like protein 1,37562,-0.00950855478588577,0.00582662486041297,-0.0209287395122952,0.00191162994052365,0.10272147362364
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40359,-0.0127209052278043,0.00781121794389634,-0.0280308923978411,0.00258908194223256,0.103429577149837
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MANSC4,MANSC domain-containing protein 4,37562,0.0099774815131659,0.00614242843582672,-0.00206167822105448,0.0220166412473863,0.104324203282104
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPM1F,Protein phosphatase 1F,37990,-0.00788283360708239,0.00486985984641416,-0.0174277589060541,0.00166209169188936,0.105535498239041
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THTPA,Thiamine-triphosphatase,37884,-0.0132979478020135,0.00823137650833764,-0.0294314457583553,0.00283555015432825,0.106221765366048
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL36G,Interleukin-36 gamma,37551,-0.0103794905589847,0.0064285593144359,-0.0229794668152791,0.00222048569730964,0.106423497484865
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,40042,-0.0094355555667296,0.00584677190953746,-0.020895228509423,0.00202411737596381,0.106589752071277
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINB9,Serpin B9,40228,-0.00503547466883483,0.00312486112508953,-0.0111602024740103,0.00108925313634065,0.107107451942808
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40044,-0.010815403259538,0.00671227982512284,-0.0239714717167787,0.00234066519770282,0.107137617319239
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37900,-0.00819756477468411,0.00509136643377918,-0.0181766429848913,0.00178151343552307,0.107401397652561
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL31,Interleukin-31,37598,0.00874095579571317,0.00543063947704335,-0.00190309757929178,0.0193850091707181,0.10751732497824
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SDC4,Syndecan-4,40359,0.00677044438880823,0.00421013823378034,-0.00148142654940124,0.0150223153270177,0.107826826790055
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNF,Tumor necrosis factor,40014,-0.00596256626810357,0.0037093129256721,-0.0132328196024209,0.00130768706621373,0.107974132173629
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,37541,0.0085724787674154,0.00534053643149031,-0.00189497263830561,0.0190399301731364,0.108480114362881
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYOM1,Myomesin-1,37541,0.00701468286389664,0.00437313489336203,-0.00155666152709293,0.0155860272548862,0.108729384575316
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37998,0.00333613405456806,0.00208170793814376,-0.000744013504193699,0.00741628161332983,0.10904748614685
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37959,0.00636489432940944,0.00397364394549765,-0.00142344780376594,0.0141532364625848,0.109228156717642
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,37541,0.01363045290295,0.00850972170995475,-0.00304860164856131,0.0303095074544613,0.109234875143348
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD5L,CD5 antigen-like,37934,0.00696643594207893,0.0043506928950103,-0.00156092213214126,0.0154937940162991,0.109350639031003
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,37482,-0.0115670050560099,0.00722617534419085,-0.025730308730624,0.00259629861860413,0.109465594357398
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYH4,Myosin-4,37562,0.00709965033821693,0.00444872833700446,-0.00161985720231182,0.0158191578787457,0.110539000204847
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37598,0.00419003595606926,0.00262860678826753,-0.000962033348935101,0.00934210526107362,0.110956945098286
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHA10,Ephrin type-A receptor 10,39961,0.00971520345698708,0.00609963083707483,-0.00224007298367957,0.0216704798976537,0.111236060147534
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STK4,Serine/threonine-protein kinase 4,40359,-0.0127433097851641,0.00800107592731128,-0.0284254186026942,0.002938799032366,0.111247484736535
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TP73,Tumor protein p73,37572,0.00520015692412945,0.00326877921016871,-0.00120665032780121,0.0116069641760601,0.111666086048491
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RPS10,40S ribosomal protein S10,37562,0.00626453231677344,0.00395144985958769,-0.00148030940801844,0.0140093740415653,0.112905133059413
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37959,-0.012567316405261,0.00795083456856101,-0.0281509521596406,0.00301631934911858,0.113986400726581
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,40380,-0.00694593180555542,0.00441793287168654,-0.015605080234061,0.0017132166229502,0.115921007568527
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMA4,Laminin subunit alpha-4,40422,0.004781785350924,0.0030533663290448,-0.00120281265400381,0.0107663833558518,0.117352047958981
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37562,-0.00965400488636937,0.00616828981281925,-0.0217438529194951,0.00243584314675637,0.117583048439667
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LPO,Lactoperoxidase,39831,-0.00863982564130386,0.00552302275623524,-0.0194649502435249,0.0021852989609172,0.117760858863745
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GUCA2A,Guanylin,40276,-0.00486373314496965,0.00311350095889618,-0.0109661950244062,0.00123872873446687,0.118274346480213
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NLGN2,Neuroligin-2,37541,0.00704956835016972,0.00451399283293839,-0.00179785760238952,0.015896994302729,0.118379422212751
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,40273,0.00489363627644567,0.00313501343446177,-0.00125099005509939,0.0110382626079907,0.118552761020698
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDIA2,Protein disulfide-isomerase A2,37482,0.00607122374270114,0.00388939366647749,-0.00155198784359473,0.013694435328997,0.118555302493899
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40341,-0.0117617791103478,0.00753754350969083,-0.0265353643893418,0.00301180616864625,0.118679153036755
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA9,Serpin A9,40228,-0.0104652278222832,0.00671812627498012,-0.0236327553212442,0.00270229967667784,0.119310230389148
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDIA5,Protein disulfide-isomerase A5,37482,-0.00890878112460171,0.0057323321450635,-0.0201441521289262,0.00232658987972275,0.120178039719251
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37572,0.00563150967736694,0.00362552023500754,-0.00147450998324784,0.0127375293379817,0.120376318550721
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37562,0.00907546443800777,0.0058545224119328,-0.00239939948938052,0.0205503283653961,0.121126519361491
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCRL3,Fc receptor-like protein 3,40044,0.00791072291811751,0.00510618202004507,-0.00209739384117083,0.0179188396774058,0.121343321773989
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37987,0.003732819079672,0.00241070349863632,-0.000992159777655181,0.00845779793699918,0.121540839495444
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39961,-0.00797691608468495,0.00515713933332645,-0.0180849091780048,0.00213107700863489,0.121938761436683
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40044,-0.00604181609425937,0.00392199764709309,-0.0137289314825618,0.00164529929404309,0.123460137532552
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LHB,Lutropin subunit beta,39980,0.0121645589458305,0.00790088337051211,-0.00332117246037325,0.0276502903520342,0.123667182492177
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFD,Complement factor D,38013,-0.00272488630776042,0.00177648861544812,-0.00620680399403873,0.000757031378517884,0.125087221393352
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPMT,Thiopurine S-methyltransferase,39980,-0.0105564353401683,0.0068828097499539,-0.0240467424500779,0.00293387176974138,0.125114190954823
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37900,-0.00722700958330694,0.00471410489796924,-0.0164666551833266,0.00201263601671277,0.125284390255764
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBM17,Splicing factor 45,37959,-0.0108720968605198,0.00710013690994088,-0.0247883652040039,0.00304417148296436,0.125730611768528
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37598,-0.0057794338416625,0.00378084795859974,-0.013189895840518,0.001631028157193,0.126385750336048
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PALM,Paralemmin-1,37824,0.00415811061325372,0.00272572074154734,-0.00118430204017908,0.00950052326668652,0.127155923468441
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCTN3,Tectonic-3,37990,-0.00414266560602602,0.00271573501584727,-0.00946550623708668,0.00118017502503463,0.127175062440768
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNCA,Alpha-synuclein,37671,0.0161572783272714,0.0106033291441988,-0.00462524679535826,0.0369398034499011,0.127584359730422
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBP7,Retinoid-binding protein 7,37901,-0.00828016065916196,0.00544026579286666,-0.0189430816131806,0.00238276029485669,0.12802908504473
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37714,-0.00510097637193221,0.00335922088728125,-0.0116850493110035,0.00148309656713904,0.128912277565069
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,XRCC4,DNA repair protein XRCC4,39961,-0.00526689499189053,0.00347225051979771,-0.012072506010694,0.00153871602691299,0.12932408388901
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37562,-0.00566206059840592,0.00374443879657777,-0.0130011606396983,0.00167703944288651,0.130526096155533
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL1,Growth-regulated alpha protein,40329,-0.0136701224048614,0.00904188625746041,-0.0313922194694838,0.00405197465976101,0.130587801519771
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VEGFB,Vascular endothelial growth factor B,37598,-0.00401257554080285,0.00265754497526516,-0.00922136369232256,0.00119621261071687,0.131097933412295
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTPN,Myotrophin,40042,0.00466603151273299,0.00309107806145111,-0.00139248148771118,0.0107245445131772,0.131187258210759
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,37482,0.00662337237048519,0.00439390981097652,-0.00198869085902878,0.0152354355999992,0.131732826392608
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DGCR6,Protein DGCR6,37541,-0.00638911217464964,0.00424010147132089,-0.0146997110584386,0.00192148670913931,0.131878366135296
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,40403,-0.00639499365567183,0.00425708748655576,-0.0147388851293211,0.00194889781797745,0.133065452277068
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RYR1,Ryanodine receptor 1,37562,0.00485218659868592,0.00323101123008379,-0.00148059541227831,0.0111849686096501,0.133184531681917
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37562,0.00534417436242054,0.0035707608491339,-0.00165451690188191,0.012342865626723,0.134508780187124
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37562,-0.0096797824488468,0.00648659050945015,-0.0223934998473691,0.00303393494967549,0.135650904229465
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37225,0.0150484670084088,0.0100850112179894,-0.00471815497885038,0.0348150889956679,0.135681469587158
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,40283,0.00446780875997127,0.00300115771889441,-0.00141446036906178,0.0103500778890043,0.136587597796903
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,37572,0.00500613092867556,0.00336712851933866,-0.00159344096922822,0.0116057028265793,0.137100754012775
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF12,Fibroblast growth factor 12,37598,0.00668685572202768,0.00449788128953898,-0.00212899160546873,0.0155027030495241,0.137126527444771
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GC,Vitamin D-binding protein,38013,-0.0035981959043876,0.00242414774440327,-0.008349525483418,0.00115313367464281,0.137748937971995
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,37628,0.0051977684613015,0.00350781470000555,-0.00167754835070937,0.0120730852733124,0.138425882912721
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37671,-0.0113295970975074,0.00766208008523837,-0.0263472740645746,0.00368807986955978,0.139255532030117
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP12,Macrophage metalloelastase,40346,-0.00711538146519317,0.0048145849267935,-0.0165519679217084,0.0023212049913221,0.139459565627368
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39961,-0.0103564693045801,0.00701950018769055,-0.0241146896724536,0.00340175106329336,0.140129212207499
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37990,-0.00405867058178125,0.00275116022573973,-0.00945094462423113,0.00133360346066863,0.140166502647273
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDCD1,Programmed cell death protein 1,40455,0.00598350945592349,0.00407236559855358,-0.00199832711724152,0.0139653460290885,0.141772247090571
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA5,Annexin A5,39896,-0.00419252240293937,0.00285532071086963,-0.00978895099624386,0.00140390619036511,0.142037886732513
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37714,-0.0100077136236862,0.00682352979239089,-0.0233818320167724,0.0033664047693999,0.142495653988182
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,37541,0.00871816973380215,0.00594896447671498,-0.00294180064055922,0.0203781401081635,0.142810300733833
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37900,0.00747058927736202,0.00510963075417399,-0.00254428700081901,0.017485465555543,0.143747999663633
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL20,Interleukin-20,40044,0.00695332955098603,0.00476281360487582,-0.00238178511457058,0.0162884442165426,0.144332052501019
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL14,C-X-C motif chemokine 14,40044,-0.00837139694875353,0.00573542504165333,-0.0196128300303941,0.00287003613288699,0.144421597085385
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BEX3,Protein BEX3,37482,0.00651717023832473,0.00446734302705146,-0.00223882209469612,0.0152731625713456,0.144631311362527
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,40357,0.00360931556235137,0.00247709955390753,-0.0012457995633074,0.00846443068801014,0.145115896014441
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39836,-0.0163470577184341,0.0112402190981114,-0.0383778871507326,0.00568377171386427,0.145873515269795
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRYBB2,Beta-crystallin B2,37942,-0.00929849149010539,0.00640725819890372,-0.0218567175599567,0.0032597345797459,0.146735335169648
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMOTL2,Angiomotin-like protein 2,37855,-0.0064763272197884,0.00447574928111493,-0.0152487958107737,0.00229614137119686,0.147925440833329
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDN1,Endothelin-1,37628,-0.0039263183946412,0.00271347227125264,-0.00924472404629638,0.00139208725701398,0.147928555756159
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37900,-0.00661075173048468,0.0045692155698917,-0.0155664142474724,0.00234491078650305,0.147975601729277
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DLGAP5,Disks large-associated protein 5,37959,0.00720474779489058,0.00501140216411236,-0.00261760044676964,0.0170270960365508,0.150550577914169
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37598,0.00785441662160146,0.00546483140548352,-0.00285665293314624,0.0185654861763492,0.150666213275818
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37959,-0.00892174011686586,0.00621402988903801,-0.0211012386993804,0.00325775846564864,0.151099090671228
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37572,0.00494068770353456,0.00344403545956592,-0.00180962179721464,0.0116909972042838,0.15143534494769
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,40451,-0.00397442984726753,0.00277762159893501,-0.00941856818118015,0.00146970848664509,0.152485518276407
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX1B,Syntaxin-1B,37572,0.00573919053377189,0.00401540423400119,-0.00213100176487043,0.0136093828324142,0.152943747968017
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37990,-0.00516177924422031,0.00361313984621969,-0.0122435333428109,0.00191997485437028,0.153138511235496
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSBP1,Heat shock factor-binding protein 1,37628,-0.0127154991008997,0.0089058904131633,-0.0301710443106997,0.00474004610890042,0.153383841325295
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39961,0.00526875028281397,0.00369591147552658,-0.00197523620921814,0.0125127367748461,0.154014989588126
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLXNB3,Plexin-B3,40310,-0.00618860325679527,0.0043414899391555,-0.0146979235375401,0.00232071702394952,0.154045087480216
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37900,-0.00377332263939622,0.00264757704185355,-0.00896257364142918,0.00141592836263674,0.154123058395144
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37901,-0.00436777436104713,0.00306495918703606,-0.0103750943676378,0.00163954564554354,0.154160835821775
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAPPA,Pappalysin-1,40044,0.00625306530660404,0.00438941485984088,-0.00235018781868409,0.0148563184318922,0.154299140723943
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FRMD4B,FERM domain-containing protein 4B,37562,-0.00935405581320649,0.0065697632508627,-0.0222307917848974,0.0035226801584844,0.154526989269696
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37959,-0.00627638158342135,0.00441792642364397,-0.0149355173737635,0.00238275420692083,0.155438036317309
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LCN15,Lipocalin-15,37959,-0.00844125745008387,0.00594798678163894,-0.0200993115420962,0.00321679664192844,0.155869936037925
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,37541,0.0100199079306804,0.00706244509273092,-0.00382248445107223,0.023862300312433,0.155993083726858
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37671,-0.0156162953024506,0.0110344947033555,-0.0372439049210275,0.00601131431612623,0.157026026337493
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37942,-0.00630369955769523,0.0044549335443639,-0.0150353693046485,0.00242797018925802,0.157093645563987
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TP53BP1,TP53-binding protein 1,37598,0.0117337362673178,0.00829398138104003,-0.00452246723952062,0.0279899397741563,0.157171643195066
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,40311,0.00533674539392528,0.00377643684658424,-0.00206507082537983,0.0127385616132304,0.157625516282789
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MST1,Hepatocyte growth factor-like protein,37787,-0.00810573329045574,0.00574005613331081,-0.0193562433117449,0.00314477673083344,0.157933594845578
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APCS,Serum amyloid P-component,37882,-0.00472200386833078,0.00334431774602707,-0.0112768666505438,0.00183285891388228,0.157988343507825
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37900,-0.012381738415725,0.00877300752671215,-0.0295768331680808,0.00481335633663078,0.158166109839176
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LCP1,Plastin-2,37998,0.0061653999268763,0.00438052179076275,-0.00242042278301869,0.0147512226367713,0.159314602963599
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37942,-0.0037036156436393,0.00263393862271117,-0.00886613534415319,0.0014589040568746,0.159713571192319
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37562,0.00637282854115125,0.00453275626663008,-0.00251137374144371,0.0152570308237462,0.159762680703757
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,37482,0.00335751231166919,0.00238863786838549,-0.00132421791036637,0.00803924253370476,0.159861440075636
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEMA7A,Semaphorin-7A,40490,0.00351035516720897,0.00250378989617061,-0.00139707302928543,0.00841778336370337,0.160929623013277
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40516,0.00454604294317559,0.00324923180255203,-0.00182245138982639,0.0109145372761776,0.161798362593578
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIF22,Kinesin-like protein KIF22,37562,-0.0159497399883282,0.0114077729949591,-0.038308975058448,0.00640949508179168,0.162092675390906
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37562,-0.0131969363247886,0.00945740534681109,-0.0317334508045384,0.00533957815496108,0.162916562952152
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD2,T-cell surface antigen CD2,37562,-0.00497653163369869,0.00357018386413753,-0.0119740920074083,0.00202102874001087,0.16336700159294
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC1A4,Neutral amino acid transporter A,37572,-0.0068369711582529,0.00491103075127823,-0.0164625914307582,0.00278864911425243,0.163895662986171
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37900,-0.00586791035179184,0.00421648293105779,-0.0141322168966651,0.00239639619308141,0.16404841828268
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37628,-0.00649746680257677,0.00467986633456867,-0.0156700048183314,0.00267507121317782,0.165042624603122
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP164,Centrosomal protein of 164 kDa,40044,-0.00828991570731836,0.0059712992889428,-0.0199936623136463,0.00341383089900952,0.165067538978616
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SYAP1,Synapse-associated protein 1,37671,0.00730467250455957,0.0052621016445289,-0.00300904671871707,0.0176183917278362,0.16510978566742
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DXO,Decapping and exoribonuclease protein,37942,-0.00590537696114134,0.00426293423997514,-0.0142607280714926,0.00244997414920993,0.165988379392572
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGR,Progesterone receptor,37598,0.0133666433675094,0.00966146730386251,-0.00556983254806116,0.0323031192830799,0.166534993125437
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37942,0.00590349826829242,0.00426968371983189,-0.00246508182257809,0.0142720783591629,0.16679365521982
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSAP,Gamma-secretase-activating protein,39980,0.0114364698156714,0.00832159039154504,-0.00487384735175689,0.0277467869830997,0.169364367981002
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RCC1,Regulator of chromosome condensation,37900,-0.00652561791342414,0.00475826373058231,-0.0158518148253655,0.00280057899851718,0.170264337693474
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37990,-0.0136516459668831,0.00995839146696355,-0.0331700932421316,0.00586680130836551,0.170438653282932
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,40305,-0.0147964172418634,0.0107943368962399,-0.0359533175584937,0.00636048307476686,0.170469999383301
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40422,-0.00336135063152844,0.00245936679069836,-0.00818170954129723,0.00145900827824034,0.171721508451132
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37714,-0.00888317957157518,0.0065164201221478,-0.0216553630109849,0.00388900386783452,0.172842839249101
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37755,0.00172261354909387,0.00126553299898106,-0.000757831128908998,0.00420305822709674,0.173481031590471
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,40128,0.022186349278655,0.0163028930887516,-0.009767321175298,0.0541400197326081,0.173569857693581
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD101,Immunoglobulin superfamily member 2,37901,-0.00535371717401004,0.00395869332159158,-0.0131127560843295,0.00240532173630946,0.176271716735114
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39980,0.00415748549249005,0.00308167291086462,-0.00188259341280462,0.0101975643977847,0.177324460570835
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GH2,Growth hormone variant,39980,0.0211954207652055,0.0157193281471349,-0.00961446240317892,0.05200530393359,0.177560091461783
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXN,Thioredoxin,37819,-0.00560110466592429,0.00415409378413871,-0.0137431284828362,0.00254091915098758,0.177573921471768
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37621,-0.00359416594592929,0.00266574846695463,-0.00881903294116037,0.00163070104930178,0.177592664267617
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A3,Protein S100-A3,37900,0.00576822075185566,0.00427880829581974,-0.00261824350795104,0.0141546850116624,0.177651987361432
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL3,Interleukin-3,37482,0.00758262024184716,0.005630872912868,-0.00345389066737413,0.0186191311510684,0.178127550448834
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,37482,0.00746701091359682,0.0055559684137352,-0.00342268717732416,0.0183567090045178,0.178984046790882
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFL4,Insulin growth factor-like family member 4,37598,-0.00984893290411215,0.00734442206748128,-0.0242440001563755,0.00454613434815116,0.179940840504528
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL4,Interleukin-4,40044,-0.0112373055463125,0.00838777320593319,-0.0276773410299415,0.00520272993731658,0.180354443666335
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,37628,0.0072402712301604,0.00540939940647217,-0.00336215160652505,0.0178426940668458,0.180769234512724
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37900,-0.0106031819433432,0.00794223228719043,-0.0261699572262364,0.00496359333955009,0.181886507202171
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,37562,0.00477387665882125,0.00357743463414983,-0.00223789522411241,0.0117856485417549,0.182082436514646
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37567,-0.00737500156868561,0.00554074845248432,-0.0182348685355549,0.00348486539818367,0.183196389651059
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP9,Fatty acid-binding protein 9,40341,0.00692402510710425,0.00520562770427516,-0.00327900519327505,0.0171270554074836,0.183503170530696
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GKN1,Gastrokine-1,39602,-0.00346164951296215,0.00260778356136324,-0.0085729052932341,0.00164960626730981,0.18438656209487
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPR15L,Protein GPR15L,37901,0.0074379800877726,0.00561266888288625,-0.00356285092268444,0.0184388110982296,0.185123126632506
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37990,0.00334045102255485,0.00252301786618973,-0.00160466399517701,0.00828556604028671,0.18552864100091
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPN1,Epsin-1,37714,-0.00546853001302029,0.00413117091058093,-0.0135656249977589,0.00262856497171832,0.185617546944643
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAS2,Growth arrest-specific protein 2,37714,-0.00659053740004417,0.00499083565720391,-0.0163725752881638,0.00319150048807549,0.186681637051681
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,37541,0.00968802621410145,0.00734355901342857,-0.00470534945221854,0.0240814018804214,0.187106986994492
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,40228,-0.00278083350161572,0.00211146301270436,-0.00691930100651626,0.00135763400328482,0.187851925663517
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37901,0.00676196868919544,0.00514783028105693,-0.00332777866167614,0.016851716040067,0.189017722369805
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBM19,Probable RNA-binding protein 19,37562,-0.00587792472956284,0.00447486675253584,-0.0146486635645331,0.00289281410540741,0.189023417048094
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37572,0.00442406017569306,0.00337032856355197,-0.00218178380886879,0.0110299041602549,0.189324035207273
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37714,0.00504929932573383,0.00384750601409696,-0.00249181246189621,0.0125904111133639,0.189422606610342
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRDT,Bromodomain testis-specific protein,37562,0.00455281215596519,0.0034742263929185,-0.00225667157415507,0.0113622958860854,0.190065420484787
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCL2L1,Bcl-2-like protein 1,37942,-0.0121505945413169,0.00928218208397786,-0.0303436714259136,0.00604248234327965,0.190548685599967
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ST13,Hsc70-interacting protein,37671,-0.00694536688371153,0.00530797792684059,-0.0173490036203191,0.00345826985289602,0.190734329519304
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39961,0.0103388534915486,0.0079113469089623,-0.00516738645001748,0.0258450934331147,0.191286910551167
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40489,-0.00766024530032382,0.00586299840233766,-0.0191517221689056,0.003831231568258,0.191387526816972
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDI2,Protein DDI1 homolog 2,37671,-0.0094970647328837,0.00729285629963306,-0.0237910630801645,0.00479693361439709,0.192856315636285
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFRC,Transferrin receptor protein 1,40391,0.00477059816491841,0.0036866799978726,-0.00245529463091189,0.0119964909607487,0.195680961195141
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UBXN1,UBX domain-containing protein 1,37671,-0.00832830818115016,0.00643694082150044,-0.020944712191291,0.00428809582899071,0.195746697200879
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37990,-0.0089104751027601,0.00691543535439699,-0.0224647283973782,0.00464377819185799,0.197597175065408
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YY1,Transcriptional repressor protein YY1,37598,0.00337448168011816,0.002619977504659,-0.00176067422901348,0.00850963758924981,0.197775190200968
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,40465,-0.007648840191212,0.00594331410980884,-0.0192977358464373,0.00400005546401333,0.198124917805057
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37959,-0.008707541311638,0.0067669339444349,-0.0219707318427304,0.00455564921945441,0.198193751105134
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL28,C-C motif chemokine 28,40278,-0.00714462051667814,0.00555434229231033,-0.0180311314096064,0.0037418903762501,0.198352801481452
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37671,-0.00254215832130228,0.00197870435838403,-0.00642041886373498,0.00133610222113042,0.198899010171502
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37990,0.00298598698748942,0.00232640157412444,-0.00157376009779449,0.00754573407277332,0.199331318380079
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37901,-0.00470961754171983,0.00366938849855437,-0.0119016189988864,0.00248238391544673,0.199343138011075
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RASA1,Ras GTPase-activating protein 1,39961,-0.00389375376998011,0.00304044970618863,-0.00985303519410982,0.00206552765414959,0.200335566399238
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP7,Matrilysin,40015,0.00572499757245322,0.0044977295853527,-0.00309055241483808,0.0145405475597445,0.203085359227604
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,40044,-0.00784103695961987,0.00617215576120725,-0.0199384622515861,0.00425638833234634,0.203965160745665
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MANSC1,MANSC domain-containing protein 1,40411,0.00323957838100883,0.00255156735157575,-0.00176149362807965,0.0082406503900973,0.204230512309655
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAT1,Diamine acetyltransferase 1,37562,0.00620045980488999,0.00488406946850654,-0.00337231635338282,0.0157732359631628,0.204275574674022
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40411,-0.00858553563988619,0.00676505500399521,-0.0218450434477168,0.00467397216794442,0.20442368007216
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37628,-0.012102497674365,0.00954144164357995,-0.0308037232957817,0.00659872794705166,0.204672572701349
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37598,-0.0110782575571312,0.00875104705833639,-0.0282303097914705,0.00607379467720809,0.205558755224405
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BSND,Barttin,37482,0.0040577628863168,0.00320738695391733,-0.00222871554336116,0.0103442413159948,0.205847194717358
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40470,0.00345966405699767,0.0027360286488403,-0.00190295209472932,0.00882228020872466,0.206074809443171
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF16,Fibroblast growth factor 16,37598,0.00578983978422188,0.00458145024329122,-0.00318980269262891,0.0147694822610727,0.206339670884869
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YAP1,Transcriptional coactivator YAP1,37942,0.00312920041896555,0.00248026671912818,-0.00173212235052568,0.00799052318845679,0.207100647122436
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP13,Collagenase 3,39961,0.00387627727647718,0.00307638669369549,-0.00215344064316598,0.00990599519612035,0.20768479845005
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,40377,-0.00465302473738131,0.00370873008003423,-0.0119221356942484,0.00261608621948577,0.20963732594664
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MN1,Transcriptional activator MN1,37572,0.00699589194387074,0.0055776095850339,-0.0039362228427957,0.0179280067305372,0.209762088502433
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37714,-0.00784256345009247,0.00626348046403445,-0.0201189851596,0.00443385825941506,0.210552044366257
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37671,-0.00712646297488053,0.00569184773373094,-0.0182824845329932,0.00402955858323211,0.210574756563694
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRDX2,Peroxiredoxin-2,37763,-0.00732273784456947,0.00585562625258598,-0.018799765299638,0.00415428961049905,0.211121654758684
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37901,-0.00893206329266681,0.00715856752299881,-0.0229628556377445,0.00509872905241086,0.212146361596132
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MUCL3,Mucin-like protein 3,37482,0.00525943068590085,0.0042155935963161,-0.0030031327628787,0.0135219941346804,0.212195122642687
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOST,Sclerostin,40330,0.00448616360553505,0.00359660027963484,-0.00256317294254924,0.0115355001536193,0.21229326999056
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,40291,0.00400344321910422,0.00321550788596899,-0.002298952237395,0.0103058386756034,0.213134634783946
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP3R1,Calcineurin subunit B type 1,40228,-0.00478025635858847,0.00384709339950167,-0.0123205594216118,0.00276004670443481,0.214047337818608
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RILPL2,RILP-like protein 2,37990,0.011214015663308,0.0090521800586366,-0.00652825725161976,0.0289562885782357,0.215433890675481
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,40044,0.00448913752757662,0.00362490008860446,-0.00261566664608812,0.0115939417012413,0.215580162421964
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39925,-0.0054138744446517,0.00438657459060965,-0.0140115606422466,0.00318381175294321,0.217150182047567
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYH7B,Myosin-7B,37482,0.00526319073935008,0.00427322332517177,-0.00311232697798658,0.0136387084566868,0.218095503146452
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TERF1,Telomeric repeat-binding factor 1,37598,0.00340542556487127,0.00277160773922414,-0.00202692560400805,0.00883777673375059,0.219212913357663
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ELAVL4,ELAV-like protein 4,37541,-0.00999064235939367,0.00813658460189895,-0.0259383481791156,0.00595706346032828,0.219519042353136
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37959,-0.00375949488033894,0.00306205113232182,-0.00976111509968972,0.00224212533901183,0.219554671690225
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSNL1,Visinin-like protein 1,37942,-0.0042724023707218,0.00348605396467264,-0.0111050681414802,0.00256026340003656,0.220382013818978
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40324,0.00277952849299871,0.0022686602412489,-0.00166704557984913,0.00722610256584654,0.220523706464343
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37572,0.00471685679061983,0.00386265425002613,-0.00285394553943139,0.012287659120671,0.222053472646833
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37990,-0.0101983732310411,0.00837502176018645,-0.0266134158810065,0.00621666941892438,0.223354262368754
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TTF2,Transcription termination factor 2,37572,-0.00551903557001816,0.00453762121416583,-0.0144127731497832,0.00337470200974687,0.223898678563915
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37879,-0.00471074299355552,0.00387611464037998,-0.0123079276887003,0.00288644170158923,0.224263139193827
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SORT1,Sortilin,40330,-0.00409856139813895,0.00337929603483835,-0.0107219816264221,0.00252485883014422,0.225207232888982
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYO6,Unconventional myosin-VI,37959,0.00422407764375996,0.00349161117334607,-0.00261948025599833,0.0110676355435183,0.226384904253733
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37942,-0.0268939668162491,0.022230699019647,-0.0704661368947573,0.0166782032622591,0.226389498376132
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37900,-0.00875218031545776,0.00724727078867035,-0.0229568310612517,0.00545247043033613,0.227202426383002
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37900,-0.00580828645015529,0.00481662938694475,-0.015248880048567,0.00363230714825642,0.227884225832644
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL17,C-C motif chemokine 17,40333,-0.0101433108576853,0.00841867080495054,-0.0266439056353884,0.00635728392001777,0.228275712647841
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39980,-0.00855824742656022,0.00711464271903096,-0.0225029471558609,0.00538645230274046,0.229030983692058
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37541,0.00732805735168968,0.00609382851649681,-0.00461584654064406,0.0192719612440234,0.229177096585627
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1R,Complement C1r subcomponent,38013,0.00223182467754937,0.00185670353189445,-0.00140731424496375,0.00587096360006249,0.229370530234177
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37714,-0.0059800912770769,0.00497791909295834,-0.0157368126992752,0.00377663014512144,0.229647184439284
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,40330,-0.00543476086886618,0.00452849409697167,-0.0143106092989307,0.0034410875611983,0.230108541069649
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37671,-0.00425243310053938,0.00354514559319847,-0.0112009184632084,0.00269605226212962,0.230351689979495
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,37541,-0.0111366836289264,0.00928596456439142,-0.0293371741751335,0.00706380691728081,0.230431922951127
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB2B,Ras-related protein Rab-2B,37900,0.00684057104366952,0.00570924470961149,-0.00434954858716899,0.018030690674508,0.230877049265498
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA12,Carbonic anhydrase 12,40305,-0.00360787202110743,0.00301128277373951,-0.00950998625763688,0.00229424221542202,0.230889003366009
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40453,0.00733945245602869,0.00615154075314877,-0.0047175674201429,0.0193964723322003,0.23284477110339
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARG2,"Arginase-2, mitochondrial",37900,-0.00493892747796828,0.00414182451288257,-0.0130569035232181,0.00317904856728156,0.23310504882799
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CORO6,Coronin-6,37541,0.00405117357547582,0.00340520493044437,-0.00262302808819515,0.0107253752391468,0.234185758296902
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,40042,-0.00889196681827619,0.00747805366910505,-0.0235489520097221,0.00576501837316971,0.234428257609105
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37562,-0.00426103623554708,0.00358374855704994,-0.011285183407365,0.00276311093627081,0.234465682003786
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37998,-0.00651015299043972,0.00548167843427009,-0.0172542427216091,0.00423393674072965,0.235003831231002
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCTD,Deoxycytidylate deaminase,37671,-0.0104486708298094,0.00879914958927907,-0.0276950040247964,0.00679766236517758,0.235066099018189
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NECTIN4,Nectin-4,40411,-0.00336996651158574,0.00284509153097767,-0.00894634591230197,0.00220641288913049,0.236239010962793
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRND,Prion-like protein doppel,37942,-0.00592089878969709,0.0050036183688422,-0.0157279907926278,0.00388619321323362,0.236701847842386
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,40289,-0.00302329398993502,0.00255589373842445,-0.00803284571724694,0.0019862577373769,0.23687781525473
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP2,Microtubule-associated protein 2,37942,-0.00504367145236662,0.0042655920352808,-0.013404231841517,0.00331688893678375,0.23706456923803
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39961,-0.0123667874999895,0.0104610327050936,-0.0328704116019729,0.00813683660199396,0.237153781715432
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL22,C-C motif chemokine 22,40204,-0.00565483910918916,0.00478543456345066,-0.0150342908535525,0.00372461263517414,0.237351631452969
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37990,-0.00374552893030573,0.00316991469582446,-0.00995856173412168,0.00246750387351022,0.237390502872022
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37598,0.00505679246612147,0.00428151850890319,-0.00333498381132879,0.0134485687435717,0.237594483464959
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37714,-0.0100950901994706,0.00855939269297443,-0.0268714998777005,0.00668131947875926,0.238253468112057
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CORO1A,Coronin-1A,39990,-0.00985191282015721,0.00836537077644334,-0.0262480395419862,0.00654421390167173,0.238933518270328
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLAMF7,SLAM family member 7,40341,-0.00632339116571078,0.00537593960157537,-0.0168602327847985,0.00421345045337694,0.23951690631193
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37987,0.00430644474932546,0.00367536527083703,-0.00289727118151513,0.011510160680166,0.241336043040832
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSPAN1,Tetraspanin-1,40042,-0.00333553101939251,0.00284754899494527,-0.00891672704948525,0.00224566501070022,0.241468332926115
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK8,Kallikrein-8,39801,-0.00386181793635997,0.0032983399378063,-0.0103265642144603,0.00260292834174037,0.241682540150919
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37628,-0.00311818212945986,0.00266394304764438,-0.00833951050284284,0.00210314624392312,0.241815429282731
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIFBP,KIF-binding protein,40305,-0.00897538322811325,0.00767062324968575,-0.0240098047974973,0.00605903834127082,0.241979002495476
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA3,Carbonic anhydrase 3,40500,-0.0066508640616696,0.00568417024947985,-0.0177918377506501,0.0044901096273109,0.241991098028322
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DAPK2,Death-associated protein kinase 2,37598,-0.00570280177398466,0.00487569193551372,-0.0152591579675916,0.00385355441962224,0.24216728862706
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37900,-0.00401999907882474,0.00343821491205983,-0.010758900306462,0.00271890214881253,0.242339308959958
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AHCY,Adenosylhomocysteinase,40359,-0.00735631446766171,0.00631104774174128,-0.0197259680414746,0.00501333910615121,0.243783608612224
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCDH1,Protocadherin-1,40475,0.00235431538679107,0.00202697105641518,-0.00161854788378269,0.00632717865736483,0.245458230090863
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZNF75D,Zinc finger protein 75D,37714,-0.00641354748579663,0.00555762737011689,-0.0173064971312257,0.00447940215963249,0.248517607839905
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTR,Methionine synthase,37562,0.00704983058257983,0.00611895740427369,-0.0049433259297966,0.0190429870949563,0.249288921662945
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGA6,Integrin alpha-6,40341,-0.00569897733247259,0.0049478976092368,-0.0153968566465767,0.00399890198163154,0.249421523056757
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,37482,0.00390603211830157,0.00340521043785604,-0.00276818033989627,0.0105802445764994,0.251371643994365
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSNK1D,Casein kinase I isoform delta,37598,-0.00680249631242408,0.00593245546480615,-0.0184301090234441,0.00482511639859597,0.251543949106844
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOS,Proto-oncogene c-Fos,37457,-0.00376210318241956,0.00328518597037083,-0.0102010676843464,0.00267686131950726,0.252158963810118
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37598,0.00667357547673925,0.00583108672318092,-0.00475535450069535,0.0181025054541739,0.252444516319736
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANK2,Ankyrin-2,37562,0.00794373428499487,0.00694244497002539,-0.00566345785625489,0.0215509264262446,0.25255032124218
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UBQLN3,Ubiquilin-3,37562,0.00482412412676493,0.00421953759532874,-0.0034461695600794,0.0130944178136093,0.252942132289614
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37959,-0.00251698889579324,0.00220314194885817,-0.00683514711555526,0.00180116932396878,0.253285500622126
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCN5,CCN family member 5,40332,-0.00416602587218247,0.00364844365039594,-0.0113169754269585,0.00298492368259357,0.253527838897937
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MORN4,MORN repeat-containing protein 4,37482,-0.00842049782402677,0.00737918565235789,-0.0228837017026482,0.00604270605459469,0.253843132433381
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37942,-0.00600276911618544,0.00526184331187555,-0.0163159820074615,0.00431044377509063,0.253968803584772
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHD,SH2 domain-containing adapter protein D,37531,0.00936078967024164,0.00820954589286766,-0.00672992027977897,0.0254514996202623,0.254210399824157
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40451,0.00367297230928044,0.0032219575700659,-0.00264206452804873,0.00998800914660961,0.25431103746619
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRC1,Macrophage mannose receptor 1,37987,0.00298240323002872,0.00263654704777404,-0.0021852289836084,0.00815003544366585,0.258000347221003
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37942,-0.00395915504531662,0.00350143668478427,-0.0108219709474938,0.00290366085686055,0.258191793352949
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAA10,N-alpha-acetyltransferase 10,37562,-0.00541153099988514,0.00478960318630979,-0.0147991532450523,0.00397609124528205,0.258560296830381
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PITHD1,PITH domain-containing protein 1,37457,0.00867004009926213,0.00768042234481354,-0.0063835876965724,0.0237236678950967,0.258982194929157
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C2orf69,UPF0565 protein C2orf69,37572,-0.00632654714953666,0.00562698298038128,-0.017355433791084,0.00470233949201066,0.2608965366366
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",40332,0.00387455856188655,0.00344750402171707,-0.00288254932067891,0.010631666444452,0.26108366520372
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HIP1,Huntingtin-interacting protein 1,37562,0.00357287394638777,0.00318262663422094,-0.00266507425668528,0.00981082214946082,0.261620326122968
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATXN2,Ataxin-2,37541,0.0120253535921252,0.0107478955515714,-0.00904052168895467,0.0330912288732051,0.263221864374731
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37714,0.00392478426206413,0.00352023801337963,-0.00297488224415994,0.0108244507682882,0.264904848133589
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40305,-0.00979133793704997,0.00879930537760098,-0.0270379764771479,0.00745530060304795,0.265837038648681
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,40341,-0.00340727020744904,0.00306496463167776,-0.00941460088553746,0.00260006047063938,0.266291133456784
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37572,0.00899942487154879,0.00809976162579125,-0.00687610791500206,0.0248749576580996,0.266557373103394
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAFB2,Scaffold attachment factor B2,37959,-0.00286466527044961,0.00258069468719397,-0.00792282685734978,0.00219349631645057,0.267003064241417
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39925,-0.0049208134592861,0.00444330611565227,-0.0136296934459646,0.00378806652739235,0.268109427340246
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,40215,0.0097130996445452,0.00877722309503062,-0.00749025762171481,0.0269164569108052,0.268472728320561
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHP1,Calcineurin B homologous protein 1,37541,0.00754142321052204,0.00682313447700086,-0.00583192036439966,0.0209147667854437,0.269061826258234
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39980,-0.00479252223934984,0.00433626658327116,-0.0132916047425613,0.00370656026386163,0.269082027505877
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRYBB1,Beta-crystallin B1,37990,-0.0066608526799834,0.00603207969207299,-0.0184837288764465,0.00516202351647965,0.269509458942628
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APRT,Adenine phosphoribosyltransferase,40216,-0.00498260688085264,0.0045138859854423,-0.0138298234123195,0.00386460965061427,0.269679497629024
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37714,-0.00792421210599163,0.00719390971471215,-0.0220242751468274,0.00617585093484419,0.270691805802626
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACRBP,Acrosin-binding protein,37900,-0.00387540445417628,0.00352116947156935,-0.0107768966184522,0.00302608771009964,0.271089825738538
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF6,Fibroblast growth factor 6,37598,0.00441185407458652,0.0040138742210585,-0.00345533939868813,0.0122790475478612,0.271722313530329
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37714,-0.00504218810463299,0.00459502350083531,-0.0140484341662702,0.00396405795700423,0.272523649416274
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40286,0.0183659672098605,0.0167455907071823,-0.0144553905762169,0.0511873249959379,0.272761089706038
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ISM2,Isthmin-2,37998,0.00455078063091453,0.00415081490247371,-0.00358481657793394,0.012686377839763,0.272941468086122
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCUN1D1,DCN1-like protein 1,37541,0.00765006356971483,0.00698874498537366,-0.00604787660161755,0.0213480037410472,0.273700562136897
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,37671,-0.00545930159435829,0.00499050880202564,-0.0152406988463285,0.00432209565761197,0.274002598581885
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLC,Galectin-10,40333,0.00666246335149929,0.00612755067105148,-0.00534753596376162,0.0186724626667602,0.27692237196449
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37863,-0.00538383721722658,0.00495323604318669,-0.0150921798618725,0.00432450542741933,0.277085821476229
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37900,0.00457860527038617,0.00421464961437196,-0.00368210797378288,0.0128393185145552,0.277341477376572
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37598,-0.00389483374314145,0.00359044941660248,-0.0109321145996823,0.00314244711339942,0.278040722858445
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DBN1,Drebrin,37598,-0.00521820528739217,0.00481525500152937,-0.0146561050903897,0.00421969451560541,0.278525683216071
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,37482,0.00339962886609728,0.00314171133622976,-0.00275812535291306,0.00955738308510762,0.27923052088309
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F13B,Coagulation factor XIII B chain,37934,0.00260203041198826,0.00240724490386184,-0.00211616959958094,0.00732023042355746,0.279753652751606
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37598,0.00605454381869719,0.00564812460445967,-0.00501578040604376,0.0171248680434381,0.283759254305483
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39980,-0.00765351903339538,0.00714056384719184,-0.0216490241738914,0.00634198610710064,0.28381000337761
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37959,-0.0098703039479535,0.00921428846692882,-0.027930309343134,0.00818970144722699,0.284100693626849
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37959,-0.00368363207462586,0.0034412863678202,-0.0104285533555535,0.00306128920630173,0.284448078638611
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MESD,LRP chaperone MESD,40332,-0.0120212151987711,0.0112400423764446,-0.0340516982566025,0.0100092678590604,0.284861090450317
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39961,0.00558256636033957,0.00522122558386936,-0.00465103578404437,0.0158161685047235,0.284993441255862
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,37541,0.00541965627994109,0.00507088410439717,-0.00451927656467736,0.0153585891245595,0.285188810748908
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAP1A,Ras-related protein Rap-1A,37598,0.00693815708787774,0.00650448685052523,-0.0058106371391517,0.0196869513149072,0.286139349315107
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COPE,Coatomer subunit epsilon,39961,-0.00481159497012817,0.00451112519538961,-0.0136534003530918,0.00403021041283546,0.286166215934528
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37562,0.0096631204092432,0.00908754374090667,-0.00814846532293386,0.0274747061414203,0.287648791445501
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MLLT1,Protein ENL,37482,0.00712008321842661,0.00670087695916441,-0.00601363562153563,0.0202538020583888,0.288001267988118
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTF1,Cardiotrophin-1,40042,-0.00837039120388642,0.00787837344435044,-0.0238120031548133,0.00707122074704045,0.288047134257924
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,37482,-0.00815468930582134,0.00767878740444288,-0.0232051126185294,0.00689573400688671,0.288266181760938
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEMA3G,Semaphorin-3G,37671,0.00424958382017292,0.00403259848263897,-0.00365430920579946,0.0121534768461453,0.291990172981605
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37990,-0.00877793267676894,0.00835669672792308,-0.0251570582634982,0.0076011929099603,0.293549781958454
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EXOSC10,Exosome component 10,37562,0.00617032353361041,0.00587426515972518,-0.00534323617945094,0.0176838832466718,0.293553966558496
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",40314,0.0106894091092154,0.0101799170466704,-0.0092632283022585,0.0306420465206893,0.293711700152059
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK13,Kallikrein-13,40032,-0.00424098515450546,0.00404303267920628,-0.0121653292057498,0.00368335889673886,0.294212162880442
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COPB2,Coatomer subunit beta',37562,-0.00422934409704476,0.00403276264727742,-0.0121335588857085,0.00367487069161898,0.294314323819551
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLHL41,Kelch-like protein 41,37959,-0.00464122650720078,0.00442759808844462,-0.0133193187605522,0.00403686574615069,0.294542527544759
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXNL1,Thioredoxin-like protein 1,37525,-0.0093380585172527,0.00890846570288401,-0.0267986512949054,0.00812253426039995,0.294555261190716
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRR4,Proline-rich protein 4,37577,0.00673197008526103,0.0064235248020526,-0.00585813852676206,0.0193220786972841,0.294649578300259
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37990,-0.00690733734312931,0.00659419537551824,-0.0198319602791451,0.00601728559288644,0.294893486774671
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSTP1,Glutathione S-transferase P,39871,0.00682358640353834,0.00651902880222933,-0.00595371004883115,0.0196008828559078,0.295245952898516
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA7,Carbonic anhydrase 7,37714,0.00343298634411516,0.00328246735622842,-0.00300064967409255,0.00986662236232287,0.295646841093138
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,40044,-0.00587661710809352,0.00562055406970818,-0.0168929030847215,0.00513966886853451,0.295781206726245
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",37482,0.00885711717676553,0.00847355377588393,-0.00775104822396697,0.025465282577498,0.295919463839077
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37959,0.00359436759218005,0.00343902866479977,-0.00314612859082749,0.0103348637751876,0.295963378455855
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37998,-0.00586944193994589,0.0056191557761265,-0.0168829872611538,0.00514410338126206,0.296253524423655
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37562,-0.00652039797746538,0.00626414426452758,-0.0187981207359394,0.00575732478100868,0.297937436454874
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,40044,-0.00661382220596281,0.00636092435982145,-0.0190812339512128,0.00585358953928723,0.298468453547571
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALMS1,Alstrom syndrome protein 1,37714,0.00437304361162228,0.00421018017279482,-0.00387890952705556,0.0126249967503001,0.298971011679028
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37541,0.00479189574511293,0.00462268537628332,-0.00426856759240238,0.0138523590826282,0.299939437561073
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RSPO3,R-spondin-3,40489,-0.00275395089270518,0.00265861394717893,-0.00796483422917589,0.00245693244376552,0.300283246799004
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCRN1,Secernin-1,40341,0.00542174046912582,0.00523537384643108,-0.00483959226987909,0.0156830732081307,0.300405683506964
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZNF830,Zinc finger protein 830,37900,-0.00774147964856103,0.00752671752962803,-0.022493846006632,0.00701088670950991,0.303717531674071
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARFIP1,Arfaptin-1,37959,0.00656537482056126,0.00639456923999347,-0.00596798088982593,0.0190987305309485,0.304574936295075
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,37541,0.00543921306879099,0.00529924969756755,-0.00494731633844141,0.0158257424760234,0.30471642846083
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMMR,Hyaluronan mediated motility receptor,37460,0.00467176115291843,0.00455460188833591,-0.00425525854821996,0.0135987808540568,0.305041114891861
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MILR1,Allergin-1,40044,-0.00477195716916785,0.00465892931079025,-0.0139034586183167,0.00435954427998104,0.305728149768368
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,37628,-0.00533584152245089,0.00521062080988766,-0.0155486583098307,0.00487697526492893,0.305839044632898
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AK1,Adenylate kinase isoenzyme 1,40359,-0.0060898845102988,0.00595214767706463,-0.0177560939573455,0.00557632493674787,0.306256887421206
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCIN,Adseverin,37541,-0.0070121027980796,0.00686259486525326,-0.020462788733976,0.00643858313781679,0.306901119917564
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SH3GLB2,Endophilin-B2,37942,-0.00635745023275299,0.00623003846247193,-0.018568325619198,0.005853425153692,0.307532821210121
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,40422,-0.00826632066831338,0.00810103860647763,-0.0241443563370095,0.00761171500038278,0.307553029555901
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MSLNL,Mesothelin-like protein,37572,0.00358646364217674,0.00351486827778121,-0.00330267818227443,0.0104756054666279,0.307572168006229
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37671,-0.0082980971310563,0.00813377261634052,-0.0242402914590837,0.00764409719697111,0.307650987560667
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,37541,0.00473704336584284,0.00465636723500852,-0.00438943641477385,0.0138635231464595,0.309017184596001
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRYGD,Gamma-crystallin D,37942,-0.00907363243985007,0.00893238968943377,-0.0265811162311403,0.00843385135144012,0.309736935691079
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40359,-0.00924958968760565,0.0091339141043146,-0.0271520613320623,0.00865288195685096,0.311235888283592
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EHD3,EH domain-containing protein 3,37628,-0.0110447046625579,0.0109101987940418,-0.0324286942988797,0.010339284973764,0.311399624173198
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1S,Complement C1s subcomponent,38013,0.00195491319803163,0.00193368513159088,-0.00183510965988648,0.00574493605594975,0.312044979511029
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37901,0.00895546788504703,0.00886044399955875,-0.00841100235408811,0.0263219381241822,0.312166487880023
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDIA3,Protein disulfide-isomerase A3,37671,0.0024054512280399,0.00238172009726622,-0.00226272016260189,0.00707362261868169,0.312531089954081
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FN1,Fibronectin,38013,0.0024623650877948,0.00244266139687352,-0.00232525125007729,0.00724998142566689,0.313440532108987
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAG6,Large proline-rich protein BAG6,40042,-0.00337108858953862,0.00334661146267794,-0.00993044705638738,0.00318826987731014,0.313799536332621
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOP56,Nucleolar protein 56,37562,0.0103852427128845,0.0103450060675393,-0.00989096917949239,0.0306614546052615,0.315450418341058
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM26,Tripartite motif-containing protein 26,37482,-0.00515897121068926,0.00514202470282675,-0.0152373396282297,0.00491939720685117,0.315736847148621
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GGH,Gamma-glutamyl hydrolase,40077,-0.0031948709623357,0.00318547067391471,-0.00943839348320852,0.00304865155853713,0.315900040713922
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40359,-0.00543633031125743,0.00542790557915759,-0.0160750252464063,0.00520236462389146,0.316575193082045
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",37482,0.00463440306051409,0.00463153672750155,-0.00444340892538895,0.0137122150464171,0.317029683654539
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37562,0.0037981801148521,0.00381765115500742,-0.00368441614896246,0.0112807763786666,0.319803394985064
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37562,0.00454752811248793,0.00458246736784803,-0.00443410792849421,0.0135291641534701,0.321032725927593
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EVI2B,Protein EVI2B,37482,0.00390365926919405,0.00394112885053788,-0.00382095327786019,0.0116282718162483,0.321951758836044
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FRMD7,FERM domain-containing protein 7,37572,0.00307278093053794,0.00311117999390882,-0.00302513185752334,0.00917069371859923,0.323338522562968
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40516,0.00637234398685436,0.00645465347214527,-0.00627877681855036,0.0190234647922591,0.323535925840679
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37562,0.00333652271729015,0.00338368739543216,-0.00329550457775687,0.00996855001233718,0.324121299281795
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RP2,Protein XRP2,40305,0.00378869681275627,0.00384852198183137,-0.00375440627163321,0.0113317998971457,0.324906857499452
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UNG,Uracil-DNA glycosylase,37900,0.00310768292315564,0.00315700735612663,-0.00308005149485256,0.00929541734116384,0.324948282252897
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRX,Cone-rod homeobox protein,40042,0.0098726445878937,0.0100320226578023,-0.00979011982139876,0.0295354089971862,0.325075194837285
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEDD9,Enhancer of filamentation 1,37598,-0.00302861325306819,0.00308002452949376,-0.00906546133087596,0.00300823482473959,0.325473891538143
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39980,0.00326147812841612,0.00331997934502044,-0.00324568138782395,0.00976863764465618,0.325928453048985
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BMP6,Bone morphogenetic protein 6,40024,-0.00386229035106496,0.00394519681452058,-0.0115948761075253,0.00387029540539538,0.327602368419248
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNN,Tenascin-N,37998,-0.00398256127124055,0.00407363976062011,-0.011966895202056,0.00400177265957486,0.328268882156555
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37901,-0.00750145861191635,0.00767449696605777,-0.0225434726653896,0.00754055544155688,0.328362611386516
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,40042,0.00510348917241454,0.00522451992171871,-0.00513656987415413,0.0153435482189832,0.328666452319288
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37562,0.00354732115116139,0.00364090595941595,-0.00358885452929388,0.0106834968316166,0.329927424908167
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37572,0.00459745295065915,0.00475521507717344,-0.00472276860060079,0.0139176745019191,0.333650172655585
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICAM2,Intercellular adhesion molecule 2,40536,-0.00280401246489174,0.00290275759353369,-0.00849341734821776,0.00288539241843429,0.334067560449355
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37901,-0.0081485437232343,0.00845394288063035,-0.0247182717692698,0.00842118432280117,0.335125957330321
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37541,0.00514422967993222,0.00534729497468603,-0.00533646847045239,0.0156249278303168,0.336054983673268
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37959,-0.00434752071827602,0.00452480833487745,-0.0132161450546358,0.00452110361808377,0.33666050515864
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL9,Interleukin-9,37714,0.00513024187294325,0.00537106767291802,-0.00539705076597607,0.0156575345118626,0.339512988301255
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICAM1,Intercellular adhesion molecule 1,40291,0.00253404289767775,0.0026560957428187,-0.0026719047582469,0.00773999055360241,0.340073892838751
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37990,-0.00478763189271676,0.00504089805013013,-0.0146677920709718,0.0050925282855383,0.342252322311909
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37998,0.0035522556009466,0.00374305206536095,-0.00378412644716087,0.0108886376490541,0.342624064755618
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPLX2,Complexin-2,37482,0.00274576079202172,0.0028984554007684,-0.00293521179348435,0.00842673337752779,0.343494009397374
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,37598,0.00950404903735624,0.010041529711221,-0.0101773491966369,0.0291854472713493,0.343924159815931
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37959,-0.00259823699500858,0.00274535966073586,-0.00797914193005086,0.00278266794003371,0.34395622198987
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,40305,-0.00273166356958173,0.00288791135583278,-0.00839196982701398,0.00292864268785052,0.344216091209119
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37900,-0.00442837613019401,0.00468950059163572,-0.0136197972898,0.00476304502941199,0.345024537356161
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPL,Periplakin,37598,0.0028942905756409,0.00307316535426238,-0.00312911351871336,0.00891769466999517,0.346315109714873
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIF1C,Kinesin-like protein KIF1C,37562,-0.00330425008470015,0.00351057883146668,-0.0101849845943748,0.00357648442497454,0.346606104088914
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HDAC9,Histone deacetylase 9,37541,0.00557368956221584,0.00592730996403383,-0.00604383796729046,0.0171912170917221,0.347060289351161
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,H2AP,Huntingtin-interacting protein M,37482,0.00458162250839388,0.00487394160581059,-0.00497130303899488,0.0141345480557826,0.347222631013374
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCN2B,Sodium channel subunit beta-2,37572,0.00259944439978255,0.00277224464119461,-0.00283415509695889,0.00803304389652399,0.348432441547103
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUP50,Nuclear pore complex protein Nup50,37562,-0.00311226391227177,0.00332167621347357,-0.00962274929067998,0.00339822146613643,0.348798535512968
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37900,0.00371826034222911,0.00397716079497509,-0.00407697481592206,0.0115134955003803,0.349854976045658
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS7_LGALS7B,Galectin-7,40270,-0.00349638632606767,0.00373985843488935,-0.0108265088584508,0.00383373620631546,0.349855118041076
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37901,0.00226378049266695,0.0024233633753836,-0.0024860117230849,0.0070135727084188,0.350244231717013
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,37482,0.00832003565116489,0.00892407916108566,-0.00917115950456301,0.0258112308068928,0.351192028763947
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40341,-0.00867082082746204,0.00936178409760137,-0.0270199176587607,0.00967827600383665,0.354359649902499
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,37541,0.00613470492121041,0.0066323265851724,-0.00686465518572749,0.0191340650281483,0.354998423969486
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD6,T-cell differentiation antigen CD6,40502,-0.00456929918913562,0.00494388794585383,-0.0142593195630091,0.00512072118473788,0.355379459728709
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATRN,"Attractin, Isoform 2",38013,-0.00140619381157185,0.00152432131608917,-0.00439386359110662,0.00158147596796292,0.356281712226976
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SATB1,DNA-binding protein SATB1,37959,-0.00257336650593745,0.00280745783503093,-0.00807598386259808,0.00292925085072318,0.359359191448426
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TLR3,Toll-like receptor 3,40516,-0.00516751172457721,0.00567043592061214,-0.016281566128977,0.00594654267982259,0.362146962882711
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,37482,0.00546426689529613,0.00600168921159759,-0.00629904395943514,0.0172275777500274,0.362599537688169
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,37482,0.00479520721056489,0.0052799770739957,-0.00555354785446668,0.0151439622755965,0.363796160438258
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLNS1A,Methylosome subunit pICln,37572,-0.00284739336723168,0.00314092026763015,-0.00900359709178677,0.0033088103573234,0.364662792213821
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BLNK,B-cell linker protein,37598,-0.00323224940709413,0.00356832720575588,-0.0102261707303757,0.00376167191618739,0.365049624956195
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GJA8,Gap junction alpha-8 protein,37482,-0.00525907310010327,0.00582548564135943,-0.0166770249571678,0.00615887875696122,0.366664716484509
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37901,0.00855500512461145,0.00948627336269706,-0.0100380906662748,0.0271481009154977,0.36716337450887
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,40291,-0.00362039378873767,0.0040194293272785,-0.0114984752702035,0.00425768769272818,0.367749133230593
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPSAB1,Tryptase alpha/beta-1,40498,-0.00440497598592856,0.00490980235143021,-0.0140281885947318,0.00521823662287465,0.369636388956771
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRADD,Death domain-containing protein CRADD,40192,-0.00637896334766776,0.00712410490638664,-0.0203422089641856,0.00758428226885005,0.370584006807327
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENO1,Alpha-enolase,40299,-0.00660179217678225,0.00737672591633003,-0.0210601749727891,0.00785659061922462,0.370828038543035
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL16,C-X-C motif chemokine 16,40517,-0.00197551711866237,0.00221070059625672,-0.00630849028732554,0.0023574560500008,0.371540843013079
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGAL,Integrin alpha-L,37598,-0.00362262998494932,0.0040594536758589,-0.0115791591896328,0.00433389921973411,0.372198399954604
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THBD,Thrombomodulin,40359,0.00230551753131539,0.00258414975994147,-0.00275941599816989,0.00737045106080067,0.372311864230828
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,37541,0.00503311326950847,0.0056685517210257,-0.00607724810370189,0.0161434746427188,0.374610272001692
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PALM3,Paralemmin-3,37562,0.00601700974368603,0.00677860748966192,-0.00726906093605134,0.0193030804234234,0.374747015675425
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,40305,-0.00174901842072854,0.00197117416552259,-0.00561251978515281,0.00211448294369573,0.374932072246256
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUMF1,Formylglycine-generating enzyme,37598,0.00555362917895351,0.00626011334788768,-0.00671619298290634,0.0178234513408134,0.375016989337709
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37572,-0.00569288026217696,0.00642551162772741,-0.0182868830525227,0.00690112252816876,0.375644084114288
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LXN,Latexin,40183,0.00546318075452999,0.00618365748102231,-0.00665678790827373,0.0175831494173337,0.376986725863756
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPHS2,Podocin,37598,0.00862298047754645,0.0097884962504742,-0.010562472173383,0.0278084331284759,0.378371787341514
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNPEP,Aspartyl aminopeptidase,37942,-0.00487672131395073,0.00553628798365835,-0.0157278457619211,0.00597440313401963,0.378406684046368
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CABP2,Calcium-binding protein 2,37572,0.00535491002982009,0.00610487717622738,-0.00661064923558558,0.0173204692952258,0.38041971697242
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINI2,Serpin I2,37901,-0.00455836777654181,0.00520816068824384,-0.0147663627254997,0.00564962717241611,0.381461343057969
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMOD4,Tropomodulin-4,37482,0.00341485542165784,0.00391567994198865,-0.00425987726463993,0.0110895881079556,0.383171156767597
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GET3,ATPase GET3,37990,-0.00456065542246383,0.005229792273991,-0.0148110482794862,0.00568973743455852,0.383194994550467
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37562,-0.0039718118602942,0.0045641084183305,-0.012917464360222,0.00497384063963357,0.384192119056504
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37714,0.00331650565175206,0.00381835468687922,-0.00416746953453122,0.0108004808380353,0.385098470601374
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EXTL1,Exostosin-like 1,37562,0.00387110061657418,0.00446075377475308,-0.00487197678194186,0.0126141780150902,0.3855125349777
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HRAS,GTPase Hras,37697,0.00796413176784817,0.00920135730453063,-0.0100705285490319,0.0259987920847282,0.386758805926229
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,40042,0.00266265811435635,0.00308375317225556,-0.00338149810326455,0.00870681433197725,0.387904908003979
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37562,0.00712081698282561,0.00829227978144287,-0.00913205138880242,0.0233736853544536,0.390506022645129
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CR2,Complement receptor type 2,40403,0.00371994844612234,0.00433258324714675,-0.0047719147182853,0.01221181161053,0.390575098928265
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37879,-0.00561920301796232,0.00655196250447815,-0.0184610495267395,0.00722264349081485,0.391108451720509
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRN,Progranulin,40262,-0.00193367507346256,0.00225649646292011,-0.00635640814078597,0.00248905799386084,0.391492749506273
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,40305,-0.00258388894522397,0.00301741817263077,-0.00849802856358028,0.00333025067313234,0.39183128615746
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX5,Syntaxin-5,37598,-0.00334404710004439,0.00390518709126713,-0.010998213798928,0.00431011959883919,0.391842457430152
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40471,-0.00455921748678703,0.00532580446525613,-0.014997794238689,0.00587935926511499,0.391976429537992
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NMI,N-myc-interactor,37857,0.00569617320105961,0.00666529992785348,-0.00736781465753322,0.0187601610596524,0.392787245155393
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,37598,-0.00163001485427284,0.00190813717610782,-0.00536996371944417,0.00210993401089849,0.392985339551381
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37598,0.00288515229912252,0.00338586103650796,-0.00375113533243307,0.00952143993067812,0.394164262385485
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37572,0.00311844191830929,0.00366527910136712,-0.00406550512037026,0.0103023889569888,0.394892584310626
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37901,-0.00379954621570598,0.00446740763699641,-0.0125556651842189,0.00495657275280699,0.39506030870433
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37714,-0.0056131640335926,0.00661853789906711,-0.0185854983157641,0.00735917024857894,0.396399098779753
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PMCH,Pro-MCH,37562,0.0067184799594319,0.00794505887404805,-0.00885383543370228,0.0222907953525661,0.397781653407993
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37572,-0.00232835660743743,0.00275646382967712,-0.00773102571360459,0.00307431249872972,0.398299513652607
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RELB,Transcription factor RelB,37598,-0.00406163372695935,0.00481056034477453,-0.0134903320027174,0.00536706454879873,0.398508135308808
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37562,0.00256097380885481,0.00303736885101047,-0.00339226913912571,0.00851421675683532,0.399156946735496
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37572,-0.00480666769347733,0.00570392270736526,-0.0159863561999132,0.00637302081295858,0.399414352155048
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYOM3,Myomesin-3,37671,0.00706750470481634,0.00840403275680419,-0.00940439949851987,0.0235394089081526,0.400382267292846
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37714,0.0043918664847839,0.00524784892936957,-0.00589391741678044,0.0146776503863483,0.402670103458017
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37572,0.00545499863605455,0.00655325773914609,-0.00738938653267178,0.0182993838047809,0.405192593419148
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGLON5,IgLON family member 5,37482,0.00732874254744643,0.00881088429011868,-0.00994059066118617,0.024598075756079,0.40554676229616
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40332,-0.00918175133494047,0.0110801044607756,-0.0308987560780607,0.0125352534081798,0.407303560663285
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DUOX2,Dual oxidase 2,40042,0.00560697989092128,0.00676810888008772,-0.00765851351405065,0.0188724732958932,0.407433393656928
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40341,0.00944749423547253,0.0114055428383806,-0.0129073697277535,0.0318023581986985,0.407499011052556
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHA4,Ephrin type-A receptor 4,37671,-0.0021765161357741,0.00262913869204261,-0.00732962797217762,0.00297659570062941,0.407773917127428
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,37500,0.00266255205164975,0.00321883937402795,-0.00364637312144503,0.00897147722474452,0.408151493473201
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37628,0.00599785563997,0.00726302545103109,-0.00823767424405094,0.0202333855239909,0.408928660994457
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,37482,0.00488887193874537,0.00593886059200136,-0.00675129482157729,0.016529038699068,0.41040915262148
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP9,Caspase-9,37598,-0.00478385403789486,0.00581509990141671,-0.0161814498446716,0.00661374176888189,0.410715903009293
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37714,0.00522250664213595,0.00634977762670928,-0.00722305750621423,0.0176680707904861,0.410823789856679
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PARD3,Partitioning defective 3 homolog,37714,-0.00567534161779109,0.00692050228584283,-0.019239526098043,0.00788884286246086,0.412187209736364
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DAND5,DAN domain family member 5,37598,0.00416298520894667,0.00508032011167195,-0.00579444220993036,0.0141204126278237,0.412553903068775
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CST6,Cystatin-M,39992,-0.0036338088320791,0.0044482780194086,-0.01235243375012,0.00508481608596176,0.413996749365782
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37482,0.00442186635917393,0.00541747399813415,-0.006196382677169,0.0150401153955169,0.41438758048533
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FH,"Fumarate hydratase, mitochondrial",37541,0.00651353527342597,0.00799767102833652,-0.00916189994211361,0.0221889704889656,0.415414043792796
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDAN1,Codanin-1,37942,0.00175605118294706,0.00216428634825047,-0.00248595005962387,0.00599805242551799,0.417163778873861
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAGE2A,G antigen 2A,37482,-0.00472520039064178,0.00582519434347331,-0.0161425813038495,0.00669218052256591,0.417285085838816
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37671,0.00476220497551804,0.00588805237024341,-0.00677837767015905,0.0163027876211951,0.418649811480718
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DEFB116,Beta-defensin 116,37541,0.00597718451095757,0.00739347738545432,-0.0085140311645329,0.020468400186448,0.418851897547303
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,37482,0.00246051457311183,0.00304364440223676,-0.00350502845527222,0.00842605760149588,0.418868977772533
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD244,Natural killer cell receptor 2B4,40516,0.00200241333581604,0.00247887043473937,-0.00285617271627313,0.00686099938790521,0.419221913941153
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BPIFA2,BPI fold-containing family A member 2,37150,0.00834449894221105,0.0103463526659528,-0.0119343522830564,0.0286233501674785,0.419960492227285
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37572,-0.00429143332685313,0.00533286454983573,-0.0147438478445312,0.00616098119082491,0.420999042993155
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37942,0.00247947147645747,0.00308406410775805,-0.00356529417474831,0.00852423712766325,0.421432876724596
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP6,Gastrotropin,40017,0.00418398014243921,0.0052114656352452,-0.00603049250264139,0.0143984527875198,0.422078693317958
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,37482,0.0036949031679207,0.00461321134220836,-0.00534699106280769,0.0127367973986491,0.423181277494843
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,37482,0.00417801312261643,0.00522053647633415,-0.00605423837099851,0.0144102646162314,0.423549620948543
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PMS1,PMS1 protein homolog 1,37572,-0.00387700674288693,0.0048579743160551,-0.0133986364023549,0.00564462291658107,0.424843934164976
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37959,-0.00622832721811269,0.00782223458678266,-0.0215599070082067,0.00910325257198133,0.425910175091702
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,POMC,Pro-opiomelanocortin,37628,0.00505384610349129,0.00635680938943038,-0.00740550029979226,0.0175131925067748,0.426611109974447
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL8,C-C motif chemokine 8,40470,-0.00445910102922614,0.00561016120593028,-0.0154550169928495,0.00653681493439721,0.426726600606701
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1B,Interleukin-1 beta,39946,-0.00417595397111773,0.00526324795225962,-0.0144919199575466,0.00614001201531112,0.42754666417722
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37628,-0.00230546717418003,0.00291429429999146,-0.0080174840021633,0.00340654965380324,0.428906094782744
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37959,-0.00578190018062264,0.00731279609122451,-0.0201149805194227,0.00855118015817741,0.429159113402306
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINB5,Serpin B5,40042,-0.00359354610382811,0.00455566128664314,-0.0125226422256487,0.00533555001799244,0.430235710106118
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLSPN,Claspin,39925,-0.00250737783002651,0.00318317351798816,-0.00874639792528331,0.00373164226523029,0.4308857329039
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAPT,Microtubule-associated protein tau,39961,-0.00384104832194254,0.00495912215614955,-0.0135609277479957,0.00587883110411058,0.438622157168715
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SDK2,Protein sidekick-2,37671,0.00275679134464855,0.00355936301931558,-0.00421956017320998,0.00973314286250708,0.438638277922272
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37901,-0.00382515478555271,0.00494085171917216,-0.0135092241551301,0.00585891458402472,0.438832433840189
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37562,-0.00342581277656307,0.00443733074412161,-0.0121229810350414,0.00527135548191529,0.440102524573917
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37572,-0.0038804259022667,0.0050298573056723,-0.0137389462213844,0.00597809441685101,0.440437357620216
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37572,0.00521901398581133,0.00677443294779629,-0.0080588745918694,0.0184969025634921,0.441077326747251
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39980,0.00355437805212236,0.00463871574097151,-0.0055375048001818,0.0126462609044265,0.443544069136353
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37714,-0.00757035417284086,0.0098951496296552,-0.0269648474469651,0.0118241391012833,0.444251176118532
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37562,0.00512905914765777,0.00672762018335108,-0.00805707641171034,0.0183151947070259,0.445841982539221
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACTN4,Alpha-actinin-4,40044,-0.0022978916011849,0.00303308187765052,-0.00824273208137992,0.00364694887901011,0.448696249177208
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TEX101,Testis-expressed protein 101,37572,0.00277836725181213,0.00367243776123071,-0.00441961076020007,0.00997634526382433,0.449335626130478
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC39A14,Zinc transporter ZIP14,39961,-0.00235823623313694,0.00311726047194228,-0.00846806675814381,0.00375159429186994,0.449355448403067
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL17RA,Interleukin-17 receptor A,40332,0.00308493000281919,0.00408043292300929,-0.00491271852627902,0.0110825785319174,0.449642379598217
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37628,-0.00333091100189868,0.00441094943466871,-0.0119763718938494,0.005314549890052,0.450174858386545
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],40044,0.00403988851764887,0.00535377445367066,-0.00645350941154562,0.0145332864468434,0.450508232405197
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STXBP3,Syntaxin-binding protein 3,39980,0.00310039990369498,0.00411045144894139,-0.00495608493623016,0.0111568847436201,0.450697135262432
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37998,-0.00194662705040361,0.00258452055619898,-0.00701228734055361,0.00311903323974639,0.451350694190646
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCARE,Photoreceptor cilium actin regulator,37541,-0.00605345781494047,0.00805145672745786,-0.0218343130007579,0.00972739737087694,0.452157023756067
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PFDN2,Prefoldin subunit 2,39961,-0.00392599228509535,0.00523835144624098,-0.0141931611197277,0.00634117654953697,0.453584763381389
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HDGF,Hepatoma-derived growth factor,40471,-0.00663946185351136,0.00887857738635578,-0.0240414735307687,0.010762549823746,0.454587588399957
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCARB1,Scavenger receptor class B member 1,39961,-0.00412693724970897,0.00553349870020028,-0.0149725947021015,0.00671872020268357,0.455793656274857
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KDM3A,Lysine-specific demethylase 3A,37598,0.00644477162291939,0.00864249433097786,-0.0104945172657972,0.023384060511636,0.455857545801484
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HK2,Hexokinase-2,40042,-0.001923596254543,0.002582634554288,-0.00698555998094748,0.00313836747186148,0.456392147850301
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37562,0.00467951962874751,0.00628306859866696,-0.00763529482463974,0.0169943340821348,0.45641655758508
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37598,0.00336707770389393,0.0045281587086884,-0.00550811336513533,0.0122422687729232,0.457139959600719
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37598,-0.0020392060279407,0.0027452456898796,-0.00741988758010471,0.00334147552422332,0.457607770713392
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,40042,0.00236037431436483,0.00318503318422732,-0.00388229072672071,0.00860303935545037,0.45865420874091
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DGKZ,Diacylglycerol kinase zeta,40044,-0.00241227091034928,0.00326915048632167,-0.00881980586353976,0.00399526404284119,0.460592873640547
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39961,0.00336830006581278,0.00464273773163683,-0.00573146588819542,0.012468066019821,0.468157105120788
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39530,-0.00193520918232552,0.00267197641220938,-0.0071722829502559,0.00330186458560486,0.468916551832801
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39980,0.00317999011224104,0.00442257312390082,-0.00548825321060458,0.0118482334350867,0.472129444095749
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37998,0.00167193834583145,0.00232532264934772,-0.00288569404689009,0.00622957073855298,0.472145012722599
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37572,0.00283889412221454,0.00395092437163687,-0.00490491764619373,0.0105827058906228,0.472437669033011
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ESR1,Estrogen receptor,37598,0.00390273354748342,0.00543207399754231,-0.0067441314876995,0.0145495985826663,0.47248582904172
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCRL2,Fc receptor-like protein 2,40442,0.00324641038593466,0.00453460097134248,-0.00564140751789661,0.0121342282897659,0.474051358085294
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39961,0.00451513025065514,0.00631836563577301,-0.00786886639545996,0.0168991268967702,0.474864440543321
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DEFB118,Beta-defensin 118,37541,0.00388830544618337,0.00544619808376574,-0.00678624279799748,0.0145628536903642,0.475271699911489
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37990,0.00183609239826731,0.00257206845056883,-0.00320516176484759,0.00687734656138221,0.475327114779549
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGM2,Phosphoglucomutase-2,37572,0.00400072314739577,0.00560808887644636,-0.00699113105043909,0.0149925773452306,0.475620609196325
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARTN,Artemin,40044,0.00296213870236069,0.00415671927089237,-0.00518503106858835,0.0111093084733097,0.476094958990607
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FZD10,Frizzled-10,37572,-0.00403912160556741,0.00569472944176427,-0.0152007913114254,0.00712254810029056,0.47816727294316
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,37541,0.00334678198635727,0.00471936952578783,-0.00590318228418688,0.0125967462569014,0.478238626638163
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMB1,Laminin subunit beta-1,37628,-0.00194924441891793,0.00275062741523669,-0.00734047415278183,0.00344198531494598,0.47855146133075
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLASP1,CLIP-associating protein 1,37482,-0.00472659809062048,0.00667233048174888,-0.0178043658348483,0.00835116965360732,0.478717084705521
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39961,-0.00940413058340058,0.0132802600443779,-0.0354334402703812,0.01662517910358,0.478876106524821
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BSG,Basigin,40502,-0.00133050593050398,0.00188039973092471,-0.00501608940311642,0.00235507754210845,0.479225412472321
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSP90B1,Endoplasmin,39878,0.0046207680237255,0.00654777198363611,-0.00821286506420128,0.0174544011116523,0.480384870710508
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERC2,ERC protein 2,37572,-0.00506323827903812,0.0071874627870709,-0.0191506653416971,0.00902418878362085,0.481162472369207
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37714,-0.00555642477893237,0.00789861918401866,-0.0210377183796089,0.0099248688217442,0.481776575505534
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MKI67,Proliferation marker protein Ki-67,37598,-0.00246758642050705,0.00352051432547683,-0.00936779449844163,0.00443262165742753,0.483367560591005
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEPTIN7,Septin-7,37714,0.00342767682549116,0.00490292541908296,-0.00618205699591144,0.0130374106468938,0.484496488435839
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NGF,Beta-nerve growth factor,40228,0.000791103648146666,0.00113675944344993,-0.00143694486101521,0.00301915215730854,0.486483664921694
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40403,0.00271667419055375,0.00391823569615752,-0.00496306777391499,0.0103964161550225,0.488105556471491
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37714,-0.00442907109407143,0.0064021142070364,-0.0169772149398628,0.00811907275171991,0.489066366734033
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC44A4,Choline transporter-like protein 4,37572,-0.00449513530861255,0.00655035120278584,-0.0173338236660728,0.0083435530488477,0.492571758256113
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37900,0.00281119796404463,0.00410161312470874,-0.0052279637603845,0.0108503596884738,0.493110690174569
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEMA4D,Semaphorin-4D,40471,0.0019007519376148,0.00277365419362973,-0.00353561028189948,0.00733711415712907,0.493172118139413
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL2,Interleukin-2,40044,-0.00200313947317628,0.00292511661552807,-0.0077363680396113,0.00373008909325875,0.493476082622288
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37959,-0.00790559217987864,0.0116855338802501,-0.0308092385851689,0.0149980542254116,0.498716988026922
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VCAM1,Vascular cell adhesion protein 1,40372,-0.00170268064883271,0.0025193954888264,-0.00664069580693245,0.00323533450926703,0.499159007991805
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39980,-0.00530850783215928,0.00786089433236532,-0.0207158607235953,0.0100988450592767,0.499491531337441
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GM2A,Ganglioside GM2 activator,37714,-0.00239624966970708,0.00357996134402414,-0.00941297390399439,0.00462047456458024,0.503283437664157
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APPL2,DCC-interacting protein 13-beta,37671,0.00695773127863137,0.0103967039180239,-0.0134198084006955,0.0273352709579582,0.503363826480776
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA9,Carbonic anhydrase 9,40489,0.00279699542210943,0.00418778954743809,-0.00541107209086924,0.0110050629350881,0.504211492472469
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTTG1,Securin,37714,0.00257504477198645,0.00386107908126708,-0.00499267022729703,0.0101427597712699,0.50483253635901
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TREML1,Trem-like transcript 1 protein,37987,-0.0032661127405286,0.00491814066135816,-0.0129056684367906,0.0063734429557334,0.506640807021077
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37687,0.00313443222396125,0.00472725375791442,-0.00613098514155101,0.0123998495894735,0.507306472970557
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD48,CD48 antigen,40396,-0.00181134842494808,0.00273260287802495,-0.00716725006587698,0.00354455321598082,0.507426222413095
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37628,0.00422899153308004,0.00639313633266629,-0.00830155567894589,0.016759538745106,0.508310115811083
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRTN,Neurturin,40044,-0.00305135503129716,0.00462153795380447,-0.0121095694207539,0.00600685935815959,0.5091053023759
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPR101,Probable G-protein coupled receptor 101,37541,0.0039711422014744,0.00603506743047505,-0.0078575899622567,0.0157998743652055,0.510542481178161
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,40314,0.0017243100159145,0.00262941256784951,-0.00342933861707054,0.00687795864889954,0.511976704936095
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NECTIN1,Nectin-1,37598,0.00194400879677722,0.0029770351371372,-0.00389098007201169,0.00777899766556613,0.513766647214733
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37628,-0.00554896648736305,0.00851117534318323,-0.0222308701600022,0.0111329371852761,0.514436786902418
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK12,Kallikrein-12,39980,0.00868508083547649,0.0133352895104276,-0.0174520866049616,0.0348222482759146,0.514871837964978
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37714,-0.004583488351499,0.00707196949973935,-0.0184445485709881,0.00927757186799012,0.516918241583156
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40044,0.00725922942967348,0.0112133231991173,-0.0147188840405964,0.0292373428999434,0.517398553384123
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37482,0.00385130322257208,0.005957100679775,-0.00782461410978693,0.0155272205549311,0.517962894182717
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37562,-0.00509542209700667,0.00789310700973771,-0.0205659118360926,0.0103750676420792,0.518579920211789
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37598,-0.00371880178757311,0.00576601089798878,-0.0150201831476311,0.00758257957248489,0.518969375191505
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHPK,Sedoheptulokinase,37714,0.00257901727551909,0.00400405908316962,-0.00526893852749335,0.0104269730785315,0.519521272715888
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37959,-0.00479178133464777,0.00745188086713221,-0.0193974678342269,0.00981390516493137,0.520215690516634
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MPI,Mannose-6-phosphate isomerase,40305,0.00509630193059998,0.00799526832607981,-0.0105744239885164,0.0207670278497164,0.523863930922574
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,40338,-0.00556671817726075,0.00873958029585616,-0.0226962955571388,0.0115628592026173,0.524163422803214
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39961,-0.00411593895981187,0.00646819833076282,-0.016793607688107,0.00856172976848326,0.524567691847287
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37562,0.00574294241266955,0.00903650549096244,-0.0119686083496168,0.0234544931749559,0.525095914333682
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39980,0.00271024665313408,0.00426646715752739,-0.00565202897561961,0.0110725222818878,0.525278805304468
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTLA,B- and T-lymphocyte attenuator,37482,0.0052722552954874,0.00830986330182658,-0.0110150767760927,0.0215595873670675,0.525793417570459
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ESPL1,Separin,37482,0.00336753285926199,0.00536154742510865,-0.00714110009395096,0.0138761658124749,0.529956170251977
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37714,-0.00322894674498698,0.00516495556157054,-0.0133522596456652,0.00689436615569128,0.531873869829484
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37541,0.00321555107998589,0.0051463432586424,-0.00687128170695322,0.013302383866925,0.532098450809601
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPA4,Carboxypeptidase A4,37410,-0.00255505954562414,0.00409250562299978,-0.0105763705667037,0.00546625147545543,0.532424202046002
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37598,0.00238943652694576,0.00382882375257284,-0.00511505802809701,0.00989393108198853,0.532595447431151
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP1B4,Protein ATP1B4,37482,0.00246579866872088,0.00395449052925114,-0.00528500276861137,0.0102166001060531,0.532938040977713
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37987,0.00203226017533142,0.00326285862044643,-0.00436294272074359,0.00842746307140643,0.533395870699381
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,40332,-0.00182107813441413,0.00292532584215075,-0.0075547167850296,0.00391256051620134,0.533607971310702
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MSLN,Mesothelin,40271,-0.00311358377870695,0.00505079976473632,-0.0130131513175901,0.00678598376017623,0.537604047003089
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAG,S-arrestin,37541,0.00307324490264072,0.00498978020948781,-0.00670672430795539,0.0128532141132368,0.537966036640637
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37562,0.00302048818398277,0.00493569065045103,-0.00665346549090125,0.0126944418588668,0.540569080080717
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOA2,Apolipoprotein A-II,37987,0.00271367671856449,0.00443580815494945,-0.00598050726513642,0.0114078607022654,0.540702847323068
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37541,0.00344768784923077,0.00563914627812737,-0.00760503885589887,0.0145004145543604,0.540955536029102
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39961,-0.00156974096823577,0.0025749198498928,-0.00661658387402566,0.00347710193755413,0.542117774276748
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDCL2,Phosducin-like protein 2,37482,0.00304995541675668,0.00504423404714158,-0.00683674331564081,0.0129366541491542,0.545427467574603
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37959,0.00639088185253422,0.0106178046083012,-0.0144200151797361,0.0272017788848046,0.547249223423343
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NENF,Neudesin,37900,0.00606054729692082,0.0100856265343006,-0.0137072807103084,0.02582837530415,0.547910492036607
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAG,Myelin-associated glycoprotein,37572,0.00261732507557239,0.0043578314230176,-0.0059240245135421,0.0111586746646869,0.548115050900411
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HLA_DRA,,40288,0.00201727251211146,0.00335976059235294,-0.0045678582489003,0.00860240327312322,0.548233951380659
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37987,0.00403299239197862,0.00672435261689011,-0.009146738737126,0.0172127235210832,0.548676763411502
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37598,-0.00243986368965612,0.00407619836099625,-0.0104292124772088,0.00554948509789653,0.549474293441413
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CERT,Ceramide transfer protein,39961,-0.00340378516443888,0.00573121207536207,-0.0146369608321485,0.00782939050327078,0.552585523863646
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39980,0.00665643146150989,0.0112822837596891,-0.0154568447074807,0.0287697076305005,0.555206124933532
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37482,0.00277588747405418,0.00473126174073403,-0.00649738553778453,0.0120491604858929,0.557407391542222
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37714,-0.00297778550284089,0.00508173321438167,-0.012937982603029,0.00698241159734718,0.557900054495457
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAD2,Glutamate decarboxylase 2,37598,0.00258920755228881,0.00442062878061456,-0.00607522485771573,0.0112536399622934,0.558080304902457
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37541,0.00177786186736941,0.00304087647277577,-0.0041822560192711,0.00773797975400992,0.558790185588601
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37875,0.00146445618418369,0.00252377992611789,-0.00348215247100738,0.00641106483937475,0.561746995465161
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXK,Tyrosine-protein kinase TXK,37714,0.00411182600652971,0.00708907615009469,-0.00978276324765588,0.0180064152607153,0.561909076408589
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40042,0.00164049622396,0.00282927266015924,-0.00390487818995211,0.00718587063787212,0.562037868400855
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37901,-0.0093475726404881,0.016158842044401,-0.0410189030475141,0.0223237577665379,0.562949545128256
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCC,Netrin receptor DCC,37572,0.00125862490628665,0.00218285485304094,-0.0030197706056736,0.0055370204182469,0.564222439378819
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39980,-0.00288046403749608,0.00500696097729434,-0.012694107552993,0.00693317947800083,0.565102242089103
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37714,-0.0041621995782536,0.00725911935138953,-0.0183900735069771,0.0100656743504699,0.566400347473694
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,37482,0.00754055743695649,0.0132368982462872,-0.0184037631257664,0.0334848779996794,0.568916813983885
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VIM,Vimentin,40042,-0.00627999984539449,0.0110497255282269,-0.0279374618807193,0.0153774621899303,0.569812380250922
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37901,-0.00681255965639488,0.0119970202347819,-0.0303267193165673,0.0167016000037776,0.570143377524238
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39980,0.00668068147622212,0.011785913233104,-0.0164197084606617,0.029781071413106,0.570833712471597
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSLP,Thymic stromal lymphopoietin,40042,-0.00322097665720902,0.00568653525634831,-0.0143665857596517,0.00792463244523366,0.571115337339476
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37562,0.00318108529648371,0.00568526328744363,-0.00796203074690581,0.0143242013398732,0.575808430130742
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARG1,Arginase-1,40227,0.00271404238692641,0.00491432387205493,-0.00691803240230125,0.0123461171761541,0.580769986944017
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,37562,-0.00242829721713649,0.00443086860685076,-0.011112799686564,0.006256205252291,0.583673150754524
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40396,0.00451467012126464,0.00825908485271786,-0.0116731361900624,0.0207024764325917,0.584640057232
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37900,-0.00267859572778362,0.00493076730897758,-0.0123428996533797,0.00698570819781243,0.586972778085509
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",40422,-0.00557143368957713,0.0102830676855501,-0.0257262463532554,0.0145833789741011,0.587959319872047
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRDX1,Peroxiredoxin-1,39953,-0.00444057575602646,0.00829228296276715,-0.0206934503630501,0.0118122988509972,0.592306985795154
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37990,-0.00440968418342549,0.00824231130228701,-0.020564614335908,0.011745245969057,0.592654647852092
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,37482,0.00131776100686212,0.00246716149243042,-0.0035178755183015,0.00615339753202575,0.593267426229835
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSPB1,Heat shock protein beta-1,40116,-0.00335568514866446,0.00630393857872392,-0.0157114047629633,0.00900003446563442,0.594514946526392
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37572,0.00414727880078411,0.00781666472061312,-0.0111733840516176,0.0194679416531858,0.595726567324385
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40489,0.00186668939210123,0.00352483704844156,-0.00504199122284422,0.00877537000704668,0.59640927741236
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGA5,Integrin alpha-5,40332,-0.00122421925484762,0.00231309834209476,-0.00575789200535336,0.00330945349565811,0.59663584812187
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NLGN1,Neuroligin-1,37572,-0.00340328897233882,0.00651635425311739,-0.0161753433084489,0.00936876536377127,0.601491958178766
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37959,-0.00230386089035805,0.00443230754287919,-0.0109911836744013,0.00638346189368515,0.603219765011689
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LMOD2,Leiomodin-2,37541,0.00312884254535729,0.00607651922856343,-0.00878113514262703,0.0150388202333416,0.606626674136116
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37959,-0.00162233896161459,0.00315425843337202,-0.00780468549102375,0.00456000756779458,0.607027661849121
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37598,-0.00177126825412618,0.00344430230007993,-0.00852210076228285,0.00497956425403049,0.607078593604493
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACTN2,Alpha-actinin-2,37562,0.00262523568135445,0.00510808176236966,-0.00738660457289009,0.012637075935599,0.607304225657397
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,P4HB,Protein disulfide-isomerase,40266,-0.0018371893209257,0.00359362545271254,-0.00888069520824228,0.00520631656639087,0.60919321983039
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STAM,Signal transducing adapter molecule 1,37900,-0.00178486599882095,0.00349313332736102,-0.00863140732044856,0.00506167532280665,0.60938452858868
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASQ2,Calsequestrin-2,37562,0.00239294488421029,0.00468911849420942,-0.00679772736444018,0.0115836171328608,0.609836791124212
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37572,-0.00370969227186214,0.00729927605790241,-0.0180162733453509,0.0105968888016266,0.611302404849954
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSC1,Hamartin,37598,0.00360759820364368,0.00711300159447209,-0.0103338849215216,0.017549081328809,0.612034464378054
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP15,Matrix metalloproteinase-15,37990,0.00235453817812835,0.004650367339032,-0.00676018180637438,0.0114692581626311,0.612645675300301
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL3,C-X-C motif chemokine 3,40350,-0.00437278838130613,0.00865678707320706,-0.021340091044792,0.0125945142821797,0.613475707934596
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPD52L2,Tumor protein D54,37671,-0.00507725669821832,0.0100520962615504,-0.0247793653708571,0.0146248519744205,0.613501012988595
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37714,-0.002106489422861,0.004200466047881,-0.0103394028767078,0.00612642403098577,0.616035022637212
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INHBB,Inhibin beta B chain,37671,0.00240478253946629,0.00480585528198669,-0.00701469381322761,0.0118242588921602,0.616811663126512
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40042,0.00125923764577871,0.00252837835222479,-0.00369638392458188,0.0062148592161393,0.618461733904132
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,37541,-0.00342496548968345,0.00690016347623591,-0.0169492859031058,0.0100993549237389,0.619648740870332
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUGT1,Protein SGT1 homolog,39980,0.0036675286599495,0.00756764690371329,-0.0111650592713285,0.0185001165912276,0.62794379553242
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,40471,0.00200943451460177,0.00415742294595557,-0.00613911445947115,0.0101579834886747,0.628863389458289
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RGS8,Regulator of G-protein signaling 8,40044,-0.00298347189528516,0.0062067447669132,-0.015148691638435,0.0091817478478647,0.630749109199861
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HRG,Histidine-rich glycoprotein,37934,-0.00141063752886672,0.00294016090689086,-0.0071733529063728,0.00435207784863936,0.631389894411784
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCS,Copper chaperone for superoxide dismutase,40228,0.00215620488323661,0.00449730332070522,-0.00665850962534561,0.0109709193918188,0.631629477158665
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP152,Centrosomal protein of 152 kDa,37482,0.00186194694644176,0.00388408334539901,-0.0057508564105403,0.00947475030342382,0.63167726666332
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDC123,Cell division cycle protein 123 homolog,37482,-0.00286805275421483,0.00599632378110385,-0.0146208473651784,0.00888474185674872,0.632443404911445
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MIA,Melanoma-derived growth regulatory protein,40411,0.00164115101997006,0.00344108882275437,-0.0051033830726285,0.00838568511256862,0.633420045236431
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM171A2,Protein FAM171A2,37959,-0.00714346390769144,0.0149973537344814,-0.0365382772272751,0.0222513494118922,0.63385771531329
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDC25A,M-phase inducer phosphatase 1,37482,0.00182103725379772,0.00383132953259943,-0.00568836863009716,0.0093304431376926,0.634579949372774
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSH,Pro-cathepsin H,40013,0.00319816777976987,0.00675168785761793,-0.0100351404211613,0.016431475980701,0.635731776024473
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SKIV2L,Helicase SKI2W,37562,0.00179621162512775,0.0037950620735593,-0.00564211003904847,0.00923453328930397,0.636005398740991
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,37541,-0.00188548714389738,0.00406030886556605,-0.00984369252040684,0.00607271823261207,0.642390135925919
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37628,-0.00357852431409421,0.0077077893051738,-0.0186857913522349,0.0115287427240464,0.642459292663849
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFIC,Nuclear factor 1 C-type,37959,-0.00188561254646851,0.00406506485652736,-0.00985313966526212,0.00608191457232511,0.642757014933829
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37482,0.00262600406339191,0.00567072262984574,-0.00848861229110574,0.0137406204178896,0.643314022442157
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37714,-0.00309694667450398,0.00669696947330319,-0.0162230068421782,0.0100291134931703,0.643773394858515
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MUC16,Mucin-16,40305,-0.00807411290409083,0.0174708134207329,-0.0423169072087273,0.0261686814005456,0.643981063743861
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BST2,Bone marrow stromal antigen 2,40471,-0.00230088412895748,0.0049797164125781,-0.0120611282976105,0.00745936003969559,0.644050852686379
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,40311,0.0008126880488685,0.00176296136913096,-0.00264271623462818,0.00426809233236518,0.644820041998591
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRTAP,Cartilage-associated protein,37572,0.00208135971366588,0.00452412568761227,-0.00678592663405418,0.0109486460613859,0.64548229322631
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37942,-0.00449868611467622,0.00981795867934594,-0.0237418851261943,0.0147445128968418,0.646809010553543
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37482,-0.00284764833332632,0.00621790946365151,-0.0150347508820833,0.00933945421543064,0.646977895272807
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37598,0.000953449692253362,0.00208728056011525,-0.00313762020557252,0.00504451959007925,0.647829264154958
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACTA2,"Actin, aortic smooth muscle",40042,0.00185919993687595,0.00407473449543119,-0.00612727967416919,0.00984567954792108,0.648198514719341
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENO2,Gamma-enolase,40471,-0.00278134092538617,0.00611467298264604,-0.0147660999713724,0.00920341812060006,0.649213681343736
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37942,-0.00228956915489434,0.00505000542275132,-0.0121875797834869,0.00760844147369824,0.650282756388182
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DENND2B,DENN domain-containing protein 2B,37562,0.0022213640674624,0.00490756658004343,-0.00739746642942273,0.0118401945643475,0.650815021260254
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37714,0.00283685060688674,0.00627915672513068,-0.0094702965743694,0.0151439977881429,0.65142876539814
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37692,-0.00235098894924255,0.00520505006211663,-0.0125528870709911,0.00785090917250605,0.651510811412899
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PMM2,Phosphomannomutase 2,37562,-0.00253506719915968,0.00564187882790705,-0.0135931497018575,0.00852301530353814,0.653200819121101
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRD3,Bromodomain-containing protein 3,37562,0.00203178276516004,0.00452493796426484,-0.00683709564479905,0.0109006611751191,0.653425429080534
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,37572,0.0020794029262776,0.00463971687916768,-0.00701444215689105,0.0111732480094463,0.654034644329263
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOX2,Transcription factor SOX-2,37937,0.000973289751482865,0.00217410077725339,-0.00328794777193377,0.00523452727489951,0.654395228129941
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37959,-0.0018672398486496,0.00421579540794072,-0.0101301988482134,0.00639571915091421,0.657834168707498
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C5,Complement C5,38013,0.000630481410168696,0.00142645113971381,-0.00216536282367038,0.00342632564400777,0.658501323785012
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTA,Lymphotoxin-alpha,40341,0.00165690231842716,0.00374934192555444,-0.00569180785565954,0.00900561249251387,0.658554436860734
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNNI3,"Troponin I, cardiac muscle",40042,-0.00348255433556422,0.00790486410312886,-0.0189760879776968,0.0120109793065684,0.659538828191128
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37714,0.0014828156047278,0.00337154380217981,-0.00512541024754464,0.00809104145700023,0.660086848349844
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYOM2,Myomesin-2,37562,-0.00193003016228718,0.00439016336899057,-0.0105347503655087,0.00667469004093434,0.660215219799496
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPC1,Glypican-1,40489,0.00119786415781587,0.00273120537877775,-0.00415529838458853,0.00655102670022026,0.660968587972393
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37598,-0.00356407533914241,0.00818489469114745,-0.0196064689337914,0.0124783182555066,0.663246258725292
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37562,0.00253622423866585,0.0058850676982469,-0.00899850844989807,0.0140709569272298,0.666505101195071
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37900,-0.00258894593654613,0.00605363489881618,-0.0144540703382258,0.00927617846513358,0.668899697772429
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,37688,0.00209685780635737,0.00490485476029023,-0.00751665752381149,0.0117103731365262,0.669017329964172
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39961,0.00204311566026926,0.00479143166206432,-0.00734809039737681,0.0114343217179153,0.669814838706589
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMIGO1,Amphoterin-induced protein 1,37572,0.00198739201662494,0.00466966123742498,-0.00716514400872803,0.0111399280419779,0.670408787955343
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RTKN2,Rhotekin-2,37562,0.00209023887127413,0.00492627965244242,-0.00756526924751302,0.0117457469900613,0.67135127569056
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37628,-0.0103889393432163,0.0245140612155163,-0.0584364993256283,0.0376586206391957,0.671722160518354
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNX2,Sorting nexin-2,37900,-0.00307307962355859,0.00725703597096043,-0.017296870126641,0.0111507108795239,0.671964923861778
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,37572,0.00401917027840219,0.00949175159407431,-0.0145846628459835,0.0226230034027878,0.671982514740568
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RALB,Ras-related protein Ral-B,37598,-0.0011673059812422,0.00276203770994455,-0.00658089989273352,0.00424628793024913,0.672575850272877
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37900,-0.00268450343188107,0.00637062547637525,-0.0151709293655766,0.00980192250181443,0.673478709583848
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37562,-0.00190869018926885,0.00454773237573928,-0.0108222456457178,0.00700486526718013,0.67471039220375
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37714,-0.00289592337225782,0.00691513333862956,-0.0164495847159718,0.0106577379714561,0.6753832995091
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CST1,Cystatin-SN,36179,-0.00407126082393721,0.00973678160397821,-0.0231553527677345,0.0150128311198601,0.675858201452206
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39980,0.00310279026214534,0.00746308553773569,-0.0115248573918166,0.0177304379161073,0.677597474030146
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SH3GL3,Endophilin-A3,37643,-0.00321736421677765,0.00774413802711315,-0.0183958747499194,0.0119611463163641,0.677813401503715
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37900,0.00367175130193792,0.00883860621766446,-0.0136519168846844,0.0209954194885603,0.677839646237734
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK15,Kallikrein-15,37880,0.00197304144536204,0.00477204950507953,-0.00738017558459384,0.0113262584753179,0.679277782470238
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTNL10,Butyrophilin-like protein 10,37482,0.00160965862863719,0.00391489781198477,-0.00606354108285296,0.00928285834012734,0.68096024716647
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IST1,IST1 homolog,37812,0.0038279040160256,0.0093151398996259,-0.0144297701872412,0.0220855782192924,0.681127811406099
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,40044,0.00143180547537585,0.00350336375879891,-0.00543478749187002,0.00829839844262171,0.682769488509039
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ROBO4,Roundabout homolog 4,37628,0.000681403864612846,0.00166764413792287,-0.00258717864571597,0.00394998637494167,0.682837903726798
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CST5,Cystatin-D,40070,-0.00209685928252648,0.00513591954810003,-0.0121632615968025,0.00796954303174957,0.683078570478086
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPGN,Epigen,37900,-0.00188145683937566,0.00461011027159129,-0.0109172729716946,0.00715435929294327,0.683195476997639
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37541,0.00278347197360554,0.00682559182283625,-0.0105946879991535,0.0161616319463646,0.683427653702697
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37901,-0.00429624877119676,0.010541079475963,-0.0249567645440843,0.0163642670016908,0.683594416681458
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37761,0.0017043888686272,0.00418432676739005,-0.00649689159545729,0.00990566933271169,0.683774456190702
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL25,Interleukin-25,37429,-0.00132755252971978,0.00326502816553045,-0.00772700773415946,0.0050719026747199,0.684310284874559
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB6B,Ras-related protein Rab-6B,39961,-0.00184445625195357,0.00455299213794268,-0.0107683208423212,0.00707940833841409,0.6854032758454
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40471,-0.00271164100710612,0.0067170953255134,-0.0158771478451124,0.0104538658309001,0.686444243734375
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYL6B,Myosin light chain 6B,37572,-0.00341583572325575,0.00864978621408182,-0.0203694167028561,0.0135377452563446,0.692920110682087
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,37541,0.00398160980484002,0.0101101929233352,-0.015834368324897,0.023797587934577,0.693719357293617
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RPA2,Replication protein A 32 kDa subunit,37598,-0.00119361368911112,0.00304208371727388,-0.00715609777496792,0.00476887039674567,0.69479332267469
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37942,-0.00235980856841231,0.00603025966827736,-0.0141791175182359,0.00945950038141131,0.695561094079324
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKCQ,Protein kinase C theta type,40044,-0.00162019186394437,0.0041420415542238,-0.00973859331022303,0.00649820958233428,0.695685943400839
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37942,-0.000798236125953405,0.00204361799247394,-0.00480372739120232,0.00320725513929551,0.696099477611243
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD99L2,CD99 antigen-like protein 2,40332,-0.000853473450397647,0.00220917373917365,-0.005183453979178,0.00347650707838271,0.699256334879293
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37457,0.00185700693180133,0.00480752032324102,-0.00756573290175107,0.0112797467653537,0.699302102360481
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,METAP1,Methionine aminopeptidase 1,39961,-0.00110710489338823,0.00286716585930952,-0.00672674997763488,0.00451254019085842,0.699404103512405
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TET2,Methylcytosine dioxygenase TET2,37697,-0.00362893001641937,0.00941456657256465,-0.0220814804986461,0.0148236204658074,0.699903520246204
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39961,0.0017684553224347,0.00461929929846816,-0.00728537130256289,0.0108222819474323,0.701843201666817
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37562,-0.00163506203472587,0.00427105483796453,-0.0100063295171364,0.00673620544768461,0.701856517225334
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PFDN6,Prefoldin subunit 6,37572,0.00236274941819538,0.00618279892710948,-0.0097555364789392,0.01448103531533,0.70235715879598
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCRG1,Scrapie-responsive protein 1,37990,-0.000974163124652227,0.00255608106975228,-0.00598408202136669,0.00403575577206224,0.703123233891096
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37572,0.00137659027533504,0.00362693601355302,-0.00573220431122887,0.00848538486189895,0.704288345259521
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39980,0.00126786012120005,0.00334801791260446,-0.00529425498750469,0.00782997522990478,0.704923430922074
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CYTH3,Cytohesin-3,37482,-0.00259301124342486,0.00690012677379683,-0.0161172597200666,0.0109312372332169,0.707077782315441
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,40411,0.000948980790815867,0.00252976451908241,-0.00400935766658565,0.00590731924821738,0.707571644775986
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZPR1,Zinc finger protein ZPR1,37541,0.00340268174233228,0.00908528972743818,-0.0144044861234466,0.0212098496081111,0.70801871374475
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40374,-0.00197840289277895,0.00530741808196239,-0.0123809423334252,0.00842413654786734,0.709330673425566
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SWAP70,Switch-associated protein 70,37901,0.00121226928738188,0.00327270490260643,-0.00520223232172671,0.00762677089649047,0.711076787626899
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39980,0.00111733786990341,0.00302040849417766,-0.00480266277868481,0.00703733851849163,0.711440147880475
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37598,0.00154033686209965,0.00416395617851398,-0.00662101724778775,0.00970169097198705,0.711446949932775
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL34,Interleukin-34,39934,0.00122186614471382,0.00334906714943095,-0.00534230546817084,0.00778603775759848,0.715237502640357
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37572,0.00182973703278968,0.00501915367369162,-0.0080078041676459,0.0116672782332253,0.71545254085933
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EBI3_IL27,Interleukin-27,40453,-0.00104969768489516,0.00290018007621276,-0.00673405063427218,0.00463465526448186,0.717399970383279
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLIT2,Slit homolog 2 protein,39961,-0.00176516624817065,0.00488988438902139,-0.0113493396506526,0.00781900715431127,0.718116902296918
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENSA,Alpha-endosulfine,37900,-0.00176812321281478,0.00491282489751243,-0.0113972600119391,0.00786101358630958,0.718927944262715
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",37460,0.000847479569235295,0.00236233472117117,-0.0037826964842602,0.00547765562273079,0.71979047976859
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ELN,Elastin,37990,-0.00117024582702904,0.00327068895489281,-0.00758079617861894,0.00524030452456087,0.72050009732803
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCLN,Nicalin,40044,-0.00178356598084219,0.00498688389293824,-0.0115578584110011,0.00799072644931676,0.720609052297552
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39980,-0.00225656717209347,0.00631031176351947,-0.0146247782285916,0.0101116438844047,0.720647575792132
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDNRB,Endothelin receptor type B,37598,-0.00157928506385493,0.00442194036611657,-0.0102462881814434,0.00708771805373355,0.720987099348906
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37562,0.00111849054794856,0.00313439386718988,-0.00502492143174361,0.00726190252764073,0.721214122199117
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,40203,-0.000804535533362056,0.00225524088090527,-0.00522480765993639,0.00361573659321227,0.721290936937505
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CGN,Cingulin,37572,-0.00139916304567596,0.0039240082138925,-0.00909021914490526,0.00629189305355333,0.721423397137772
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRG2,Bone marrow proteoglycan,37998,0.00172715122801542,0.00485621162451372,-0.00779102355603147,0.0112453260120623,0.722102130060461
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL13,Interleukin-13,40044,0.00157825771647662,0.00447877693194,-0.00720014507012577,0.010356660503079,0.724553658367663
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNPY4,Protein canopy homolog 4,40305,0.00243275728799323,0.00696282608093663,-0.0112143818306426,0.016079896406629,0.726799511268373
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37564,0.00124278183534616,0.00356289197184994,-0.00574048642947971,0.00822605010017204,0.727235557110273
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A11,Protein S100-A11,40207,-0.00145204543996663,0.00418729646734693,-0.00965914651596662,0.00675505563603335,0.728765761710561
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,40042,-0.002049702442606,0.00592837270160185,-0.0136693129377456,0.00956990805253362,0.729539379588275
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37714,-0.00240191415754246,0.00697799448717385,-0.0160787833524032,0.0112749550373183,0.730691807352107
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PROS1,Vitamin K-dependent protein S,38013,0.000803131055931461,0.00233902286400598,-0.00378135375752025,0.00538761586938318,0.731331630949584
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39897,0.00182474188538999,0.00532677328413665,-0.00861573375151784,0.0122652175222978,0.731933816973031
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37998,-0.00196137645595947,0.00577209134104235,-0.0132746754844025,0.00935192257248353,0.734009830446625
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCDH12,Protocadherin-12,37959,-0.000810456465557313,0.002387029212003,-0.00548903372108318,0.00386812078996856,0.7342194284656
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD33,Myeloid cell surface antigen CD33,40411,-0.00249730739715381,0.00738891627530008,-0.016979583296742,0.0119849685024344,0.735382554772177
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37572,0.00111098628838444,0.00330547061361044,-0.00536773611429203,0.00758970869106091,0.736796814812639
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NME1,Nucleoside diphosphate kinase A,37598,0.000682670216773504,0.00204818766604835,-0.00333177760868126,0.00469711804222827,0.738909739737589
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,40422,0.000862128890060875,0.00259209575114942,-0.00421837878219198,0.00594263656231373,0.739441237068402
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MDM1,Nuclear protein MDM1,37572,-0.000970649787757889,0.00291991592306664,-0.00669368499696851,0.00475238542145273,0.739574518080828
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAA4,Serum amyloid A-4 protein,38013,-0.00100818707977541,0.00304687674079514,-0.00698006549173389,0.00496369133218306,0.740731191873559
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITM2A,Integral membrane protein 2A,40341,0.00181819212786944,0.00550898478757527,-0.0089794180557781,0.012615802311517,0.74137315825586
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40422,-0.003590449204149,0.0110519688362535,-0.0252523081232059,0.0180714097149078,0.745283986182347
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL18,C-C motif chemokine 18,40172,-0.00212093697138901,0.00654220102083932,-0.0149436509722341,0.0107017770294561,0.745796096235999
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZNF174,Zinc finger protein 174,37598,0.00115481557982858,0.00362249776847495,-0.00594528004638231,0.00825491120603947,0.749890927775832
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37901,-0.00288769277782594,0.00909939172548569,-0.0207225005597779,0.014947115004126,0.750982900525275
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40042,-0.00102802324680419,0.00326570668721769,-0.00742880835375086,0.00537276186014249,0.75292265805822
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PER3,Period circadian protein homolog 3,37598,-0.00345993983116019,0.0109918766026172,-0.0250040179722899,0.0180841383099695,0.752939433280347
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EGFLAM,Pikachurin,37901,0.000897072615120473,0.00286553928335183,-0.00471938438024911,0.00651352961049006,0.754243408942723
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,37572,-0.00125398919917173,0.00401264214699354,-0.00911876780727906,0.00661078940893561,0.754658233788567
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37671,0.00105848102051412,0.00339453825871189,-0.00559481396656119,0.00771177600758944,0.755183114311359
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37572,0.001056747752544,0.00341392376667809,-0.00563454283014505,0.00774803833523305,0.75691530655525
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RUVBL1,RuvB-like 1,39980,0.0030945784853744,0.0100057995938819,-0.0165167887186341,0.0227059456893829,0.757113849496156
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37572,-0.00209812024021592,0.00679852490802331,-0.0154232290599416,0.0112269885795098,0.757620039132341
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,40403,0.000780998514431419,0.00253269578874627,-0.00418308523151128,0.00574508226037411,0.757807503105436
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TST,Thiosulfate sulfurtransferase,39923,-0.00216099982876678,0.0070675499050428,-0.0160133976426507,0.0116913979851171,0.759788723669339
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39980,0.00117795892508417,0.00386558327179934,-0.00639858428764253,0.00875450213781087,0.760575935133857
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TAGLN3,Transgelin-3,37482,-0.00173681736899632,0.00570590679467979,-0.0129203946865687,0.00944675994857607,0.760836127047742
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS1,Galectin-1,40359,-0.000952725527519468,0.00313152052574052,-0.00709050575797089,0.00518505470293195,0.760951045943419
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39961,0.000856478659833351,0.00282628915425778,-0.0046830480825119,0.0063960054021786,0.761863444320707
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PMVK,Phosphomevalonate kinase,39951,0.00311409243224412,0.0103199107075552,-0.0171129325545641,0.0233411174190524,0.76284231150583
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40536,0.000638100424607501,0.00213142839259958,-0.00353949922488767,0.00481570007410268,0.764656353827496
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DUSP29,Dual specificity phosphatase 29,37572,-0.00184470695335133,0.00623125548669273,-0.0140579677072691,0.0103685538005664,0.767203474550911
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,37482,-0.00245980692765949,0.00831767921765498,-0.0187624581942633,0.0138428443389443,0.767439192646701
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,37598,-0.00177653498014733,0.00602714750134603,-0.0135897440827855,0.0100366741224909,0.768185303780414
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL17F,Interleukin-17F,40044,0.00217514679929459,0.00742723571418463,-0.0123822352005073,0.0167325287990965,0.76963238760074
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GBP6,Guanylate-binding protein 6,37562,0.00128529687010153,0.00443895214558924,-0.00741504933525338,0.00998564307545644,0.772165399107804
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39961,-0.00103208627609766,0.00357052393411482,-0.0080303131869627,0.00596614063476738,0.772541335118242
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KHDC3L,KH domain-containing protein 3,37482,0.00183245284522316,0.00638070713739085,-0.0106737331440629,0.0143386388345092,0.773974101907222
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40341,0.00318688328299064,0.0111037646559223,-0.0185764954426171,0.0249502620085984,0.774108972069297
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPB41L5,Band 4.1-like protein 5,37572,0.00170836378136238,0.00595469655701096,-0.00996284147037911,0.0133795690331039,0.774198392326031
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHC1,SHC-transforming protein 1,37482,0.00307137117148336,0.0109240114555395,-0.0183396912813741,0.0244824336243408,0.77859382459276
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37714,-0.00213280480443557,0.00770320124315538,-0.0172310792410201,0.012965469632149,0.781882302461514
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TLR2,Toll-like receptor 2,37714,-0.000592804947298171,0.00214719104256923,-0.00480129939073385,0.00361568949613751,0.782487902988169
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRD1,Bromodomain-containing protein 1,37714,0.000792912528508472,0.00289492341622409,-0.00488113736729074,0.00646696242430768,0.78416759419639
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37942,0.000658278573800505,0.00243007205881335,-0.00410466266147366,0.00542121980907467,0.786480934992547
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCDH9,Protocadherin-9,37901,-0.000852075486222674,0.00314631682319216,-0.00701885645967931,0.00531470548723396,0.786536086100759
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOS2,"Nitric oxide synthase, inducible",37562,-0.000994298240728686,0.00367348729915401,-0.00819433334707054,0.00620573686561316,0.786650069442437
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OSTN,Osteocrin,37572,-0.00108843153503588,0.00402330892222561,-0.00897411702259807,0.00679725395252632,0.786755692192057
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIF20B,Kinesin-like protein KIF20B,37541,-0.00197295579040871,0.00730199437338745,-0.0162848647622481,0.0123389531814307,0.787015192110765
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37900,0.00143903020758159,0.00535876782358873,-0.00906415472665232,0.0119422151418155,0.788289719401292
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37482,-0.00139934671417169,0.00525145292860179,-0.0116921944542312,0.00889350102588782,0.789882642840762
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSCA,Prostate stem cell antigen,37901,-0.00645347964628363,0.0242244251726744,-0.0539333529847255,0.0410263936921582,0.789932299909115
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GBP1,Guanylate-binding protein 1,37931,0.00159497075336241,0.00599104175920121,-0.010147471094672,0.0133374126013968,0.790069274757587
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,37541,0.00297148397203448,0.0111668570253382,-0.0189155557976284,0.0248585237416974,0.790167536801698
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,37541,0.000954149332653788,0.00358801112670833,-0.00607835247569454,0.00798665114100212,0.79029955506214
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37482,-0.00110718339787834,0.0041752712716014,-0.00929071509021707,0.0070763482944604,0.790877770439455
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA12,Serpin A12,39903,0.00282298008774458,0.0106544083891771,-0.0180596603550425,0.0237056205305316,0.791044675308121
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINC1,Antithrombin-III,37981,0.000363557530869421,0.0013733508671165,-0.00232821016867893,0.00305532523041777,0.791226907949418
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40359,0.00119036285351165,0.00454566526860267,-0.00771914107294959,0.0100998667799729,0.793426842565833
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IKZF2,Zinc finger protein Helios,39980,0.00227462354387948,0.0087253278532426,-0.014827019048476,0.019376266136235,0.794333459608647
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THPO,Thrombopoietin,40042,0.000926168974761597,0.00355739365293522,-0.00604632258499144,0.00789866053451463,0.794596912604579
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C2,Complement C2,40372,0.000578828130443477,0.00223326665008089,-0.00379837450371508,0.00495603076460203,0.795496230433534
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SSB,Lupus La protein,39961,-0.00145419072635757,0.00563823528850081,-0.0125051318918192,0.00959675043910401,0.796475208567733
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40332,-0.00116093462294063,0.00451854649543043,-0.0100172857539843,0.00769541650810301,0.79723879265956
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FXN,"Frataxin, mitochondrial",40489,0.0017509883987341,0.00687577201297943,-0.0117255247467056,0.0152275015441738,0.798988495647512
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MINK1,Misshapen-like kinase 1,37942,-0.00219024258880467,0.00861488242964868,-0.0190754121509161,0.0146949269733067,0.799314484184835
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37628,0.000613451455051461,0.00243162360483744,-0.00415253081042993,0.00537943372053285,0.800828119510381
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37541,-0.0012898502668618,0.00512652808437614,-0.011337845312239,0.00875814477851542,0.801351826019561
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37714,-0.00203160708601932,0.0081332384961012,-0.0179727545383777,0.013909540366339,0.802753104861076
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37714,0.00146944997396744,0.00589471067573865,-0.0100841829504803,0.0130230828984152,0.803145896707553
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPRR1B,Cornifin-B,37714,0.00198286831752272,0.00796226528427252,-0.0136231716396514,0.0175889082746969,0.803338965112818
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,40042,0.00135657439551695,0.00547887125401804,-0.00938201326235841,0.0120951620533923,0.80444634196227
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLTA,Clathrin light chain A,40042,-0.00109420152884538,0.00441962029628905,-0.00975665730957192,0.00756825425188117,0.804464059002605
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37541,0.00141978749138293,0.00577896501820553,-0.0099069839442999,0.0127465589270658,0.805932284895748
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37562,-0.000945049126294628,0.00384871417380807,-0.00848852890695844,0.00659843065436919,0.806034972995806
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40471,0.00107367144631159,0.00441272944511022,-0.00757527826610444,0.00972262115872762,0.807766575335515
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,37482,-0.0006569748059244,0.00272850236910842,-0.0060048394493769,0.0046908898375281,0.809727713637713
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37482,-0.00193688129009855,0.00805075800700445,-0.0177163669838273,0.0138426044036302,0.809881556112059
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPT1,Translationally-controlled tumor protein,40044,0.00148277480909424,0.00620993638207668,-0.0106887004997761,0.0136542501179645,0.811283538230078
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37562,-0.00129416666924692,0.00542283423994714,-0.0119229217795433,0.00933458844104949,0.811379680092152
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,JCHAIN,Immunoglobulin J chain,40044,0.00137415041945511,0.00576512100646287,-0.00992548675321212,0.0126737875921223,0.811608225875856
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37541,-0.00101312408352032,0.00429049437932861,-0.0094224930670044,0.00739624489996376,0.813333745675828
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40516,-0.000721995675763539,0.00306782055387861,-0.00673492396136561,0.00529093260983853,0.813944110528819
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37562,0.00131908258402006,0.00560819166338639,-0.00967297307621726,0.0123111382442574,0.814052210754127
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37628,0.000716720324710965,0.00305597870761899,-0.00527299794222225,0.00670643859164418,0.814576773934551
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TLR1,Toll-like receptor 1,37598,0.000572045323572573,0.00244184152940879,-0.00421396407406866,0.00535805472121381,0.814780577750649
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP4,Caspase-4,37714,-0.00369686975489894,0.015959555782404,-0.0349775990884107,0.0275838595786129,0.816821295630134
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AHNAK2,Protein AHNAK2,37628,0.000616045236031807,0.00267017970442159,-0.00461750698463451,0.00584959745669812,0.81754133628003
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DKKL1,Dickkopf-like protein 1,40305,0.00188964526534362,0.00820085580904983,-0.014184032120394,0.0179633226510813,0.817768009084657
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HDAC8,Histone deacetylase 8,37598,0.00134091056139956,0.0058367333465595,-0.0100990867978571,0.0127809079206562,0.818300121946734
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,37562,-0.000867355908287337,0.0038100682647293,-0.00833508970715676,0.00660037789058208,0.819923147285431
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX3,Syntaxin-3,37942,-0.000818361924634697,0.00360605902036842,-0.0078862376045568,0.00624951375528741,0.820473213347153
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,37482,-0.000920866620665883,0.00407779639996889,-0.00891334756460491,0.00707161432327314,0.821341408001028
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GBP2,Guanylate-binding protein 2,40044,-0.00124898764023372,0.00555234307309952,-0.0121315800635088,0.00963360478304133,0.822022791524254
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LUZP2,Leucine zipper protein 2,37900,0.000920938026954819,0.00415946631353091,-0.00723161594756577,0.0090734920014754,0.824778329669065
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1A,Interleukin-1 alpha,40044,-0.0011033257819397,0.00502941346186171,-0.0109609761671887,0.00875432460330926,0.826361092626066
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37921,-0.000787117936721341,0.00359669798561642,-0.00783664598852953,0.00626241011508685,0.82677441789553
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40228,-0.000703797930032423,0.00323777820665739,-0.0070498432150809,0.00564224735501606,0.827922318946044
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37482,0.000613136549672173,0.00282151966970765,-0.00491704200295481,0.00614331510229916,0.827972345910469
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37746,-0.00111893179566687,0.00518184995370499,-0.0112753577049287,0.00903749411359491,0.829043378268875
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37900,-0.000775577167524431,0.00359825459650247,-0.00782815617666927,0.00627700184162041,0.829347567725824
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37562,0.000807731194379066,0.00380598898543075,-0.0066520072170652,0.00826746960582333,0.831933740932967
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39757,0.0012852846510406,0.00606726378885229,-0.0106065523751099,0.0131771216771911,0.832235261868067
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37942,0.000774985603216627,0.00371743965985665,-0.0065111961301024,0.00806116733653566,0.834862850729311
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRSS27,Serine protease 27,40314,-0.000776187179774374,0.00376507897724084,-0.00815574197516643,0.00660336761561768,0.836673038698956
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37714,-0.00163178456074066,0.00793119484199193,-0.0171769264510448,0.0139133573295635,0.836995146896228
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37671,0.00169514737063302,0.00828700426565666,-0.014547380990054,0.0179376757313201,0.837923040089888
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GBA,Lysosomal acid glucosylceramidase,37572,0.000995507835596924,0.0049329831034834,-0.00867313904723055,0.0106641547184244,0.840071163298015
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37779,0.000152303333221689,0.000757427619696695,-0.00133225480138383,0.00163686146782721,0.840639308341793
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37572,-0.000805902638973434,0.00400973016896938,-0.00866497377015342,0.00705316849220655,0.840712049427862
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL33,Interleukin-33,40044,-0.000722172854091985,0.00361107084817261,-0.00779987171651029,0.00635552600832632,0.841492137361022
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37901,-0.000998201133979775,0.00503357769238073,-0.010864013411046,0.00886761114308646,0.842806715841599
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA4,Annexin A4,40279,0.00131028185510618,0.00668301839828889,-0.01178843420554,0.0144089979157524,0.844564635658399
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37883,0.000767466036127949,0.00392258389249009,-0.00692079839315263,0.00845573046540853,0.844884588003966
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CYB5A,Cytochrome b5,37482,0.00132452170198304,0.00686225189888312,-0.0121254920198279,0.014774535423794,0.846949755148312
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37482,-0.000477239871348138,0.00247745587982103,-0.00533305339579735,0.00437857365310108,0.847249365118665
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37998,-0.0024639750472372,0.0128226576551343,-0.0275963840513005,0.0226684339568261,0.847621397752633
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCUN1D2,DCN1-like protein 2,37482,0.00143662990961637,0.00756572605246489,-0.0133921931532148,0.0162654529724476,0.849400959968442
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LBP,Lipopolysaccharide-binding protein,40403,0.00102538992557853,0.00542556934542551,-0.00960872599145547,0.0116595058426125,0.850101386775091
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACHE,Acetylcholinesterase,37671,0.000558119095407188,0.00297933659895429,-0.00528138063854321,0.00639761882935759,0.85140478556336
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,40305,-0.000454463325988742,0.00245291042290309,-0.0052621677548788,0.00435324110290132,0.85301560478982
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37628,0.000696949282599372,0.00379664498114347,-0.00674447488044182,0.00813837344564057,0.854353797224471
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP3,Stromelysin-1,40332,-0.000824044285134039,0.00449364221908891,-0.0096315830345483,0.00798349446428022,0.854502178112341
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37900,-0.000693881122130363,0.00381496193411976,-0.0081712065130051,0.00678344426874437,0.855676382065198
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAPN3,Calpain-3,37900,0.000628805885380153,0.0034592542323595,-0.00615133241004447,0.00740894418080478,0.85576205636015
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA11,Annexin A11,40312,0.00113605525706946,0.00626717567864007,-0.0111476090730651,0.013419719587204,0.856157427564794
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOSB,Protein fosB,39961,0.000660521882060957,0.00364809212654492,-0.00648973868596708,0.00781078245008899,0.856323208050315
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AFAP1,Actin filament-associated protein 1,37671,0.00142738600232402,0.00789756641752428,-0.0140518441760236,0.0169066161806716,0.856576434015526
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCN2,Transcobalamin-2,40497,-0.00050172761598473,0.0027809436235893,-0.00595237711821976,0.0049489218862503,0.856828021210293
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFNB2,Ephrin-B2,37572,-0.000975542340923276,0.00541345533618194,-0.0115859147998399,0.00963483011799333,0.856992876077503
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTX3,Pentraxin-related protein PTX3,40341,0.000815740672102679,0.0045761981500536,-0.00815360770200237,0.00978508904620773,0.858523193220093
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCP11,T-complex protein 11 homolog,37714,-0.00100692839763335,0.00567863417364961,-0.0121370513779866,0.0101231945827199,0.859260720070863
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBR1,T-box brain protein 1,37572,-0.000803129206035618,0.00456086495583383,-0.00974242451946992,0.00813616610739868,0.860224835831359
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FADD,FAS-associated death domain protein,40359,-0.00124132226241604,0.00710590916964193,-0.0151689042349142,0.0126862597100821,0.861326445422014
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLKB1,Plasma kallikrein,37721,0.000410091404461623,0.00234950157533425,-0.00419493168319351,0.00501511449211675,0.861440616872356
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRXN3,Neurexin-3,37572,-0.000565151173312437,0.00325717254971198,-0.00694920937074793,0.00581890702412305,0.862253446676573
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP8,Caspase-8,40434,-0.000997180936255395,0.00574989474705479,-0.0122669746404828,0.010272612767972,0.862318828422977
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TTN,Titin,37562,0.00104643739282852,0.00613752843131268,-0.0109831183325443,0.0130759931182014,0.864621000993909
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL7,Interleukin-7,40341,-0.00100547400598567,0.00599657154092469,-0.0127587542261981,0.0107478062142267,0.866841246649674
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37562,-0.000798568096060508,0.00477097637617572,-0.0101496817933649,0.00855254560124391,0.867073301092679
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRR5,Proline-rich protein 5,37598,-0.000744309532681096,0.004501400563763,-0.00956705463765657,0.00807843557229438,0.86867053291112
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCNE1,G1/S-specific cyclin-E1,37598,0.00142887457094336,0.00873979694105325,-0.015701127433521,0.0185588765754077,0.870134693629529
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,37541,-0.00100526719477655,0.00622734497829828,-0.0132108633522412,0.0112003289626881,0.871758888812388
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37572,-0.00101007860093758,0.00627776901811361,-0.0133145058764402,0.0112943486745651,0.87217645048962
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37562,-0.00083147910414524,0.0051898176566432,-0.0110035217111659,0.00934056350287543,0.872715325241554
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPBGL,Trophoblast glycoprotein-like,37572,0.000619370407259532,0.00390419137992882,-0.00703284469740096,0.00827158551192002,0.873953039565623
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACE,Angiotensin-converting enzyme,37987,-0.000374005233710481,0.00238415357137403,-0.00504694623360359,0.00429893576618262,0.875348630886199
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,40357,0.000733989437725155,0.00468290681145718,-0.00844450791273091,0.00991248678818122,0.875453328629499
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HEBP1,Heme-binding protein 1,40042,0.000785851510235649,0.00508631592808945,-0.00918332770881967,0.010755030729291,0.877215077696471
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37562,-0.00171247877597162,0.0111731543344354,-0.023611861271465,0.0201869037195218,0.878189875396155
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37900,-0.000872092110566299,0.00578435594571081,-0.0122094297641595,0.0104652455430269,0.880161491285978
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37714,0.000642498571420675,0.00433086473777733,-0.0078459963146229,0.00913099345746425,0.88206611852279
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCDH7,Protocadherin-7,37901,-0.000479469607150189,0.0032456072568561,-0.00684085983058814,0.00588192061628776,0.882559030605381
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39980,0.00041538475563154,0.00281190380965997,-0.005095946711302,0.00592671622256508,0.882562767165605
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,37628,0.000321571891993672,0.00219068130802198,-0.0039721634717294,0.00461530725571675,0.883299381457559
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40490,-0.0006152052450987,0.00421812681318463,-0.00888273379894057,0.00765232330874317,0.884043236834007
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTO1,Protein LTO1 homolog,40044,0.000553881403903278,0.00384284241422173,-0.00697808972797132,0.00808585253577788,0.885397104196674
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPSD1,Tryptase delta,37959,-0.000511756104249404,0.00356227754301316,-0.00749382008855519,0.00647030788005638,0.885771254371415
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEB,Nebulin,37562,0.000483782843849135,0.0034051389511517,-0.0061902895004082,0.00715785518810647,0.887023475275978
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCT,Secretin,37572,-0.000602806019945996,0.00428957395215083,-0.00901037096616162,0.00780475892626963,0.888244846374246
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37671,-0.000877445935494439,0.00628131781041926,-0.0131888288439162,0.0114339369729273,0.888905967762281
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRUNE2,Protein prune homolog 2,37714,-0.000377582126664532,0.0027585183384704,-0.00578427807006651,0.00502911381673745,0.89112883254797
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CENPJ,Centromere protein J,37714,0.000935059474822212,0.00684630375440898,-0.0124836958838194,0.0143538148334638,0.891365862729173
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37598,-0.000393235908832861,0.00292776553643531,-0.00613165636024607,0.00534518454258035,0.893157417254872
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37714,-0.000657647759876431,0.00495483778128173,-0.0103691298111886,0.00905383429143576,0.894410184300455
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRP2BP,LRP2-binding protein,37572,0.00107457661189632,0.00812165521277468,-0.014843867605142,0.0169930208289347,0.894741087009271
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLMP,CXADR-like membrane protein,40489,-0.000250620068237499,0.00189728316192309,-0.00396929506560676,0.00346805492913176,0.894911454433845
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DHODH,Dihydroorotate dehydrogenase,37562,-0.000593892434519409,0.00452036724270085,-0.00945381223021307,0.00826602736117426,0.895475572682744
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB39B,Ras-related protein Rab-39B,37562,0.00109032732869039,0.00832496110285122,-0.015226596432898,0.0174072510902788,0.895800367467523
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39980,-0.000576224688267857,0.00443103232446963,-0.00926104804422833,0.00810859866769262,0.896534099516835
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL11,Interleukin-11,40044,0.000763583447586328,0.00596180312826318,-0.0109215506838095,0.0124487175789822,0.89808788556079
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37714,-0.00078962826533703,0.00621222710602845,-0.0129655933931528,0.0113863368624787,0.898856273177833
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37959,0.00107449987391387,0.00845353364200506,-0.015494426064416,0.0176434258122438,0.898857924102983
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40228,-0.000709446242576935,0.00565360943343192,-0.0117905207321035,0.0103716282469496,0.900140769542634
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37572,0.00121400154305488,0.00969574802468383,-0.0177896645853254,0.0202176676714352,0.900359469489497
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,37541,0.000468623026479408,0.00375557030179443,-0.00689229476503768,0.00782954081799649,0.900699012662621
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,38013,0.000220312223047048,0.00177335182926826,-0.00325545736231875,0.00369608180841284,0.901131115374117
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTN,Pleiotrophin,40042,0.000579026270623507,0.00468173633176852,-0.00859717693964279,0.0097552294808898,0.901572082040136
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40471,0.000529601186726636,0.0042923129554495,-0.00788333220595438,0.00894253457940765,0.901804861208451
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,40305,-0.000607083973345028,0.00501347665192264,-0.0104334982111134,0.00921933026442336,0.903620954908699
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FSTL1,Follistatin-related protein 1,37628,0.000251763965512427,0.00209769133976722,-0.00385971106043132,0.00436323899145618,0.904469493077314
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOLR2,Folate receptor beta,40471,0.000325419074593085,0.0027401120216355,-0.00504520048781249,0.00569603863699867,0.905466014193437
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MSMB,Beta-microseminoprotein,40236,0.000755206676452019,0.0064503706706291,-0.011887519837981,0.0133979331908851,0.906798482395612
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37628,-0.000291042478381435,0.00248847554197495,-0.00516845454065234,0.00458636958388947,0.906896597579415
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGAX,Integrin alpha-X,37714,0.000601026439376623,0.0051606684340091,-0.00951388369128121,0.0107159365700345,0.907287446677369
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DLL4,Delta-like protein 4,37628,-0.000908833081241677,0.00786772127732053,-0.0163295667847899,0.0145119006223066,0.908039371270256
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40305,-0.00047818169263929,0.00419321413208868,-0.0086968813915331,0.00774051800625452,0.909209882013554
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASE3,Eosinophil cationic protein,40288,-0.00113076678204549,0.0101103678159271,-0.0209470877012626,0.0186855541371717,0.910949865499725
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRK5,G protein-coupled receptor kinase 5,40042,-0.000531074132334894,0.00490703887525124,-0.0101488703278273,0.00908672206315753,0.913817014795751
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NID1,Nidogen-1,40355,-0.000388083234653565,0.00368567248709894,-0.0076120013093675,0.00683583484006037,0.916142982932493
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OMP,Olfactory marker protein,37541,-0.000494416746645643,0.0047341388934921,-0.00977332897789016,0.00878449548459887,0.916824583520906
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39961,0.000419019745664696,0.00402279838615539,-0.00746566509119986,0.00830370458252926,0.91704272419948
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK3,Prostate-specific antigen,37998,-0.000543998840840077,0.00532557601458151,-0.0109821278294198,0.00989413014773967,0.918640430211797
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40044,0.000344106613017096,0.00337133154090031,-0.00626370320714752,0.00695191643318171,0.91870364932485
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37598,-0.000367668577787479,0.00364721194615815,-0.00751620399225745,0.00678086683668249,0.919704318545887
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DRAXIN,Draxin,40228,0.000406715680396908,0.00403712123336101,-0.00750604193699067,0.00831947329778449,0.919754974311673
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40167,-0.000298517039045374,0.00300232870543253,-0.00618308130169314,0.00558604722360239,0.920799323550254
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40341,-0.000759775362120621,0.00766741518085703,-0.0157879091166004,0.0142683583923592,0.921066902966597
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPM1B,Protein phosphatase 1B,37598,0.000585515526600243,0.00591756277466039,-0.0110129075117341,0.0121839385649346,0.921183142348379
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,40042,0.000447159378509735,0.00464819116129374,-0.008663295297626,0.00955761405464547,0.9233623883155
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37901,-0.000190421516970758,0.00200012953706229,-0.00411067540961284,0.00372983237567133,0.924153740876652
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37959,-0.000598104301981367,0.00643966632326136,-0.0132198502955736,0.0120236416916109,0.926001741068197
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFBR1,TGF-beta receptor type-1,37598,-0.000186275546648924,0.00200930070312508,-0.00412450492477408,0.00375195383147624,0.926138022706243
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHB6,Ephrin type-B receptor 6,40192,-0.000263227401041749,0.00290707470466409,-0.00596109382218336,0.00543463902009986,0.927853560083703
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FBN2,Fibrillin-2,37572,0.000513146602383353,0.00569603886388559,-0.0106510895708324,0.0116773827755991,0.928218401692155
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39961,0.000543854286583121,0.00612354678197325,-0.0114582974060845,0.0125460059792507,0.929231189162887
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PYDC1,Pyrin domain-containing protein 1,37628,0.000349857208123562,0.00398446613473551,-0.00745969641595803,0.00815941083220516,0.930032766827949
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37598,0.000442369072509879,0.00512380741511312,-0.00960029346111184,0.0104850316061316,0.931200630795547
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBP1,Retinol-binding protein 1,37572,-0.000549757344512615,0.00644124200128254,-0.0131745916670264,0.0120750769780012,0.931984772908998
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUSD4,Sushi domain-containing protein 4,37900,-0.000345174186087326,0.00415547411662293,-0.00848990345466827,0.00779955508249362,0.933801143825077
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GP5,Platelet glycoprotein V,37671,0.000272499108568449,0.00334522494261409,-0.00628414177895517,0.00682913999609207,0.935078060765556
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,40411,0.000189384469907111,0.00234869268121672,-0.00441405318527765,0.00479282212509187,0.935734042570537
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMBN,Ameloblastin,40044,0.000218552604524856,0.00277117787832068,-0.00521295603698368,0.00565006124603339,0.937139963664464
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,40192,0.000166317839654353,0.00221287684161994,-0.00417092076992074,0.00450355644922944,0.94008907808245
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHH,Sonic hedgehog protein,37598,0.000301260462808986,0.00405460455941717,-0.00764576447364866,0.00824828539926663,0.94077215128364
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NDRG1,Protein NDRG1,39961,0.000451262920483504,0.00641791953926081,-0.0121278593764677,0.0130303852174347,0.943945473930905
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF3,Fibroblast growth factor 3,37598,0.000197736853200599,0.00284334690729264,-0.00537522308509298,0.00577069679149418,0.944557910127526
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36973,-0.000318747583417469,0.00467942613450483,-0.00949042280704693,0.00885292764021199,0.945693736227289
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ABHD14B,Protein ABHD14B,40171,0.000346953849996172,0.0054481485291855,-0.0103314172672074,0.0110253249671998,0.949223537691451
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37990,-0.000420191022154367,0.00683460587364815,-0.0138160185345047,0.012975636490196,0.950977913245792
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASS1,Argininosuccinate synthase,37562,-0.000438515498359649,0.00749242761205619,-0.0151236736179898,0.0142466426212705,0.953329090692574
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37714,0.000239829921236606,0.00425415959708947,-0.00809832288905876,0.00857798273153197,0.95504360819456
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37598,-0.000333477196850801,0.00636983111766625,-0.0128183461874766,0.012151391793775,0.9582485404267
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IMPA1,Inositol monophosphatase 1,40228,0.000290272372199369,0.00567443499529046,-0.0108316202185699,0.0114121649629687,0.95920312772315
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37900,-0.000219228969726027,0.00434714546147399,-0.00873963407421506,0.008301176134763,0.959780034858838
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37562,0.000268235493181456,0.00537996242953959,-0.0102764908687161,0.0108129618550791,0.960236109867595
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37714,-0.0002481980661697,0.00507424766543589,-0.010193723490424,0.00969732735808465,0.960989147005976
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37598,-0.000218855562063549,0.00456552090960435,-0.00916727654488808,0.00872956542076098,0.96176749635011
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PFDN4,Prefoldin subunit 4,37482,-0.000225394808142307,0.00508340351428522,-0.0101888656961413,0.00973807607985673,0.964634585088849
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,40305,-0.000144631261965922,0.00334480047029972,-0.00670044018375337,0.00641117765982152,0.965510266078654
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,38013,-7.8285946143662e-05,0.00182618387974643,-0.00365760635044667,0.00350103445815934,0.965806910488798
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40434,0.000130476516438459,0.00314034625221167,-0.00602460213789641,0.00628555517077333,0.966859188382515
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMEM25,Transmembrane protein 25,37959,-0.000159778909036696,0.0040843699686148,-0.0081651440475217,0.00784558622944831,0.968795614570173
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,40044,0.000168692243740833,0.0043180452123536,-0.00829467637247223,0.0086320608599539,0.968837624209841
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHIT1,Chitotriosidase-1,40398,0.00043338457367165,0.0138943007562604,-0.0267994449085988,0.0276662140559421,0.975117180783321
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KEL,Kell blood group glycoprotein,39961,0.000103245412154312,0.0033233787430473,-0.00641057692421839,0.00661706774852702,0.975216985693261
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EP300,Histone acetyltransferase p300,37598,8.44112476607231e-05,0.00278115166729906,-0.00536664602024544,0.00553546851556689,0.975787436686668
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37671,7.0786230692537e-05,0.0023328033825903,-0.00450150839918445,0.00464308086056953,0.975793285290425
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SF3B4,Splicing factor 3B subunit 4,40305,-0.000200623406839819,0.00683554818303453,-0.0135982978455875,0.0131970510319079,0.976585811384208
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LY6D,Lymphocyte antigen 6D,40268,0.00010001721618326,0.00348077272825347,-0.00672229733119353,0.00692233176356005,0.977076943320399
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNPY2,Protein canopy homolog 2,40042,-0.000157227948578281,0.00570281728998664,-0.0113347498369521,0.0110202939397955,0.978005283541876
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPRING1,SREBP regulating gene protein,37482,-0.00014836272586956,0.00538711342577384,-0.0107071050403863,0.0104103795886472,0.978029218147283
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPM3,Tropomyosin alpha-3 chain,37562,0.000106612211315386,0.00396698446909209,-0.00766867734810511,0.00788190177073588,0.978559942257218
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37901,-0.000104695544110224,0.00405067838935622,-0.00804402518724841,0.00783463409902796,0.979380218059293
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TAP1,Antigen peptide transporter 1,37714,0.000146595290481391,0.00576053955977084,-0.0111440622466695,0.0114372528276322,0.979697858398905
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,40042,7.19860963675014e-05,0.00314918399368406,-0.00610041453125325,0.00624438672398825,0.98176331641214
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NTF4,Neurotrophin-4,39980,-8.43781304176576e-05,0.00380099641762878,-0.00753433110897007,0.00736557484813475,0.982289540189029
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL24,Interleukin-24,40044,-8.82374860709789e-05,0.00460564987859512,-0.00911531124811741,0.00893883627597545,0.984714884117986
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA8,Carbonic anhydrase-related protein,37598,4.2539651378443e-05,0.00259552831738372,-0.00504469585069366,0.00512977515345054,0.986923831356571
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCP2,Non-specific lipid-transfer protein,39980,-0.000113943418107945,0.0072649127703025,-0.0143531724479008,0.0141252856116849,0.987486635292208
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37714,9.19308394344504e-05,0.00596083220430175,-0.011591300280997,0.0117751619598659,0.987695357894625
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37598,4.09566914704957e-05,0.00270756608613076,-0.00526587283734579,0.00534778622028678,0.987931284771506
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37482,-7.47748055102821e-05,0.00528033136279409,-0.0104242242765867,0.0102746746655661,0.988701746163273
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RGS10,Regulator of G-protein signaling 10,37959,7.08147145286106e-05,0.00557775403666906,-0.0108615831973428,0.0110032126264,0.989870581723553
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INSL3,Insulin-like 3,37942,-6.93683607440471e-05,0.0055626898576662,-0.0109722404817698,0.0108335037602817,0.990050589697777
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37901,8.78939935527015e-05,0.00812086456288902,-0.0158290005497098,0.0160047885368152,0.991364640173368
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF7,Fibroblast growth factor 7,37482,-3.4403167754745e-05,0.00757990708301436,-0.0148910210504629,0.0148222147149534,0.996378697629879
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,37671,5.16003097386334e-05,0.0116623210656777,-0.0228065489789897,0.0229097495984669,0.996469812717743
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA13,Carbonic anhydrase 13,40173,-3.09975487654325e-05,0.00965722963081499,-0.0189591676251628,0.018897172527632,0.997439014007336
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37628,1.47699767113535e-05,0.00575566284951994,-0.0112663292083477,0.0112958691617704,0.997952538195087
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37959,-6.2525623548036e-06,0.00365771253297747,-0.00717536912699064,0.00716286400228103,0.998636107086952
